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Thesis Abstract 
Antibody fragments such as Fab fragments are invaluable for therapeutic and 
diagnosis purposes. Utilising the robust and relatively low cost Escherichia 
coli expression system for Fab production seems very promising. However, 
Fab production in E. coli currently suffers from issues including low yield and 
poor solubility of the Fab fragments. In this study, E. coli strain CLD048 was 
initially employed for the production of Fab D1.3 targeted into the periplasm 
with a target yield of ≥ 100 mg/L. Unfortunately, the fermentation was not 
successful. Thus, strategies for improving Fab production were explored, 
comprising lowering cultivation temperature, altering the timing of induction 
and harvest, and lowering the concentration of the inducer IPTG. The location 
of Fab D1.3 was shifted from extracellular to the periplasm, the overall Fab 
yield was increased 50-fold (from 1.4 mg/L to 48 mg/L) and the solubility of 
Fab D1.3 was improved. Subsequently, optimising release conditions for 
periplasmic proteins was investigated. Employing 0.1% sodium deoxycholate 
showed better protein release efficiency than the osmotic shock method. 
However, the overall titre of Fab D1.3 was not sufficient to meet the goal of ≥ 
100 mg/L.  
A successful fermentation was demonstrated by expressing A33 Fab in E. 
coli strain W3110, which produced 300 mg/L of A33 Fab in the periplasm. 
Various selective protein release methods (osmotic shock, SMALPs 
(poly(styrene-co-maleic acid) lipid particles) and heat treatment) were 
subsequently investigated. Heat treatment displayed the highest selectivity for 
A33 Fab release. Consequently, the method was applied to generate a large 
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quantity of crude E. coli periplasmic extract containing A33 Fab, which was 
directly employed in the Aqueous Micellar Two-Phase System (AMTPS) for 
Fab’ purification. The system successfully demonstrated the feasibility of 
continuous protein separation with a highly purified final product (~98%).  
In other work, thermo-responsive polymer brush surface modified magnetic 
particles manufactured in our laboratories were benchmarked against 
Chelating Sepharose Fast Flow. Haemoglobin and His6-GFP were employed 
to exploit the feasibility of thermally mediated target protein elution under 
binding conditions. 
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1. Introduction 
1.1. Background of the Project 
All the research works have done in this thesis is part of the European 
Framework Programme 7 titled MagPro2Life, which its broad aim is to address 
these barriers and demonstrate the use of fermenting E.coli for expressing 
recombinant antibody fragments and functionalised thermoresponsive 
polymer brush modified  magnetic (nano) particle separation at pilot-scale for 
select feed, food and pharmaceutical products. The main objective of the 
MagPro2Life project is to scale-up innovative nanotechnology based process 
to pilot-line-scale and demonstrate the feasibility of this technology (Fig. 1.1). 
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Fig. 1.1 Triangular diagram illustrating the starting point of the European Commission Project 7 and the objective of each working package (European
Framework Programme 7). 
 3 
The first phase of this Ph.D research project was focusing on Work Package 3 
(WP3), starting with optimising growth condition for 5 litre scale fermentation 
of Anti-Hen Egg White Lysozyme Fab D1.3 (expressed from CLD048 E.coli 
strain provided by Avecia) and subsequently systematically examining 
selective periplasmic release method and applied different purification 
strategies. Key importance parameters of the E.coli fermentation have been 
altered such as, the cultivation temperature, induction timing and inducer 
concentration, we have managed to boost the overall production from the 
initial condition, and directing target protein into periplasm of E.coli. Also 
surprisingly discovered the solubility of Fab D1.3 was also improved. Taking 
the advantages of above successful example will lead to an easier purification 
process to perform. Despite the above merits, the overall Fab D1.3 titre was 
still insufficient to provide for the project partners (i.e. project goal is aiming for 
production titre with a minimum 100mg/L per batch of 5 L fermentation). 
Inevitable, another candidate E.coli strain was required for antibody fragment 
production to carry on the research for the project. UCB Celltech has kindly 
provided A33 Fab expressed from pTTOD A33gL4gH2Fab plasmid to us then 
transforming into W3110 E.coli strain to continue the research (Biopharma 
Line) for the MagPro2Life project. We then employ recombinant A33 Fab for 
testing newly developed magnetic particles with functionalised ligands and 
other separations techniques (AMTPS), also evaluating the adsorption and 
desorption behaviour with the currently conventional chromatography support. 
In the end, two module proteins (Haemoglobin and His6-GFP) were empolyed 
to study of recombinant protein purification on thermoresponsive polymer 
sureface modified magnetic particles and Chelating Sepharose Fast Flow. 
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1.2. Antibodies 
Antibodies, often termed 'immunoglobulins', there are five chemically and 
physically distinct classes of antibody in humans (IgG, IgM, IgA, IgE,IgD) 
serve two functions: targeting foreign cells and macromolecules and to initiate 
key defence against pathogenic organisms and toxins (Huber, 1976; Kuby, 
1997). The antibody repertoire is able to selectively bind molecules, so called 
‘antigens’ recognised as foreign to the organism (Braden and Poljak, 1995; 
MacCallum et al., 1996). In 1930’s, antibodies were identified as the protective 
agent in the serum (Kuby, 1997), from the late 1950's to early 1960's the basic 
structure of antibody was revealed by Gerald M Edelman and Rodney R 
Porter (Johnstone et al., 1985; Raju, 1999). A key discovery from their 
fundamental research was able to locate the papain derived Fc and Fab 
fragments within a framework of light and heavy polypeptide chains and this 
led to the proposal of the basic four chain model of immunoglobulin G in 1962 
(Johnstone et al., 1985). ‘Polyclonal antibodies’  means the antibodies are a 
population of molecules, recognising many antigenic determinants or 
'epitopes' on an antigen with a range of affinities (Kuby, 1997). Those are 
typically produced by inoculation of a suitable mammal, such as a mouse, 
rabbit or goat (Cooper and Paterson, 2001; Nakazawa et al., 2010). An 
antigen is injected into the mammal. This induces the β-lymphocytes to 
produce IgG immunoglobulins specific for the antigen. This polyclonal IgG is 
purified from the mammal’s serum (Bak, 2004), and these antibodies are 
usually produced by immunisation of mammal, such as a mouse, rabbit or 
goat. Polyclonal antibodies have variety of applications. They can be exploited 
as a mean of inducing passive immunisation (e.g. for treatment against 
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Hepatitis A, snakebites and tetanus); they are also extensively employed in 
diagnostics, immunoturbidemetry, and immunohistochemistry (Bak, 2004). 
‘Monoclonal antibodies’, developed by Kohler and Milstein (1975), to create 
cell lines producing predetermined, monospecific and monoclonal antibodies 
(mAB). An immortal cell (a myeloma tumour cell) was fused with a specific 
predetermined antibody-producing B cell from immunised animals or humans. 
The resulting hybridoma cell is immortal and synthesises homogeneous, 
specific mAB. They are identical antibodies identifying one epitope on antigen 
(Kuby, 1997). Because of their single epitope specificity, monoclonal 
antibodies have wide applications in diagnostics, research, and therapeutics, 
ranging from in vitro pregnancy tests against the hCG hormone to in vivo 
cancer treatments (Bak, 2004) 
1.2.1. Structure of antibodies 
Basic unit (Ig) is Y-shaped molecule composing four polypeptide chains. 
Featuring two identical heavy (H) of 50 kDa and two identical light (L) of 25 
kDa chains held together by non-covalent interactions and disulphide bridges 
(Fig. 1.2). 
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Fig. 1.2 Structure of the immunoglobulin G (IgG). Showing the two heavy chain comprising 
three constant domains CH1-3 and VH, and two light chains containing once constant region 
(CL) and one variable region (VL).(Adopted from Jalalirad, 2010) 
 
Antibody are composed of several globular domains that are rich in β-sheet 
and have a conserved disulphide bond. The Ig folds are connected by short 
interdomain linkers, named as elbow, or longer linkers known as hinges. Each 
variable region has three hypervariable loops (complementary determining 
regions, CDRs) allows millions of antibodies with different tip structures, that 
together form a common six-loop antigen binding site. (Padlan, 1994; Halaby 
et al., 1999; Humphreys, 2007) 
1.2.2. Antibody Expression history 
The history of antibody has been heavily involved with the testing and 
production of therapeutic proteins in mammalian tissue culture, most notably 
using CHO cells (derived from Chinese Hamster Ovaries (Chadd and 
Chamow, 2001). 
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The demand for new and improved antibody production systems has arisen in 
recent years. Many researchers have been working towards alternative 
antibody expression systems such as yeasts (Saccharomyces or Pichia), 
filamentous fungi, transgenic plants, and E. coli (Harrison and Keshavarz-
Moore, 1996; Peeters et al., 2001; Holliger and Hudson, 2005; Farid, 2007; 
Steinmeyer and McCormick, 2008).  
Until Simmons and colleagues (2002)  was able to expressed the first full-
length immunoglobulins in Escherichia coli, the application of E. coli 
expression systems was limited mainly to the production of the fragment 
antigen binding (Fab fragment)  and the portion of the antibody responsible for 
binding the target antigen. The applications for Fab fragments are frequently 
used in diagnostic applications, therapeutics, and in testing variable regions 
slated for reincorporation into full-length monoclonal antibodies (Boleti et al., 
1995; Spiridon et al., 2004; Quintero-Hernández et al., 2007; Weisser and Hall, 
2009).  
Antigen-binding antibody fragments can also be produced by proteolysis of 
whole antibodies (Johnstone et al., 1985; Raju, 1999). The protease papain 
digests the full-length IgG and releases the four N-terminal domains and has a 
molecular weight around 50 kDa. Pepsin cleaves the heavy chains slightly 
after hinge; thus, the dimeric Fab’ fragment, or F(ab)’, is produced (Fig. 1.3). 
Both enzymes release the C-terminal four domains or Fc fragment, which is 
glycosylated in the CH2 domain and has effector functions such as serum half-
life, complement activation, and recruitment of immune cells (Holliger and 
Hudson, 2005; Humphreys, 2007).  
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On the other hand, the smallest fragment (~30 kDa) contains the whole 
antigen binding site of a whole IgG antibody, which is composed of both the 
variable heavy chain (VH) and variable light chain (VL) domains. This 
heterodimer fragment, called Fv fragment (for fragment variable), is still 
capable of binding the antigen, but native Fv fragments are unstable because 
the non-covalently associated VL and VH domains tends to dissociate from 
each other (Boleti et al., 1995; Braden and Poljak, 1995; Holliger and Hudson, 
2005). 
 
Fig. 1.3 Chemical treatment to digest a Full-length antibody. Papain digestion results in 
cleavage of the immunoglobulin into Fab and Fc fragments, and pepsin digestion causes 
cleavage of the IgG molecule into F(ab)'2. Pepsin also digests the Fc regions into 
fragments.(Adopted from Jalalirad, 2010) 
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1.2.3. Current state of Fab production 
In recent years, various forms of antibody fragment (i.e. Fab, Fv, scFv, VHs, 
diabodies, triabodies, etc.) has been successfully produced in E.coli 
(Humphreys, 2003; Holliger and Hudson, 2005). These smaller fragments 
have various features (e.g., monomeric binding, lack of effector functions, 
rapid systemic clearance, and rapid tissue penetration). However, the 
production of single domain antigen binding fragment (VHs) in soluble form is 
difficult, due to the sticky behaviour of the fragment which would cause 
aggregation plus low thermal stability. (Huston et al., 1993; Nieba et al., 1997; 
Arndt et al., 1998). An recent example demonstrated by Quintero-Hernández 
and his co-workers (2007)  in obtaining scFv fragment from a neutralizing 
mouse antibody (BCF2) was used to produce three derived scFvs. Only one 
of them was neutralising, however when expressed as Fab, all of them 
became neutralising fragments in vivo. In striking contrast, the stability of the 
four Fabs derived from their respective scFvs was improved when tested in 
the presence of guanidinium chloride. This result has shown by changing the 
protein conformation from scFv to Fab can improve the functional stability and 
avoid additional maturation steps. Hence, the antigen-binding fragment (Fab) 
has been considered a more functionally stable version of recombinant 
antibodies than single chain antibody fragments (scFvs) (Wörn and Plückthun, 
1999, 2001; Humphreys, 2007). Since then, the recombinant antibodies are 
increasingly popular over a broad spectrum of therapeutic and research 
applications. In the clinic, antibodies can be fused to species such as tumour, 
cancer targeting, clot imaging, enzymes, viruses, radionuclides and toxins for 
drug therapy (Humphreys et al., 1997; Hudson, 1998; Wörn and Plückthun, 
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2001; Jurado et al., 2002; Natarajan et al., 2008). Several successful 
applications by fusion a functional protein with a Fab in E. coli have reported 
(Boleti et al., 1995; Dennis et al., 2002; Kellner et al., 2011). The antigen 
targeting-specific Fab region is fused to a functional protein sequence, thus 
creating targeted therapeutics with enhanced cell killing. In human medicine, a 
new concept was developed by fusion of an effector protein onto an antigen 
recognising antibody fragment for specifically targeting on tumour treatments, 
called ‘magic bullet’ (Spooner et al., 1994; Boleti et al., 1995). The effector 
protein gene directly fused to the gene of an antibody fragment, resulting in 
new bi-functional recombinant proteins (Neuberger et al., 1984). An example 
is the employment of cancer-specific bi-functional antibodies targeting 
cytotoxic molecules to tumour cells and consequently eliminates these tumour 
cells without harming healthy cells (Boleti et al., 1995). In the laboratory, 
antibodies have been widely used in immuonoblotting, enzyme-linked 
immunosorbent assay (ELISA), and affinity purification. The increasing 
demand for recombinant antibodies has been driving the development 
towards a multi production systems as can be in yeasts, mammalian cells, 
transgenic plants and animals, and Escherichia coli (Hudson, 1998; Joosten 
et al., 2003; Andersen and Reilly, 2004). In comparison to other expression 
systems, E. coli has taken the advantage of offering substantially low-cost and 
robust protein expression, based on well understand with the genetics, 
physiology and regulatory systems of this organism. A considerable defect of 
in E.coli was lack of post-glycosylation and high-level expression in producing 
recombinant protein has been resolved by the genetically engineered of the 
host. For example, there has been reported on production of aglycosylated 
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Fc-containing antibody in the periplasm of E. coli (Simmons et al., 2002). 
Although, it is deemed that manufacturing of full-length antibody is very 
difficult in E. coli because this organism is not especially well-adapted for the 
expression of very large, disulphide bond-rich and multimeric proteins. 
Nevertheless, for many of the mentioned applications, the presence of 
glycosylation in the Fc constant regions is unnecessary; thus, in these 
applications, aglycosylated full-length antibodies or smaller antibody 
fragments can be employed (Andersen and Reilly, 2004). As a type of 
antibody fragments, the Fab fragment of an antibody contains the antigen-
binding site and the four domains (i.e. VH, CH1, VL and CL); VH and VL 
domains are fused to the following constant antibody domains CH and CL, 
respectively (Fig. 1.2). The smaller size of Fab is more suitable for 
applications such as tumour penetration and imaging (Boleti et al., 1995), and 
Fab exhibits a shorter half-life than full-length Manufacture of recombinant 
proteins in E. coli. immunoglobulin G molecules (Andersen and Reilly, 2004), 
resulting in the faster clearance of the toxic labelled antibody fragments from 
the circulation in normal organ (Joosten et al., 2003). However, from 
therapeutic point of view, the short circulating half-life of Fab fragment would 
be a drawback, but this constraint can be addressed by approaches by 
employing polyethylene glycol (PEG) attach to Fab fragment (Chapman et al., 
1999; Leong et al., 2001; Chapman, 2002) and albumin-binding peptide 
(Dennis et al., 2002), which have been proved to increase the circulating half-
life. In contrast to some of the heavily engineered antibody fragments, the Fab 
has native sequence; subsequently, it is less likely for the Fab to be 
immunogenic when used as therapy. The remarkable feature of Fab' is 
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thermal (> 60°C) and chemical (> 2 M guanidine hydrochloride) stability which 
makes it resistant to harsh conditioning and purification processes in 
downstream (Weir and Bailey, 1995; Humphreys, 2007).  
1.2.4. Anti − Hen Egg White Lysozyme (HEWL) Fab 
Since high-resolution structures complexes of HEWL protein with Fab D1.3 
and Fv D1.3 fragments are available (Amit et al., 1985, 1986; Fischmann et al., 
1991; Bhat et al., 1994), the conformation of Fab D1.3 has been defined in 
great details, which is around 50 kDa size protein containing one disulphide 
bond to link heavy and light chains (Ginnette et al., 1986; Kenett et al., 1987; 
Fischmann et al., 1991). Apart from their intrinsic interest, antigen–antibody 
complexes represent a valuable model for the study of protein interactions 
(Kenett et al., 1987; MacCallum et al., 1996) because (1) the size of the 
interface typically falls in the standard category (B ≈ 1290 Å2, measured in the 
HEWL–Fab D1.3 complex) (Fischmann et al., 1991), and (2) negligible 
conformational changes are expected upon complex formation (the measured 
RMSD between free and complexed HEWL is 0.64 Å) (Amit et al., 1986; 
Braden and Poljak, 1995). This allows Fab D1.3 becoming a great tool as an 
useful mean for the identification of contact surfaces between proteins, based 
on a general photochemical modification of the polypeptide chain with 
methylene carbine. 
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1.2.5. A33 Fab' 
Thermo stable A33 Fab’ has different toleration profiles when expressed in 
E.coli compared with Fab D1.3 (Humphreys, 2007). It is a disulphide bonded 
protein with hinge around ~55 kDa and binding to a tumour-associated 
(human colorectal carcinoma) antigen. The importance of maximising the 
possible yield is to find the right expression conditions. In an early work, Fab’ 
was expressed with human protein disulphide isomerise (PDI) to increase the 
yield of antibody fragment in the periplasm of E. coli (Humphreys et al., 1996). 
However, this approach proved to be only helpful with Fab’ where 
inappropriate intra-domain disulphide bonds could be formed (ibid). Moreover, 
the co-expression of PDI can have a negative effect in overall Fab’ production 
as over-production of chaperone can add to the metabolic burden of the cell, 
leading to even more decreased growth rates and reduced final biomass 
(Martínez-Alonso et al., 2010). The production system used in the present 
work was optimised to deliver a balanced expression of the light (LC) and 
heavy (HC) chains, which gave the highest Fab yield. A small excess of LC is 
allowed, otherwise the HC is surpassed by the LC’s hoard of the folding and 
secretion machinery (Humphreys et al., 2002). 
It is advantageous to target the product to the periplasm rather than the 
cytoplasm as it accumulates vast majority of host proteins plus DNA and RNA 
(Hockney, 1994) Furthermore, less degradation, the oxidising environment 
promotes disulphide bond formation required in the hinge of the Fab’ and 
downstream processing is facilitated (Mücke et al., 2009). Relevant factors 
affecting secretion through the Sec pathway (the protein translocation 
pathway from the cytoplasm across the cytoplasmic membrane) are culture 
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medium, amino acid composition, size of protein and signal peptide, where in 
the present work the LC and HC are preceded by the OmpA signal peptide 
(Mori and Ito, 2001; Humphreys, 2007; Mergulhão and Monteiro, 2007). 
Leakage to the culture broth is also not desired as the viscosity of the culture 
broth is increased and this negatively affects operations such as filtration and 
centrifugation and Fab’ from the supernatant may be degraded or incorrectly 
folded. Leaking cells are less robust and they could lyse during recovery or 
periplasmic extraction, increasing the level of contaminants for the 
subsequent downstream processing steps (Flaschel and Friehs, 1993; Choi et 
al., 2006). 
The reasons for failure to produce high yields of recombinant protein are well 
known, mostly due to the accumulation of incorrectly folded proteins caused 
by the overwhelming expression rates which provoke saturation of the post-
translational modifications machinery (N-terminal, C-terminal and cross-linking 
modifications, glycosylation, etc) (Sevastsyanovich et al., 2009). This causes 
a toxic effect on the cell that triggers stress responses that lead to growth 
arrest, loss of cultivability and ultimately death and lysis. Not only does stress 
affect cellular physiology, it can also have negative effects on recombinant 
protein quantity and quality caused by increased proteolysis and/or 
mistranslation of the product (Ramírez and Bentley, 1995; Hoffmann and 
Rinas, 2004). Since it is desired to partition Fab in the soluble form to the 
periplasm, accumulation of the product is achieved through a long period of 
induction during which expression is done at moderate levels to reduce stress. 
This permits growth to higher biomass concentrations and thus higher 
quantities of Fab. 
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1.2.6. Expression Fab in E.coli periplasm 
There are three locations for the manufacture of soluble proteins in E. coli: the 
cytoplasm, the periplasm, and leak into the culture media. The periplasm is 
preferable for expression of soluble antibodies, mainly because it is the 
naturally oxidizing environment to facilitates the formation of disulphide bonds, 
accurately cleaved N-terminal extension "signal peptide" to form correct N-
terminus, and the exposure to extracellular chemical agents (<500 Da in size) 
which aid the folding and modification of antibodies. Key importance of 
locating proteins in the periplasm can prevent highly diluted when leak to 
culture media and avoid contamination with DNA or RNA in cytoplasm, with 
careful considered harvest and extraction can result in very useful 
concentration of the periplasm proteins (Humphreys, 2007). A diversity of 
approaches, including optimising the expression of light and heavy chains to 
obtain augmented titres of antibody fragments (Humphreys et al., 2002), host 
cell engineering to hinder proteolysis of the light chain (Chen et al., 2004), and 
co-expression of chaperones to ameliorate folding or disulphide bond 
formation (Ramm and Plückthun, 2000; Humphreys et al., 2002) have been 
implemented to enhance the periplasmic production level of antibody 
fragments up to 2 g/L using the E. coli system (Carter et al., 1992; Chen et al., 
2004). Having achieved desirable levels of expression in the periplasm, it is 
required to develop the extraction processes to release the maximise amount 
of the recombinant protein while minimising the release of other host proteins 
and biomolecules. At large scale, the prevalent technique for purifying 
proteins from periplasm includes breaking the cytoplasmic membrane and the 
outer membrane and discharging the entire content of the bacterial cells. In as 
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much as approximately 80% of the total cellular protein is located in the 
cytoplasm, this method of non-selective-protein release makes the purification 
process burdensome (Pugsley, 1993). in the laboratory scale, the methods 
frequently used for cell fractionation and isolating periplasmic fraction are 
spheroplasting and osmotic shock treatment (Neu and Heppel, 1965; Neu et 
al., 1967), but these techniques are not capable to deal with the culture 
volume over 10 litres (Neu and Heppel, 1965). Directing Fab into periplasm 
and looking for cell disruptions techniques which is selective and effective at 
large scale and smooth the subsequent protein recovery processes is still a 
goal to be achieved. 
1.3. Strategies for improving Fab accumulation in 
E.coli periplasm 
1.3.1. Influence of cultivation temperature and shifting 
temperature upon induction for Fab expression 
E.coli can maintain balanced growth between 20°C and 37°C. Raising the 
temperature above 40°C or lowering it below 20°C results in progressively 
slower growth, until growth ceases at the maximum temperature of growth, 
49°C, or the minimum, 8°C (Jones et al., 1987). Comprehensive studies on 
the factors that influence expression conditions and product yield are still 
required for full process development (Yee and Blanch, 1992; Yoon et al., 
1994; Ramírez and Bentley, 1995; Corisdeo and Wang, 2004; Pelegrine and 
Gasparetto, 2005; Wunschel et al., 2005). An early example of applying low 
temperature resulting in higher yield of soluble Fd' fragment production, which 
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was expressed with a complementary ƙ light chain fragment in order to form of 
Fab fragment. The higher yield of active, soluble Fab fragments was obtained 
at 21°C and 30°C then at 37°C (Cabilly, 1989). A study was done by (Pinsach 
et al., 2008) showed a group of E.coli fed-batch fermentation was conducted 
under different temperature (37°C, 33°C and 28°C). The effects of lowering 
the temperature were analysed by the specific enzyme active and protein 
content. Reduction of the specific activity loss was observed when the 
process temperature was decreased to 28°C. Lower plasmid copy number 
and specific production rates probably alleviated the metabolic load on host 
cell during recombinant protein overexpression. More recently (Rodríguez-
Carmona et al., 2012) has also investigated the influence of temperature 
(37°C, 33°C and 28°C) on recombinant Fab expression and secretion to 
periplasm in E. coli. The results has shown that biomass yield was not 
affected within this temperature range whilst product yield increased as 
temperature decreased, but the decrease of temperature might lead to the 
protein leakage into culture broth. Above results have proven that carefully 
choosing the cultivation temperature would massively affect on the protein 
activity and its yield and also the location of recombinant proteins.  
Temperature obviously is a very crucial factor to control the proteolysis by 
preventing the possible stress response (heat stress and induction stress), 
which might lead to increase protein production yield due to reduce the 
degree of proteolysis associated with chaperons and proteolysis proteins. 
(Enfors, 1992). It has been examined the usefulness fermentation and strain 
engineering approaches in circumventing the problem of cspA promoter 
repression following prolonged incubation at low temperature. Temperature 
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cycling and successive temperature downshift in fermentors are found to only 
marginally improve yield. Vasina and coworkers in 1998 investigated whether 
successive temperature downshifts could be used to maximise the yields of β-
galactosidase. This approach appeared feasible since temperature drops as 
small as 7°C have been shown to be sufficient to induce the cspA promoter in 
shake flask cultures. Meanwhile, in 2.5-L batch fermentors were transferred 
from 37°C to 29°C, about 4000 U of activity accumulated within 1 h before 
becoming diluted as a result of biomass increase, which is a rather simple 
tactic of controlling of proteolysis on cultivation level. Further, it has been 
reported lowering the bacterial growth temperature could decrease 
periplasmic aggregation and increase the yield of soluble antibody protein 
(Skerra and Plückthun, 1991). Moreover, protein degradation rate will 
decrease with decreased temperature in accordance to the Arrhenius’ Law, 
and protein misfolding often occurs at high temperatures due to either heat 
damage or due to an increase of protein synthesis rate (Enfors, 1992). For 
these reasons, the most straightforward as well as promising strategy to 
improve the quality for Fab fragment production in E.coli was to identify the 
optimal process temperature for recombinant protein production. 
1.3.2. Influence of inducer concentration (Isopropyl β-
D-1-thiogalactopyranoside) 
Genes are either expressed constitutively or regulated. Two different classes 
of regulators have been described, transcriptional repressors and 
transcriptional activators. Repressors bind to operators located either within 
the promoter region or immediately downstream from it and, in most cases, 
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prevent RNA polymerase promoter binding or act as a road-block. To relieve 
repression, the repressor has to dissociate from its operator. In some cases, 
an inducer will be either synthesised by the cell or taken up from the 
environment which binds to the repressor causing dissociation from its 
operator (Schumann and Ferreira, 2004). Isopropyl β-D-1-
thiogalactopyranoside (IPTG) a very commonly inducer for expression 
recombinant protein in E.coli system, often working in the combination ranges 
of promoter which regulate tightly and strongly for the protein expression 
(Yansura and Henner, 1984; Weickert et al., 1996; Jeong and Lee, 2000).The 
disadvantage of using IPTG as an inducer is the high metabolic load imposed 
by it, often causing the stress response from cells and leads to inhibit protein 
production (Kilikian et al., 2000). When compared with lactose induction, as 
assessed by the cell protein content and stability, indicates that lactose is 
probably the most appropriate inducer for the synthesis of this heterologous 
protein (Neubauer et al., 1992; Donovan et al., 1996; Gombert and Kilikian, 
1998). However, unlike IPTG as an enzyme cannot be consumed, lactose 
gets metabolised by the cells, depletion of lactose eventually would cause 
transcriptional response decreases, also change the pH of the medium which 
might potentially influence protein expression and bacterial growth. A generic 
improving protocol for recombinant protein production in E.coli  was 
developed by (Sevastsyanovich et al., 2009). By using a C-terminal green 
fluorescent protein (GFP) fusion to a model target protein, Escherichia coli 
CheY, was exploited both as a reporter of the accumulation of soluble 
recombinant protein, and to develop a generic approach to optimise protein 
yields. Eight micro mole of [IPTG] as inducer suggested obtaining the optimal 
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product yields. The improved protocol was shown to be suitable for process 
scale-up and intensification. 
1.4. Selective release of periplasmic proteins and 
purification techniques  
1.4.1. Release methods 
1.4.1.1. Cold osmotic shock 
 This is by far the best and easiest method for do fractionation of periplasmic, 
cytoplasmic and membrane. However, it is rather labour intense and only 
practical in the small scale. Cell pellets obtained from 1 mL fermentation 
samples were resuspended in an osmotic shock solution (designated OS1) 
containing 20 mM Tris-HCl buffer, pH 8.0, supplemented with 2.5 mM EDTA 
and 20% sucrose. The use of adding sucrose here was to stabilise the inner 
membrane for preventing leakage from cytoplasm. After a static incubation on 
ice for 600 s, the cells were harvested by centrifugation (15,800 g, 120 s) and 
the supernatants were immediately frozen at −20°C. The resulting cell pellets 
(spheroplasts) were then resuspended in a second osmotic shock solution 
(designated OS2) without adding sucrose (i.e. 20 mM Tris-HCl buffer pH 8.0, 
containing 2.5 mM EDTA) and incubated on ice for 600 s. Following 
centrifugation (15,800 g, 120 s), the supernatants were then removed and 
stored at −20°C until required (Neu and Heppel, 1965; Neu et al., 1967; 
Humphreys, 2007; Jalalirad, 2010). 
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1.4.1.2. Heat treatment 
This method is only applicable to the thermally stable protein, such as Fab'. 
The extraction buffer comprises 100 mM Tris, 10 mM EDTA, pH 7.4. The ratio 
of sample to resuspension buffer is 1:1 (i.e. 1mL fermentation pellet 
resuspend with 1mL extraction buffer) Incubation was performed at 60°C for 
16 h. The elevated temperature will ensure the removal of any incorrectly 
folded non-disulphide Fab and truncated Fab species, as well as to pre clean 
a substantial percentage of host proteins, thereby resulting in enrichment of 
heterologous protein (Weir and Bailey, 1995; Humphreys et al., 1997; 
Popplewell et al., 2005; Humphreys, 2007). 
1.4.1.3.  Poly(styrene-co-maleic acid) lipid particles- SMALPs 
In order to study the structure and function of a protein, it is generally required 
that the protein in question is purified away from all others. For soluble 
proteins, this process is greatly aided by the lack of any restriction on the free 
and independent diffusion of individual protein particles in three dimensions 
(Jamshad et al., 2011). This is not the case for membrane proteins, as the 
membrane itself forms a continuum that joins the proteins within the 
membrane with one another. The membrane therefore needs to be disrupted 
in order to separate and hence purification of membrane proteins. The recent 
advances in the methods employed to separate membrane proteins before 
purification generally moves away from solubilisation methods based on the 
use of small surfactants, which have been shown to suffer from significant 
practical problems(Froner et al., 2011; Jamshad et al., 2011). On contrast, the 
poly(styrene-co-maleic acid) lipid particles (SMALPs) is created from one of 
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the nanotechnology that uses a range of reagents that fragment the 
membrane into nanometre-scale particles to surround the protein completely 
with the local membrane environment and encapsulate the membrane protein 
in a 10 nm disc-like structure (Jamshad et al., 2011). Moreover, the 
amphipathic polymer poly(styrene-co-maleic acid) is reversible via a pH 
dependent conversion (Knowles et al., 2009), which makes this polymer more 
applicable in different environment conditions. More importantly, SMA has 
been proved can be used for in vivo administration which makes it ideally suits 
to purification and further biochemical study (Froner et al., 2011). 
1.4.2. Newly developed separation techniques- Mix 
brushes smart polymers on magnetic particles (thermo 
responsive) 
1.4.2.1.  Magnetic particles and adsorbents 
Nowadays, there are two ways to get magnetic particles either synthesis in 
the laboratory, or commercially available products can be found on the market. 
The properties of magnetic particle such as superparamagnetism, magnetite 
content, the specific surface area, diameter size distribution, porosity, disparity 
and functionalisation possibilities, are very important to the selection of 
desirable applications. Although many of the particles are available behave 
like superparamagnetic and only responding to an external magnetic field, but 
not interacting themselves in the absence of magnetic field is suitable for High 
Gradient Magnetic Fishing (HGMF), because the magnetic particles can be 
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easily resuspended and avoid agglomeration thereby remaining in suspension 
for a long time (Teotia and Gupta, 2001).  
Traditional chromatography supports with immobilised affinity ligands are 
enabling magnetic separation to bind specific target molecular, such as, 
antibodies, protein A and Protein G are used most often in the cases of 
proteins and peptides isolation (Cuatrecasas, 1971). Magnetic particles can 
also serve as generic solid phases to which native or modified affinity ligands 
immobilisation (i.e. protein A, protein G or antibodies) (Weetall and Lee, 1989). 
It is also feasible to immobilise other ligands of interest to both commercial 
and laboratory made magnetic particles then used as an affinity 
chromatography in HGMF system (Heebøll-Nielsen et al., 2003). The polyvinyl 
alcohol magnetic beads (M−PVA) manufactured by Chemagen Biopolymer 
Technologie AG (Baesweiler, Germany) were used to carry out all studies in 
this thesis (Fig. 1.4)  
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These beads have been developed by an innovative suspension-based 
production process, which is patented worldwide and allows a very 
economical production of biocompatible magnetic beads based on polyvinyl 
alcohol. The main advantages of these magnetic beads are the hydrophilicity 
of the PVA surface, the biocompatibility, which enables the use of M−PVA 
beads in medical therapy, the individually tunable sizes of the M−PVA beads, 
and depending on the application, the chemical functionality of the matrix can 
be used for the most different modifications (www.chemagen.de). These 
advantages lead to excellent magnetic particles applicable in a huge variety of 
separation and purification processes. 
Fig. 1.4 SEM reveals the m-PVA particles from the batch number
R2-109027 supplied from Chemagen Biopolymer Technologie AG
(Baesweiler, Germany), with magnetite content 50-60%, sized
distribution: 1-3 μm, Mr: 130,000, degree of hydrolysis: 86.7-87.8%,
and specific surface area: ca. 40 m2/g. 
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1.4.2.2. ‘Smart’ polymers-Thermoresponsive 
‘Smart’ or stimulus-responsive polymers undergo strong conformational 
changes when only small changes in the environment (e.g. pH, temperature, 
ionic strength, electric or magnetic field, or other parameters) occur. They are 
also named ‘intelligent’ or ‘environmental’ polymers, and they undergo fast, 
reversible changes in microstructure from a hydrophilic to a hydrophobic state 
(Galaev and Mattiasson, 2007). 
Since 10 years ago, smart polymeric materials have become to widely apply 
in biotechnology in numerous ways. Since the term "smart polymeric 
materials" encompasses a wide spectrum of different compounds with huge 
potential for bioseparation applications, scientists have grown great interest in 
generating and manipulating these compounds (Roy and Gupta, 2003). 
Recently a group of polymers has been described and characterised by their 
unique properties. The solubility decreases when the temperature is increased 
by few degrees. The phenomenon as such may not be unique, but this 
property started to attract attention among biotechnologists for developing 
further applications. Temperature is absolutely critical for these class of 
polymers due to the phase transition occurring when the temperature reaches 
the lower critical solution temperature (LCST) (Fig. 1.5). For example the most 
commonly used thermoresponsive polymer, poly(N-Isopropylacrylamide) 
(p(NIPAAm)) possesses inverse solubility upon heating, a property contrary to 
the behaviour of most polymers in organic solvents under atmospheric 
pressure near room temperature. Its macromolecular transition from a 
hydrophilic to hydrophobic structure occurs suddenly at the lower critical 
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solution temperature (LCST), which experimentally lies between 30°C and 
35°C (Schild, 1992).  
 
Fig. 1.5 Schematic presentation of the mechanism of collapsed and expanded smart 
polymers. 
 
The concept of using metal chelates in affinity techniques presents a 
milestone in bioseparation (Porath et al., 1975). Immobilised metal affinity 
(IMA) techniques (Andersson et al., 1991; Arnold, 1991), IMA-chromatography 
(IMAC) and metal chelate affinity precipitation (MCAP) (Galaev et al., 1997; 
Kumar et al., 1998), are now being widely applied in protein purification, 
particularly when dealing with products requiring high purity. The technique 
offers a number of important advantages over other type affinity techniques 
for protein purification, especially subject to the binding capacity, ligand 
stability, matrix regeneration and protein recovery (Arnold, 1991). The 
technique is based on the selective interaction between the electron donor 
groups on the proteins and on the transition-metal ions [Cu(II), Ni(II), Zn(II) or 
Co(II)] which are loaded on the chelating ligands coupled to a solid support. 
The amino acids histidine, cysteine, tryptophan, and arginine have strong 
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electron donor groups in their side chains, the position of those amino acids 
on protein and the presence of such exposed residues are important factors 
for the success of proteins interaction with chelated metal ion ligands. Various 
ligands like protease inhibitors, antibodies, nucleotides, carbohydrates, and 
triazine dyes have been successfully used in affinity precipitation (Gupta and 
Mattiasson, 1994). Chelating metal ions offer many advantages over classical 
biological affinity types, as they are small molecules, inexpensive, chemically 
and physically tolerant, and easily coupled on matrices at high density 
resulting in high binding capacity adsorbents. 
The metal chelating ligand, poly-vinylimidazole, p(VI) has been proposed for 
metal chelate affinity precipitation of proteins (Galaev et al., 1997). When it is 
copolymerised with p(NIPAAm), the mixed polymer brushes of p(VI + NIPAAm) 
forms a complex with metal ions in such a way that two to three imidazole 
residues coordinate with a single metal ion (Kumar et al., 1998). This is 
possible since the flexible p(VI + NIPAAm) copolymer in solution can have a 
conformation in which imidazole groups are close enough to coordinate with 
the same metal ion. It is therefore an unusual but excellent behaviour for 
downstream separation, by grafting thermoresponsive polymers with metal 
chelated ligands on magnetic particles to create an intellectual polymer brush 
layers on magnetic particle used in High-Gradient Magnetic Fishing (HGMF). 
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1.5. Aim of this thesis. 
The broad objective of this thesis has been to design an improved new 
process for periplasmic recombinant protein production and demonstrate the 
feasibility of newly innovated purification technology. 
Initially, recombinant proteins. E. coli CLD048 expresses anti hen egg white 
lysozyme Fab (so called Fab D1.3) in the periplasm. Due to the nature of this 
particular Fab, lysozyme is prohibited during cell lysis must be accepted. The 
aim of chapter 2 was to optimise the fermentation process for Fab D1.3 
production from E. coli strain (CLD048), and to improve production titre, 
location and solubility by altering fermentation conditions (i.e. temperature, 
induction concentration, timing for induction and harvest during fed-batch 
cultivation).  
The aim of chapter 3 was to investigate periplasmic protein release by 
examining different extraction method and condition systematically to identify 
better/optimum condition applied for periplasmic proteins release. 
Subsequently, exploring the possibilities of direct capturing Fab D1.3 from the 
culture broth and periplasmic fraction (i.e. supernatant from osmotic shock 1 
solution) by employing cation exchange (HiTrap SP_XL) and affinity 
chromatography (HiTrap rProtein G). 
The aim of chapter 4 was to employ an alternative periplasmically expressed 
A33 Fab for large quantity Fab production ( 100 mg/L). Due to the poor yield 
of Fab D1.3 from fermentations and problematic conditioning occurring in the 
chromatography purification steps, the stain was forced to abandon. Initially, 
 29 
the preliminary shake flask result was to identify the potential growth condition 
and production of the A33 Fab fermentation. Later, three selective 
periplasmic release methods (i.e. osmotic shock, heat treatment and SMALPs) 
were investigated to determine which method is more suitable to apply for 
extracting A33 Fab from the periplasm.  
The aim of chapter 5 was to demonstrate direct capture of the antibody 
fragment A33 Fab´ from a crude E. coli periplasmic extract on CEX 
functionalised magnetic nano-particle sorbents with two aqueous micellar 
systems (ATPS). Also it was benchmarking with commercial available 
chromatographic columns (HiTrap rProtein G and Fractogel EMD SO3 cation 
exchanger) to evaluate the purification performance. We also investigated the 
feasibility of using ATPS in continuous protein separation. 
The aim of chapter 6 was to employ two model proteins with rich histidine 
(GFP-His6, Haemoglobin) to study the kinetic of protein adsorption and 
desorption behaviour on the thermoresponsive polymer brush surface 
modified M-PVA particle created by Ce(IV) reaction. Further investigation the 
influence of additives on the temperature induced phase transition of 
ungrafted polymers (i.e. poly(N-vinylimidazole), poly(N-isopropylacrylamide)) 
in solution. 
. 
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2. Controlling the location and solubility of 
Fab D1.3  
2.1. Abstract 
The periplasm of E. coli has shown several important features to be an ideal 
location for accumulating recombinant proteins. The oxidative environment 
aids protein folding and correct disulphide bond formation. Since less than 
10% of total cellular proteins accumulate in the periplasmic space, employing 
selective release methods (such as osmotic shock) would simplify subsequent 
downstream purification. Avoiding direct contact with DNA and RNA in the 
cytoplasm or chemical reagents in culture broth are especially beneficial when 
localising the desired recombinant protein product in the periplasm of E. coli. 
Despite these merits, there are still some issues that need to be addressed. 
The antibody fragment (Fab D1.3) employed in this work can easily leak from 
the periplasm into the culture broth, also a high percentage of the target 
protein is likely to be retained within the cytoplasm, possibly in insoluble form. 
In the worst case, cells lysed a few hours after induction, the target proteins 
mixing with cell components, resulting in a very difficult situation for product 
recovery. In this work, Preliminary shake flask experiments were conducted to 
identify the factors (such as temperature, IPTG concentration and induction 
timing determined by OD600 reading) effect on the E. coli growth and location 
of recombinant protein production. The best result of Fab production in the 
periplasm was achieved with 50 M [IPTG] for induction at OD600~1 at 25°C. 
We then demonstrate that considerable control over the location and solubility 
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of the Fab product can also be achieved in 5 L feb-batch fermentation process 
through systematic variation of growth and induction temperature, inducer 
concentration and points of induction and cell harvest. At different times 
during fed-batch cultivation, cells were centrifugally separated from the 
suspending broth and subjected to osmotic shock procedures. The Fab 
concentration in the resulting fractions (broth, periplasmic and cytoplasmic) 
was then measured by ELISA, SDS-PAGE and Western blotting. We describe 
how changes in all of the above fermentation parameters influence product 
titre, location, and solubility. We have obtained total ~ 48 mg/L of Fab D1.3 
mainly in the culture broth (21.09 mg/L) and OS1 (25.08 mg/L, periplasmic 
fraction). The optimum condition for Fab D1.3 production was cultivated at 
25°C and decreased to 20°C upon induction. The induction was performed at 
OD600 ~ 20 with 0.2 mM of [IPTG]. Cells were harvested at 18.15 h post-
induction. Furthermore, the ratio of soluble to insoluble was 60% to 40%, 
which suggested the majority of Fab D1.3 was soluble. Despite the above 
merits, the titre of Fab D1.3 was not sufficient to meet our goal (require ~100 
mg/L of releasable Fab D1.3) 
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2.2. Introduction 
E. coli is one of the microorganisms being studied and commonly used for 
production of recombinant proteins because of the thorough understanding of 
its cell structure and genomic information. Indeed, through modern genetic 
technology, gene alteration offers a wide range of possibilities to produce 
desired products (Hockney, 1994; Weickert et al., 1996; Baneyx, 1999; Jana 
and Deb, 2005; Sørensen and Mortensen, 2005; Chen, 2011). By inserting a 
genetically modified plasmid into hosts, it enables bacteria to produce proteins 
according to the recombinant gene sequence from the plasmid (Cheah et al., 
1987; Humphreys et al., 2002; Carton et al., 2007). The flexible scale of 
fermentation process in E. coli provides a robust and rapid production of 
invaluable recombinant protein for the biopharmaceutical industry (Harrison 
and Keshavarz-Moore, 1996; Chadd and Chamow, 2001; Farid, 2007). The 
current bottleneck is the linkage between the upstream production 
(fermentation) and the downstream purification. Export of large quantities of 
recombinant protein into the culture broth could allow simple recovery but the 
initial purity would be low therefore requiring many steps of concentration and 
clarification. In comparison, periplasmic targeting of recombinant protein could 
result in higher purity and fewer conditioning steps required, although the yield 
may be less and protein extraction from the periplasm is still required 
(Houdebine, 2002; Kelley, 2009; Mücke et al., 2009; Rosa et al., 2010; Chen, 
2011). This means producing good purity and higher yield of the target protein 
as a feedstock for downstream process and subsequent chromatography 
purification needs to be well balanced (i.e. high yield but low purity or low yield 
but high purity) for optimising whole production.  
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Targeting recombinant protein into the periplasm seems to be an good 
solution for proteins which require disulfide bonds and avoid exposing to 
extracellular chemical agents (Humphreys, 2007). In addition, utilising the 
periplasm for protein accumulation could simplify the downstream process. 
Although an outer membrane disruption step is required, only around ten per 
cent of soluble cellular protein is in the periplasm; this also avoids 
contamination from DNA or RNA (Van Wielink et al., 1990; Humphreys et al., 
2004; Humphreys, 2007). Several studies have provided possible solutions for 
improvement of protein production and accumulation in the periplasm. A very 
common strategy is by boosting the titre of target product with a stronger 
promoter (Sockolosky and Szoka, 2012). In particularly, to increase the yield 
of Fab production in the periplasm, human protein disulphide isomerase can 
be co-expressed, or a Eukaryotic Signal Peptide can be used at the 5 end of 
the coding sequence to effectively target protein in the periplasm (Humphreys 
et al., 1996, 2000) . 
Changing the growth media and cultivation conditions are the easiest and 
simplest method to achieve above the goals, improving the production titre 
and recombinant protein folding state. In addition, it can also aid recombinant 
protein localisation of the desired products to the periplasm, subsequently 
helping downstream extraction and purification steps (Schein and Noteborn, 
1988; Wunschel et al., 2005; Sevastsyanovich et al., 2009; Rodríguez-
Carmona et al., 2012). This may be achieved by manipulating the timing of 
induction (Neubauer et al., 1992; Vila et al., 1997), and using different 
inducers (i.e. lactose) (Gombert and Kilikian, 1998). Furthermore, specific 
growth rate (µ) controlled by fed batch feeding has also been shown to impact 
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on the quality and quantity of desired products. In some case, cell growth 
phase and protein synthesis phases are separated, so a faster specific growth 
rate helps in achieving higher biomass before induction thereby increasing the 
quantity of the products (Curless et al., 1990). Another proposal raised by 
Riesenberg and co-workers (1990) suggested the opposite idea, combining 
the cell growth and protein synthesis phases by slowing the specific growth 
rate (0.02 h-1 <  < 0.4 h-1), aiding protein synthesis after induction therefore 
generating more soluble product. The same result has been demonstrated by 
Sevastsyanovich and co-workers (2009); a C-terminal green fluorescent 
protein (GFP) fusion to a model target protein E. coli CheY expressed from a 
pET20 vector. Using very low IPTG concentrations (8 M), which avoids 
growth arrest and loss of culturability post-induction, the recombinant protein 
accumulated to 30% of the total protein content of the bacteria. In addition to 
above, there are other factors that also have great influence towards 
intracellular protein production and accumulation, such as temperature (Jones 
et al., 1987; Daniel and Gottschalk, 1992; Wunschel et al., 2005; 
Sevastsyanovich et al., 2009; Rodríguez-Carmona et al., 2012) and 
concentration of inducer (IPTG in those cases) (Kilikian et al., 2000; Lin et al., 
2008; Sevastsyanovich et al., 2009). 
In this study we aimed to produce a minimum titre of 100 mg/L Anti-Hen Egg 
White Lysozyme antibody Fab fragment (so-called Fab D1.3) ideally in the 
periplasm for use in screening and testing high binding capacity cation 
exchange ligands on magnetic particles, and subsequently apply feedstock 
with magnetic particles to high gradient magnetic fishing (HGMF) or 
continuous magnetic separation devices developed by other project partners. 
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We demonstrated that alteration of the cultivation temperature, timing of 
induction and inducer (IPTG) concentration could be a generic method to 
partially control the location of the target protein accumulation to benefit the 
protein release and purification processes, and simultaneously increase the 
ratio of soluble to insoluble protein for higher percentages of soluble protein.  
2.3. Material and methods 
2.3.1. Materials 
The tetracycline resistant E. coli CLD048 harbouring pAVE046 (Hodgson et 
al., 2007), expressing the antibody fragment Fab D1.3 (targeting as heavy 
and light chains into the periplasm, codes for signal peptide is not availbe due 
to the company privacy) was provided by Avecia Biotechnology (Billingham, 
UK). Nutrient agar and phosphate buffered saline (PBS) were purchased from 
Oxoid (Basingstoke, Hampshire, UK). Yeast extract and tryptone were 
obtained from Becton, Dickinson and company (BD) (Sparks, MD, USA). 
Sodium dodecyl sulphate (SDS) and Laemmli electrophoresis and running 
buffers were obtained from Bio-Rad Laboratories (Hercules, CA, USA). 
Ammonium hydroxide, phosphoric acid, magnesium sulphate, calcium 
chloride dihydrate, manganese (II) sulphate four hydrate and HPLC grade 
methanol were purchased from Fisher Scientific (Loughborough, 
Leicestershire, UK). Bugbuster Protein extraction reagent was purchased 
from Merck Chemicals Ltd (Nottingham, UK). TMB microwell peroxidase 
substrate (2-C) and TMB membrane peroxidase substrate system (3-C) were 
obtained from KPL (Gaithersburg, MD, USA). Hybond-P PVDF membrane 
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was obtained from Amersham Biosciences (Uppsala, Sweden). Bicinchoninic 
acid (BCA) protein assay kit and Isopropyl β-D-1-thiogalactopyranoside (IPTG) 
were purchased from Thermo Scientific (Rockford, IL, USA). 
Tetramethylethylenediamine (TEMED) was supplied by Melford Laboratories 
(Suffolk, UK). SimplyBlue Safe Stain and SeeBlue Plus2 Pre-Stained 
Standard were purchased from Invitrogen (Paisley, UK). Ammonium sulphate, 
glycerol, potassium phosphate monobasic and dibasic, citric acid, ferrous 
sulphate heptahydrate, zinc sulphate, sodium molibdate dihydrate, copper (II) 
sulphate, boric acid, tetracycline, sodium chloride, sodium hydroxide, Tween 
20, ethylenediaminetetraacetic acid (EDTA), sucrose, Trizma-base, sodium 
phosphate monobasic, sodium phosphate dibasic, sodium carbonate, sodium 
hydrogen carbonate, glycine for electrophoresis, chicken egg white lysozyme 
(HEWL), albumin from bovine serum (BSA), and anti-human IgG (Fab specific) 
- peroxidise antibody produced in goat, as well as all other chemicals used in 
this study were obtained from Sigma-Aldrich Co. (St. Louis, MO, USA).  
2.3.2. Methods 
2.3.2.1. Initial Fed-batch fermentation 
E. coli strain CLD048 was stored at −80°C in 20% LB and 80% glycerol and 
propagated on Nutrient agar plates supplemented with 15mg/L tetracycline 
and incubated at 37°C overnight. The initial inoculum was prepared in a 500 
mL conical flask by inoculating 100 mL of Luria Bertani (LB) broth (comprising 
1% NaCl, 0.5% yeast extract and 1% tryptone) containing 15 mg/L 
tetracycline with a fresh single colony of E. coli CLD048 and shaking at 37°C 
 46 
 
and 200 rpm for 13 h. The inoculum was transferred into a complex medium 
(composition provided by Avecia Biotechnology; Table 2.1). Fermentation was 
conducted using a 5 L Electrolab fermentor (Tewkesbury, UK) equipped with 
6-bladed rushton turbine impellers and four baffles located around the edge of 
the vessel. The vessel containing 3 L of medium (Table 2.1) was sterilised at 
121°C for 0.5 h then cooled down to set temperature; post sterilisation and 
trace metal additions (Table 2.1 and Table 2.2) were added after cooling. 
Table 2.1 Culture medium composition, the grey part indicates the components needed to be 
added after sterilisation and cooling of the medium to 37°C prior to inoculation of the 
fermentor. 
Component of medium Concentration 
(NH4)2 SO4  14 g/L 
Glycerol  35 g/L 
Yeast extract  20 g/L 
KH2PO4  2 g/L 
K2HPO4  16.5 g/L 
Citric acid  7.5 g/L 
Conc. H3PO4  1.5 mL/L 
1 M MgSO4.7H2O solution  10 mL/L 
1 M CaCl2.2H2O solution  2 mL/L 
Antifoam AF204  0.2 mL/L 
15 mg/mL Tetracycline  1 mL/L 
 
Table 2.2 Trace metal composition, 34 mL solution was sterilised through a 0.22 m sterile 
filter into a suitable sterile container and added into 1 L medium in the fermentor. 
 
Table 2.3 Glycerol and magnesium sulphate feed composition. 
Component Concentration 
FeSO4.7H2O  3.36 g/L 
ZnSO4.7H2O  0.84 g/L 
MnSO4.H2O  0.51 g/L 
Na2MoO4.2H2O  0.25 g/L 
CuSO4.5H2O  0.12 g/L 
H3BO3  0.36 g/L 
Conc. H3PO4  48 mL/L 
Component of medium Concentration 
Glycerol  714 g/L 
1 M Mg SO4.7H2O 30 mL/L 
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The pH of the medium was adjusted to 7.0 using ammonium hydroxide. The 
fermentor was inoculated with 100 mL (ca. 3% inoculum/medium ratio) from 
the overnight shake flask inoculum, and initially operated in batch mode. The 
starting conditions were: temperature 37°C; agitator speed 200 rpm; air-flow 
rate 1.0 VVM; pH 7.0. Agitation rate was increased according to dissolved 
oxygen level in the medium (up to maximum value of 1000rpm), to sustain the 
DOT set point of 30%. The pH was maintained at 7.0 throughout the 
fermentation by the automatic addition of NH4OH (10% v/v). Once carbon 
source was depleted, indicated by an increased reading of dissolved oxygen 
measured in the fermentor, the glycerol/magnesium sulphate feed (Table 2.3) 
was initiated at a constant rate of 9.0 ± 2.0 (g glycerol/h).  
2.3.2.2. Bugbuster for fractionation of soluble (S) and insoluble 
(I) protein from cell pellets 
Routinely, the cells were separated from 1mL of fermentation sample by 
centrifugation (15,800 g 600 s). The supernatants were discarded and the cell 
pellets resuspended in Bugbuster protein extraction reagent; the volume of 
reagent (L) employed was determined using the Manufacturer’s formula: 
Reagent volume (L) = ((OD600 value) x (sample volume (mL)) x 100) /1.5 
Following gentle mixing by inversion, the reagent / cell cocktail was incubated 
at room temperature for 300 s, before centrifuging at 15,800 g at 4°C for 20 
minutes. Soluble proteins were in the supernatant, and insoluble proteins 
remained in the pellet. Ten microlitre portions of the supernatant fractions 
were mixed with equal volumes of Laemmli sample buffer. The pellet fractions 
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were washed with 160 L PBS buffer, before centrifuging at 15,800 g for 600 
s at 4°C, carefully discarding the supernatants and resuspending in Laemmli 
buffer (the volume used was equal to that of the Bugbuster reagent initially 
employed). Both sample types (10 L for soluble and 5 L for insoluble 
fraction) were then boiled for 600 s and pulse centrifuged for 10 s at 15,800 g 
before loading onto 14% polyacrylamide gels and performing SDS-PAGE for 
protein separation.  
2.3.3. Improved protocol  
2.3.3.1. Coupled shake flask experiments 
E. coli strain CLD048 was stored at −80°C in 20% LB and 80% glycerol and 
propagated on Nutrient agar plates supplemented with 15mg/L tetracycline 
and incubated at 37°C overnight. A fresh single colony of E. coli CLD048 was 
cultivated in a 500 mL conical flask with 100 mL of Luria Bertani (LB) broth 
(comprising 1% NaCl, 0.5% yeast extract and 1% tryptone) containing 15 
mg/L tetracycline. The first set of experiment was cultivated at 30°C and 25°C 
and shaking at 200 rpm, induction was performed with 8 M and 20 M of 
[IPTG] at OD600~0.5, respectively. The second set of experiment was 
cultivated at 25°C and shaking at 200 rpm. IPTG concentration was increased 
to 20 M and 50 M for induction when OD600 reached 0.5 and 1, respectively. 
All samples were collected at 24 h post-induction employing osmotic shock to 
extract proteins from periplasm and cytoplasm, ELISA to analyse the [Fab] in 
the culture broth, periplasmic fraction (OS1) and cytoplasmic fraction (OS2). 
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2.3.3.2. 5 litre fed batch fermentation experiment with improved 
protocol 
Fermentation conditions applied were subject to the results of the shake flask 
experiments. The same medium as initial fed-batch fermentation was 
employed, but the temperature was set at 25°C, inducer concentration varied 
between 0.008 mM to 0.2 mM, timing of induction was decided by OD600nm 
value between 1 and 20. Fed batch feeding strategy was to increase the 
feeding rate according to the increase of biomass (i.e. OD600 reading) thus 
controlling the specific growth rate (µ). Feeding rate was calculated with 
exponential feeding for the fed batch fermentation (Yee and Blanch, 1992; 
Equation 2.1) with set E. coli specific growth rate (µ=0.3) and maximum 
flowrate was 54 mL/h (Jalalirad, 2010).  
ܨ ൌ ൬1S൰ ൈ ൬
μ
Yଡ଼ୗ ൅ m൰ ൈ X଴ ൈ e
ஜ௧ ൈ 60 
Equation 2.1 
ܺ଴	 ൌ ܱܦ଺଴଴௡௠ 	ൈ ܸ	 ൈ 0.4 
Equation 2.2 
Where, F, the feeding rate into the bioreactor (mL/h); X0, initial biomass (g); V, 
the initial volume of medium (L); µ, specific growth rate (1/h); t, time (h); S, 
glycerol concentration in the feeding solution (g/L); Yxs, cell yield on glycerol 
(g/g) and m, the maintenance coefficient for glycerol (g of the substrate per g 
of cell per h)., Every parameter in Equation 2.1 were used as following, S = 
0.714 g/L, V = 3 L, Yxs = 0.6167 g/g, maintenance coefficient = 0.003683 
(Wallace et al., 1986) , µ = 0.3 1/h. X0 was calculated following the Equation 
2.2 
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2.3.4. Osmotic shock 
Cell pellets harvested by centrifugation (15,800 g, 180 s) from 1 mL 
fermentation samples were re-suspended in an osmotic shock solution 
(designated OS1) made of 20 mM Tris-HCl buffer (pH 8.0) supplemented with 
2.5 mM EDTA and 20% sucrose. After a static incubation on ice for 600 s, the 
cells were harvested by centrifugation (15,800 g, 180 s) and the supernatants 
(periplasm) were immediately decanted and frozen at −20°C. The resulting 
cell pellets (spheroplasts) were then re-suspended in a second osmotic shock 
solution (comprising 20 mM Tris-HCl buffer pH 8.0 2.5 mM EDTA) and 
incubated on ice for 600 s. Following centrifugation (15,800 g, 180 s), the 
supernatants (cytoplasm) and pellets (unbroken cells) were then separated 
and stored at −20°C for further analysis.  
2.3.5. Analysis 
2.3.5.1. Optical density 
OD600nm measurements were done in a Uvikon spectrophotometer 922 
(NorthStar Scientific, UK). Sterile ‘production medium’ was used as reference 
for calibration. The instrument was re-calibrated with PBS solution prior to 
every measurement. When required, samples were diluted in PBS solution to 
obtain readings within the working range of the instrument. 
2.3.5.2. BCA Assay 
Protein concentrations of Culture broth, OS1 and OS2 supernatant fractions 
were measured with the Pierce® BCA Protein Assay Kit (Thermo Scientific, 
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2011a). Twenty-five microlitres of 2 mg/mL BSA (standard) and unknown 
samples were loaded into microplate wells. Two hundred microlitres of the 
kit’s working reagent were added to each well and pipette mixed at least 10 
times. Microplates were covered and incubated for at 37°C and 300 rpm in 
microplate shaker (Infors AG, Switzerland) for 0.5 h. Microplates were cooled 
to room temperature; absorbance was measured at 562 nm on a GloMax®-
Multi Detection System (Promega, UK). 
2.3.5.3. DPA Assay 
The amount of DNA present in the samples was measured by a modified 
diphenylamine (DPA) assay. Standards were prepared from calf thymus DNA 
(Deoxyribonucleic acid sodium salt from calf thymus) dissolved in Tris/EDTA 
solution pH 8 to the final concentration of 1 mg/mL and incubated at 2-8°C 
overnight for dissolving DNA thoroughly. Chromogenic reagent was mixed 
with 0.5 mL of acetaldehyde diluted in 25 mL of distilled water and 1.5 g 
diphenylamine was dissolved in 100 mL of glacial acetic acid with 1.5 mL 
concentrated sulphuric acid and then stored at 4°C. Reference standards 
were made with 150, 100, 75, 50, 25, 20, 15, 10, 5 and 0 L of the original 
DNA stock solution (1mg/mL) and filled up with Tris/EDTA pH 8 solution to the 
final volume of 175 L. Aliquots (175 L) of samples and calf thymus DNA 
standards were pipetted into screw capped starstedt tubes. To these, 5 µL 
portions of BSA (2 mg/mL, dissolved in distilled water) and 200 µL aliquots of 
0.4 M perchloric acid (PCA) were added. The tubes were sealed and after 
vortex mixing incubated at 4°C for 0.5 h. 
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After incubation, each sample was centrifuged at 15,800 g for 20 minutes and 
the supernatant discarded. 250 L of 1 M PCA was added to each pellet, 
vortexed and incubated at 70°C for 0.5 h, then cooled down to room 
temperature and 500 L of freshly prepared chromogenic reagent was added 
to each well. Samples and standards were incubated at 37°C overnight 
followed by centrifugation at 15,800 g for 600 s. Two hundred microlitres of 
each supernatant was transferred into a 96-well flat bottom micro plate and 
the absorbance was measured at 600nm.  
2.3.5.4. SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
for Fab D1.3 separation 
Proteins were separated using 14% polyacrylamide gels at 150 V/20 mA for 
2.5 h using Laemmli electrophoresis and running buffers (Bio-Rad). Prior to 
electrophoresis, all samples were diluted 1:1 with the Laemmli Sample Buffer 
(65.8 mM Tris-HCl, pH 6.8, 2.1% SDS, 26.3% (w/v) glycerol, 0.01% 
bromophenol blue), boiled at 110°C for 600 s, and then centrifuged in a 
microcentrifuge (7,000 g 15 s), before loading into the wells of the gel. 
SeeBlue Plus2 Pre-Stained Standard was used for estimation of molecular 
weight of protein bands on the gel. Following electrophoresis, gels were 
rinsed three times with 100 mL of distilled water and then stained with 
sufficient Simply Blue Safe Stain (5 mL/cm2) to cover the gel, for 1 h at room 
temperature with gentle shaking. The stain was discarded and the gel was 
subsequently washed twice with 100 mL of distilled water for 1 h with gentle 
shaking. 
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2.3.5.5. Western Blotting Fab D1.3 
For Western blotting, SDS-PAGE gels were not stained. The stacking gel was 
removed and the resolving gel was soaked in protein transfer buffer (3.03 g/L 
Trizma-base, 14.4 g/L glycine and methanol (20% v/v)) for 0.5 h. Hybond-P 
PVDF membrane (GE Healthcare, RPN303F) and 5 mm thick filter paper 
were cut according to the dimensions of the gel, soaked in 100% (v/v) 
methanol for 10 s, washed in distilled water for 300 s, and equilibrated in the 
protein transfer buffer for 0.5 h. The electroblotting cassette was assembled 
and placed between the electrodes in the blotting unit according to the 
manufacturer’s instructions (Mini Trans-Blot electrophoretic Transfer Cell, Bio-
Rad, CA, USA). The band-transfer was carried out initially for 1 h at 100 V, 
with cold transfer buffer at 4°C, and was then perpetuated at 4°C, at 30 V, 
overnight. Following transfer, the membrane was removed from the blotting 
cassette, the orientation of the gel on the membrane was marked, and the 
membrane was rinsed briefly in phosphate buffered saline (PBS; 11.5 g/L di-
sodium hydrogen orthophosphate, 2.96 g/L sodium dihydrogen 
orthophosphate, and 5.84 g/L sodium chloride; pH 7.5). 
For immuno-detection, gentle shaking was applied throughout the whole 
process. Non-specific binding sites on the membrane were blocked using 3% 
(w/v) BSA made in PBS, for 1 h, and then rinsed for 300 s twice with PBS 
containing 0.1% (v/v) Tween 20. The blot was washed with an excess volume 
of PBS containing 0.1% (v/v) Tween 20 for 300 s and incubated with anti-
human IgG (Fab specific) - peroxidise antibody (diluted down in PBS 10,000-
fold) for 1 h. The blot was washed three times with PBS/Tween 20, and 15mL 
of the enzyme substrate for each PVDF membrane (TMB membrane 
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peroxidise substrate system (3-C)) solution was added to the blot and 
incubated at room temperature until the desired band intensity was achieved. 
Subsequently distilled water was used to stop the reaction; blots were dried in 
air then stored at 4°C for further analysis. 
2.3.5.6. Sandwich ELISA method for Fab D1.3 
Each well of a 96-well microplate was coated overnight at 4°C with 100 L of 
0.1% hen egg white lysozyme, made in coating buffer (1.59 g/L Na2CO3 and 
2.93 g/L NaHCO3). Two hundred microlitres of PBS-BSA (1 PBS tablet with 1 
g BSA in 100mL distilled water)  was added to block unspecific binding, with 
shaking (500 rpm) in a microplate incubator shaker (Infors AG type AK120, 
Infors HT, Bottmingen Switzerland) for 1 h, at 37°C. The wells were then 
washed three times with 300 L wash buffer (1 PBS tablet and 100 l Tween 
20 in 100 mL of distilled water) per well and tap dried. Both standards and 
samples (100 L), having been diluted in PBS on a separate plate, were 
transferred to the washed ELISA plate, incubated at 37°C, 500 rpm for 1 h, 
washed again with the wash buffer three times and tap dried. The plate was 
then loaded with 100 L anti-human IgG (Fab specific) - peroxidase antibody 
produced in goat, which was diluted 10000-fold in the blocking buffer, 
incubated at 37°C, 500 rpm for 1 h, and then washed three times with the 
wash buffer and tap dried, before 100 L of peroxidase substrate was added 
to each well. The reaction was stopped after 600 s by adding 100 L of 1 M 
H3PO4 to each well, and the plate was read at the wavelength of 450 nm 
using a microplate reader (Promega Glomax-Multi detection system, Turner 
BioSystems Inc., Sunnyvale, CA, USA). 
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2.4. Results and discussions 
2.4.1. Fab D1.3 fermentation at 37°C, induced at 
OD600nm~40 with 0.1 mM IPTG. 
Five litre scale fermentations were performed with CLD048 E. coli strain. We 
aimed to produce recombinant Fab D1.3 with a minimum concentration of 100 
mg/L for the MagPro2Life project (European Framework 7) partners; also, for 
experiments conducted on the newly designed cation exchange ligands on 
the magnetic particles in a continuously magnetic separation device. 
According to the fermentation protocol described in (Hodgson et al., 2007; 
Jalalirad, 2010) the titre of Fab D1.3 was estimated at around 70-120 mg/L in 
the culture broth by the end of fermentation process (ca. ~8−12 h post-
induction). The result of the first fermentation is shown in Fig. 2.1 (Batch No.1). 
The fermentation was inoculated with 100 mL of overnight culture of E. coli 
strain CLD048, cultivation temperature was set at 37°C, pH 7, the dissolved 
oxygen was maintained at 30% and the initial agitation rate at 250 rpm. 
Agitation rate was increased subject to the percentage of dissolved oxygen. 
The maximum speed was limited to 1000 rpm. The feed was started at 8 h 
after inoculation. For induction, 0.1 mM IPTG was added 8 h after inoculation 
at an OD600 of around 45. Data in Fig. 2.1(a) was automatically recorded by 
Electro Lab software. Fermentation samples were manually taken every 2 h 
after induction. Cells were harvested when a decrease in the OD reading was 
observed after induction (8 h post-induction). 
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Fig. 2.1 Fed-batch fermentative production (initial volume 3 L) of Fab D1.3 (anti lysozyme) in 
recombinant E. coli at 37°C. Induction (arrow) was performed with 0.1 mM IPTG at OD600~ 
47.9. (a) Fermentation parameters (Dissolved oxygen%, Temperature and pH value) were 
recorded by software, optical density was measured by photospectrometer at 600nm 
wavelength. The arrow indicated the point of induction. (b) Concentration of active Fab D1.3 
measured by ELISA from three subcellular locations. 
 
Result from Fig. 2.1(a) showed important parameters (e g. pH, dissolved 
oxygen percentage (DOT), temperature) and the OD600 measured during the 
fermentation process. In the first 2 h after inoculation, cells were growing 
steadily to the conditions in the fermentation indicated by a steady decrease 
of DOT from 95% to the set point of 30%. Then a fluctuation was observed in 
DOT suggested that cells were demanding more oxygen therefore agitation 
speed was changing rapidly. Further decrease of DOT was detected at 6 h 
after inoculation because of the maximum agitation speed was reached 
(1000rpm) could not enable sufficient oxygen to be dissolved to reach a DOT 
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of 30%. Induction was performed at 8 h after inoculation with 0.1M IPTG at 
OD600 of 47.9. A steady increase of OD was shown every 2 h post-induction 
and reached a peak at 6 h post-induction at an OD600 of around 70. Cell 
harvesting was performed at 7 h post-induction when a decrease in OD600 
was observed (from 70 to 61.8).  
Unexpectedly, applying the same conditions as described in (Hodgson et al., 
2007; Jalalirad, 2010) in this first fermentation was not successful. Analysis of 
culture broth, periplasmic and cytoplasmic fractions at different time points 
showed a much lower titre than previously reported Fig. 2.1 b). Between 2 to 
4 h post-induction, the majority of Fab was detected in the periplasm (OS1) at 
a concentration of around 0.9 mg/L, and 0.2 mg/L of Fab was in the cytoplasm 
(OS2). Almost no Fab was detected in culture broth in the first 4 h after 
induction shown in Fig. 2.1(b). By the end of process, the [Fab] in culture 
broth increased to 0.4 mg/L but still the periplasm held the most Fab. In total, 
approximately 1.3 mg/L of Fab was produced across three locations. However, 
there was ~11.5 g/L of total protein measured in the culture broth at the end of 
fermentation (see below Table 2.4). This was very poor purity (0.005%) for the 
Fab and very difficult to use it as an initial feedstock for purification. As the 
result, the priority at this stage was to increase Fab titre in the culture broth. 
A lot of research has demonstrated that when recombinant protein production 
from a certain gene sequence cannot be achieved, lowering the fermentation 
temperature might be an effective solution to improve the yield of the 
recombinant protein and the ratio of soluble to insoluble protein. Decreasing 
the temperature for E. coli cultivation is likely to slow the protein synthesis 
process therefore preventing the stress response from the cells for better 
 58 
 
quality of recombinant protein production in terms of protein solubility (Daniel 
and Gottschalk, 1992; Weickert et al., 1996; Panda, 2003; Vallejo and Rinas, 
2004; Singh and Panda, 2005; Wunschel et al., 2005; Ventura and Villaverde, 
2006; Gasser et al., 2008). Recently, Pinsach and co-workers (2008) 
investigated the effects of cultivation temperature reduction in E. coli from 
37°C to 33°C and 28°C and suggested that further reduction to 28°C showed 
success in improving the yield of final product. Therefore, it is reasonable to 
reduce temperature from 37°C to 30°C to apply on the next fermentation for 
trying increase the yield of Fab D1.3. 
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Table 2.4 Summary of the [Fab], [total protein] and [DNA] in batch No.1 and No.2. 
 
 
                                            
1 All samples were measured in the end of fermentation (harvest). Fab was measured using ELSIA, total protein using BCA assay and DNA using DPA assay. 
CB= Culture broth 
Batch No. 
Temperature 
(°C) 
Induction 
OD600nm 
IPTG
(mM)
Fab (mg/L) Total Protein (g/L) 
Purity of Fab in different 
location (%) 
DNA1 
in 
culture 
broth 
(mg/L) 
CB1 OS11 OS21 Total CB1 OS11 OS21 CB1 OS1 OS2 
1 37 47.9 0.1 0.582 0.686 0.117 1.385 11.568 - - 0.005 - - - 
2 30 42.3 0.1 28.038 4.700 0.242 32.98 7.780 - - 0.36 - - 0.985 
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2.4.2. Fab D1.3 fermentation at 30°C, induced at 
OD600nm~40 with 0.1 mM IPTG. 
 
Fig. 2.2 Fed-batch fermentative production (initial volume 3 L) of Fab D1.3 (anti lysozyme) in 
recombinant E. coli at 30°C. Induction (arrow) was performed with 0.1 mM IPTG at OD~ 
42.3. . (a) Fermentation parameters (Dissolved oxygen%, Temperature and pH value) were 
recorded by software, optical density was measured by photospectrometer at 600nm 
wavelength. The arrow indicated the point of induction. (b) Concentration of active Fab D1.3 
measured by ELISA from three subcellular locations. 
 
The same fermentation procedures were followed from previous experiments, 
overnight inoculum was added into 5L fermentation vessel with 3L initial 
medium for the fermentation. Cultivation parameters were as described in 
Batch 1 (Fig. 2.1), except that the temperature was set at 30°C. As the 
temperature was decreased to 30°C, the cells grew much slower to adapt to 
the colder environment compared with the previous batch (see Fig. 2.1 a). 
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0.1mM IPTG was added 14 h after inoculation, at an OD600 of around 42.3. 
Unfortunately, there was an uncontrolled temperature increase occurring 2 h 
post-induction, which could potentially compromise the yield of the Fab. 
Results in Fig. 2.2 (b) indicate that Fab rapidly accumulated; at 2 h post-
induction, the majority of Fab was detected in the periplasm (~5 mg/L) and 
there was a barely detectable amount of Fab in the cytoplasm and culture 
broth. At 4 h post-induction, [Fab] had increased 2 fold in periplasm and 
significantly in culture broth (~15 mg/L). This implied that only 40% of Fab was 
retained in the periplasm, while 60% of the Fab had leaked into culture broth. 
At this stage, the overall yield of Fab reached a peak of 31.8 mg/L (Fig. 2.2 b). 
Noticeably, Fab concentrations did not increase after 4 h post-induction; the 
overall [Fab] in the periplasm decreased and that in the culture broth 
increased. This might be explained by the decrease in OD600 after 4 h post-
induction, indicating that cell integrity was decreased. Despite the fact that the 
majority of Fab was detected in the culture broth (ca. ~82%) at the point of 
harvest, and the rest was in the periplasm, nearly no Fab was detected in the 
cytoplasm. This fermentation proved that decreasing the temperature 
successfully improved the yield of Fab around 30-fold in comparison to batch 
No.1, (Fig. 2.1 b and Fig. 2.2 b). Furthermore, the total protein concentration 
of the culture broth was measured to compare the purity between batches 1 
and (Table 2.4). The [total protein] was 33% lower in the culture broth of batch 
2 compared to batch 1 (i.e. from 7.8 g/L versus 11.6 g/L), and along with the 
increased Fab concentration in the culture broth of batch 2, the culture broth 
Fab purity increased from 0.005% in batch 1 to 0.36% in batch 2. Because of 
the harvest was 2 h further delayed compared to batch 1, the [DNA] in the 
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culture broth was measured in order to understand the relationship between 
the decrease in OD600 and the culture broth DNA concentration, indicating cell 
lysis. Table 2.4 indicates that [DNA] in batch 2 culture broth was nearly 1 mg/L, 
which may be problematic for downstream purification. The batch 2 culture 
broth contained a high concentration of total protein (7.8 g/L) and high salt 
concentration leading to high conductivity (~35 mS/cm), with a very high DNA 
concentration (~1 mg/L). One of the most commonly used techniques for 
antibody fragment capture is Cation Exchange Chromatography (CEX). Lacki 
et al. (2007) demonstrated the effect of feedstock conditions (i.e. pH, 
conductivity) on the binding capacity of Fab using CEX. Their results 
suggested that ideal feedstock conditions for CEX are low pH (3-5) and low 
conductivity (~5 mS/cm). Unfortunately, the culture broth generated from 
batch 2 would need extensive conditioning to meet those conditions, and as a 
consequence it would be expected that the Fab concentration would decrease 
during these conditioning steps.  
As mentioned in the introduction, the periplasm can offer a much better 
environment for protein targeting compared to the extracellular environment 
(Humphreys, 2007). More importantly, cells can be concentrated by 
centrifugation then disrupted with a generic chemical method (e g. osmotic 
shock). This would potentially provide a better feedstock for downstream 
processing when compared to culture broth. In order to localise the Fab into 
the periplasm for resolving the above problems and identifying the operational 
window for Fab D1.3 production, a series of shake flask experiments were 
conducted by systematically examining the effects of each cultivation 
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parameter, (i.e. temperature, induction timing and IPTG concentration) to fulfil 
our goals.  
2.4.3. Identification of conditions for Fab D1.3 
production and optimisation by coupled shake flasks 
experiments 
 
Fig. 2.3 ELISA analysis shows the active [Fab] in the culture broth, OS1 and OS2 from 
coupled growth & DSP optimisation – shake flask experiments. (a) Effects of decrease in 
incubation temperature and increase in [IPTG] for induction on Fab production in three 
different locations. (b) Effects of Induction at different of OD600nm value and increase in [IPTG] 
for induction on Fab production in three different locations. 
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the production window to produce an acceptable titre of periplasmic Fab D1.3 
(~100 mg/L). Fig. 2.3 shows results from a series of scoping shake flask 
experiments. One hundred millilitres of LB media in 500mL shake flasks was 
used to cultivate E. coli strain CLD048 at either 25°C or 30°C to the desired 
OD600 (i.e. 0.5 or 1). At this point, cultures were induced with different 
concentrations of IPTG; 8 M, 20 M or 50 M). Samples from all the shake 
flask experiments were harvested at 24 h post-induction. Samples were 
centrifuged to separate cells and culture broth, and then periplasmic (OS1) 
and cytoplasmic (OS2) fractions were extracted from the cells using osmotic 
shock. Active Fab concentration in different locations (periplasm, cytoplasm 
and culture broth) was measured by ELISA (Fig. 2.3). From Fig. 2.3 (a), it was 
observed that decreasing incubation temperature and [IPTG] aided 
periplasmic Fab production. At 30°C, increasing [IPTG] from 8 M to 20 M 
increased overall Fab titre, but the majority of Fab leaked into the culture broth 
at the higher inducer concentration. In striking contrast, decreasing the growth 
temperature to 25°C maintained a high Fab titre but also allowed periplasmic 
accumulation. Corisdeo and Wang (2004) compared Fab production in E. coli 
at three different temperatures (16°C, 25°C and 37°C), the result suggesting 
that although cultures at 37°C generated more Fab, it was mostly in the 
culture broth. Cultures at 25°C generated Fab in the cells. This is in 
agreement with the results here. Moreover, regardless of the decrease in 
temperature, using 20 M of IPTG to induce Fab production was shown to 
generate more Fab than 8 M induction. Cultivation at 25°C generated at 
least 2 fold more Fab in the periplasm when compared to 30°C, which is the 
desired location for the Fab accumulation.  
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Since higher [IPTG] and decreased cultivation temperature were effective in 
improving the yield of Fab, the lower temperature (25°C) and higher [IPTG] 
(i.e. 20 M and 50 M) were selected for the next experiments (Fig. 2.3 
b).The goal was to investigate Fab production in relation to induction at 
different biomass concentrations (OD600 of 0.5 versus 1). Earlier result in Fig. 
2.3 (a) showed higher [IPTG] (20 M) at an induction point of OD600=0.5 
generated more Fab compared to 8 M IPTG, but increased the proportion of 
Fab leaking into the culture broth at 30°C. Inducing at an OD600 of 1 with the 
same [IPTG] generated more periplasmic Fab. Here, in Fig. 2.3 (b) shows the 
positive impact of the point of induction in relation to biomass with increasing 
inducer concentrations from 20 M to 50 M on Fab production and location. 
Cells induced at higher biomass showed a significant increase of the overall 
Fab titre, 50% higher than induction at OD600nm~0.5. Noticeably, although use 
of a higher concentration of inducer generated an increased yield of Fab, 
between 40% and 50% of total Fab leaked into culture broth. This might imply 
that E. coli cannot grow and produce this recombinant Fab simultaneously 
and that growth and production phases must be separated, or that cells at a 
higher OD600 are more capable of generating Fab.  
Several groups (Kosinski et al., 1992; Miao and Kompala, 1992; Donovan et 
al., 1996; Kilikian et al., 2000) have reported that when induced with relatively 
high [IPTG], cells might lyse after a certain period of cultivation time. As 
results showed from above experiments, many factors are important for 
growing E. coli to generate correctly folded recombinant protein with directing 
to the desired location, such as temperature, inducer concentration and 
induction timing subject to biomass. The investigation by conducting shake 
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flask experiments has identified those parameters which will be crucial for Fab 
D1.3 fermentation.  
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2.4.4. Adapting improved protocol to Fab D1.3 
fermentations 
 
 
Fig. 2.4 Fed-batch fermentative production (initial volume 3 L) of Fab D1.3 (anti lysozyme) in 
recombinant E. coli at 25°C. Induction (arrow) was performed with 0.02 mM IPTG at OD600~ 1. 
(a) Dissolved oxygen %, Temperature and pH value were recorded by computer, optical 
density was measured by photospectrometer at 600nm wavelength. The arrow indicated the 
point of induction. (b) Concentration of active Fab D1.3 measured by ELISA in three 
subcellular fractions from osmotic shock treatment (c) [total protein] was measured by BCA 
assay in the three subcellular fractions and [DNA] in culture broth was measured by DPA 
assay. 
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According to the studies done by (Corisdeo and Wang, 2004; 
Sevastsyanovich et al., 2009) and the results of the shake flask experiments 
(Fig. 2.3), the cultivation temperature was set at 25°C for the batch No.3 
fermentation (Fig. 2.4 a).  Fab production was induced with 0.02 mM of IPTG 
when the OD600 reached 1. The other parameters were the same as batch 
No.2 fermentation. The improved protocol of (Sevastsyanovich et al., 2009) 
was applied to minimise stress, attempt to increase the titre and solubility of 
Fab, and to shift the majority of Fab into the periplasm. The strategy here was 
to induce with a low concentration of IPTG (0.02 mM) at very early growing 
phase (OD600~1), guided by the results of shake flask experiments (Fig. 2.3 b). 
Cells were harvested after 31.5 h cultivation time, when the final OD600 
reached 47. A great advantage of applying fed-batch feeding in fermentation 
is the higher biomass that can be achieved in comparison with shake flask 
growth. Although the final OD600 reading was much higher than the shake 
flask, the overall yield of Fab was only 11 mg/L (Fig. 2.4 b). This is possible 
because of the induction was performed at low biomass or the [IPTG] was too 
low (Miao and Kompala, 1992). 
Result in Fig. 2.4 (b) was observed a similar behaviour of Fab production to 
the shake flask experiments (Fig. 2.3 b), that the majority of Fab accumulated 
in the OS1 (periplasm fraction). In addition, the [DNA] detected in the culture 
broth at the end of fermentation was significantly reduced when compared to 
batches 1 and 2 to 0.11 mg/L (Table 2.4 Fig. 2.4 c). The [Fab] in the culture 
broth very slowly increased, which suggested that the cells were still mainly 
intact at the harvest stage, therefore the majority of Fab was kept inside of 
cells. In contrast, batch No. 2 showed (Fig. 2.2 b) that [Fab] in culture broth 
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increased rapidly (0.1 mg/L to 17.3 mg/L) at 2 to 4 h post-induction with nearly 
1 mg/L DNA detected in the culture broth at the end of fermentation. More 
importantly, the concentration of total protein was around 1.6 g/L in the OS1 
fraction (Fig. 2.4 c) in the end of fermentation, which was almost 80% less 
than batch No.2 (7.5 g/L in culture broth). This would hugely simplify CEX 
purification. 
In terms of improving the yield of Fab D1.3, the result from batch No.3 was not 
successful, but invaluable experience was gained from the earlier shake flask 
results (Fig. 2.3 b) and this batch to realise that an induction at higher 
biomass could be a strategy to increase protein production (Kilikian et al., 
2000; Lin et al., 2008; Sevastsyanovich et al., 2009). Therefore, the next 
fermentation was induced at a higher OD600 of around 20 with the same 
concentration of IPTG (20 M) and temperature (25°C). 
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Fig. 2.5 Fed-batch fermentative production (initial volume 3 L) of Fab D1.3 (anti lysozyme) in 
recombinant E. coli at 25°C. Induction (arrow) was performed with 0.02 mM IPTG at OD~ 20. 
(a) Dissolved oxygen %, Temperature and pH value were recorded by computer, optical 
density was measured by spectrometer at 600nm wavelength. The arrow indicated the point 
of induction. (b) Concentration of active Fab D1.3 measured by ELISA in three subcellular 
fractions from osmotic shock treatment (c) [total protein] was measured by BCA assay in the 
three subcellular fractions and [DNA] in culture broth was measured by DPA assay. 
 
Cultivation conditions applied in this fermentation was the same as described 
in batch 3 (Fig. 2.4), except that induction was delayed until an OD600 of 20. In 
this fermentation, Fig. 2.5 (a) illustrates that each parameter applied to this 
fermentation was stably controlled at pH 7 but temperature increased by 5°C 
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near the end of fermentation due to the failure of cooling system. Induction 
was performed with 0.02 mM of IPTG at OD600~20 18 hours after inoculation. 
Cells were harvested after a total of 34.5 h cultivation time at a final OD600 of 
86. The earlier results in shake flask experiment showed that inducing with the 
same concentration of IPTG (i.e. 0.02 mM) at higher biomass concentration 
resulted in an increase of overall protein production (Fig. 2.3 b). The first 8 h 
post-induction did not show any significant Fab production in any 
compartment of E. coli. Noticeably, from 7 to 17 h post-induction nearly 75 % 
of Fab was produced and accumulated in cytoplasm. This showed Fab was 
made in cytoplasm, but was not transported to the periplasm, resulting in a 
very low overall titre of Fab production. However, the overall Fab production 
still had a slight increase compared with batch No.3 (from 11 mg/L to 15 mg/L), 
which was induced at a much lower biomass (OD600 of 1). The result might 
explain the positive effect by delaying induction with higher biomass was 
compromised by insufficient [IPTG] per cell, resulting in overall low titre of Fab 
production. Therefore, this was not a consistent result from the above findings.  
Miao and Kompala (1992) has concluded that [IPTG] of higher than 0.1 mM 
should be used to overcome culture instability during induction at 
midexponential phase. However, induction with 50 M [IPTG] should occur at 
low cell density (OD600~1) to allow the cells have enough time for protein 
synthesis. This might explain our results in batch No.4 that induction with 20 
M [IPTG] at OD600~20 resulted in insufficient [IPTG] per cell to trigger rapid 
protein synthesis, hence most Fab was still in the cytoplasm. Because of low 
protein synthesis rate and much higher biomass in the end of fermentation 
were observed, which could indicate stress response causing by producing 
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recombinant proteins was not significant, thereby leading the low Fab 
production in this fermentation. In addition, the [DNA] in the culture broth was 
even lower than the previous result (0.08 mg/L). This suggests that when the 
low [IPTG] (20 M) was applied for induction, cells would keep intact resulting 
in low [DNA] in culture broth (Fig. 2.4 and Fig. 2.5). Whereas high [IPTG] (e.g. 
0.1 mM [IPTG] in batch No.2) was applied resulting in cell lysis thereby 
increase of [DNA] in culture broth was detected (i.e. batch No.2, 0.985 mg/L 
[DNA] was detected in the culture broth Table 2.4). 
Comparing batches 3 and 4, induction was performed at higher biomass in 
batch 4 (OD600~20), therefore the [IPTG] per cell was diluted 20 fold between 
batches 3 and 4. Thereafter, increasing [IPTG] induction should be a logical 
way to improve Fab titre with current fermentation conditions for the next 
batch.  
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Fig. 2.6 Fed-batch fermentative production (initial volume 3 L) of Fab D1.3 (anti lysozyme) in 
recombinant E. coli at 25°C. Induction (arrow) was performed with 0.1 mM IPTG at OD~ 20. 
(a) Dissolved oxygen %, Temperature and pH value were recorded by computer, optical 
density was measured by spectrometer at 600nm wavelength. The arrow indicated the point 
of induction. (b) Concentration of active Fab D1.3 measured by ELISA in three subcellular 
fractions from osmotic shock treatment (c) [total protein] was measured by BCA assay in the 
three subcellular fractions and [DNA] in culture broth was measured by DPA assay. 
 
Cultivation conditions applied in this fermentation was the same as described 
in batch No.4, except an increase of [IPTG] from 0.02 mM to 0.1 mM. Fig. 2.6 
(a) illustrates the each parameter applied to this fermentation, seeming stable 
for pH and temperature maintained at 7 and 25°C respectively. Unlike the 
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previous batch, induction was performed with 0.1 mM IPTG at OD600 around 
20; then the fermentation was left overnight (8 h). Thus, the first sample was 
collected at 8 h post-induction then every 2 h until the end of fermentation. 
Cells were harvested after total 33 h cultivation, the final OD600 was 34.2. 
Clearly, the highest OD600 value in this batch (43.11) was only half of the 
previous batch (89). This was because the high [IPTG] caused a significant 
reduction in cell growth rate; this has been observed by many research  
groups (Miao and Kompala, 1992; Jeong and Lee, 1999; Choi et al., 2000, 
2006).  
With similar length of cultivation time after Induction, a much lower OD600 
value was reached in this batch compared to batch No.4 (Fig. 2.5 a). In 
striking contrast, the results in Fig. 2.6 (b), showed a dramatic increase for the 
overall [Fab] in the end of fermentation, which was 2 fold higher than Fig. 2.5 
No. 4 (Fig. 2.5 b). Furthermore, the majority of Fab production was in the 
culture broth in this fermentation instead of cytoplasm. There was not any 
obvious increase of [Fab] observed in cytoplasm, but Fab accumulated in the 
periplasm (to a maximum concentration of 12 mg/L) then gradually decreased 
after 11 h post-induction. The total [Fab] was 36.17 mg/L at the end of 
fermentation, but only 10% was in the periplasm (3.61 mg/L) and 4% was in 
the cytoplasm (1.6 mg/L); more than 85% of [Fab] was detected in the culture 
broth (31 mg/L). Unfortunately, there was no sample collected between 
induction and 8 h post-induction, so we could only speculate based on results 
(Fig. 2.4 and Fig. 2.5). Previously, Batch No.4 showed that when the cells 
were intact at the end of fermentation, [DNA] and [total protein] in the culture 
broth were measured around 80 mg/L and around 3500 mg/L, respectively. 
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Following the same principle, in Batch 5, between 0 to 8 h post-induction or 
earlier Fab was initially synthesised in cytoplasm then transported and 
accumulated in the periplasm.  Cells were still intact, implied by the [DNA] (ca. 
108 mg/L) and [total protein] (ca. 4000 mg/L) in the culture broth, not 
significantly higher than the corresponding results in batch 4. In addition, the 
[Fab] measured at 8 h post-induction in the periplasm (11.5 mg/L) was slight 
higher than in the culture broth (8.5 mg/L) in the fermentation. Taking 
collectively, before 8 h post-induction, most Fab was stored in the periplasm. 
However, Fab leaked into the culture broth; between 8 and 10 hours post-
induction, there was more Fab in the Culture broth than the periplasmic 
fraction (Fig. 2.6b). Despite this, Fab was still being generated by the cells up 
to the point of harvest.  
Results in Fig. 2.6 (c) show a rapid increase of [DNA] and [total protein] in the 
culture broth after 8 h post-induction, this implied that cell integrity was 
decreasing over time, resulting in [Fab], [total protein] and [DNA] increasing in 
the culture broth. Consequently, although E. coli was still producing Fab but 
fewer and fewer cells were able to retain the Fab in the cell thereby a 
decrease of [Fab] in the periplasm and increase of [Fab] in culture broth. This 
was also observed in batch No.2 (Fig. 2.2), where the same [IPTG] (0.1 mM) 
for induction was performed at 30°C but with higher biomass at OD600 around 
40 (Fig. 2.2 a). Although the temperature had been decreased by 5°C, the 
cells were still not able to maintain the Fab in the periplasm but in the culture 
broth due to cell lysis. This might suggest that the concentration of IPTG per 
cells for induction was still too high. However, in terms of Fab purity in the 
culture broth, this is a promising result compared with previous batch No.4. 
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Even though the total protein concentration in the culture broth was 2 fold 
higher than batch.4 (7.3 g/L cf. 3.3 g/L), batch 5 generated 3 litres of culture 
broth containing around 99 mg of Fab and 21.9 g of total protein in the end of 
fermentation, the Fab purity in the culture broth was much higher than batch 4 
which had 3.6 mg of Fab within 9.9 g of total protein. As the result, the purity 
of Fab in culture broth has increased over 10 fold (0.42% cf. 0.036%). 
Interestingly, the peak OD600 (~43.11) corresponded to the peak overall Fab 
production (41.6 mg/L) and [Fab] in the culture broth (34.9 mg/L) at 14 hours 
post induction, which might indicate there were correlations between biomass 
and the yield of Fab. Thus, if high cell density fermentation can be achieved 
with high [IPTG] induction, then cells could be harvested before lysis. This 
might offer an opportunity to exploit the optimum conditions and operation 
window to improve the Fab production and retain the product in the periplasm.  
Thus far, the yield of Fab in culture broth had been improved over 50-fold 
compared with the initial conditions in batch No.1 (30.97 mg/L cf. 0.58 mg/L). 
The only comparable result was generated in batch No.2 (ca. 28 mg/L), which 
was very difficult to apply on CEX due to the nature of the feedstock 
composition (i.e. pH, conductivity and total protein concentration). 
Unfortunately, although we have successfully produced a slightly higher titre 
of Fab in batch No.5 (ca. in total 36.18 mg/L), but 85% of Fab was in the 
culture broth, which will encounter the same problems as batch No.2 for the 
feedstock clarification and in conditioning for CEX. As mentioned from the 
introduction, temperature plays an extremely important role for E. coli 
cultivation, many studies (Daniel and Gottschalk, 1992; Holt et al., 2000; 
Ramos et al., 2001; Corisdeo and Wang, 2004; Ami et al., 2009) have 
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suggested further reduction of temperature to decrease periplasmic misfolded 
proteins and soluble aggregates as an effective means to increase the yield of 
soluble protein and improve the cell stability thereby benefitting the quality of 
protein folding and production. It might be sensible to take the advantage of 
lowering the temperature upon induction for prolonging the cell viability 
thereby increasing the overall titre of Fab and allowing better translocation into 
the periplasm.  
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Fig. 2.7 Fed-batch fermentative production (initial volume 3 L) of Fab D1.3 (anti lysozyme) in 
recombinant E. coli at 25°C then decreased to 20°C upon induction. Induction (arrow) was 
performed with 0.1 mM IPTG at OD~ 20. (a) Dissolved oxygen %, Temperature and pH value 
were recorded by computer, optical density was measured by spectrometer at 600nm 
wavelength. Arrow indicated the point of induction. (b) Concentration of active Fab D1.3 
measured by ELISA in three subcellular fractions from osmotic shock treatment (c) [total 
protein] was measured by BCA assay in the three subcellular fractions and [DNA] in culture 
broth was measured by DPA assay. 
 
Cultivation conditions applied in this fermentation were the same as described 
in batch No.5, except that the temperature was reduced by 5°C upon 
induction to 20°C. Fig. 2.7 (a) shows the each parameter applied to this 
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fermentation, pH was controlled at 7. Induction was performed with 0.1 mM 
IPTG at 18.5 h after inoculation when the OD600 was around 20, cells were 
harvested after 42.5 h total cultivation, and the final OD600 was 43. Fig. 2.7 (b) 
shows clearly that most Fab accumulated in the periplasm (OS1), followed by 
the cytoplasm (OS2) and finally the culture broth. The Fab concentration in 
each fraction increased along with the increase of the OD600 value, which 
matched with the observation in batch .5 that the yield of Fab increased 
concurrently with biomass when a sufficient quantity of inducer was added. 
Noticeably only a little Fab leaked out into the culture broth 18 h post-
induction. Fig. 2.7 (c) shows the same result of DNA content in the culture 
broth started to increase 18 h after post-induction. Those results indicated that 
to prevent periplasmic Fab leaking into culture broth and to preserve the 
integrity of cells, harvesting should be earlier than 18 h post-induction. Thus 
we have effectively defined the harvest window. Furthermore, in combination 
of Fig. 2.7 (b and c) compared with batch No.5 (Fig. 2.6 b and c) show the 
Fab purity in the periplasmic fraction (OS1) at the end of fermentation had 
been greatly improved (1.6% cf. 0.24%). As mentioned in batch.5, there was a 
certain period of time during fermentation when the majority of Fab was 
retained in the periplasm (e.g. at 8 h post-induction); because the [total protein] 
was much lower in the periplasm compared to the culture broth (1.7 g/L cf. 4 
g/L), hence the purity of Fab in the periplasm was higher than the culture 
broth (0.67% cf. 0.21%). In order to maximise the Fab purity and yield in the 
periplasm, the current decision for cell harvest needs to be revised. We need 
to investigate the optimal timing for harvesting not depending on the decrease 
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of OD value. Therefore we can determine the “operation window” for the 
fermentation. 
Fig. 2.7 (b and c) illustrate that the purity of Fab in the periplasmic fraction 
(OS1) was 1.85% at 18 h post-induction, 2 h later hit a peak of 2% then 
decreased nearly 0.2% every 2 h; at 24 h post-induction it was 1.63%. Further, 
the [Fab] in culture broth increased from 1.4 mg/L to 5 mg/L (18 h to 24h post-
induction). Likewise, Fig. 2.7 (c) shows that [DNA] was just above 60 mg/L in 
the culture broth 18 h post-induction, then gradually increased every 2 h and 
was nearly 100 mg/L in the end of fermentation. The above suggest that from 
18−24 h post-induction, some cells began to lyse but fortunately most Fab 
was still in the periplasm. Noticeably, a distinct difference was observed; in 
batch No.5 the most of Fab leaked out into culture broth, but in batch No.6 
most Fab accumulated in the periplasm. The result suggested that further 
lowering the cultivation temperature upon induction had effectively slowed 
down the protein synthesis process (compare total [Fab] in Fig. 2.6 and Fig. 
2.7), thereby prolonging the duration of protein production meanwhile 
maintaining both the cells integrity and protein accumulation in the desired 
compartment. This can be seen as a means to manipulate the location of Fab. 
However, this strategy can neither prevent cell lysis after 18 h post-induction, 
which was indicated by the increase in [DNA] in the culture broth, nor increase 
the overall titre, which was similar to batch No.5. Although reducing 
temperature upon induction seems to be effective in controlling the location for 
accumulation, the overall titre was still not competitive with the result 
mentioned in Hodgson et al. (2007) and Jalalirad, (2010). 
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The results from shake flask experiments have shown an increase in overall 
titre by increasing the [IPTG] when induced at the same biomass. To increase 
the Fab production and extend the operation window, in the next fermentation 
we doubled the concentration of inducer and harvested cells earlier, allowing 
simultaneous cell growth and production and harvest before cells lysis 
occurred (Kilikian et al., 2000).  
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Fig. 2.8 Fed-batch fermentative production (initial volume 3 L) of Fab D1.3 (anti lysozyme) in 
recombinant E. coli at 25°C then decreased to 20°C upon induction. Induction (arrow) was 
performed with 0.2 mM IPTG at OD~ 20. (a) Dissolved oxygen %, Temperature and pH value 
were recorded by computer, optical density was measured by spectrometer at 600nm 
wavelength. Arrow indicated the point of induction. (b) Concentration of active Fab D1.3 
measured by ELISA in three subcellular fractions from osmotic shock treatment (c) [total 
protein] was measured by BCA assay in the three subcellular fractions and [DNA] in culture 
broth was measured by DPA assay. 
 
Cultivation conditions applied in this fermentation was the same as described 
in batch No.6, except that 0.2 mM IPTG was applied for induction. Fig. 2.8 (a) 
showed the each parameter applied to this fermentation stably maintained at 
pH 7 and temperature was set at 25°C then decreased to 20°C upon induction, 
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the level of dissolved oxygen was decreased when the biomass was 
increased, 0.2 mM IPTG was added 18.15 h after inoculation when the OD600 
was 20 and cells were harvested after 38.15 h cultivation, the final OD600 
being 25.4. Compared to the previous fermentation (batch No.6) (Fig. 2.7 and 
Fig. 2.8), cultivation time to reach OD600~20 was very similar (batch No.6 was 
18.5 h cf. batch No.7 was 18.15 h) but the growth rate after induction was 
much slower than batch No.6, resulting in lower final OD600 value (ca. ~25.4). 
Not surprisingly, the reduction of cell growth rate was due to the higher [IPTG] 
of 0.2 mM (Miao and Kompala, 1992; Jeong and Lee, 1999; Choi et al., 2000, 
2006) 
Both Fig. 2.8(b) and Fig. 2.7(b) show a steady increase of Fab accumulated in 
the OS1 fraction during the first 8 h post-induction. Notably, increase in [IPTG] 
from 0.1 mM to 0.2 mM has received a positive effect on the overall Fab yield 
at the end of the fermentation increased by 22% compared with batch No.6 
(48 mg/L in batch No.7 cf. 37.5 mg/L in batch No.6). At the end of 
fermentation, Fab yield in the OS1 fraction (periplasm) increased by 28% (25 
mg/L in batch No.7 cf. 18 mg/L in batch No.6). Further, the Fab production 
rate at first 8 h post-induction was 2 times faster in batch No.7, which 
suggested using high [IPTG] for induction might be possible to accumulated 
significant amounts of the recombinant proteins in the cell (Kilikian et al., 
2000). 
However, the consequence was an overall increase in [DNA] and [total protein] 
in culture broth between 8 h post-induction and harvest (Fig. 2.8 c), which 
imply the optimum production duration should be  no longer than 8 h post-
induction and that cell harvesting should be no later than 6 to 8 h post-
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induction. Also, this might indicate that E. coli strain CLD048 was not capable 
of growing and producing this recombinant Fab simultaneously. A better 
strategy to apply on this strain for Fab production would be separating the cell 
growth phase and protein expression phase. First to achieve relatively high 
biomass and induction is performed with 0.1~0.2 mM [IPTG], then harvesting 
in a short period of time after induction, as seen in batches 6 and 7. Another 
speculation was mentioned in (Stock et al., 1977; Van Wielink et al., 1990) 
that the periplasmic space of E. coli is of limited physical size (i.e. between 
20% to 40% of the total cell volume) and therefore has a specific capacity for 
proteins. Although the overall titre of Fab was systematically increased over 
the process, it might be possible that we have reached the natural limit for 
proteins accumulated in the periplasm in E. coli. Thus far, although the overall 
Fab titre was increased massively from 1 to 50 (mg/L) with partially controlling 
the location of Fab accumulation, the fermentation system still did not meet 
the goal we set to achieve at the beginning (≥ 100 mg/L of releasable Fab 
D1.3). As the results, an alternative strain is required from UCB Celltech to 
express A33 Fab (Chapter 4) to carry on further research and provide to 
project partners as initial feedstock for testing on the aqueous micellar two 
phase systems for continuously protein separation (Chapter 5).  
2.4.5. Summary of the shake flasks experiments and 
fermentation results 
In this section, the condition changes for the fermentations are summarised in 
Table 2.5 and Table 2.6 list all the conditions applied to different batches of 
fermentation to illustrate the change on the different parameters and the 
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subsequent effect on the Fab 1.3 production in periplasm, cytoplasm and 
culture broth. In addition, the purity of Fab in each location was calculated 
from the concentration of Fab dived by concentration of total protein to allow 
comparing feedstock conditions for the following purification. Initially, our goal 
in this study was to employ E. coli strain CLD048 to produce a minimum 100 
mg/L of the releasable anti-Hen Egg White Lysozyme antigen binding 
fragment (anti-HEWL Fab D1.3) in the culture broth or from intracellular (ca. 
40 mg/L could be potential yield from the periplasm) as a model feedstock for 
screening and testing the high binding capacity cation exchange ligand 
coupled on magnetic particles. 
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Table 2.5 Summary of cultivation conditions applied to 3L E. coli fermentations for (Anti-HEWL) Fab D1.3 production. 
Batch Temperature (°C) 
OD600 at 
induction 
IPTG 
(mM) 
Cultivation time to 
induction (hours) 
Post- induction 
(hours) 
Total cultivation 
time (hours) 
Final OD600 
1 37 47.9 0.1 8 7 15 61.8 
2 30 42.3 0.1  14 7 21 49.9 
3 25 1 0.02 3.5 27.5 31 47 
4 25 20 0.02 18 16.5 34.5 86 
5 25 20 0.1 17 16 33 34.2 
6 25  20 20 0.1 18.5 24 42.5 43 
7 25  20 20 0.2 18.15 20 38.15 25.4 
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Table 2.6 Summary of the [Fab], [total protein] and [DNA] in different condition fermentations. 
                                            
2 All samples were measured in the end of fermentation (harvest). Fab was measured using ELSIA, total protein using BCA assay and DNA using DPA assay. 
CB= Culture broth, OS1= Supernatant of osmotic shock 1 solution (periplasmic fraction), OS2= Supernatant of osmotic shock 2 solution (cytoplasmic fraction) 
Batch No. 
Temperature 
(°C) 
Induction 
OD600nm 
IPTG
(mM)
Fab (mg/L) Total Protein(g/L) 
Purity of Fab in different 
location (%) 
DNA2 
in 
culture 
broth 
(mg/L) 
CB2 OS12 OS22 Total CB2 OS12 OS22 CB OS1 OS2 
1 37 47.9 0.1 0.582 0.686 0.117 1.385 11.568 - - 0.005 - - - 
2 30 42.3 0.1 28.038 4.700 0.242 32.98 7.780 - - 0.36 - - 0.985 
3 25 1 0.02 4.027 6.600 0.828 11.455 2.637 1.605 0.400 0.153 0.411 0.207 0.11 
4 25 20 0.02 1.196 2.246 11.64 15.082 3.347 0.782 2.260 0.036 0.287 0.515 0.08 
5 25 20 0.1 30.968 3.610 1.597 36.175 7.329 1.510 1.037 0.422 0.239 0.154 0.307 
6 25->20 20 0.1 5.05 18.19 14.31 37.55 4.040 1.113 2.609 0.125 1.634 0.548 0.099 
7 25->20 20 0.2 21.09 25.08 1.89 48.06 5.744 1.477 1.116 0.367 1.698 0.169 0.161 
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In batch No.1, cultivation temperature was set at 37°C and induction was 
performed with 0.1 mM IPTG at OD600~ 45 which resulted in a very short 
production phase overlapping with severe cell lysis. More than 40% of the 
active and soluble Fab leaked into the culture broth, which has a total protein 
concentration of 11.57 g/L (Table 2.6). Following by temperature reduction 
cultivation at 30°C in batch 2, although the overall Fab titre was improved 
hugely (ca. ~33 mg/L), however the most of Fab was again in the culture broth, 
which was heavily contaminated with DNA (ca. ~1 g/L) and over 7 mg/L of 
total protein. Because of the complex media used for E. coli strain CLD048, 
the ionic strength of the culture broth was around 35 mS/cm at the end of 
fermentation. Therefore, it was very difficult to purify Fab directly from the 
complex and heavily contaminated culture broth by CEX (Lacki et al., 2007). 
Jalalirad (2010) mentioned that a dialysis process would be necessary if trying 
to purify Fab from the culture broth, but more than 50% of the Fab product 
was lost during the process. Therefore, directing Fab into the periplasm would 
be more suitable for this study (Humphreys, 2007). Coupled shake flask 
experiments were conducted based on the concept provided from 
Sevastsyanovich et al. (2009) to investigate the effects on growth temperature, 
IPTG concentration and timing of induction for the Fab production and location 
(i.e. cytoplasm, periplasm or culture broth). The results suggested that 
decreased cultivation temperature (i.e. 30°C to 25°C) with an increase of 
[IPTG] (i.e. 8 M to 50 M) improved the overall Fab production. Further, 
induction with higher biomass (OD600 ~ 0.5 cf. OD600 ~ 1) showed increase in 
the total Fab production too. Noticeably, induction with higher [IPTG] per cell 
result in Fab leaking into the culture broth (Fig. 2.3).  
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According to results from the shake flask experiment along with the improved 
protocol of Sevastsyanovich et al. (2009), batch No.3 (Fig. 2.4) was induced 
with 0.02 mM of IPTG at OD600 of 1 at 25°C. Noticeably, the overall Fab 
production was decreased 65% compared to batch No.2 (11.45 mg/L cf. 32.98 
mg/L) but 60% of the Fab was detected in OS1 fraction (periplasm) (Table 
2.6). The result indicates that induction was performed at low [IPTG] (0.02 mM) 
and low biomass (OD600~1) allowed Fab accumulated in the periplasm and 
avoided leaking into the culture broth even with the longest cultivation time 
(27.5 h post-induction) compared with the other fermentations (Table 2.5), the 
cells remained intact. Therefore, low [DNA] was detected in the culture broth 
(0.11 mg/L) at the end of fermentation. The possible reason for low titre of Fab 
production is because of the induction at low biomass (OD600~1), which is also 
observed from the result of the shake flask experiments (Fig. 2.3). Therefore, 
in the next fermentation induction was performed at OD600~20 (Fig. 2.5). 
Surprisingly, Table 2.6 shows the induction with 0.02 mM of [IPTG] at OD600 of 
20 did not result in a significant increase in overall Fab production compared 
with batch No.3 (15 mg/L cf. 11.45 mg/L). In striking contrast, around 77% of 
Fab was accumulated in cytoplasm, which suggested that: (i) although Fab 
was synthesised after induction, it was not translocated into periplasm; and (ii) 
a low [DNA] (~0.08 mg/L) was detected in the culture broth with high final OD 
value (~86) which suggested that cells were as intact as in the previous 
fermentation. In order to improve the yield of Fab, Miao and Kompala (1992) 
suggested higher than 0.1 mM [IPTG] should be used to overcome culture 
instability when induction at midexponential phase. Therefore, we have 
increased [IPTG] to 0.1 mM for induction.  
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Comparing between batches No.5 and No.4, the increase in [IPTG] for 
induction seems to be an effective strategy that increased the total yield of 
Fab more than 2 fold (36.2 mg/L cf. 15.1 mg/L), despite of fact that majority of 
Fab (ca. 85%) was detected in the culture broth in the end of fermentation 
batch No. 5 (Table 2.6). Similar result was observed in batch No.2 (Table 2.6) 
that the most Fab (ca. 85%) leaked into culture broth indicated that cells after 
induction were not able to kept protein the Fab within the cells. Furthermore, 
shake flask results (Fig. 2.3), demonstrated that the majority of Fab was 
shifted from the culture broth to the periplasm when the temperature was 
decreased from 30°C to 25°C. Therefore, we decided to decrease the 
cultivation temperature from 25°C to 20°C upon induction, in order to keep the 
majority of Fab in the periplasm. 
The last two fermentations (batch No.6 and No.7) were considered successful 
examples. Using the same [IPTG] (0.1 mM) in batches No.5 and No.6 (Table 
2.5) did not increase the overall Fab titre but decrease in temperature from 
25°C to 20°C upon induction in batch.6 has successfully directed the Fab to 
accumulate in the periplasm and the cytoplasm (Table 2.6). The majority of 
Fab was in OS1 (18.19 mg/L) and OS2 (14.31 mg/L) fraction by the end of 
fermentation (Table 2.6). Similar Fab production behaviour was also observed 
in batch No.4 (Fig. 2.5 b) that cytoplasm contained higher amount of [Fab] 
suggesting that a further increase [IPTG] was feasible to increase the yield of 
Fab. Since targeting the Fab accumulation in the periplasm and adopting the 
improved protocol from Sevastsyanovich et al. (2009), we have improved the 
purity of Fab in the periplasmic fraction (OS1) by 4 times (0.41% cf. 1.63%), 
compared with the result obtained in batch No.3 (Table 2.6). Therefore, we 
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have tried to double the [IPTG] for induction in batch No.7 for increase the 
overall titre of Fab and allocate the majority of Fab into the periplasm. 
As expected, the overall titre of Fab increased 30% (ca. 48 mg/L) in batch 
No.7 compared with batch No.6 by doubling the [IPTG] for induction. In 
addition, periplasm (ca. 52%) and culture broth (ca. 43%) are two main 
locations where Fab was detected for batch.7 (Table 2.6). Not only the yield of 
Fab in the periplasm was increased, but also the purity of Fab in the periplasm 
slightly increased to nearly 1.7%, which was the highest purity compared to 
the other batches (Table 2.6). Further, it can be noticed that [Fab] in the 
periplasm increased in the first 8 h post-induction, whereas after 8 hours only 
increased slightly. Whereas [DNA] and [Fab] in the culture broth increased 
after 8 h post-induction until in the end of fermentation, which might suggest to 
maintain the cell integrity and avoid Fab leakage from the periplasm into the 
culture broth, the operation window for cell harvesting should be done in the 
early stage after induction (i.e. 8 h post-induction). 
2.4.6. Improvement of solubility of target protein 
As demonstrated by the above fermentation data, adapting the improved 
protocol from Sevastsyanovich et al. (2009) appears to improve the overall 
Fab titre and enable us to partially control the location of Fab. To extend the 
study in order to investigate Fab solubility, Bugbuster was employed to isolate 
soluble and insoluble proteins from cell pellets collected from each 
fermentation batch. Soluble and insoluble fractions were separated by 14% 
polyacrylamide gel electrophoresis, transferred to PVDF membrane and Fab 
D1.3 was detected using Western blotting. Utilising densitometry software 
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"ImageJ" allowed us to compare the ratio of soluble to insoluble Fab in each 
fermentation (Fig. 2.9). 
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Fig. 2.9 Western blot analysis of soluble (S) and insoluble (I) samples arising from Bugbuster fractionation. Whole cell pellet (1 mL) fraction derived from 
Bugbuster was washed in PBS buffer, centrifuged, and the obtained soluble and insoluble samples. Prior to Western blotting, samples were subjected to 14% 
reducing SDS-PAGE. Conditions applied to different fermentation batches were described above, arrow indicates the protein band of Fab D1.3.  
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In the first two batches (No.1 and 2) showed more than 50% of Fab was in 
insoluble form, while in batches where the growth temperature was decreased 
to 25°C (i.e. batch No.3 thereafter), a significant change was observed in 
favour of soluble Fab production. Although the total Fab production was not 
promising in batch No.3 (11.45 mg/L), it showed that 92% of the Fab was 
soluble, only 8% insoluble form was detected, which was the best result 
among those conditions. The results suggest the ratio of soluble to insoluble 
was highly related to temperature, [IPTG] and timing of induction (Schein and 
Noteborn, 1988; Vera, 2007; Sevastsyanovich et al., 2009). Comparing 
batches No.3 and 4, where induction was performed at higher biomass 
(OD600~20), resulted in an increase in the quantity of insoluble Fab, yet still 
77% of Fab produced in the cell remained soluble.  
Increase in [IPTG] showed significant increase in the overall yield of Fab in 
batch No.5, but the ratio of soluble to insoluble decreased more than 10% 
compared to batch No.4. Fernández-Castané and co-workers (2012) 
suggested that the rate of IPTG intake by cells increases when higher [IPTG] 
was supplied for induction, thereby increasing the protein synthesis rate. 
Consequently, a lower ratio of soluble to insoluble Fab was observed in batch 
No. 5.  
In batch No.6, decrease temperature upon induction from 25°C to 20°C aided 
Fab retaining in the cell (i.e. periplasm and cytoplasm, total [Fab] was 32.5 
mg/L), but also increased the ratio of soluble to insoluble (from 64% to 76%) 
compared with batch No.5. The result implied that temperature effect on 
protein synthesis rate was greater than additional IPTG, therefore slowing the 
rate of protein synthesis, and then improving Fab solubility. Taking 
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advantages of altering cultivation conditions in terms of temperature and 
induction timing, batch No.6 has shown the completely opposite soluble to 
insoluble ratio versus batch.1 suggested that the cultivation strategy adopted 
from the improved protocol (Sevastsyanovich et al., 2009) is applicable to this 
expression system, thereby increasing the correct folding of Fab D1.3. 
In the last batch of fermentation (batch No.7), 0.2 mM of [IPTG] was used for 
induction. Not surprisingly, a decrease in solubility of Fab was observed when 
[IPTG] was increased (60%), which was similar to batch No.5 (ca. 64%). Yet 
again, the Fab titre increased to 48.06 mg/L, mainly being present in the 
periplasm (ca. 25 mg/L) and culture broth (ca. 21 mg/L). Taken collectively, 
batch No.7 might not have the highest ratio of soluble to insoluble, but the 
total yield of Fab was the best, especially in periplasmic fraction. Whereas 
batch No.3 had the highest ratio of soluble to insoluble (ca. 92%) but the total 
Fab production was too low (ca. 11.455 mg/L). As the result, carefully balance 
between the titre of Fab and solubility is crucial to enable more soluble active 
Fab. 
2.5. Conclusions 
Shake flask experiments coupled to osmotic shock extraction helped us to 
identify suitable cultivation condition for the production of Fab D1.3. Following 
a systematic improved protocol (Sevastsyanovich et al., 2009) we investigated 
the impact of temperature, induction timing and inducer concentration on the 
titre, location and solubility of Fab.  
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From the last two fermentations we have also determined the growth 
conditions suitable for this strain and the Fab production window should be 
between 6 to 8 h post-induction for harvesting. If the cells were harvested later 
than this stage, the Fab began to leak out into culture broth. In conclusion, we 
have demonstrated substantial control over the length of the production phase, 
Fab D1.3 distribution and form, and the level of contamination by DNA also 
identifying the optimal conditions for maximising the accumulation of Fab D1.3 
in periplasm, which is using a cultivation temperature of 25°C then decreasing 
to 20°C upon induction at OD600 of 20 with 0.2 mM of [IPTG] and harvest 
between 6 to 8 h after induction. However, it was not possible to accumulate 
all of the soluble Fab D1.3 in the periplasm and the titres achieved are low (≤ 
25 mg/L of original culture, 1.7% initial Fab purity in the periplasmic fraction) 
(Table 2.6, batch No.7). Furthermore, cell integrity appears to be poor, even 
after low temperature growth and induction and early harvesting. Evidence for 
this comes from the overly high protein and DNA content of OS1 (data not 
shown). The unexpectedly heavy contamination of OS1 seriously 
compromises the subsequent separation performance. Taken collectively, the 
unsuccessful fermentation for Fab D1.3 production was due to the nature of 
this strain. Despite all the progress we have achieved thus far, the basic and 
the most important issue still remains unsolved; the titre of Fab is still far too 
low to meet our goal (≥ 100 mg/L of releasable Fab D1.3). As the result, we 
have decided to abandon this strain and looked for an alternative strain, which 
will be provided from the UCB Celltech to express A33 Fab in periplasm.  
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3. Periplasmic release for Fab D1.3 from 
E.coli cells 
3.1. Abstract 
Sample obtained from a fermentation batch (cultivation temperature 25°C 
then decreasing to 20°C upon induction at OD600nm~20, with 0.1 mM IPTG.) 
described in chapter 2 was used in this chapter for the selectivity periplasmic 
release experiment. Following by purification by affinity and ion exchange 
chromatography were used in order to purify Fab D1.3 from culture broth 
and/or osmotic shock fluid samples. In the release experiments suggested 
that the optimum condition for releasing protein from periplasm should be 
using 0.1% Sodium deoxycholate (Doc) with shaking for either 0.5 or 2 h, with 
ratio of cell concentration to buffer  between 0.5 to 1. However, due to the 
issue of large amount of DNA also being released by 0.1% Doc, the osmotic 
shock was more suitable and employed for the later purification experiments. 
Impact of feedstock conditioning towards Fab loss and subsequent 
chromatographic purification with 5 mL HiTrap SP Sepharose XL columns 
was also examined. A small (~10%) loss in Fab occurred following dilution of 
cell-free broth (~10 mS/cm), pH adjustment (to pH 5) and clarification 
(filtration through a 0.2 m membrane); however, this was offset by a greater 
loss in contaminating host protein (~ 30%), resulting in improved feedstock 
quality (1.2 fold purification of Fab). Breakthrough studies conducted with 
conditioned cell-free broth (lacking benzonase) and OS1 revealed extremely 
low capacity Fab binding to the SP Sepharose XL. The purity of Fab eluates 
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coming off OS1 loaded columns were roughly twice those eminating from 
columns supplied with conditioned broth (10% cf. 5%). The presence of non-
proteinaceous material (nucleic acids, LPS) plus high protein contamination 
likely contribute to the disappointing CEX purification peformance observed 
with both conditioned broth and OS1 feedstocks. Attempts to purify Fab D1.3 
from these same feedstocks by Protein G affinity chromatography also proved 
unsuccessful.  
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3.2. Introduction 
Periplasmic release has received much attention in recent decades for 
exploring protein production and purification in E.coli (Ito et al., 1981; Khosla 
and Bailey, 1989; Naglak and Wang, 1990; Van Wielink et al., 1990; French et 
al., 1996; Link et al., 1997; Pierce et al., 1997; Chen et al., 2004a; Liu et al., 
2004). This offers a great potential for production, purification and protection 
of recombinant protein compared with protein secretion into culture broth, 
which was mentioned briefly in the Chapter 2. In this study, Fab D1.3 (anti-
HEWL antibody fragment) has been used throughout all the experiments.  
Fab D1.3 is one of the many antibody that requires disulfide bonds for the 
final folded state for which it is translocated across the cytoplasmic membrane 
into the periplasm in E.coli where it interact with enzymes, mainly DsbA, DsbB, 
DsbC and DsbD that catalyse the formation and isomerisation of disulfide 
bonds (Akiyama et al., 1992; Wunderlich and Glockshuber, 1993; Jeong and 
Lee, 2000; Nakamoto and Bardwell, 2004). The disulfide bond formation 
occurs due to an oxidative process, where the thiol (SH) groups of two 
cysteines are joined together by a covalent force (Ehrmann, 2006). In the 
early 1990s, scientists (Bardwell et al., 1991; Akiyama et al., 1992; Peek and 
Taylor, 1992) discovered the periplasmic DsbA (disulfide bond binding) 
protein in E.coli which illustrated a clearer mechanism of disulfide bond 
formation, where enzymes were catalysts crucial for disulfide bonds formation. 
Generally speaking, E.coli does not secrete proteins to culture broth, but extra 
signal sequences can be inserted upstream of genes for periplasmic targeting 
(de Marco, 2009), which provides a much cleaner environment for the 
proteins than the cytoplasm. Further, cells often exposed to a series of 
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variable threats from the surrounding environment, for example, a sudden 
change of pH, temperature, salt concentration and the presence of proteases 
or detergents, where store the invaluable proteins in the periplasmic space 
can protect them from degradation or denatured in comparison to the outer 
membrane environment. Another factor taken into account is the size of the 
periplasm, which was mentioned by Schlegel (1986) that periplasmic layer 
was only 7 nm wide. This would only occupy approximately 4.5% of the total 
cell volume, which is very small space for the protein accumulation, especially 
for the titre up to a few hundred grams per litre production. However, Van 
Wielink and co-worker (1990) suggested the periplasmic layer, which was 
believed to be ~7 nm wide, as 4.5% of cell volume was rather underestimated. 
The actual space for the periplasm determined by electron microscopy 
comparises 20-40% of the cell volume is between 32 to 71nm wide (Stock et 
al., 1977). There should be sufficient space in the periplasm for the protein 
accumulation. 
Much research has looked into methods of selectively and effectively release 
proteins from the periplasm, such as osmotic shock, chemical 
permeabilisation using  surfactants (anionic, cationic, non-ionic), chelators 
and chaotropic agents or organic solvents (Pierce et al., 1997; Chen et al., 
2004b; Jalalirad, 2010), heat treatments (Katsui et al., 1982; Weir and Bailey, 
1995). Taking consideration of scalable and generality, osmotic shock seems 
the better option among the other methods for protein release from the 
periplasm. Because it does not require detergent uses nor high temperature, 
which might cause conformation change for some proteins or losing its 
function (Argos et al., 1979; Digel et al., 2006). A well balance between 
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selectivity and efficiency are equally important for the protein release and 
subsequent downstream process; the former provides better purity. 
Consequently, the feedstock may not require many clarification steps (i.e. 
multiple cycles of high speed centrifugation, filtration), leading to higher 
overall yield and less loss of the target product. It also would ease the 
conditioning process for the initial feedstock when purification is performed on 
chromatographic system. The latter offers higher titre for the target protein, 
surely this is the general goal for the protein production, but without 
selectively release, the product might be heavily contaminated with other 
protein spices or nucleic acid when the cell is completely burst. As the result, 
we should strive the optimise condition for both effective and selective protein 
release in the periplasm. The standard osmotic protocol (Neu et al., 1967) 
states cells were harvested during late exponential or stationary phase then 
re-suspended in osmotic shock buffer (concentrated sucrose, EDTA and Tris 
buffer). The mixture was incubated at low temperature (ca ~4°C) for a short 
period of time. After liquid-solid separation by centrifugation, the supernatant 
was collected as the released protein from the periplasm. Here, cells are 
shrinking due to the high osmotic strength from sucrose solution, EDTA works 
as a cation chelator to destabilise the cell envelope thereby releasing 
lipopolysaccharide (LPS), therefore increasing the permeability of the outer 
membrane. The cold environment can rapidly increase the cell size and aid 
the protein release from periplasm simultaneously (Chen et al., 2004b). In 
contrast to osmotic shock, chemical permeabilisation relies on purely on the 
functions of chemical interactions between the reagents and cell wall. Unlike 
the requirement of accurate temperature control (~4°C) and time consuming 
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routine procedure of osmotic shock, chemically releasing is a robust method 
to apply on protein release. However, due to the nature of protein and use of 
reagents, it has certain disadvantages, such as causing protein unfolding, 
degradation, more importantly the toxicity of using surfactants might not be 
acceptable for the final products. Although heat treatment has been identified 
as a more effective technique for periplasmic protein release, due to its own 
limitations, many proteins are not able to tolerate the high temperature 
environment for long period of time (ca.~ 60°C, 16 h), resulting in protein 
degradation, changes to conformation or loss of activity. Therefore, this 
method would only be possible when the target protein is thermally stable.  
In this chapter, we have focus on investigating the periplasmic protein release 
mechanism. All the samples were taken from a single batch of fermentation, 
which produced was 40 g/mL Fab D1.3 in the periplasm. For evaluation 
purposes, release methods were tested by modifying the conditions of the 
standard osmotic shock (i.e. incubation time, static or with vortex, buffer 
concentration) to identify the optimum conditions for periplasmic release, also 
comparing the selectivity of release between osmotic shock and chemical 
permeabilisation (0.1% Sodium deoxycholate, so called 0.1% Doc). 
Subsequently, culture broth and OS1 fraction (extraction from periplasm) were 
used as feedstock with SP_XL HiTrap (CEX) and HiTrap rProteinG (Affinity) 
columns following protocols described in Ljunglöf et al., (2007) to obtain 
preliminary purification results.  
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3.3. Material and methods 
3.3.1. Materials 
All the materials were carried out from Chapter 2. Experiment samples were 
obtained from fed-batch fermentation described in Chapter 2 (section 2.4.3. 
Fig. 2.8). Prior to the release experiments by various osmotic shock and 
sodium deoxycolate (0.1% Doc) conditions, all the fermenation samples were 
centrifuged at 15,800 g for 600 s to remove the culture medium. 
3.3.2. Methods 
3.3.2.1. Modified osmotic shock for periplasmic protein release 
Initially, a large proportion of cell pellet was resuspended in PBS buffer to 
OD~25. One millilitre fermentation aliquot sample was centrifuged for 600 s at 
15,800 g. Supernatant was removed and kept for further analysis. Different 
volumes of osmotic shock solution (0.5, 1, 2, 3 mL) were mixed with the 
pellets and incubated for 10 or 30 minutes on the ice statically or shaking 
(1000 rpm). 
3.3.2.2. 0.1% sodium deoxycholate for periplasmic protein 
release 
Initially, a large proportion of cell pellet was resuspended in PBS buffer to 
OD~25. One millilitre fermentation aliquot sample was centrifuged for 600 s at 
15,800 g. Supernatant was removed and kept for further analysis. Different 
volumes of 0.1% Doc solution (0.5, 1, 2 mL) were mixed with the pellets on 
 109 
 
the shaker (1000 rpm) and incubated for various time length (i.e. 900s, 1 and 
2 h) at the room temperature. 
3.3.2.3. Pre-treatment with Benzonase Nuclease 
Samples pre-treated with Benzonase nuclease (9025-65-4, Sigma) was 
adding 9 U/mL was added according to the suggesting concentration by 
manual. The samples were incubated at 37°C overnight for the best 
performance of Benzonase, no additional separation was for the enzyme 
removal for further purification or analysis processes. 
3.3.2.4. Fab D1.3 purification 
Purification from osmotic shock fluid and culture broth sample obtained from a 
fed-batch fermentation, described in chapter 2 (Fig 2.8, batch No.7), was used 
in this chapter for the purification studies. 
3.3.2.4.1. Fab D1.3 purification on HiTrap SP Sepharose XL 
Purification from culture broth sample was performed on a 5-mL HiTrap 
SP_XL Sepharose column. Prior to application of cell-free culture fluid onto 
the column, the feedstock was extensively dialysed overnight against 15 mM 
sodium acetate, pH 5.0, at 4°C with changing the buffer in order to reduce 
both the conductivity (from ca. 40 to 5.0 mS/cm) by dilution and pH (from 7.0 
to 5.0) by using 15 mM sodium acetate at pH 5 for optimal sorption of the Fab 
on the cation exchange (CEX) matrix. The 6-fold dilution buffer was added 
into culture broth sample for reduction conductivity to desire value. Sample 
was re-centrifuged (9390 g for 30 minutes) and filtered through 0.45 and 
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subsequently 0.22 m Millipore filters. The sample (1200 mL) was then 
loaded at a flow rate of 2.5 mL/minute on the HiTrap SP_XL column which 
was pre-equilibrated with 15 mM sodium acetate buffer, pH 5.0. Following 
wash step was done at the same flow velocity with the equilibration buffer for 
25 mL (5 column volumes, CVs). Finally the elution was achieved by 
employing 20 mM MES (2- morpholinoethanesulfonic acid, 4.5 mM sodium 
MES, 1.5 M NaCl, pH 5.5) to elute the binding Fab for 5 CVs. Eluted fractions 
containing Fab D1.3 from chromatography on HiTrap SP_XL was store at 
−20°C for further analyse. The amount of Fab D1.3 and total protein in various 
fractions was measured by ELISA and BCA assay, respectively. 
3.3.2.4.2. Fab D1.3 purification on HiTrap rProtein G column 
For this purpose, 1 mL HiTrap rProtein G was equilibrated with 20 mM sodium 
phosphate buffer, pH 7.0. The culture broth sample (50 mL) from fed-batch 
fermentation was centrifuged at 9390 g for 600 s (Sigma 3K30, SciQuip, 
Shropshire, UK) and clarified by filtration through 0.45 and subsequently 0.22 
m syringe filters (Millipore, MA, USA). The sample (pH 7.0) was put through 
the HiTrap rProtein G column using an AKTA explore system (GE Healthcare, 
Life Sciences, Buckinghamshire, UK) at a flow velocity of 1 mL/minute. After 
loading, the column was extensively (5 CVs) washed with 20 mM sodium 
phosphate buffer, pH 7.0, and elution (10 CVs) was made with 0.1 M glycine-
HCl, pH 2.7 at the same flow rate. The eluate was instantaneously neutralised 
with 1 M Tris-HCl, pH 9.0, and stored at 4°C. The amount of Fab D1.3 in 
various fractions was measured using ELISA. 
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3.4. Results and discussions 
3.4.1. Releasing Fab D1.3 by modified osmotic shock 
and 0.1% Sodium deoxycholate (Doc) in various 
conditions. 
 
 
Fig. 3.1. The impact of total protein and Fab D1.3 released by various conditions of osmotic 
shock and 0.1% Doc. In case of the osmotic shock treatment variable time and volume of the 
OS solution was used also incorporated with vortex to enhance the protein release. For 0.1% 
Doc, time variable and volume of the solution were tested. On the left side of the graph, total 
protein released was measured by BCA assay and right side was the amount of Fab released 
in different conditions, both data had already expressed in the same volume. 
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OS1 0.5mL 0.5 hour shaking then 0.5mL cold water 0.5 hour shaking
OS1 0.5mL 0.5 hour static then 0.5mL cold water 0.5 hour static
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OS1 0.5 hour shaking
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This chapter described the further release experiment of Fab D1.3 from 
periplasmic space. As demonstrated in Chapter 2, partially controlled location 
of target protein to accumulate in the periplasm is feasible. Subsequently, the 
extraction procedures can be achieved by different means, namely osmotic 
shock and chemical permeability. Alteration the conditions of osmotic shock 
standard protocol (Neu et al., 1967) suggested more selective and better 
efficiency of the protein releasing. The amount of total protein and Fab D1.3 
released by two different techniques were shown in the Fig. 3.1 (osmotic 
shock and 0.1% Doc). Interestingly, the most release was measured in the 
supernatant of cell re-suspension. There are two possible explanations. Firstly, 
It could be that the cells were frozen after 24 h. Due to the repeat freezing and 
thawing (Johnson and Hecht, 1994), and the formation of ice crystals in the 
cells, the cells perforates and releases the majority of contains. Secondly, the 
integrity of the cells at harvesting stage could be another reason, as already 
discussed in Chapter 2. Although the titre of Fab D1.3 was boosted up to 40 
mg/L in the periplasm, however the cells were incapable of holding intact 
shape, which was suggested by the increase of the DNA concentration in the 
culture broth over time. As shown in Fig. 3.1, most of the target product was 
released during the first re-suspension step (ca ~38 g). Not surprisingly, the 
following osmotic shock could only extract a very little remaining target protein 
within the cells (ca ~5 g). When double or triple the resuspension buffer, 
slightly increase of Fab release was observed (up to 11 g), which also led 
more DNA leaking into the extractions, possibly because the outer membrane 
had been severely damaged after repeating disrupting the cells with sudden 
temperature changes. Comparing various length of incubation time with 0.1% 
 113 
 
Doc to release protein at shaking condition, despite of the volume increase of 
extraction solutions, the length of incubation time shows significant effect on 
protein releasing. Especially doubling the length of incubation time, which 
increased from 15 to 30 minutes with shaking, almost increases 2 fold of 
protein release. As mentioned in the introduction section, that ETDA acting as 
a cation chelator to un-stabilised the outer membrane thereby releasing 
protein from periplasm.  When the incubation time is more than 2 h, mixing 
seemed to enhance the interaction between ETDA and outer membrane 
therefore improving the permeability, which showed above 30 g of Fab D1.3 
was released regardless the length of incubation time for the case of 0.1% 
Doc was employed.   
As suggested by Neu et al., (1967) osmotic shock can be accomplished by 
adding cold water or magnesium solution. Here, 0.5 mL of cold water was 
added to final 1:1 ratio for the final cell concentration in various incubation 
conditions. The results illustrated that incubation with shaking had better 
release than static, in average shaking was 30% more efficient. Up to 0.5 h, 
both conditions showed similar release profile, which implied that shaking 
movement was effectively shorten the length of incubation to achieve that 
same magnetite of protein release in contrast to statically incubation. However, 
it could very much depend on the cell concentration of re-suspension, the high 
OD value might require longer time for incubation in both cases.  The profiles 
of protein release from OS2 (cytoplasm) illustrate that only very little protein 
remained in the cells, causing by the first re-suspension damaged the cell wall 
and primarily target proteins accumulated in periplasm. Employing 0.1% Doc 
as a chemical mean to penetrate bacterial membrane seems to be a more 
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effective method of protein release in comparison of osmotic shock. Only by 
giving minimum 0.5 h to incubate at shaking condition, it was possible to 
release at least 10 g or more regardless different cell concentrations in the 
re-suspension. In particular, the optimum condition, which was 0.1% Doc with 
shaking and 1:1 ratio of cell concentration nearly, matched the amount of Fab 
being released by the first re-suspended step with Tris buffer.  
 
Fig. 3.2. The impact of DNA and Fab D1.3 released by various conditions of osmotic shock 
and 0.1% Doc. In case of the osmotic shock treatment variable time and volume of the OS 
solution was used also incorporated with vortex to enhance the protein release. For 0.1% Doc, 
time variable and volume of the solution were tested. On the left side of the graph, total 
protein released was measured by BCA assay and right side was the amount of Fab released 
in different conditions, both data had already expressed in the same volume. 
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Combining Fig. 3.1 Fig. 3.2 shows the more effective on protein release with 
the higher DNA leakage from cells. Because the main interests in this chapter 
focus on understanding the protein release from periplasm, therefore OS2 
fraction (cytoplasm) was not measured and compared. As shown on Fig. 3.2, 
the average amount of DNA being released by osmotic shock was less than 
0.1% Doc, because the large DNA molecular seemingly acts as large cation 
adsorbents under low pH condition, therefore competing with the cation 
exchange resin of the functional groups of the chromatography material. To 
prevent the aggregation forming and subsequently clogging chromatograph 
column, the less amount of DNA in the feed stock would definitely be better to 
start with chromatographic purification procedure. For the reason, although 
the optimum release condition from periplasmic protein should be using 0.1% 
Doc with shaking for either 0.5 or 2 h, with cell concentration could be 
between 0.5-1 to its original sample volume, but osmotic shock was selected 
for protein extraction method.  
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3.4.2. Releasing Fab D1.3 with Benzonase pre-
treatment in different pH value conditions. 
 
Fig. 3.3 The effects on pH adjustment of osmotic shock 1 solution for protein release and the 
impact on total protein and Fab release after applying Benzonase with samples. On the left 
side of the graph, DNA released was measured by DPA assay and right side was the amount 
of Fab released in different conditions. 
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Fig. 3.4 The effects on pH adjustment of osmotic shock 1 solution for protein release and the 
impact on total protein and Fab release after applying Benzonase with samples On the left 
side of the graph, total protein released was measured by BCA assay and right side was the 
amount of Fab released in different conditions. 
 
The cells were first re-suspended with 20 mM sodium acetate buffer to the 
same optical density value as harvest (OD600nm~25.4). One millilitre of mixture 
was aliquot to 1.5 mL eppendorf tube and centrifuged (15,800 g, 120 s), the 
supernatant was stored for further analyse. Cell pellets were used for the 
osmotic shock or 0.1% Doc chemical release. All the supernatants were 
measured by ELISA (active Fab D1.3 concentration), BCA assay (total protein 
concentration) and DPA assay (DNA concentration) to obtain the results in Fig. 
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3.3 and Fig. 3.4. Benzonase was employed here as a pre-treatment to reduce 
the concentration of DNA in the supernatant by cutting it into small fragments. 
Benzonase was added into supernatant and incubated at 37°C for overnight.  
A speculation reason for the large molecular DNA would eventually acting as 
a cation adsorbent at low pH condition to capture the Fab D1.3 and other 
proteins, whose isoelectric point is higher than 8, would possess positive 
charge on the surface when the pH is below 8. This experiment was designed 
to understand the effect of pH towards releasing efficiency of osmotic shock 
and 0.1% Doc, also to investigate whether DNA was the potential issue for the 
loss of target protein during the pH adjustment.  
It is very clear that the major release occurred at the first step of cells re-
suspension (~40 g/mL), 0.1% Doc could also release around 30 g of Fab 
when applied with the optimum condition. In total, there was nearly 70 g of 
Fab released from 1mL cell pellet, which suggests that the total of Fab is very 
likely underestimated due to the insufficiently releasing ability of osmotic 
shock. Likewise, using 0.1% Doc or osmotic shock for extraction protein from 
the cells observed similar behaviour, not surprisingly, the more protein 
released along with more Fab. However, neither extraction methods showed 
high purity for the Fab release, only 0.6~0.9% of the total protein, which was 
measured regardless the benzonase pre-treatment was performed (Fig. 
3.3).This suggests DNA may not be the reason of Fab loss during the protein 
extraction from the cells because benzonase should eliminate possibility of 
DNA acting as cation exchanger to bind Fab. Further, at pH 7.5, the efficiency 
of release are very similar for both methods, but there is 40% decrease of 
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DNA concentration with pre-treated benzonase sample by using 0.1% Doc 
extraction method. This again has implied that loss of Fab may not be the 
large negative charged DNA group to bind proteins. It is more likely due to the 
precipitation occurred prior to pH adjustment, which showed in Fig. 3.3 and 
Fig. 3.4 that both results with pH 5 condition had much lower amount of Fab 
regardless the benzonase pre-treatment was applied. 
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Fig. 3.5 The effects on using different pH for osmotic shock and afterwards pH adjustment for 
total protein, DNA and Fab release. Data showed in left side was amount of total protein and 
DNA measured in each condition, amount of Fab was shown in right.  
 
In order to prove adjusting pH could be the potential reason of losing Fab 
D1.3 more than the cause of DNA-protein binding mechanism, a step-wise pH 
adjustment was conducted to reveal the story behind it. Differently, this was 
done by directly re-suspended with OS 1 and 2 (1:1 ratio) with 1 mL cell pellet. 
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in the OS2 (cytoplasm). Unlike the previous results, OS 1 fraction extracted 
nearly 35 g of Fab D1.3 from 1 mL pellet, but the purity still remained 
unchanged (0.9%). Close to 400 g of DNA was also released, which is the 
combination amount of DNA from the supernatants of suspended cell at pH 
7.5 in 20 mM sodium acetate and OS1 pH 7.5 (without Benzonase pre-
treatment). This implied the there was no selective release from osmotic in 
this condition, and cell integrity after frozen-thaw and re-suspension process 
were severely compromised. Taken collectively, osmotic shock and 0.1% Doc 
did not perform well at pH 5, only around 10 g or less of Fab was released, 
whereas at pH 8, both can release ~30 g of Fab from 1 mL re-suspended 
cell pellet. Further reduction on pH from 8 to 5 causes a significant lost (~30%) 
of Fab in both cases (Fig. 3.5).  
 
 
 
 
 
 122 
 
3.4.3. Fab D1.3 purification on cation exchange and 
affinity chromatography 
3.4.3.1.  Breakthough study of Fab D1.3 purification on HiTrap 
SP Sepharose XL with culture broth 
 
Fig. 3.6 Chromatogram for the purification of Fab using HiTrap SP_XL (CEX) column. The 
conductivity was reduced from 35 mS/cm to 10 mS/cm and pH was reduced from 7 to 5, 
1200mL of sample from culture broth was loaded. 
 
Table 3.1 Amount of total protein and Fab D1.3 measured by BCA assay and ELISA from 
each step of CEX purification. 
 
  Volume (mL) 
Fab 
D1.3 
(mg) 
Total 
protein 
(mg) 
Target 
yield 
(%) 
Total 
protein 
yield 
(%)
Purity 
(%) 
Purification 
factor 
Load 1200.00 7.77 1996.34 100.00 100.00 0.39 1.00 
FT 1200.00 6.55 1968.78 84.35 98.62 0.33   
Wash 25.00 0.04 7.52 0.48 0.38 0.49   
Elution 50.00 1.18 20.04 15.18 1.00 5.88 15.18 
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Following by the release experiments, it is important to know whether the feed 
stock is suitable for chromatography purification. For the capture purpose, 
cation exchange chromatography (CEX) is very commonly used. Especially, 
the isoelectric point of Fab D1.3 is 8.7, so simply adjust the pH and 
conductivity of feed stock to binding condition should reveal how the Fab 
behaving under binding condition in CEX. Breakthrough experiment is to 
determine the dynamic binding capacity of feed stock applied to CEX. More 
than 1 litre of culture broth was applied to CEX column (HiTrap SP_XL 5mL) 
with pH adjusted from 7 to 5 and reduced conductive from 35 to 10 by 5 time 
dilutions. Culture broth then passed through 0.45 and 0.22 m syringe filters 
for further clarification. 1200 mL of conditioned culture broth on HiTrap SP_XL 
5 mL CEX column with a flow rate of 150 mL/h, then 5 CVs of equilibration 
buffer for washing and 20 CVs of elution buffer for linear elution were applied. 
The chromatogram showed in Fig. 3.6, the binding action occurred before 
loading 100mL of feedstock, which indicated by the slightly fluctuated UV280 
reading. This also suggested that column were quickly saturated by proteins 
in the feedstock. Theoretically commercial CEX column would have minimum 
100-150 mg/L of protein binding capacity which was much higher than the 
amount of total from the elution step (Table 3.1). Another speculation was due 
to the pH adjustment, proteins were precipitating slowly over the loading 
process, which was observed from samples stored overnight in the fridge at 
4°C. While loading the culture broth into the column, the protein precipitation 
was quickly formed due to higher pressure, consequently clogged the 
channels between adsorbents and proteins, thereby preventing protein 
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binding occurs. As the result, the binding capacity of column was dramatically 
decreased. 
3.4.3.2. Fab D1.3 purification on HiTrap SP Sepharose XL with 
OS 1 fraction 
 
Fig. 3.7 Chromatogram for the purification of Fab using HiTrap SP_XL (CEX) column. The pH 
was reduced from 7 to 5, and conductivity was 5 mS/cm without conditioning, 400mL of 
sample from OS1 supernatant was loaded. 
 
Table 3.2 Amount of total protein and Fab D1.3 measured by BCA assay and ELISA from 
each step of CEX purification. 
 
  Volume (mL) 
Fab 
D1.3 
(mg) 
Total 
protein 
(mg) 
Target 
yield 
(%) 
Total 
protein 
yield 
(%)
Purity 
(%) 
Purification 
factor 
Load 400.00 24.91 1450.03 100.00 100.00 1.72 1.00 
FT 400.00 21.43 1399.72 86.01 96.53 1.53   
Wash 25.00 0.37 16.90 1.47 1.17 2.17   
Elution 50.00 3.12 33.41 12.52 2.30 9.34 5.43 
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From the earlier release experiments shown, it could be featured that the 
extract from periplasm (OS1 fraction) is a much better feedstock to start with 
downstream purification in terms of Fab purity, DNA concentration and 
conductivity. There is no requirement for additional dilution to reduce 
conductivity, but still a pH adjustment is required. From previous breakthrough 
experiment, it was noticed that slowly precipitation could be a potential issue 
for chromatography, thereby loading less amount of feedstock from OS1 
fraction would be enough to determine the binding capacity of 5 mL HiTrap 
SP_XL column in relation to use OS1 as feed stock. The purification applied 
400 mL OS1 extract with adjusted pH to 5 after releasing, following by 10 CVs 
of wash phase with equilibration buffer and then 20 CVs of linear elution 
strategy, which can be seen in Fig. 3.7. 
In striking contrast, the protein concentration was higher than in previous 
experiment according to the UV reading, which suggested majority of proteins 
were in the flow through but not bound to the column or the column was not 
blocked due to the condition of feed stock. Furthermore, Table 3.1 illustrates 
that 62% more Fab had been eluted despite of less amount of Fab was 
loaded to the column initially. This was possible due to much cleaner 
environment of periplasm, lower concentration of DNA (See results from 
Chapter 2 ) and higher purity of Fab, comparing Table 3.1Table 3.2, shows 
the significant improve of initial purity of Fab between culture broth and OS1 
(periplasm). Although a huge lost (ca. 60%) of Fab during the pH adjustment 
(showed in Fig. 3.5) could be detected, but extraction from periplasm seems 
offering a promising result for purification via chromatography system. 
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3.4.3.3. Effect of Benzonase pre-treatment for Fab D1.3 
purification on HiTrap SP Sepharose XL. 
 
Fig. 3.8 Chromatogram for the purification of Fab using HiTrap SP_XL (CEX) column. 50 mL 
culture broth conditioned to conductivity of 10 mS/cm, pH 5 was applied.  
 
Table 3.3 Amount of total protein and Fab D1.3 measured by BCA assay and ELISA from 
each step of CEX purification. 
 
  Volume (mL) 
Fab 
D1.3 
(mg) 
Total 
protein 
(mg) 
Target 
yield 
(%) 
Total 
protein 
yield 
(%)
Purity 
(%) 
Purification 
factor 
Load 50.00 0.21 82.48 100.00 100.00 0.25 1.00 
FT 50.00 0.01 72.85 6.28 88.33 0.02   
Wash 25.00 0.01 5.17 5.80 6.27 0.23   
Elution 50.00 0.18 4.45 87.92 5.40 4.09 16.29 
 
The presence of DNA influence on protein purification from above 
experiments remained unknown. This could be the issue of causing 
precipitation during pH adjustment, thereby resulting to the loss of Fab as 
DNA molecular acted as a large cation exchange adsorbent to bind and drag 
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positive charge protein forming precipitation also clogging the column while 
loading the feedstock into it. In order to reveal the mechanism for inhibition of 
protein binding, a control experiment was performed by loading 50mL of 
culture broth on the CEX column followed by 5 CVs of wash and 10 CVs of 
elution. Although elution phase was observed very similar between Fig. 3.6 
and. Fig. 3.8, proteins in the loading phase very quickly occurred in 
flowthrough fraction based on the UV reading. This showed either the column 
was instantly saturated by the protein loaded onto it even though with much 
less amount of feed stock loading, or at the pressure and tiny space condition, 
the column was quickly been clogged because of the precipitation formed 
much quicker than the room temperature condition, which could be a possible 
scenario that precipitation was observed when feed stock left statically in the 
room temperature over a period of 1 hour. Despite all the drawbacks from the 
feedstock condition, the purification factor was 16.29 implied more effective 
on Fab purification than previous two trails (Table 3.1, purification factor: 
15.18; Table 3.2, purification factor: 5.43). Further experiment was conducted 
to check whether adding Benzonase would be an effective solution to resolve 
the binding problem.  
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Fig. 3.9 Chromatogram for the purification of Fab using HiTrap SP_XL (CEX) column. 50 mL 
culture broth with benzonase pre-treatment then conditioned to conductivity of 10 mS/cm, pH 
5 was applied. 
 
Table 3.4 Amount of total protein and Fab D1.3 measured by BCA assay and ELISA from 
each step of CEX purification. 
 
  Volume (mL) 
Fab 
D1.3 
(mg) 
Total 
protein 
(mg) 
Target 
yield 
(%) 
Total 
protein 
yield 
(%)
Purity 
(%) 
Purification 
factor 
Load 50.00 0.24 80.81 100.00 100.00 0.29 1.00 
FT 50.00 0.12 73.64 52.10 91.13 0.17   
Wash 25.00 0.00 5.40 0.84 6.68 0.04   
Elution 50.00 0.11 1.77 47.06 2.19 6.33 21.50 
 
To identify the binding was inhibited by the presence of DNA at low pH 
condition; 50 mL culture broth was pre-treated with benzonase and incubated 
at 37°C for overnight, following by centrifugation and filtrations for loading on 
the CEX column. Notably, at the first half loading phase (~25 mL) showed 
much higher UV reading in comparison with Fig. 3.8. This suggested that 
benzonase was effectively cutting large DNA molecular to small fragments 
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thereby preventing proteins bound to it, as the result more proteins detected 
in the flow through, a peak was clearly spotted at very early of loading phase.  
Although the yield of target protein dropped below 50% by treating sample 
with benzonase, the final purity of Fab and the purification factor had 
increased 2% and 5, respectively. Nevertheless, the elution peak seemed 
smaller than one of the previous results (Fig. 3.8), but the Fab purity was 
increased from 4 to 6.3%, this could be the due to the pre-treatment of 
benzonase. An inference can be drawn from the above result that the 
presence of DNA might not be the major reason for competing protein binding 
onto CEX absorbents, so pre-treatment with benzonase did not improve the 
binding efficiency significantly. The ultimate solution should be to prevent 
precipitation after the pH adjustment so that cation exchange chromatography 
becomes a feasible tool in the capture step. However, because of the nature 
of the feedstock composition, either the binding condition was not ideal or the 
dynamic binding capacity was too low to accommodate the feed stock, 
resulting in a rapid saturation of the column. Although we mentioned using 
HiTrap Protein G column for the Fab purification, but the purification was not 
successful, results showed no binding and elution (Data no shown). Even 
though affinity adsorption is not affected by the conductivity of feedstock, but 
the HiTrap Protein G column has failed to bind any Fab, possibly due to the 
same reason as CEX, that precipitation was quickly occurring while the 
feedstock being loaded onto column. Despite of all the efforts so far, such as 
prolonged the Fab production phase, directing accumulation of Fab into 
periplasm by altering growth conditions (temperature, induction timing, IPTG 
concentration) and seeking optimisation of releasing methods and conditions 
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(osmotic shock and 0.1% Doc), still faced many unsolved problems in the 
downstream purification process. An alternative E.coli strain producing anti-
body fragment will be necessary for further research.  
3.5. Conclusions 
Growth at 25°C and induction at 20°C resulted in the greatest accumulation of 
FabD1.3 within the periplasmic space (Chapter 2). Under these conditions the 
Fab represented 1.5 –1.7% of the total soluble protein. A distinct advantage of 
the periplasmic processing route is minimal conditioning of the OS1 fraction 
(ionic strength <6 mS/cm, pH ~7.5) prior to CEX adsorption of the Fab (simple 
pH adjustment is required). Feedstock conditioning and Fab D1.3 recovery 
were examined to seek for the optimum release condition and minimal 
feedstock conditioning. From the above results suggested optimal condition 
for releasing Fab from periplasm should be using 0.1% Doc with shaking for 
either 0.5 or 2 h, with 0.5-1 ratio of the cell concentration to the original 
sample volume. However, the DNA leakage proves to be a potential issue in 
the subsequent chromatographic purification. Therefore, osmotic shock was 
still proven to be a more suitable extraction method.  
The following feedstock conditioning on composition of feedstock results 
showed that small (~10%) loss in Fab occurred following dilution of cell-free 
broth (~ 10 mS/cm), pH adjustment (~ pH 5) and clarification (filtration through 
a 0.2 µm membrane) however, this was offset by a greater loss in 
contaminating host protein (~30%), resulting in improved feedstock quality 
(1.2 fold purification of Fab). Prior treatment of the cell-free broth with 
benzonase was expected to prevent protein aggregation with large DNA 
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molecular therefore avoiding Fab loss altogether (26% loss; resulting in ~1.4 
fold enhanced Fab purity), and increased ease of clarification by filtration by 
reducing the degree of precipitation. However, benefits on CEX purification 
performance were mixed, i.e. higher degree of purification (step PF of 22 cf. 
16 and final purity of 7.1% cf. 4.1%), but lower step yield (50% cf. 88%).  
Furthermore, a breakthrough studies was conducted with conditioned cell-free 
broth (lacking benzonase) and OS1 to discover extremely low capacity Fab 
binding (0.4 mg/mL cf. 0.6 mg/mL for conditioned cell-free broth and OS1 
respectively) to the SP Sepharose XL. The purity of Fab eluates coming off 
OS1 loaded columns were roughly twice those eminating from columns 
supplied with conditioned broth (10% cf. 5%). The presence of non-
proteinaceous material (nucleic acids, LPS) plus high protein contamination 
likely contribute to the disappointing CEX purification performance observed 
with both conditioned broth and OS1 feedstocks. Attempting to purify Fab 
D1.3 directly from culture broth by rProtein G affinity chromatography was 
proved unsuccessful (Fab failed to bind), but highly pure (98-99%) Fab D1.3 
was obtained when PD10 desalted CEX elution pools were applied to rProtein 
G Sepharose columns (Jalalirad, 2010). 
Thus far, despite the clear results obtained from the release experiment 
suggested the total yield of Fab D1.3 could be underestimated (ca.  70 mg/L) 
and applying 0.1% Doc might be the better the option for Fab release 
compared with the osmotic shock, but all the subsequent chromatographic 
purification with conditioned culture broth and OS1 supernatant (CEX and 
rProteinG) results were unsuccessful. Regrettably to say, even though the 
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titre of Fab D1.3 could be improved to meet our goal (~100 mg/L), but the 
following purification would be very troublesome and nearly impossible to 
proceed. 
It is therefore an alternative E.coli strain for robust anti-body fragment 
production (A33 Fab), which is kindly offered from UCB Celltech (Humphreys 
et al., 1996, 2002), will be employed for the next chapter and hopefully 
provide workable feedstock for European Framework 7 project partners to test 
newly designed magnetic particles and devices (chapter 5) . 
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4. Production and release of periplasmic 
A33 Fab  
4.1. Abstract 
A plasmid produced A33 Fab was kindly provided from UCB Celltech. One of 
the main advantages employing this plasmid is to express Fab into periplasm 
in E.coli. A preliminary study on shake flask experiments first to confirm the 
higher protein expression titre over the Fab D1.3. In combinations of improved 
and company supplied protocols generated around 0.3 g/L releasable Fab 
from a single batch of 3 litre fermentation. Following by a systematically 
investigation of release methods and conditions, which was comparing the 
osmotic shock, heat treatment and SMALPs ([poly(styrene-co-maleic acid) 
lipid particles]) to release A33 Fab from periplasm in various conditions. 
Despite the osmotic shock has been widely accepted for the protein release, 
but in this particular case, heat treatment exhibited highly selective and 
effective for A33 Fab extraction. Although SMALPs has been proven 
successfully in few applications for the proteins extraction and possible 
designed for in vivo uses but the release ability was not significant as heat 
treatment in this study. It is therefore, heat treatment was selected to carry out 
further optimisation. The result indicated that maximum protein release 
occurred in buffer to cells ratio at 0.5 to 1 (i.e. cell density ~ 27% w/v), which 
compared with the standard protocol (provided by UCB Celltech) 1 to 1 ratio 
(i.e. cell density ~ 13% w/v), was 10% more effective in terms of [total protein] 
release. 
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4.2. . Introduction 
4.2.1. A33 Fab 
There are many forms of antibodies can be produced by E.coli, in previous 
case, Anti-HEWL Fab D1.3 was used as a model protein for assessing 
production titres by altering growth temperature, IPTG concentration and 
timing of induction (see chapter 2). Despite the significant improvements on 
the quality of Fab D1.3 in terms of solubility and purity from crude extract, the 
overall titre of Fab D1.3 was still too low to meet requirements, which 
minimum was aiming no less than 100mg/L of [Fab] per batch of fermentation. 
For this reason, another antibody plasmid was enquired and kindly supplied 
by UCB Celltech. 
Monoclonal antibodies (MAb) can be effective for the treatment of a wide 
range of diseases, dealing with illnesses from cancer to infections (Mücke et 
al., 2009). Typically MAbs are produced by the mammalian cells due to its 
complex polypeptide structure also needing post-translational modification 
after expression, mainly N-linked and O-Linked glycosylation are identical 
modification which discovered in humans. However, production in mammalian 
cells require high standard of research for building the cell line, time 
consuming cultivation and expensive media, also pathogenic viral clearance is 
required the human therapy. 
Fig. 4.1 shows the Fab as a therapeutic molecule derived from an antibody in 
which the effector functions (receptor blockade, receptor activation/cross-
linking, antigen blockade) are not required, but the therapeutic activity is 
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retained (Humphreys et al., 2002). The main disadvantage of using Fab for 
the therapeutic purpose is the short half-life in the human circulation system. 
The solution was proposed by Chapman (2002) by coupling polyethylene 
glycol in specific sites will effectively extend the half-life of Fab. Because of 
glycosylation is not required for Fab to improve its half-life which offers a very 
attractive choice Escherichia coli for more robust Fab production in 
comparison with mammalian cell (Humphreys et al., 2002). There are many 
advantages considering using this production system including the wide 
genomic knowledge available, the easiness of gene manipulation, availability 
of expression vectors, adaptability to express a wide range of recombinant 
proteins, the speed of development and the short fermentation cycle (Ramírez 
and Bentley, 1995; Baneyx, 1999; Simmons et al., 2002; Fountoulakis and 
Gasser, 2003; Hu et al., 2007). 
 
Fig. 4.1 Structural representation of an antibody and its basic regions (Adapted from Lydyard 
et al., 2004) 
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One important consideration when producing recombinant proteins such as 
Fab is the design of the expression vector that will carry the foreign gene to 
be expressed by the bacteria. In this case the expression vector consists of a 
plasmid carrying the genes for the light and heavy chains of the Fab as well 
as for tetracycline resistance, used for selection and preventing empty host 
out growing the containing cell during the production(Lee and Edlin, 1985; 
Ratledge and Kristiansen, 2006). The choice of using tetracycline has been 
made because it has been reported that tetracycline resistance marker offers 
less plasmid loss during recombinant protein production unlike ampicillin 
(Novagen, 1999). 
A low copy number of plasmid system is advantageous for expression the 
recombinant protein as the metabolic burden will not overly loaded for the 
cells (Hoffmann and Rinas, 2004). This allows separate the growth phase 
from the production phase as the plasmid’s genes will not be expressed until 
the Isopropyl β-D-1-thiogalactopyranoside (IPTG) or other inducer (i.e. lactose) 
is applied to inhibit the repressor and start the transcription for making 
recombinant proteins. IPTG is an allolactose analogue that activates the Lac 
operon. As it cannot be metabolised by E. coli the concentration remains 
constant, thus the lac controlled genes have a steady expression rate 
throughout the experiment (Ratledge and Kristiansen, 2006). Furthermore, it 
is also important to use strains in-cooperate with few mutations for the 
protease deficiencies and temperature adaptation, which would enhance 
higher yields of Fab (reviewed by Weickert et al., 1996). 
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4.2.2. SMALPs [poly(styrene-co-maleic acid) lipid 
particles] 
In the plastic industry, SMALPs [poly(styrene-co-maleic acid) lipid particles] is 
broadly used for numerous applications. This pH responsive/dependent 
polymer has brought huge interests to bioengineers recently, especially in 
drug delivery applications (Maeda et al., 2009) due to its amphipathic 
properties. It is because various ratios of combining Maleic acid (hydrophilic) 
and styrene (hydrophobic) make the polymer itself amphipathic. Depending 
on the either composition, the richer constituent decides the character of the 
polymer. Low molecular mass polymer is soluble at neutral pH, under pH 6, 
the maleic acid group dominate positive charge, the polymer becoming 
insoluble. 
 
Fig.4.2 Mechanism of SMA form a disc with membrane protein. Adopt from (Jamshad et al., 2011)  
 
Researchers (Knowles et al., 2009) have shown that, SMA will auto assemble 
a disc form in the presence of lamellar membrane that contain a lipid interior 
surrounded by an SMA annulus. This behaviour closely matches of the other 
nano-encapsulation methods offering the opportunity to use the material for 
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membrane protein purification. It was because the process produces a 
remarkably homogenous particle with a diameter between 9 and 11 nm. A 
purification example of applying SMA directly to bilayers without any 
additional treatment with surfactant, which contain the naturally abundant 
proteins bacteriorhodopsin and PagP has demonstrated the great potential for 
the protein purification. In each case, the SMA clarified the turbid membrane 
solution and was amenable to conventional protein purification methods. A 
method for directly solubilising proteins from their native environment into a 
form that is highly amenable to many downstream studies (Jamshad et al., 
2011). Seemingly, SMALPs has great potential as a generic mean dor 
periplasmic protein release by destabilising the membrane and encapsulating 
the proteins providing similar native surrounding environment but its specificity 
remains unclear. It is therefore we would like to ultilise SMALPs in this study 
to investigate the efficiency on periplasmic protein and any specificity for A33 
Fab release. 
Humphreys et al. (2002) have shown development to achieve high Fab 
production (580 mg/L) targeting in the periplasm. This would be very 
promising for us to employ similar strain provided by UCB Celltech to 
production substantial quantity of the A33 Fab. By conducting preliminary 
study on shake flasks cultivate the W3110 E.coli harbouring pTTOD 
A33gL4gH2Fab plasmid to express periplasmic A33 Fab for investing the 
effect of IPTG concentration and temperature on cell growth and recombinant 
protein production. Based on the information gathers from shake flask 
experiment, 5 L scale fermentation will be performed to obtain sufficient 
amount of Fab (≥ 100 mg/L) for further investigation on protein release 
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methods, namely osmotic shock, heat treatment extraction and SMALPs. 
Depending on which method gives the best result, a systematically study will 
be carried out for seeking the optimum operation condition. 
4.3. Material and methods 
4.3.1. E. coli transformation and cell bank production 
The A33 Fab expression plasmid DNA (pTTOD A33gL4gH2Fab) was 
received from UCB Celltech (UCB Celltech, Slough, UK). 100 l of W3110 
E.coli competent cell suspension were mixed with 3 l of Fab expression 
plasmid and incubated on ice for 1 h. Bacteria were treated with heat shock at 
42°C for 120 s to stimulate plasmid uptake. 0.5 mL of super-optimal catabolite 
repression (SOC) medium was added to treated cells and the suspension was 
incubated at 37°C for 1 h. Cells were harvested by centrifugation (Centrifuge 
5415D, Eppendorf AG, Germany), re-suspended in 100 L of SOC medium 
(2% tryptone, 0.5% yeast extract, 10 mM sodium chloride, 2.5 mM potassium 
chloride, 10 mM magnesium chloride, 10 mM magnesium sulphate, 20 mM 
glucose), spread on nutrient agar (NA) plates with tetracycline (10 g/mL) and 
incubated at 37°C overnight (Laboratory oven, LTE-Scientific Ltd, UK). 
A single colony was collected and cultivated in 80 mL LB broth with 
tetracycline (10 g/mL) at 37°C, 200rpm overnight (Cooled orbital incubator, 
Gallenkamp, UK). After growing bacteria 20 mL sterile glycerol was added to 
flask and mixed gently. Culture was loaded into Eppendorf tubes with 0.5 mL 
and stored at −80°C until required. 
 143 
 
4.3.2.  Inoculum culture 
Twenty millilitre of ‘SM6E’ production media (5.2 g/L (NH4)2SO4, 4.14 g/L 
NaH2PO4 · H2O, 4.025 g/L KCl, 1.04 g/L MgSO4 · 7H2O, 5.20 g/L citric acid, 
31.111 g/L glycerol, 0.0522 g/L CaCl2 · 2H2O, 0.0206 g/L ZnSO4 · 7H2O, 
0.0272 g/L MnSO4 · 4H2O, 8.1 mg/L CuSO4 · 5H2O; 4.2 mg/L CoSO4 · 7H2O, 
0.1006 g/L FeCl3 · 6H2O, 0.3 mg/L H3BO3, 0.2 mg/L Na2MoO4 · 2H2O, pH 
adjusted to 6.95 with NH4OH, and 0.1 mg/L tetracycline were seeded with 3% 
(v/v) cell bank suspension (Humphreys et al., 2002). Inoculum cultures were 
shaken overnight (20−22 h) at 200 rpm and 30°C.and the final OD600nm was 
around 5.2. 
4.3.3. Shake flask experiments 
Four per cent of inoculum culture was added to 100mL ‘production medium’ in 
500mL flasks and incubated at 200rpm, 30°C and 25°C. Initial OD600nm ~0.25., 
at OD600nm 0.5, [IPTG] was added at 0, 8, 50, 100, 150, 200 and 500M to 
induce Fab expression. Experiments were carried out in duplicates. Double 
samples were taken every 2 h and up to 24 h post induction as indicated in 
the figures. Fresh samples were centrifuged at 15,800 g for 300 s. The 
supernatant was recovered and stored in sterile tubes. The supernatant and 
cell pellets were stored at −20°C until required. 
4.3.4. Modified UCB Celltech and improve protocol 
One hundred millilitre of the overnight inoculum was add into 2 L "SM6E" 
media (Humphreys et al., 2002) in a 5 L Electrolab fermentor (Tewkesbury, 
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UK) to continue culture till reached OD600nm ~30, the glycerol (714 g/L 99.9% 
glycerol, 30 mL 1M (NH4)2SO4) feed was started with feb-batch feeding rate 
(Chapter2, section 2.3.3.2, Equation 2.1) until the end of the fermentation 
process, induction was made with [IPTG] of 0.5 mM when OD600nm reached 
80, temperature was decreased from 30°C to 25°C upon induction. Samples 
were taken every 2 h to measure optical density and harvest at 24 h post-
induction.   
4.3.5. Protein release methods 
4.3.5.1. Osmotic shock 
Protocol was the same as described in Chapter 2 (methods section 2.3.4). 
4.3.5.2. Heat treatment 
The heat treatment employed was recommended by UCB Celltech Ltd and 
(Weir and Bailey, 1995; Humphreys et al., 2002). Routinely, the cell pellets 
were resuspended in 1 mL of 100 mM Tris buffer pH 7.4 supplemented with 
10 mM EDTA. 4). Incubate the suspension at 60°C for ~16 h (overnight), with 
agitation at 200 rpm, clarify the supernatant by applying centrifugation at 
15,800 g for 10 minutes, and the supernatants were immediately frozen at 
−20°C for further A33 Fab analysis. 
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4.3.5.3. Preparation of SMALPs [poly(styrene-co-maleic acid) 
lipid particles] 
Weighing 25 g of poly(styrene-co-maleic acid polymer and transferred to a 
500 ml round bottom flask then gently mixed with 250 ml 1 M NaOH for 
overnight at room temperature on a magnetic stirrer. In a Fume hood, 
removing magnetic flea and added a few anti bumping granules then placing 
round bottom flask on a heating mantle with a condenser attached and turned 
maximum heat level until polymer and NaOH solution reached boiling point, 
turned heat down to continue gentle reflux for 2 h. Ensure the condenser was 
connected to water supply and there was flow allowing polymer/NaOH to cool 
to room temperature in Fume hood with the condenser still connected and 
water flowing. The percentage of polymer content was re-calculated by the 
remaining mixture volume content of the polymer. Carefully aliquot 5mL into 
labelled tubes with volume of aliquot and percentage polymer content and 
store aliquots frozen at −20°C for further use.  
For use the polymer, first thaw sample at room temperature then dialysing 
against buffer (50 mM Tris buffer pH 8.0 or 50 mM Phosphate buffer pH 8.0). 
At least 3 changes of buffer were required over a period of 24 h for ensuring 
there was the least possible space above the polymer to the clip or knot in the 
tubing or the volume would swell too much and too low a percentage of 
polymer achieved. Using at least 1 L buffer per change for 40 to 50 ml of 
polymer dialyse. Measuring volume of dialysate and re-calculate polymer 
content percentage and store dialysed Polymer in the fridge but used at room 
temperature 
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The 2.5% SMALPs was prepared from the above dialysed stock with 1 % lipid 
in 50 mM Tris pH 8.0 at room temp for periplasmic release (2.5% SMALPs 
solution was kindly provided Prof. Tim Dufforn, School of Bioscience, 
University of Birmingham, UK).  
4.3.6. Systematically periplasmic release experiment 
A systematic release experiment was conducted with various release 
methods and conditions. Heat treatment, 2.5% SMALPs in 50mM Tris buffer 
pH 8.0 and 50 mM Tris buffer pH 8.0 were employed to extract the protein 
from periplasm in E.coli. Each cell pellet (1 mL fermentation sample harvested 
at 24 h post-induction) was added 1mL or 3 mL of different releasing buffers 
then incubating and vortexing at 200 rpm at room temperature for 2 h or 
overnight, only the heat treatment was performed at 60°C  
4.3.6.1. Heat treatment release on various cell density 
Various ratios of the heat treatment buffer were applied 4, 2, 1, 0.5, 0.4, 0.3 
and 0.2 mL to re-suspend 1mL cell pellet (24 h post-induction), then 
Incubated the suspension at 60°C for ~16 h (overnight), agitated at 200 rpm. 
Clarifying the supernatant by centrifugation at 15,800 g for 10 minutes, and 
the supernatants were immediately stored and frozen at −20°C for A33 Fab 
analysis. 
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4.3.7. Analysis 
Optical density, BCA assay and DPA assay were done as described in 
Chapter 2 (section 2.3.5.1−3). 
4.3.7.1. Colony forming units 
Serial dilutions of fermentation samples were prepared aseptically in PBS for 
viability counts. One hundred microlitres aliquots of serial dilutions were 
plated onto LB agar plates supplemented with 15 mg/L tetracycline, and 
following overnight incubation at 37°C, the number of colony forming units 
(CFU) was measured by counting colonies on plates containing less than 300 
colonies according to following formula. 
CFU/mL = No. of colonies × dilution factor × 10 
4.3.7.2. 14 % SDS-poly-acrylamide gel electrophoresis (SDS-
PAGE) for A33 Fab protein separation 
The resolving gel was prepared with 3.86 mL dH2O; 3.75 mL 1.5M Tris, pH 
8.8; 150 L 10% SDS; 7.15 mL Ultra Pure Protogel (National Diagnostics, UK); 
75 L 15% APS; and 15 L TEMED to a total 15 mL solution sufficient for 
casting 4 mini gels. The stacking gel was made by adding 3 mL dH2O; 1.25 
mL 0.5M Tris, pH 6.8; 50 L 10% SDS; 625 L Ultra Pure Protogel; 25 L 
15% APS; and 5 L TEMED to a total 5mL solution enough for casting 4 mini 
gels. Cell pellet samples were re-suspended in sample buffer according to the 
OD (Laemmli sample buffer (Bio-Rad Laboratories, USA); with β-
mercaptoethanol. Samples were boiling at 110°C for 15 minutes in the Dry 
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block heating system (Grant Instruments (Cambridge) Ltd, UK). Samples 
were spun down at 15,800 g for 10 minutes. Ten microlitre of the sample’s 
supernatant were loaded per well. Five microlitre of See Blue® Plus2 
Prestained Standard (Invitrogen, USA) was loaded as marker/reference. SDS-
PAGE tray was filled with Tris-Glycine-SDS-PAGE (TGS) buffer (Fisher 
Scientific Ltd). Gels were run at 50V for 0.5 h, followed by 2 h at 100V 
(OmniPAC MIDI, Geneflow, UK). Gels were stained with Simply BlueTM 
SafeStain (Invitrogen, USA) for 1 h and left in dH2O overnight for distaining 
and washing. 
4.3.7.3. Sandwich ELISA for A33 Fab 
ELISA plates were coated at 4°C overnight with 2 g/L sheep anti-human IgG 
(The Binding Site, UK) in PBS solution. The coating buffer was discarded and 
wells were loaded with 200 L of blocking PBS-BSA solution (prepared by 
adding 1 PBS tablet and 1 g of BSA in 100mL dH2O) and incubated at 37°C, 
250 rpm for 1h in plate shaker. The blocking buffer was discarded and ELISA 
plates washed three times with 300 L wash buffer (prepared by adding 5 
PBS tablets and 50 L of Tween−20 in 500 mL dH2O) then tap dried. ELISA 
plates were loaded with 100 L of unknown samples (CB, OS1 and OS2 
fractions) and standard (purified Fab) samples. Four consecutive 1/4 serial 
dilutions were performed per unknown sample and eight consecutive 1/3 
dilutions were carried out for the standards to develop the standard curve for 
estimating [Fab]. ELISA plates were loaded with diluted sample and 
standards then incubated at 37°C, 250 rpm for 1 h. The sample solution was 
discarded and the plates were washed three times with 300 L wash buffer 
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and tap dried. One hundred microlitre of detection antibody solution, made 
from 20 mL of blocking buffer containing 2 L of goat anti-human Fab 
peroxidase conjugate (Sigma-Aldrich, UK), were loaded into ELISA plates and 
incubated at 37°C, 250 rpm for 1 h. The detection antibody solution was 
discarded and the plates were washed three times with 300 L wash buffer 
and tap dried. One hundred microlitre of TMB Microwell Peroxidase Substrate 
System (2-C) (Insight Biotechnology Ltd, UK) were loaded per well and 
incubated at room temperature, at 250 rpm for 10 minutes. The reaction was 
stop by adding 100 L of 1 M H3PO4 per well. The absorbance was measured 
at 450nm in GloMax®-Multi Detection System. ((Humphreys et al., 1996, 2002) 
4.3.7.4. Western blotting for A33 Fab 
Protein samples were separated using gel electrophoresis as described in the 
SDS-PAGE section. Proteins were transferred onto Hybond-P PVDF 
membrane (Amersham, UK) following the manufacturer’s blotting protocol in 
the Mini Trans-Blot® Electrophoretic Transfer Cell module (BioRad, USA). 
Membrane was incubated with Mouse Anti-Human Kappa-HRP (Southern 
Biotech, USA) as primary antibody (1/10,000). Colorimetric detection was 
used for blotting development by addition of TMB Membrane Peroxidase 
Substrate System (3-C) (KPL, USA) according to product’s instructions. 
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4.4. Results and discussions 
4.4.1. Growth & DNA profiles from shake flask 
cultivations performed at 30°C with different IPTG 
concentrations  
The preliminary shake flask experiment was conducted according to the 
protocol suggested by the UCB Celltech to verify the plasmid (pTTOD 
A33gL4gH2Fab) was correctly transformed into E.coli W3110 strain. Based 
on the previous results (see chapter 2) and the improved protocol 
(Sevastsyanovich et al., 2009), different concentrations of IPTG for induction 
were tested at 30°C, 200 rpm cultivation condition. Samples were taken every 
2 h after induction and 24 h post induction to measure optical density, and 
plated on agar plates for the colony form unit (CFU) to observe the cell 
viability throughout the cultivation. DNA concentration in culture broth was 
measured by DPA assay as an indicator for cell status over the period of 
cultivation. When the DNA concentration increases in the culture broth 
meaning more cell lysis were occurring during the cultivation process, 
meanwhile CFU would decrease to reflex the loss of cell viability. Therefore, 
there would be a potential risk of losing Fab into culture broth when the cell 
integrity is compromised thereby containing the target protein with DNA and 
other protein species, eventually causing the same problems we have 
encounter with Fab D1.3 in the purification process.  
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Fig. 4.3 Results of impacts on [IPTG] for the cell viability and DNA leakage to culture broth 
from various time points. a Plot of the colony form unit with different [IPTG] induction. b 
Optical density readings after induction with different [IPTG] c [DNA] in culture broth 
measured by DPA assay. 
 
The CFU data from Fig. 4.3a illustrates the effects of induction with different 
concentration of IPTG on the cell viability. There are two separated group can 
be observed. Clearly, applied 100 M and above IPTG for induction have 
strongly negative impact on the cell viability which can be seen the CFU 
counts are decreasing in every sampling point. On the other hand, the 
negative control and low concentration of IPTG (8 and 50 M) have 
consistently increased of CFU counts within the first 8 h post induction but 
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decreased in the end of cultivation. The result has suggested the balance for 
induction at low biomass (OD600~0.5) but not affected on cell viability was 
between 50 to 100 M IPTG. Higher amount of IPTG could cause cell stress 
response and damage on cell metabolism thereby preventing the recombinant 
protein production (Kosinski et al., 1992; Miao and Kompala, 1992; Donovan 
et al., 1996; Kilikian et al., 2000). 
Similar tendency of results observed in the Fig. 4.3b, which illustrates the 
higher biomass achieved by inducing with lower concentration of IPTG. 
Whereas the higher concentration of IPTG shows flatted on the OD600 reading 
(~1). Further, Fig. 4.3 (a and b) have confirmed with each other when applied 
the IPTG concentration above 100 M resulted OD~1 thereby CFU count at 
24 h post induction was around 10 to 7th power. This has proven that cells 
could not tolerate under high concentration of inducer as compared to the 
negative control and 8 M IPTG applied. Both have ended with higher final 
OD reading also higher CFU counts (Fig. 4.3 a and b). Although using 50 M 
IPTG has reached final OD around 4 but the CFU count was similar to other 
higher concentration IPTG applied. This implies the real living cells were 
much less than it showed on OD reading, cell debris could be the factor to 
misleading the actual biomass estimated by the optical density reading.  
Measurements of DNA concentration in culture broth per OD reading gave the 
information regarding to the cell condition shows in Fig. 4.3c. Induction with 
IPTG below 50 M, there was nearly untraceable amount of DNA in the 
culture broth. Surprisingly, applied 100 M and 150 M IPTG resulted 42 
mg/L and 85 mg/L of DNA leaked into culture broth, whereas the higher 
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concentration IPTG did not lead to higher amount DNA in the culture broth. 
This might be linked with cell viability as mentioned above that cells were not 
able to tolerate under such high concentration of IPTG. Because the surviving 
cells were much less with high concentration IPTG applied compared with 
other conditions, subsequently decrease of DNA concentration in culture broth 
can be observed after reaching the peak with 150 M IPTG condition. Overall, 
the above results have suggested that induction with IPTG higher than 150 
M was unsuitable as those conditions might over-stress the cells to the point 
of death and lysis. The optimum concentration for induction seemed to be 
between 50 and 100 M to balance the cell viability and DNA leakage to the 
culture broth at 30°C. For this purpose, those two conditions were selected for 
further optimisation as it seemed to be on the borderline of cell tolerability. 
4.4.2. SDS-PAGE and western blotting analysis for 
shake flask experiments conducted at 30°C with 
different [IPTG]. 
The molecular weight of A33 Fab recombinant protein is estimated around 25 
kDa (Humphreys et al., 2002). Protein samples were pre-treated with β-
mercaptoethanol and boiling at 110°C for 10 minutes to reduce disulphide 
bond prior to loading on 14% SDS-gel for protein separation. 
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Fig. 4.4 Reducing 14% SDS-PAGE analysis shows shake flask cultivations performed at 30°C with different IPTG concentrations. Samples were 1 mL cell 
pellets collected in different time points after induction as showed on each lane. Black boxes indicate the protein band of A33 Fab on the gel. The numbers 
below the gels show the relative amount of Fab (measured by area analysis using ImageJ software). 
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Previously in Fig. 4.3 studied on the impact of IPTG concentration to the cell 
integrity and viability. Subsequently it is important to investigate the 
recombinant protein expression in relation to the inducer concentration. The 
1mL cell pellets were collected from different timing and loaded on 14% SDS-
PAGE to separate proteins in the cells. Analysing the intensity on the gel for 
A33 Fab by ImageJ, a colorimetric method, compared from 0 to 500 M IPTG 
applied for the Fab induction. As can been seen the result in Fig. 4.4, there 
are no clear protein express of A33 Fab for 0,8 and 50 M IPTG, even at 24 
h post induction. Although the software has detected very minor signal from 
the gels, but is not possible to see. Induction with higher concentration IPTG 
(i.e. 100 M of IPTG and above) have clearly showed a band just slightly 
above 22 KDa protein marker at 24 h post induction. Furthermore, the protein 
band intensities measured by colorimetry have shown huge increase between 
100 M and 200 M of IPTG from 14.5% to 23% of A33 Fab.  
Studies by Donovan et al. (1996) has review several factors (i.e. temperature, 
IPTG concentration, type of inducer lactose or IPTG, timing of induction, 
growth media and duration of induction phase) for optimising the protein 
production in E.coli. When induced with IPTG for recombinant protein 
production, will allow the separation of cell growth phase and protein 
synthesis phase, therefore when the higher biomass is achieved, the higher 
yield of protein could be produced. In addition, Kosinski and co-workers (1992) 
designed the H35 stress response protein in E.coli to demonstrate the stress 
response when the IPTG was applied for the foreign protein production and 
also suggested that IPTG might cause the decrease in specific growth rate. 
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It is therefore we can explain the reason of the highest IPTG concentration 
(500 M) did not continuously increase yield of Fab but only had 15% 
compared with other conditions. The results in Fig. 4.4 have suggested that 
there is a limit to use IPTG for protein expression in E.coli. The higher IPTG 
concentration might offer higher yield of Fab production. However, with 
excessive amount of inducer (e g. 500 M) will cause negative effect on the 
protein production (Kosinski et al., 1992; Donovan et al., 1996). Based on the 
analysis of colorimetry, the strongest band intensity of Fab occurred with 200 
M IPTG applied; also steady increase of Fab expression was observed of 
induction from 50 M to 200 M IPTG. From the results of the preliminary 
shake flask experiments allowed us to understand the limitation of this Fab 
strain and the possible operation window for the following fermentation.  
A specific and efficient protein detecting procedure after transferring from 
SDS electrophoresis to a PVDF membrane (Burnette, 1981). Due the nature 
of the immunology, A33 Fab specifically reacts with anti Fab than other 
protein species on the gel. This method allows us to clarify and confirm the 
type of proteins separated on the SDS-PAGE.  
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Fig. 4.5 Western Blot analysis shows the effect of [IPTG] on A33 Fab production in shake 
flask experiments at 30°C. Loading sample of 1 mL cell pellet (24 h post-induction), separated 
by 14% SDS-PAGE, followed by wet transferring to PVDF membrane for western blotting with 
IgG specific anti Fab produced in Goat. 
 
Undoubtedly, the result in Fig. 4.5 confirms the A33 Fab was correctly 
expressed in the shake flask experiments. Strikingly, there is strong signal 
observed from 100 M and above conditions. A very minor band barely shows 
on the membrane for the 50 M IPTG condition. Analysing the four strong 
bands by colorimetry, the results suggests the maximum production obtained 
with 150 M IPTG for induction which is around 10% higher than the 100 M. 
For the higher IPTG concentration (200 and 500 M) were down to 55~60% 
of Fab production compared to the optimal results. Despite of the higher 
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production with applying 150 M IPTG to induce, but the overall cell viability is 
poor compared with 100 M IPTG applied (Fig. 4.3 a and b). The CFU and 
OD reading was much lower in the higher IPTG condition, also the increasing 
amount of nuclear acids leaked into the culture broth. Taken collectively, we 
have selected using 50 M and 100 M of IPTG for the further optimisation 
experiment. 
4.4.3. Cultivating A33 Fab with temperature downshift 
(30°C to 25°C) upon induction in shake flask 
Taking a step forward from above results and experiences of adopting 
improve protocol (Sevastsyanovich et al., 2009), lowering the temperature 
would be a viable strategy to apply for increase the Fab production and 
maintaining the use of high concentration IPTG for impulse expression. 
Therefore, cultivation temperature was decreased from 30°C to 25°C in this 
set of shake flask experiment. The reason of lowing temperature upon 
induction was minimising the stress response caused by inducer (Vera, 2007; 
Pinsach et al., 2008) thereby prolonging the protein production phase. In 
addition, lower the chance of incorrect protein folding; simultaneously prevent 
a sudden shock to the cells leading death and lysis. Fig. 4.6 was the cell pellet 
sampled in different time intervals after induction with 0, 50 M and 100 M 
IPTG separated by 14% SDS-PAGE, when compared the results from Fig. 4.4 
and Fig. 4.6. 
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Fig. 4.6 Reducing 14% SDS-PAGE analysis of 1mL cell pellets at different point of induction , 
after reducing the temperature (30°C to 25°C) at point of induction. The number showed on 
the bottom of the gel indicated the percentage of Fab estimated by ImageJ.  
 
In striking contrast, lowering the temperature to 25°C upon induction resulted 
in significant increases in percentage of Fab content. The yield of A33 Fab 
has risen from: 3.4 to 15.7% for 50 M IPTG; and 15.4 to 24.8% for 100 M 
IPTG compared the results in Fig. 4.4 Fig. 4.6. Although there was a larger 
(12.3%) increase of Fab with 50 M but applying 100 M was able to push 
the Fab up to 24.8% of [total protein] (ca. 339.1 mg/L) within the cells, 
therefore, the potential yield of A33 Fab could be around 84.1 mg/L. This 
significant improvement on the Fab production was very promising and 
encouraging. The result has demonstrated the possibility to achieve our goal 
(100 mg/L) of producing A33 Fab in a 5L scale fermentor, as a quarter of total 
protein within the cells could be potential product. 
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4.4.4. Production of humanised A33 Fab with 
temperature shift strategy in 5 litre fermentor 
A 5 L scale fed-batch fermentation with E.coli W3110 strain harbouring 
plasmid (pTTOD A33gL4gH2Fab) (Celltech, UK) was carried out in order to 
increase the overall Fab production. Experiment was conducted as described 
in method section (4.2.4), induction with 0.5 M IPTG was performed when 
OD600 reading reached 80. However, in this batch, the induction was 
performed at OD600nm ~107.2 then harvesting at 24 h post-induction, final OD 
reading was 158. 
 
Fig. 4.7 Result of A33 Fab fermentation. Harvested at 24 h post-induction, recommended 
harvesting time will be 24-36 h post-induction (UCB Celltech) 
 
A very typical E.coli growth cure in the minimum media has shown in Fig. 4.7. 
The first 8 h cells grew steadily and slowly which can be indicated by the level 
of dissolved oxygen (DOT) constantly decrease from 100 to below 30 over the 
period of time. After the cells have adapted to the environment, because the 
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increase of biomass, the DOT was below the set point, therefore agitation 
speed starting to rise. At 16 h after inoculation, the cells were in exponential 
growing phase; OD reading was rapidly increase also started the glycerol 
feeding when OD reached 30 to avoid depletion of carbon source. Until the 
OD reading was over 80, 0.5 M of [IPTG] was added into fermentor for 
expression A33 Fab, after the induction, the OD reading was fluctuated 
between 90~160, this was possibly caused by high cell density aggregation 
and rapidly settling of cells in the PBS dilution buffer. According to Humphreys 
et al., (2002), after 24 h post-induction OD600 should be ~100, but we 
harvested at OD~158. This could be a promising result judging from the 
amount of IPTG we have added but there was no decrease of OD reading. 
The fermentation protocol was provided by UCB Celltech then modified with 
improve method (Sevastsyanovich et al., 2009), the result able to generate 
relative high biomass when compared with original protocol by Humphreys et 
al., (1996, 1997, 2002) and previous Fab D1.3 fermentations (See Chapter 2).  
4.4.5. Extraction of A33 Fab from periplasm by heat 
treatment and osmotic shock 
In chapter 3, we have systematically investigated various releasing conditions 
(i.e. Osmotic shock and 0.1% deoxycolate) regarding the cell physiology and 
membrane stability to the surrounding environment (i.e. static and vortex, 
length of incubation, pH) then trying to identify the better conditions for 
selectively and effectively extracting periplasmic proteins from of E.coli. 
Likewise, there were two release methods being investigated in this section 
(i.e. osmotic shock and heat treatment). The 1 mL pellets were collected in 
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three different timing (i.e. pre-induction, 12 h post-induction and 24 h post-
induction). Those samples were treated with osmotic shock (OS1&2) and heat 
treatment, respectively. Supernatants were separated by 14% SDS-PAGE 
based on the same amount of total protein (5 g) and left over pellets were 
resuspended in different volume of Laemmli electrophoresis buffers based on 
the OD reading accordingly (Fig. 4.8).  
 
Fig. 4.8 Reducing 14% SDS-PAGE analysis of fractions arising from osmotic shock and heat 
treatment extractions of cells harvested at various times of pre and post-induction. M: marker, 
1: Culture broth, 2: OS1 supernatant, 3: OS2 supernatant, 4: Pellet after osmotic shock, 5: 
Supernatant from heat treatment, 6: Pellet after heat treatment. 
 
As mentioned above, the protein bands represented A33 Fab was slightly 
above 22 kDa according to the protein marker. Not surprisingly, lane 1 to 6 
from the pre-induction samples did not show any clear band around 22 kDa 
position. At second bracket of sample from 12 h post induction, it was clear 
A33 Fab appeared in land 2 to 6, which means the Fab was in periplasm 
(OS1), cytoplasm (OS2) and pellet after osmotic shock. Likewise heat 
treatment fraction in lane 5 and pellet after heat treatment in lane 6 showed 
clear protein band for the Fab but seemed more intense than the samples 
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from osmotic shock (lane2 and 3). Samples collected 24 h post induction has 
significantly increased of band intensity compared to the samples in the 
middle bracket. Further, by loading the same amount of total protein, a 
stronger protein pattern and A33 Fab band was visible in the case of using 
heat treatment extraction (lane5) in comparison to osmotic shock (lane2). For 
the same reason, therefore stronger band intensity suggesting higher 
percentage of A33 Fab was produced (ca~18%) in the 24 h post-induction 
(lane6). Noticeably, two samples from culture broth between 12 and 24 h post 
induction showed slightly leakage of proteins indicated that cells were 
probably starting to lyse. However, there was still 5% increase of Fab 
production from 12 to 24 hour post induction in the heat treatment fraction. As 
the result, the lost in the culture broth was acceptable. Furthermore, this result 
also confirmed that heat treatment working better than the osmotic shock for 
the A33 Fab, because the protein bands were much clear in the lane 5 
compared with lane 2 in those two different samples. Although heat treatment 
has shown better protein release efficiency and selectivity over osmotic shock, 
but because of the high temperature requirement for the heat treatment, this 
method may not be suitable as a generic periplasmic protein release method 
when dealing with other heat sensitive proteins. In the case of releasing A33 
by heat treatment, because it is likely to be a thermal stable protein, so the 
method is well suited for the case (Humphreys et al., 2002; Humphreys, 2007). 
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4.4.6. Western blotting analysis of the fermentation 
cell extracts  
As mentioned above, western blotting is a power tool to confirm the target 
protein has been correctly expressed and a great tool to detect protein when 
the expression was not clear visualised on the SDS-PAGE. Samples from 24 
hour post-induction were firstly separated by 14% SDS-PAGE then wet 
transferring onto PVDF membrane for the western blotting. Lane 1 was 
loaded cell pellet collected before-induction performed as a negative control. 
Samples from culture broth, OS1 fraction, OS2 fraction, pellet after osmotic 
shock, heat treatment fraction and pellet after heat treatment were loaded 
from lane2 to 7, respectively. The results were shown in Fig. 4.9. 
 
Fig. 4.9 Western blotting analysis shows Fab content from the supernatant and pellet after 
osmotic shock and heat treatment extraction. Lane 1: Pellet before induction, M: Sea-Blue 
pre-stain protein marker, 2: Culture broth from 24 h post-induction, 3: OS1 supernatant from 
24 h post-induction, 4: OS2 supernatant from 24 h post-induction, 5: Pellet after osmotic 
shock, 6: Sample from heat treatment supernatant, 7: Pellet after heat treatment. 
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Noticeably, lane 1 (pellet before induction) was the pellet sample took before 
induction which did not show any single band on the membrane which 
suggested that there was no leaky express happened in this strain.  
In the previous result (Fig. 4.8), sample from culture broth at 24 h pot-
induction only showed very minor proteins band across the lane. The same 
sample was loaded here in lane2 (culture broth) , the band was also 
extremely indistinct and vague. Clearly, these results have demonstrated the 
same fact that only very little proteins were leaked into culture broth and most 
of them were not the A33 Fab. More importantly, the integrity of cells was still 
intact even though harvested after 24 h induction, thus no obvious band 
appearing in the lane2. This also suggested that if cells were able to cultivate 
for long time then possibly producing more protein or higher concentration of 
IPTG can be applied to boost expression. Moreover, it showed a great 
advantage for the following protein purification to avoid multiple locations 
distributions for the Fab accumulation, only in periplasm, which would 
consequently make the initial feedstock less contaminated and ease the 
purification process (Venturi et al., 2002; de Marco, 2009; Sockolosky and 
Szoka, 2012).  
Interestingly, the band intensity in lane3 (OS1 supernatant) was stronger than 
4 (OS2 supernatant), suggested most Fab was allocated in periplasm. 
However, in lane5 (pellet after osmotic shock) appeared most intensive Fab 
band compared with OS 1 and 2. This showed employing osmotic shock as a 
mean to disruption cell membrane was not effective to extract the majority of 
Fab from the cell envelope. In striking contrast, Fab released by heat 
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treatment showed in lane6 (heat treatment sample) was much stronger than 
osmotic shock, even stronger than the sum of two lanes2 and 3, which again 
matched up with the results showed in Fig. 4.8 that at 24 h post induction, 
lane5 are far stronger than lane2 and 3. Not surprisingly, lane7 (pellet after 
heat treatment) was much weaker than lane5 (pellet after osmotic shock). 
Presumably, equally amount of Fab was produced in cells, the more being 
released; the less remained within the cells. Those results have indicated that 
heat treatment could a more suitable extraction method than osmotic shock 
for the A33 Fab. Meanwhile, as mentioned in the introduction SMAPLs has 
demonstrated several successful applications in protein release and 
purification (Knowles et al., 2009; Jamshad et al., 2011). It would be very 
interesting to compare the SMALPs and heat treatment which are more 
suitable or effective for periplasmic release and A33 Fab. 
4.4.7. Heat treatment extraction and SMALPs release 
study on A33 Fab  
Despite the heat treatment extraction has shown very promising results from 
the above experiments for releasing the protein from periplasm, there are still 
concerns to use it as a generic protein release method. Exposure proteins 
under high temperature (60°C) for long period of time (16 h) may cause some 
proteins change their conformation (Digel et al., 2006) or denature thereby 
losing its function, such as enzyme activity (Argos et al., 1979). For the 
SMAPLs can be easily employed in the room temperature to release proteins. 
The experiments were conducted in two different volume (i.e. 1 mL and 3 mL) 
of heat treatment buffer, 50 mM Tris buffer and 2.5% SMALPs, the 
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concentration of SMALPs is based on experiment data provided from 
colleagues in school of Bioscience (Personal communication with Prof. Tim 
Dafforn, University of Birmingham, UK). The supernatant from each samples 
were separated by 14% SDS-PAGE as shown below in Fig. 4.10. 
 
Fig. 4.10 Reducing 14% SDS-PAGE analysis shows 1 mL cell pellets with different methods 
and volumes for releasing A33 Fab. Lane1-2: 1mL standard heat extraction; 3-4: 3mL 
standard heat extraction; 5-6: 1 mL 50 mM Tris RT, O/N; 7-8: 3  mL 50mM Tris RT, O/N; 9-10: 
1 mL 2.5% SMALPs, 50 mM Tris 2 h RT; 11-12: 1 mL 2.5% SMALPS, 50 mM Tris O/N RT; 
13-14: 3 mL 2.5% SMALPS, 50 mM Tris 2 h RT; 15-16: 3 mL 2.5% SMALPS, 50 mM Tris O/N 
RT. 
*RT means at room temperature incubation. O/N means incubation for overnight. 
 
From Fig. 4.10 illustrated each extract from different release conditions was 
loaded in duplicate to compare and ensure the results consistency. Since the 
purpose of this experiment was testing the release efficiency of each buffer 
and conditions, the loading was based on the ratio of dilution, for example, 
resuspension the pellet with 1 mL buffer, 5 L of sample was loaded on the 
gel, resuspension with 3 mL buffer, 15 L of sample was loaded, thus 
neglecting the dilution factor on different volume applied for pellet 
resuspension. Interestingly, samples loaded on the gel from both volume of 
heat treatment appeared similar compared between lane1 to 4, only few major 
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bands including Fab appeared on the gel. This suggested regardless the ratio 
of extraction buffer to the cell pellet; the release behaved similar level of 
effectiveness and selectivity for the heat treatment. Directly applied 1:1 ratio 
of 50 mL Tris buffer to the cell pellet was not possible to extract many proteins. 
More strikingly, increase the ratio three times of the extraction buffer was able 
to unselectively release proteins from cells. However, the release seemed 
causing by repeating frozen and thaw damaged the outer membrane 
damaged plus the excessive buffer used to resuspend the cells thereby 
causing unselective protein release from the cell envelope. Employing 
different ratio of SMALPs to the cell pellet and different incubation time length 
were shown from lane 9 to 16. Lane 9&10, 11&12 were samples tested with 1 
mL 2.5% SMALPS in 50mM Tris buffer pH 8 then incubating for 2 h and 
overnight in room temperature, respectively. This was for examining the effect 
on the length of time for extraction. The results did not appear any significant 
difference on the gel, which suggest that SMAPLs was able to release 
proteins within 2 h incubation, longer incubation time did not enhance the 
protein release. Arguably Fab seemed to be the major band on those lanes, 
but many other species proteins were also seen on the gel. Furthermore, 
there was polymer smearing on the bottom part of gel. This could be the 
problem for the further protein purification to separate polymer and the Fab. 
As demonstrated earlier, increase of volume on Tris buffer enhanced the 
ability for protein release. The results showed in lane 13-16 were obtained by 
investigating the effect on ratio of extraction buffer to the cell pellet. Triple 
amount of buffer was used to resuspend the cell pellet was shown in lane 
15&16. Comparing to lane 13&14, which used 1mL of SMAPLs buffer to 
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extract proteins was almost identical. This implied diluting the cell density did 
not increase the efficiency for protein extraction. Furthermore, using 3mL 
50mM Tris buffer in the absence of 2.5% SMAPLs was able to achieve similar 
level of protein extraction as the presence of SMAPLs. Therefore, it was 
arguably from the above results could suggest that small amount of 2.5% 
SMALPs with Tris buffer should be the better condition from the other 
conditions. This said, when the volume increases, the effect from Tris buffer 
was greater on protein release over the SMALPs. Nevertheless, the results 
from Fig. 4.10 have confirmed that the heat treatment for periplasmic release 
for the A33 Fab gave the best result compared with other chemicals and 
conditions applied. 
4.4.8. Study on heat treatment for periplasmic protein  
The result above has demonstrated SMAPLs was capable of releasing fair 
amount of Fab from periplasm. However, heat treatment owning the merits In 
terms of clarity and process complexity obviously was a better method to 
employ for the A33 Fab extraction. Taking collectively, optimisation of heat 
treatment condition was investigated in this section. From protein extraction 
point of view, maximising the protein release from periplasm was the goal to 
achieve. On the other hand, in the view of the process intensity, utilising 
minimum amount of buffer to release the proteins not only concentration the 
products in after releasing but also reduced the volume for the subsequent 
separation process. Therefore, there were two important questions need to be 
answer here. Firstly, could volume of buffer effect on the composition of 
release proteins, for example the less buffer applied might have less Fab 
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released compared to other proteins. Secondly, the relation between the 
ratios of buffer to cell pellet, if increase buffer volume to resuspend cell pellet 
would enhance protein release. In order to distinguish the change on the 
releasable protein composition, the samples were loaded equal amount of 
total protein and separated on 14% SDS-gel.  
 
Fig. 4.11 Reducing 14% SDS-PAGE analysis shows the results of heat treatment extraction 
with various cell density conditions. The percentage decreasing from lane 1 to 7 are 65.8%, 
43.9%, 32.9%, 26.3%, 13%, 6.5% and 3.25%, respectively. M represents the protein marker. 
 
In Fig. 4.11 the cell density expression was calculated from the ratio of buffer 
to the cell pellet. The wet weight of this batch of fermentation at point of 
harvest was 131.57 g/L. When resuspend with 1 mL cell pellet with equal 
volume of the heat treatment buffer, the cell density was around 13% (w/v). 
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Likewise, the cell densities were derived from resuspending 1 mL cell pellet 
with different volumes of buffer. 
Scrutiny of the gel above, every lane was nearly identical to each other 
despite the samples were treated with different release conditions. Moreover, 
all the major band of Fab appeared to be similar intensity. The result 
suggested there was no direct relation between cell density and the 
composition of releasable protein, which means regardless the volume of 
buffer applied, the percentage of every releasable proteins remaining 
consistent. More importantly, applying less heat treatment buffer for protein 
release did not influence on the releasable Fab, in contrast it might help to 
concentrate proteins in supernatant. Next result in Fig. 4.12 illustrated amount 
of total protein released against several cell densities showed above.  
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Fig. 4.12 Plots of release efficiency of heat extraction in different cell concentration. Release 
experiments were conducted of re-suspending 1 mL cell pellet in various volume of extraction 
buffer.  
 
The overall result showed a hump on the graph. Amount of total protein 
released starting from 1.5 mg at the lowest cell density, began to rise when 
the cell density increase. The peak was reached by 27% cell density was 
applied; nearly 3 mg of total protein was able to release. After that, the 
effectiveness slumped sharply to just above 2 mg of total protein released and 
then further dropped to 1.5 mg at the highest cell density was used. The 
results showed here was able to answer the second question raise above, 
that cell density had huge impact on the protein release efficiency. Not 
surprisingly, on the either sides of extreme conditions did not show effective 
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protein release compared to the other conditions, only half amount of protein 
was released. Clearly, the optimum condition of heat treatment was using 
27% (w/v) cell density for protein extraction, which was half the buffer volume. 
Several advantages could be taken here. First, as buffer volume was only half 
from the original volume, therefore protein concentration was doubled when 
released from periplasm. Second, it was always a desired goal to reduce 
handling volume for the downstream purification in the large scale, also saved 
the cost of consumable usages. Third, when the volume was reduced, the 
process time would be shorted, so the overall and labour cost would be 
benefited. Another effective release was observed at 13% cell density, which 
applied the buffer to the original volume of cell pellet for protein extraction. 
Under this condition also showed strong result, where nearly 2.7 mg of total 
protein was release, only 11% less from the optimal condition. In the lab scale, 
buffer volume was not an issue to consider would be a more suitable 
condition to employ. Because reduced half volume of heat treatment buffer 
might cause incompletely mixed, especially when the biomass was high, the 
cell pellet would require more buffer for better resuspension. As the results 
showed in Fig. 4.12 suggested two potential conditions could be applied when 
release the Fab, in large scale, half the extraction buffer not only concentrate 
the protein in supernatant but also improve the protein release. For the use of 
lab scale, same volume to the original cell pellet could offer similar protein 
release efficiency, and also ensure mixing properly because it could be very 
difficult to resuspend the cell pellet when the biomass is really high. Despite 
all the facts, this is only a preliminary result for releasing periplasmic A33 Fab, 
although the results has suggested the standard protocol might not be the 
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optimal condition to apply, but for the consistency of the experiments, 13% 
cell density for protein release was selected for further experiments.  
4.5. Conclusions 
The preliminary results from shake flask experiments in Fig 4.3 and 4.4 
revealed the effects on IPTG concentration and cultivation temperature 
towards the cell growth and the recombinant protein production. We then 
selected 50 M and 100 M IPTG for temperature reduction experiment 
showed the 15.7% and 24.8% (ca. 54.45 mg/L and 84.1 mg/L of A33 Fab) of 
total protein produced within the cell was Fab. Comparing results between 
Fig 4.4 and 4.6 showed around 10% increase of Fab production in both 
conditions. Thus, adopting the fermentation protocol provided by UCB 
Celltech and modified based on the results from the shake flask experiments 
with improved protocol (Sevastsyanovich et al., 2009), we were able to 
performed a 5 L scale fed-batch fermentation and reached relatively high 
biomass in the end (OD600nm~107). More importantly, amount of releasable 
A33 Fab from this batch estimated by Image J suggested around 300 mg/L, 
which was approximate 12.5% of total protein, was produced. Furthermore, 
the sample collected at 24 h post-induction contained 5% more Fab than the 
12 h post-induction, which suggested proteins showed in culture broth was 
very minor and the overall Fab production was increase along with the 
cultivation time. Since we were able to produce substantial amount of Fab in 
the periplasm, therefore it was crucial to investigate three current protein 
extractions method could be more effective and selective. As a generic 
method, osmotic shock was wildly used for protein release, but obviously can 
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be seen from Fig 4.8 and Fig 4.9, the heat treatment was able to more 
effectively and selectively release Fab. Comparing the results from Fig 4.10, 
Although SMALPs [poly(styrene-co-maleic acid) lipid particles] has shown few 
successful application (Knowles et al., 2009; Maeda et al., 2009; Jamshad et 
al., 2011) but the release performance seemed not as selective as heat 
treatment for the A33 Fab. Moreover, in the presence of SMALPs showed 
strong interference on the SDS gel. To elimilate the effect of polymer dialysis 
procedure would be required which clearly was a drawback when the 
SMALPs was empolyed to release periplasmic proteins. Therefore, heat 
treatment extraction was selected for the further optimisation, a systematically 
release experiment was carried out with series of different cell density 
samples. Interestingly, the result from Fig 4.11 suggested that there was no 
direct relation between cell density and the composition of releasable protein, 
regardless the volume of buffer applied, the percentage of every releasable 
proteins remaining consistent. When plotted the total protein released against 
various cell density conditions, the result was surprised suggesting that 27% 
(w/v) cell density for protein extraction, which was half the buffer volume to 
cell pellet released almost 3 mg of total protein. Another effective release was 
observed at 13% cell density, which applied the buffer to the original volume 
of cell pellet for protein extraction and also able to release nearly 2.7 mg of 
total protein, just 10% less than the optimum condition. Because the 
performance from those two conditions was not hugely different, to ensure the 
mixing and pellet resuspension, 13% (w/v) cell density was selected for 
extracting A33 Fab in the future experiments.  
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To conclude, a successful A33 Fab fermentation in 5 L fermenter was 
performed in the following condition. Cultivation temperature was at 30°C and 
decreased to 25°C upon induction, induction was performed at OD600 ~80 with 
0.1mM IPTG. Cells were harvested at 24 h post-induction. The optimum 
condition of heat treatment was using 27% (w/v) cell density for total protein 
extraction (i.e. ~ 3 g/L), but to ensure mixing performance in large scale, 13% 
(w/v) cell was recommended for protein release (i.e. 2.7 g/L). 
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5. Continuous protein purification using 
functionalised magnetic nanoparticles in 
aqueous micellar two-phase systems 
5.1. Abstract 
A novel technique for technical-scale continuous purification of proteins is presented. 
It is based on the combined use of functionalised magnetic nano-particles and an 
Aqueous Micellar Two-Phase System featuring the non-ionic surfactant, Eumulgin ES, 
which undergoes temperature induced phase separation at ~25°C. In the first step, 
conducted below the transition temperature (i.e. 15°C), the magnetic sorbent 
particles are added into the single dispersed phase and bind the protein of interest. 
Next, on raising the temperature to 30°C the protein-laden magnetic particles 
partition strongly into the micelle-rich top phase of the micellar two-phase system 
that’s formed. The magnetically susceptible top phase is then continuously separated 
from the micelle-poor phase in a flowthrough tailor-made magnetic extractor featuring 
a permanent magnet providing an upwardly acting magnetic force. This separation 
device was shown to be effective for continuous separation of a wide range of 
differently sized magnetic particle sorbents (i.e. from 2 m diameter to as small as 25 
nm) from a 10% (w/w) Eumulgin ES system; high separation efficiencies were 
recorded for the phase-forming surfactant (87 to >98%), and all magnetic sorbent 
particles tested (95 – 99.9%). Finally, protein purification by continuous magnetic 
extraction was demonstrated at 15 L scale for the recovery of an antibody fragment, 
A33 Fab´, from a crude extract of E. coli periplasm. Nearly 70% of the A33 Fab´ 
initially present in the extract at 15.6% of the total protein content was recovered in a 
2 – fold concentrated and highly purified (>98%) state. Further, the amounts of 
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magnetic sorbent and phase-forming surfactant lost in the process were very small; 
thus recycling of both components into subsequent rounds of continuous magnetic 
extraction is highly feasible.  
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5.2. Introduction 
Preparative chromatography, a core technology within the biopharmaceutical sector 
for several decades, plays critical roles in the downstream processing of modern 
biopharmaceuticals. However, against increasing pressures (rocketing product titers, 
increasing size and complexity of emerging bio-products to name but a few), it is 
increasingly being viewed as a serious bottleneck in manufacturing (Low et al., 2007; 
Leonardo et al., 2008). Against this backdrop, the modification/improvement of 
existing traditional fixed column chromatography systems (Müller et al., 2013), or 
their replacement with integrated and/or continuous separation processes represent 
increasingly important challenges to solve. Aqueous two-phase systems (ATPS) 
have long been regarded as possible alternatives ever since Albertsson (1956) 
classical demonstration of selective partitioning of (bio)molecules between two 
aqueous phases of a mixture of polymers and/or salts. Aqueous Micellar Two-Phase 
Systems (AMTPS) introduced by Bordier (1981) some 25 years later differ 
considerably from classical ATPS. AMTPS feature non-ionic surfactants which 
undergo temperature-induced phase separation resulting in two phases, i.e. one 
‘micelle-rich’ (or ‘coacervate-rich’) and the other ‘micelle-poor’ (Tani et al., 1998). 
Numerous applications and combinations of phase-forming polymers have been 
proposed since the early 1980s for the selective enrichment of a protein in one of the 
aqueous phases (also described as aqueous two-phase extraction, ATPE, or cloud 
point extraction, CPE) (Tani et al., 1998; Hatti-Kaul, 2001). A striking advantage of 
ATPE is the ease with which its operation can be up-scaled and made continuous, 
and as consequence several process schemes demonstrating the feasibility of 
continuous bioprocessing exploiting ATPS (Sarubbo et al., 2003; Vázquez-Villegas et 
al., 2011; Rosa et al., 2012) and AMTPS (Trakultamupatam et al., 2004; Ingram et al., 
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2012) have been published within the last decade. The high cost and loss of phase-
forming components in the target protein-depleted phase represent a significant 
economic hurdle to overcome, but the main reasons for ATPE’s perceived lack of 
viability are that the physical principles underlying the partitioning behavior of a given 
target protein between the phases remain unclear; and that very considerable 
experimental effort is required to identify an economically attractive system (Oelmeier 
et al., 2011). Affinity-enhanced ATPS were introduced (Kopperschläger and 
Birkenmeier, 1990) in order to circumvent the above issues. In affinity ATPS the 
phase-forming polymer is either chemically modified, or alternatively ligands are 
‘introduced’, by one of a variety of ways, into the two-phase system to enhance the 
partitioning of a molecule of interest into one of the two phases (Azevedo et al., 
2009). The introduction of ligands into ATPS by adding functionalised magnetic 
particles constitutes a particularly attractive class of affinity-enhanced ATPS (Suzuki 
et al., 1995; Franzreb et al., 2006; Gai et al., 2011). The combination of ATPS with 
magnetic particles can dramatically enhance the rate of phase separation following 
application of an external magnetic field cf. traditional affinity ATPS, provided that the 
particles partition strongly into the dispersed phase (Wikstrom et al., 1987; Flygare et 
al., 1990; Larsson, 1994).  
Previously, in our laboratories we introduced the new concept of ‘Magnetic Extraction 
Phases (MEPs)’ (Becker et al., 2009), illustrated by the successful combination of 
magnetic cation exchange micro-sorbents with a Triton X-114 based AMTPS, to 
separate lysozyme from ovalbumin. Here, sorption of the target molecule, lysozyme, 
was performed at a temperature in the single-phase regime (TS). Phase separation 
was subsequently induced by raising the temperature (TT, denoting two-phase 
regime). The protein-loaded particles accumulated in the micelle-rich phase of the 
resulting AMTPS and the micelle-poor phase was removed. In the following step, an 
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AMTPS was set up using an appropriate elution buffer and the micelle-rich phase 
that was obtained post sorption. Previously bound protein species were desorbed 
from the particles and partitioned variously within the AMTPS according to their 
individual partition coefficients (K), whilst all of the magnetic sorbent particles moved 
into the micelle-rich phase. More recently, we extended the MEP concept to nano-
scaled magnetic sorbents and an AMTPS based on the non-ionic surfactant, 
Eumulgin ES (Fischer and Franzreb, 2012). The ‘Eumuglin ES AMTPS’ represents a 
significant improvement over ‘Triton X-114 AMTPS’. For instance, it simultaneously 
reduced surfactant costs, afforded the use of a moderate phase separation 
temperature, and importantly, yielded extreme differences in the partitioning 
coefficients of the target protein and the magnetic sorbent particles. As a direct 
consequence of extreme K-values, on elution the target protein partitioned 
exclusively to the micelle-poor phase, whereas the magnetic sorbents accumulated 
entirely in the micelle-rich phase. The MEP experiments described above using the 
new improved combination (Eumuglin ES AMTPS plus magnetic nano-particle 
sorbents) were performed at laboratory scale. In this study, we detail the systematic 
transfer of lab-scale manual MEP operation to a technical-scale ‘Continuous 
Magnetic Extraction’ (CME) process. We demonstrate continuous separation of 
cation exchange functionalised magnetic nano-particles from the micelle-poor phase 
at flow rates of several liters per hour; and subsequently apply CME for the 
continuous capture and purification of an antibody fragment from a crude E. coli cell 
extract.  
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5.3.  Materials and Methods 
5.3.1. Materials 
Four different functionalised magnetic particles were employed in this study. 
‘Poly(NIPA-co-AAc)’ particles (200 nm mean diameter by dynamic light scattering), 
received as a gift from Dr. Rodica Turcu (National Institute for Research and 
Development of Isotopic and Molecular Technologies, NIIMT, Cluj-Napoca, Romania), 
featured magnetite cores embedded in a matrix of poly(N-isopropylacrylamide-co-
acrylic acid). ‘MagPrep Silica 25’ and ‘MagPrep SO3 100’ particles were kindly 
donated by Dr. Johannes Bauer (Merck KGaA, Darmstadt, Germany). Both particles 
comprised magnetite crystals coated with a thin layer of silica, however, the surface 
of the latter was further functionalised with sulfonate (SO3-) moieties analogous to 
those commonly employed for strong cation exchange (CEX) chromatography media. 
Scanning electron microscopy revealed single particles of narrow size distribution, 
measuring 25 nm and 100 nm across for the base silica coated and sulfonate 
derivatised particles respectively. Chemagen M-PVA-DEAP particles were supplied 
by PerkinElmer chemagen Technologie GmbH (Baesweiler, Germany). This material 
is a spherical beaded ‘polyvinyl alcohol (PVA) – magnetite’ composite of ca. 2 m, 
functionalised with diethylaminopropyl (DEAP) groups. The strong CEX beaded 
chromatography medium, Fractogel® EMD SO3 (M) was a further donation from Dr. 
Johannes Bauer (Merck KGaA, Darmstadt, Germany), and the HiTrap rProtein G 
column was from GE Healthcare (Uppsala, Sweden). E. coli strain W3110 expressing 
the A33 Fab´ (Humphreys et al., 1996) and protocols for its cultivation were acquired 
from UCB Celltech (Slough, UK) under a Material Transfer Agreement. The non-ionic 
surfactant, Eumulgin ES (PPG-5-Laureth-5, CAS-No.: 68439-51-0), was purchased 
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from Cognis (Düsseldorf, Germany). The chemicals, sodium tetraphenylborate (ACS 
reagent, 99.5%), barium chloride (99.9% trace metal basis), 
Tris(hydroxymethyl)aminomethane (ACS reagent, 99.8%), bicene (BioXtra, 99% 
by titration), glycine (for electrophoresis, 99%), acetone (≥99.8%), methanol 
(≥99.9%), glacial acetic acid (ACS reagent, ≥99.7%), were all obtained from Sigma-
Aldrich (St. Louis, MO, USA). Phosphate buffered saline (Dulbecco ‘A’ tablets) was 
purchased from Oxoid Limited (Basingstoke, UK), disodium hydrogen phosphate and 
sodium chloride were supplied by Carl Roth (Karlsruhe, Germany) or Sigma-Aldrich, 
and citric acid monohydrate and Coomassie Brilliant Blue R250 (C.I. 42660) were 
from Merck Millipore (Darmstadt, Germany). Pre-cast 15% mini-PROTEAN® TGX™ 
gels, Precision Plus Protein All Blue Standards and Laemmli sample buffer were 
supplied by Bio-Rad Laboratories Inc. (Hercules, CA, USA). UltraPure Protogel was 
from National Diagnostics (Hessle, Yorks, UK) and See® Blue Plus 2 Prestained 
Standard, Simply Blue™ SafeStain and Quant-iT™ PicoGreen® dsDNA kit were all 
acquired from Invitrogen Life Technologies (Carlsbad, CA, USA). The bicinchoninic 
acid (BCA) protein assay kit and bovine serum albumin (BSA; fraction V powder, 
96% pure by electrophoresis) were both obtained from Sigma-Aldrich. All other 
chemicals not stated above were from Sigma-Aldrich or Merck Millipore. The water 
used in all experiments was deionised and purified using a Millipore Milli-Q Ultrapure 
system.  
5.3.2. Determination of AMTPS phase diagrams 
The location of the curve defining the two-phase and single-phase regimes within a 
T-x diagram (where x is the mass fraction of the surfactant in the mixture) was 
determined as follows. Different fractions of surfactant and the corresponding buffers 
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were weighed into 15 mL centrifuge tubes. The centrifuge tubes were tempered in a 
temperature-controlled water bath (Model RC 20 S, Lauda Brinkmann, Deran, NJ, 
USA), and incubated for a minimum of 12 h until complete phase separation had 
been achieved. After this period the top and bottom phases of the resulting two-
phase system were quickly separated and retained for subsequent analysis of the 
surfactant concentrations in each phase (see 5.3.9 Analysis).  
5.3.3. Magnetic extractor for CME 
The tailor-made magnetic extractor constructed for the CME studies described in this 
work (Fig 5.1a) features a separation chamber, housed within a permanent magnet 
yoke (627 mm length × 235 mm width × 306 mm height) fabricated by Steinert 
Elektromagnetbau GmbH (Cologne, Germany). The specially designed magnet and 
pole shoe arrangement results in a vertical magnetic field component, which steadily 
increases towards the upper side of the separator chamber (Fig 5.1b). The above 
components are themselves accommodated in an isolated, temperature regulated 
polystyrene case. The inner dimensions of the separation chamber are 500 mm 
(length) × 120 mm (width) × 50 mm (height), and a 38 mm high fixed weir is installed 
within it to give a total liquid volume within the separator chamber of 2.28 L (500 mm 
× 120 mm × 38 mm). 
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Fig. 5.1 Schematic illustrations of (a) the CME process and component parts (see text for details) and 
(b) Finite element simulation of the magnetic field generated by the CME system’s permanent magnet. 
The magnet consists of the magnetic ferrite material (M) and a surrounding pole shoe. A settler can be 
installed in the space (S), where the vertical flux density, BY (T) steadily increases towards the upper 
side, thereby imposing a lifting force on any magnetic particles within ‘S’. 
5.3.4. Phase separation experiments  
Phase separation velocities within the magnetic extractor were determined for 
operation with and without magnetic particles. For these studies, an AMTPS 
composed of 10% (w/w) Eumulgin ES and 90% (w/w) 50 mM sodium citrate, pH 3, 
poly(NIPA-co-AAc) particles and a temperature of TT = 30°C were employed. The 
coacervate ratio, CR, (defined in the following section, 2.5) was kept constant at 0.2, 
and the feed rate ( ூܸሶ ) was varied from 0.5 to 25 L/h. The system was run at the 
corresponding flow rate until the volume in the separation chamber had been 
exchanged at least twice. Samples were taken from the top and bottom outlet of the 
magnetic separator and analysed for Eumulgin ES content (see 5.3.9 Analysis). All 
experiments were first performed in the absence of the magnetic particles, and 
thereafter with poly(NIPA-co-AAc) using the same set-up and a magnetic particle 
concentration of 2 g/L. Long-term continuous operation of the magnetic extractor was 
investigated in ‘loop mode’. In this configuration, the exiting top and bottom phases 
are re-injected into the tempered stirred tank, and continuous operation of the 
magnetic extractor for several hours without using excessive amounts of material, is 
possible. The operational parameters employed for loop mode operation were as 
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follows: the initial magnetic particle concentration in the stirred tank was 2 g/L, the 
total volume of AMTPS was 9 L, the flow rate was 9 L/h, and TS and CR were set to 
30°C and 0.33 respectively. Samples of the initial feed, and the top and bottom 
phases withdrawn at various times during operation, were analysed for magnetic 
particle and surfactant contents (see 5.3.9 Analysis). 
5.3.5. Equations describing CME performance 
The phase separation curve for the above AMTPS was obtained by plotting the 
temperature against the surfactant concentrations determined in the phases after 
complete phase separation. 
The volume fractions of the top (VT) and bottom (VB) phases can be calculated from 
the surfactant concentrations according to Equation 5.1 the ‘lever rule’ (McCabe et al., 
2005; Kamei et al., 2002): 
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Equation 5.1 
 
Here, wS,0, wS,B and wS,T are the surfactant mass fractions of the phases before and 
after phase separation, and R is denoted the ‘phase-volume ratio’. During continuous 
operation of the magnetic extractor, the phase-volume ratio between the withdrawn 
top and bottom phases can be expressed as the pump ratio, P, according to 
Equation 5.2: 
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As shown in Eqn 5.2, P is controlled by the feeding rate, IV , and the discharge rate 
of the bottom phase, BV . The amount of liquid removed by the top effluent is 
determined by the difference in flow rates between the inlet and the bottom effluent, 
and the ratio of the flow rate leaving the top effluent and the inlet flow rate therefore 
is defined as coacervate ratio, CR, (Eqn 5.3) with TV  being the flow rate of the top 
phase discharge: 
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Equation 5.3 
 
Theoretically, the ideal operation point of the magnetic extractor should occur when P 
= R. However, in order to prevent the loss of target component, particles, and 
surfactant, the CME was operated in a manner that emphasised complete removal of 
the top phase rather than preventing contamination of the top phase with traces of 
bottom phase. The theoretical minimum CR required (CR,min) to achieve complete 
removal of the top phase during CME operation was calculated according to 
Equation 5.4: 
1min,  R
RCR  
Equation 5.4 
 
The CR value employed experimentally was derived from the theoretical minimum 
value obtained, but was adjusted to include a safety factor of 5 – 10%. 
 
The rates of removal of magnetic particles and surfactant from the initial feed during 
CME are defined in terms of individual separation efficiencies for the magnetic 
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particles (SP) and phase-forming surfactant (SS) according to Equation 5.5 and 5.6; 
where the particle and surfactant concentrations are respectively: cP,I and cS,I in the 
initial streams; and cP,B and cS,B in the discharged bottom phases.  
100)1(
,
, 

IPI
BPB
P cV
cV
S 

 
Equation 5.5 
 
100)1(
,
, 

ISI
BSB
S cV
cV
S 

 
Equation 5.6 
5.3.6. Preparation of crude E. coli extract 
Pilot-scale demonstration of CME’s utility for recovery of a model bioproduct from a 
realistic biological feedstock (section 5.3.7) and parallel lab-scale chromatographic 
purification experiments (section 5.3.8) were conducted using extracts prepared from 
fed batch fermented E. coli W3110 cells expressing a recombinant antibody fragment, 
A33 Fab´ (Humphreys et al., 1996) targeted to the periplasm. Fed batch fermentative 
production of A33 Fab´ containing cells was performed in an Electrolab FerMac 300 
series reactor (initial volume = 2 L; final volume = 2.28 L) using proprietary methods 
originating from UCB Celltech (Slough, UK) and modified in house.  
At the end of cultivation (OD600 nm = 188) the cells (378 g wet weight) were harvested 
by centrifugation (11,000 gav, 0.5 h, 4°C) in the JA-10 rotor of Beckman Model J2-21 
centrifuge (Beckman Coulter, Inc., Brea, CA, USA), before resuspending with 2.28 L 
of 0.1 M Tris-HCl buffer, pH 7.4, supplemented with 10 mM EDTA and incubating at 
60°C in a water bath. After 16 h the heat permeabilised cells were removed by low 
speed centrifugation (3,255 gav, 0.5 h, 4°C) in a Jouan C422 bench top centrifuge 
(SelectScience Ltd., Bath, UK), to yield a crude extract containing periplasmic 
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species (Katsui et al., 1982; Weir and Bailey, 1995). For CME experiments (section 
5.3.7) the resulting crude periplasmic extract (conductivity = 21 mS/cm) was simply 
diluted 10 fold with 20 mM sodium phosphate buffer, pH 5.6 (yielding a feed with 
conductivity of ~4.3 mS/cm). For chromatographic experiments (section 5.3.8) the 
crude periplasmic extract was not diluted, but instead received extensive conditioning 
to remove troublesome insoluble and fouling materials (i.e. outer membrane 
fragments, lipopolysaccharide and nucleic acids) issued into the extract from the 
thermally-treated cells, and adjust the pH and/or conductivity for binding.  
5.3.7. Continuous magnetic extraction of A33 Fab´ from E. 
coli extract 
An AMPTS consisting of 10 – fold diluted crude E. coli periplasmic extract, 10% (w/w) 
Emulugin ES, 20 mM sodium phosphate buffer, pH 5.6, and 1.38 g/L MagPrep SO3 
particles was set up in the following way. Emulugin ES (1.47 kg) was first mixed with 
11.46 L of 25 mM sodium phosphate buffer in a 50 L double-walled (jacketed) glass 
stirred tank reactor (STR). Three hundred milliliter of a 68 g/L suspension of MagPrep 
SO3 particles previously equilibrated in 22 mM sodium phosphate buffer, pH 5.6, was 
then added to the vessel. Finally, after 600 s of mixing, the binding step was initiated 
by pouring a 1.47 L portion of crude periplasmic extract into the STR. In all STR 
operations the temperature was maintained at TS = 15°C, and constant stirring at 140 
rpm was provided by a PTFE coated 3-blade impeller (60 mm width × 25 mm height; 
= 45°) driven by an overhead mixer (IKA Eurostar digital, IKA-Werke GmbH, Staufen, 
Germany) After 900 s of binding in the STR, the resulting magnetic particle doped 
two-phase system was separated by magnetic extraction (TT = 30°C, CR = 0.2, IV  = 
5 L/h), and the exiting top and bottom phase streams were collected separately. For 
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the washing phase, the collected top phase was transferred back into the STR 
vessel, were it was mixed with 2 volumes of wash buffer (20 mM sodium phosphate, 
pH 5.6) for 900 s, before re-processing through the magnetic extractor and collecting 
the separately discharged top and bottom phase streams. Finally, in the elution step 
the top phase leaving the magnetic extractor unit was again transferred into the 
stirred tank, and this time mixed with 2 volumes of wash buffer supplemented with 
0.75 M NaCl (so that the final NaCl concentration during elution was 0.5 M). After 900 
s of mixing at 15°C, the STR contents were subjected to a last round of CME at 
30°C, and the two discharged phases were collected.  
During and after each step in the CME process, the top and bottom phases were 
sampled and these were analysed for magnetic particle, Eumulgin ES, DNA, total 
protein and A33 Fab´ contents (section 5.3.9). At the end of each separation when 
the top phase discharge ran dry the bottom phase was removed until it started to 
cloud, at which point the bottom valve was closed and the remaining liquor was 
added into the top phase collection tank. Prior to conducting the next CME step, the 
separation chamber was flushed with the sodium phosphate buffer solution to 
displace any residual particles from the unit back into the STR vessel. 
5.3.8. Chromatography  
All chromatography was done at room temperature using conditioned heat-treated E. 
coli derived liquors (section 5.3.6) and 1 mL packed beds (diameter ~7 mm, bed 
height ~25 mm) in plastic columns connected to an Äkta Explorer 100 Air 
chromatography workstation (GE Healthcare, Uppsala, Sweden). The mobile phase 
compositions recommended by Humphreys et al. (2002) and Pabst et al. (2009) were 
employed for Protein G affinity and CEX chromatography respectively, and for all 
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chromatographic stages the mobile phase velocity was 60 mL/h (~155 cm/h). Prior to 
application on a HiTrap rProtein G chromatography column pre-equilibrated with 
phosphate buffered saline (PBS), the extract was adjusted to pH 6.6 with 1 M acetic 
acid, and then clarified by centrifugation at 9,391 gmax and 4°C for 0.75 h in Sigma 
3K30 centrifuge (SciQuip Ltd, Merrington, UK) fitted with type 12150 rotor, followed 
by filtration through a 0.22 m Millex® GP filter unit (Merck Millipore, Nottingham, 
UK). After loading 30 mL of extract the column was sequentially washed with 5 
column volumes (CVs) of PBS and then eluted using 10 CVs of 0.1 M glycine-HCl 
buffer, pH 2.7. The pH of eluate fractions was immediately adjusted to neutrality by 
addition of 2.5 M Tris base, before storing at 4°C for subsequent analysis by SDS-
PAGE and BCA assay (5.3.9 Analysis).  
The E. coli extract feedstock employed for CEX chromatography was prepared by 
clarification (9,391 gmax, 0.75 h, 4°C; 0.22 m filtered) followed by buffer exchange 
into 20 mM sodium acetate, pH 5.6. A commercial centrifugal filter system (Amicon 
Ultra 15 - NMWT 10 kDa, Merck Millipore, Nottingham, UK) in a Jouan C422 bench 
top centrifuge (3,255 gav, 0.5 h, 4°C) was employed for the buffer exchange step as 
per the manufacturer’s instructions. Thirty milliliters of the resulting extract (~3 mS/cm) 
was loaded onto a packed bed of the Fractogel® EMD SO3 (M) matrix previously 
equilibrated with 20 mM sodium acetate, pH 5.6. After washing with 5 CVs of the 
same buffer, the column was developed with linear gradient of increasing salt (0 to 1 
M NaCl) over 15 CVs. Fractions collected during chromatography were retained for 
analysis of protein composition, A33 Fab´ and protein contents (see 5.2.9 Analysis).  
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5.3.9. Analysis 
Magnetic field simulations were performed using QuickField 5.7 finite element 
simulation software (Tera Analysis, Svendborg, Denmark). The magnetic 
characteristics of the ferrite material were supplied by the manufacturer of the 
magnet (Steinert Elektomagnetbau GmbH, Cologne, Germany).  
Eumulgin ES concentrations were determined using a potentiometric end-point 
method developed for assay of polyoxyethylated non-ionic surfactants (Fischer and 
Franzreb, 2011), relying on the formation of a pseudo cationic complex of the 
polyoxyether moiety with barium ions followed by precipitation in the presence of 
tetraphenyl boronate. Surfactant concentrations were obtained by comparing 
recorded end-point volumes with those obtained from a standard calibration curve 
prepared using solutions of known Eumulgin ES concentration. 
The magnetic particle content in samples was determined gravimetrically as follows. 
Magnetic particles in samples were retrieved from solution with the aid of a powerful 
permanent bar magnet. The supernatants were carefully removed and the particles 
were washed sequentially once with 15 mL of methanol and twice with 15 mL of 
water. In between each wash, the ‘particle/solution’ mixtures were subjected to 
magnetic separation and the supernatants were carefully discarded. The magnetic 
particles were then resuspended with 1 mL of water, transferred to pre-weighed glass 
HPLC vials and dried in an oven at 60°C for at least 16 h. After cooling to room 
temperature in a dessicator jar, the vials were re-weighed and the amount of support 
particles in each sample was calculated from the change in weight of the vial.  
Protein content in samples was determined using a micro BCA assay kit (Pierce, 
Rockford, IL, US) adapted for use with a Cobas Mira Plus automatic robotic station 
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(Roche Diagnostics, Switzerland). To eliminate the influence of Eumulgin ES on the 
BCA assay and SDS-PAGE, it was removed from samples in a prior protein 
precipitation step. Ice cold 100% (w/v) trichloroacetic acid was added to samples 
(and BSA protein standards) to a final concentration of 15% (w/v), and mixed on a 
vortex mixer before incubating on ice for 0.5 h. The resulting protein precipitates were 
recovered by centrifuging in a microfuge, and then decanting the supernatants, 
washing the pellets twice with ice cold acetone and finally drying in a centrifugal 
vacuum concentrator (5301 Vacufuge, Eppendorf, Hamburg, Germany).  
The protein compositions of fractions were analysed by reducing SDS-PAGE 
(Laemmli, 1970) in either 14% (w/v) polyacrylamide slab gels cast in house3 or 15 
(w/v) pre-cast polyacrylamide gels in a Mini-Protean Tetracell electrophoresis 
system (Bio-Rad Laboratories, Hercules, CA, USA). After electrophoresis, 15% (w/v) 
polyacrylamide gels were stained with 0.1% (w/v) Coomassie Brilliant Blue R250, 
dissolved in 40% (v/v) ethanol and 10% (v/v) acetic acid) for 1 h at room temperature, 
and were subsequently destained at the same temperature in a solution composed of 
7.5% (v/v) acetic acid and 10% (v/v) ethanol. 
The method of casting and running 14% (w/v) SDS-PAGE was the same as 
described in the Chapter 4 section 4.3.7.2. 
The A33 Fab´ content was determined by densitometric analysis of scanned TIFF 
images of appropriately loaded Coomassie Blue stained gels following 
electrophoresis. The images were captured with an HP ScanJet C7716A flat bed 
scanner (Hewlett-Packard Company, Palo Alto, CA, USA) at a resolution of 2400 dpi, 
and analysed using ImageJ software (Schneider et al., 2012). Samples and 
                                            
3 For a detailed description of the methods employed for preparation, electrophoresis, and staining the 
reader is referred to Chapter 4 (section 4.3.7.2.). 
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rProteinG affinity chromatography purified A33 Fab´ standards were loaded on the 
same gels. A linear correlation between A33 Fab´ applied and band intensity was 
found in the range 0.1 to 1 g A33 Fab´; hence, the volumes of samples applied to 
gels for ‘densitometry’ were adjusted to fall within this range. 
DNA contents were determined using a commercial fluorescence based assay 
(Quant-iT™ PicoGreen® dsDNA kit) in 96 – well plate format with an Ascent 
Fluoroskan Fluorometer (Thermo Labsystems, Waltham, MA, USA) employing 
excitation and emission wavelengths of 480 nm and 535 nm respectively. 
5.4. Results and discussion 
5.4.1. Apparatus for CME 
CME employs a novel magnetic extractor set-up, the principle of which is illustrated in 
Fig 5.1a. At the set-up’s core is a temperature-controlled magnetic field enhanced 
mixer-settler. In the mixer, sorption of the target molecule to the magnetic sorbent 
occurs at a temperature, TS, at which the fluid forms a single phase. In the following 
continuous settler, the AMTPS is heated up to a temperature, TT, at which point the 
fluid forms two phases. For phase separation, the fluid is pumped into a separation 
chamber surrounded by a specially designed permanent magnet (Fig 5.1a and  5.1b), 
which is itself located within the interior of a sealed polystyrene case containing a 
temperature-controlled heater that functions to maintain the temperature at TT. 
Micellar droplets doped with magnetic nano- or micro-particles form as fluid passes 
through the reactor. The external magnetic field generated by the permanent magnet 
simultaneously enhances: (i) the migration velocity of these micellar droplets; (ii) 
initial droplet coalescence; and (iii) coalescence at the inter-phase of the two-phase 
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system. Finally, a particle-free micelle-depleted bottom phase is discharged from the 
lower effluent of the separation chamber, while a micelle and particle-enriched phase 
is withdrawn from the upper effluent.  
5.4.2. Physico-chemical and hydrodynamic characterisation 
Fig. 5.2 illustrates the phase diagram for 10% (w/w) Eumulgin ES-based AMTPS 
concocted with various solutions. The similarity of the plots is striking. The influence 
of pH (between 3 and 8.8) on Eumulgin ES AMTPS phase transition appears 
negligible over the studied range of temperature (25 – 40°C). Further, the impact of 
proteins and other suspended species within the extract on Eumulgin ES AMTPS 
phase transition also appears to be small. In view of the transition point from the 
single-phase to the two-phase regime of ca. 26°C the application of CME with the 
present Eumulgin ES based AMTPS for thermo-labile proteins may appear 
challenging. It should be noted however, that doping the AMPTPS with additional 
components (e.g. various salts) can drastically reduce the phase transition 
temperature (Tani et al., 1998); thereby creating a much ‘friendlier’ environment for 
more temperature-sensitive proteins.  
Important process parameters, R and CR,min can be derived from the phase diagrams 
(Fig 5.2) and Table 5.1 shows the calculated values for an 10% (w/w) Eumulgin ES 
based AMTPS in 50 mM sodium citrate buffer pH 3. For complete top phase removal 
at 30°C a minimum CR of 0.19 is required. 
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Fig. 5.2 Phase diagrams (co-existence curves) for 10% (w/w) Eumulgin ES-based AMTPS in water 
(), 50 mM sodium phosphate buffer pH 7.0 (), 50 mM sodium citrate buffer, pH 3 (), 50 mM 
bicene buffer, pH 8.8 (), E. coli extract diluted with 20 mM sodium phosphate buffer pH 5.6 (). 
 
Table 5.1 Volume ratio (R) and minimum coacervate ratio (CR,min) for a 10% (w/w) Eumulgin ES-based 
AMTPS in 50 mM sodium citrate buffer, pH 3. The values were calculated using Equations 5.1 and5.4. 
Temperature (°C) Volume ratio, R (-) Minimum coacervate ratio, CR,min 
29 0.27 0.22 
30 0.23 0.19 
35 0.16 0.14 
40 0.14 0.12 
 
The phase separation efficiency of the Eumulgin ES-based AMTPS during operation 
of the CME process was initially monitored in the absence of magnetic particles, by 
analyzing the surfactant’s distribution within the top and bottom-phase effluents as a 
function of feed flow rate. In these runs the Eumulgin ES concentration of the feed 
was 9.6% (w/w), and the phase separation temperature and CR were set to 30°C and 
0.2, respectively. Fig. 5.3 shows the results obtained. When operated flow rates 
exceeding 15 L/h no phase separation is observed; both streams exit the separator 
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with Eumulgin ES concentrations practically equal to that of the feed. But as the flow 
rate is reduced from 15 L/h, phase separation starts to occur. For example, an 
approximate halving in flow rate results in top and bottom phase concentrations of 
~21% (w/w) and ~4% (w/w) respectively. At steady state the maximum top phase and 
minimum bottom surfactant concentrations achievable, of ~32% and ~0.7% 
respectively, are reached at flow rates of  2 L/h.  
 
Fig. 5.3 Eumulgin ES phase separation in the magnetic extractor during continuous operation at 
different flow rates in the absence (,) and the presence (,) of 2 g/L poly(NIPA-co-AAc) 
magnetic particles. The bottom and top phase concentrations are indicated by open symbols and filled 
black symbols respectively. 
 
The benefits of incorporating magnetic particles in the Eumulgin ES AMTPS are 
strikingly illustrated (Fig 5.3). In this case phase separation is evident even at a flow 
rate of 17 L/h, and maximum phase separation is attained at ca. 9 L/h (surfactant 
concentrations in the top and bottom phase of 38% and 0.7% respectively). The 
‘seeding’ of magnetic particles partitioning exclusively to the dispersed micellar 
droplets of the nascent two-phase system makes the droplets strongly susceptible to 
manipulation from an externally applied magnetic field. In the present system the 
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magnetic force acts upwards to enhance the lift or flotation velocity of the ‘magnetic 
droplets’ (Fig 5.1b). A further gain from the inclusion of magnetic particles is the 
increased rate of droplet coalescence observed; a direct consequence of which is 
that the maximum surfactant concentration in the micelle-rich top phase rises from 
32% to 38% (see Fig 5.3). However, in both continuous AMTPS extraction processes 
(i.e. traditional and magnetic particle doped), the maximum Eumulgin ES 
concentration in the top phase, at a phase separation temperature of 30°C, was 
much lower than that obtained from the phase diagram (i.e. ~50%; Fig 5.2). These 
differences for continuous extraction most likely reflect incomplete phase separation. 
In batch mode ‘Eumulgin ES AMTPS’ experiments, complete phase separation 
generally occurs within 16 – 20 h. In the magnetic extractor by contrast, the 
maximum residence times are just 55 minutes when operated with magnetic particles, 
and 5 h in their absence.  
Complete closing of the mass balance for the surfactant exiting the extractor against 
that entering it was not possible, especially at low flow rates in the absence of 
magnetic particles where the lowest mass balance recorded was 67%. The most 
likely reason for this is that the micelle-rich top phase accumulates in the reactor in 
front of the weir. Much better closure of the surfactant mass balance was achieved 
when the magnetic particles are introduced into the AMTPS; presumably because the 
applied magnetic field helps to ‘lift’ the magnetic particle-doped surfactant-rich phase 
over the weir. Nevertheless, ca. 8% of the surfactant entering the CME remained 
unaccounted for. An investigation into the long-term stability of CME’s phase 
separation performance over several hours (i.e. loop mode operation) was therefore 
performed, and the Eumulgin ES and the particle concentrations in the feed and 
exiting top and bottom phases were monitored throughout. 
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Fig. 5.4a shows how particle concentrations within the injected feed and the top and 
bottom phases vary during 2.7 h of continuous operation. The magnetic particles are 
continuously separated from the feed; the particles are concentrated ca. 3.5 fold 
(relative to the initial feed) to a value of ~7 g/L within the micelle-rich top phase of the 
system and the clarified bottom phase is discharged with a very low constant particle 
concentration of just 0.02 g/L (i.e. equivalent to 1% of the feed value). Also striking is 
that the injected particle concentration remained at the initial feed value of 2 g/L 
throughout operation. 
Fig. 5.4 Continuous separation of (a) magnetic particles and (b) phase-forming surfactant in the 
magnetic extractor at a flow rate of 9 L/h. The feed contained initial particle and surfactant 
concentrations of 2 g/L and 10% (w/w) respectively. Key: Initial feed (filled gray symbols), bottom 
phase (open symbols) and top phase (filled black symbols). 
 
Given that the effluents leaving the magnetic extracted are recycled back into the 
stirred feed tank, during long-term experiments any tendency for particles to build up 
within the separation chamber would result in a reduced particle concentration in the 
effluent, and consequently therefore, dilution of the recycled feed. Clearly, particles 
are not held back and accumulated within the reactor, but are instead continuously 
discharged from it. Matching continuous operation data illustrating variance of the 
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phase-forming surfactant concentrations within the feed, top and bottom phases is 
presented in Fig. 5.4b. Here again, the Eumulgin ES concentrations of the initial feed 
and both exiting leaving streams remain constant over the whole 2.7 h of operation. 
The initial feed concentration of 10% (w/w) Eumulgin ES is steadily separated so that 
the concentrations of surfactant in the discharged bottom and top phases are 
respectively 0.9% and 29% (w/w). As the CR value (Equ 5.3) employed in these long-
term recycle studies was 0.33, the surfactant mass balance closed to practically 
100%.  
In addition to the 200 nm sized poly(NIPA-co-AAc) magnetic sorbent particles 
described thus far, we have tested various other magnetic particle materials in the 
CME set-up. An illustration of this is shown in Table 5.2 which presents the particle 
separation efficiencies obtained in experiments conducted with four different 
magnetic particles seeded into Eumulgin ES based AMTPS at a concentration of 2 
g/L. Separation of the two largest functionalised magnetic particles, i.e. the 200 nm 
cation exchanger (poly(NIPA-co-AAc)) and 2 m anion exchange sorbent (M-PVA-
DEAP), was achieved at a flow rate of 9 L/h with >99% efficiencies. For the smaller 
‘MagPrep’ materials (25 and 50 nm), maintenance of high particle separation 
efficiency (>95%) required reduction in the operating flow rate to 5 L/h. This aside, 
the data confirm CME as a versatile process being able to function with a wide range 
of different magnetic particle sizes (25 – 2000 nm) and surface chemistries.  
5.4.3. Continuous magnetic extraction of an antibody 
fragment from an E. coli extract  
To demonstrate ‘proof-of-concept’, i.e. the feasibility of continuous magnetic 
extraction of proteins at liter scale, the technique was applied for the recovery of an 
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industrially relevant antibody fragment (A33 Fab´) from a crude E. coli periplasmic 
extract. The extract was prepared by incubating freshly grown E. coli cells containing 
A33 Fab´ in a buffer held at 60°C for 16 h to release the periplasmic contents. The 
fundamental basis for this periplasmic release method was first reported >30 years 
ago by Katsui and co-workers (1982) who observed ‘blebbing’ and vesiculation of the 
outer membrane (exclusively), which increased the latter’s permeability and led to 
selective release of periplasmic contents. While inappropriate for thermolabile 
products, extended thermally mediated release treatments appear well suited to 
antibody products, because removal of partially degraded and/or incorrectly folded 
antibodies from soluble correctly folded ones is facilitated (Weir and Bailey, 1995). 
 
A 10% (w/w) Eumulgin ES AMPTS seeded with MagPrepSO3 particles (1.4 g/L) was 
used and the feed flow rate was set to 5 L/h to guarantee complete particle 
separation (Table 5.2). Additional process parameters for CME were identified from a 
phase diagram constructed using 10% (w/w) Emulgin ES and the A33 Fab´ 
containing E. coli extract diluted 10 – fold with 20 mM sodium phosphate buffer, pH 
5.6. As noted earlier (Fig 5.2) the similarity of the resulting diagram to those obtained 
in water and buffered systems confirmed that the impact of proteins and other 
suspended species within the extract on Eumulgin ES AMTPS phase transitions was 
negligible. 
 
After 600 s of adsorption in the STR at TS = 15°C the temperature of the feed was 
raised to 30°C (TT) by means of a heat exchanger while being pumped into the 
separation chamber. At this temperature the single dispersed phase split into two 
constituent phases. Protein-laden magnetic CEX particles became enriched in the 
micelle-rich top phase leaving the separation chamber, while unbound host cell 
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proteins and other non-binding species present in the extract exited in the micelle-
poor bottom phase. In the subsequent washing step, the micelle-rich top phase 
containing ‘protein-loaded’ magnetic particles was mixed with two volumes of 20 mM 
sodium phosphate buffer, pH 5.6, for 900 s and then separated again by magnetic 
extraction, to remove entrained E. coli derived contaminants carried over in the top 
phase from the initial adsorption step. Finally, recovery of A33 Fab´ from the 
MagPrepSO3 rich top phase was achieved by mixing with two volumes of binding 
buffer supplemented with 0.75 M NaCl (bringing the NaCl concentration to 0.5 M), 
and once again subjecting to magnetic extraction. In this step, the micelle-poor 
bottom phase now contained the eluted target species, and the ‘eluted’ magnetic 
sorbent particles and the majority of the surfactant were discharged in the top phase.  
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Table 5.2 Magnetic particle tested in the CME set-up and achieved separation efficiencies 
Magnetic support 
(Manufacturer) 
Description of particle materials Mean 
size (nm) 
Flow rate 
(L/h) 
Separation 
efficiency (%) 
MagPrep Silica 25 
(Merck KGaA) 
Magnetite crystals coated with a thin layer of silica 25 5 >95 
MagPrep SO3- 100  
(Merck KGaA) 
Magnetite crystals coated with a thin layer of silica and then 
functionalised with sulfonate moieties 
100 5 >99 
Poly(NIPA-co-AAc) 
(NIIMPT, Romania) 
Magnetite embedded within a poly(N-isopropylacrylamide-co-
acrylic acid) matrix 
200 9 >99 
M-PVA-DEAP 
(PerkinElmer chemagen 
Technologie GmbH) 
Spherical beaded polyvinyl alcohol – magnetite composite 
particle functionalised with diethylaminopropyl groups 
2000 9 >99 
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The compositions of the initial feed and the bottom discharged phases arising from 
each step in the CME purification process are presented in Table 5.3. During CME 
processing the total volumes issuing from the each consecutive step fell 
progressively from an initial 14.7 L to a final <5.1 L. The trace levels of magnetic 
particles in all exiting bottom phases (1 – 17 mg/L) provide striking evidence for 
virtually exclusive partitioning of magnetic particles into the top phase. The 
concentrations of Eumulgin ES, DNA, protein and Fab´ carried over into the final 
eluate were 0.34% (w/w), 0.34 mg/L, 147 g/L and 145 g/L respectively, 
representing mass recoveries in this fraction of just 1.1 and 1.2% for DNA and 
Emulgin ES, 10.6% for protein and 66.7% for the target species, A33 Fab´. Mass 
balances of all relevant species (A33 Fab´, total protein, DNA, particles, surfactant) 
were calculated by adding together the masses of each component in all exiting 
bottom phases and the discharged eluate top phase and comparing the summated 
values with the initial masses supplied in the feed (Table 5.3). The low mass 
balances observed for total protein and DNA likely stem, at least in part, from 
incomplete desorption of both biopolymer types from the magnetic carrier particles. 
Support for this contention comes from reducing SDS-PAGE analysis of supernatants 
obtained after boiling supports in sample buffer, which confirmed the presence of 
several characteristic E. coli outer membrane proteins (Schnaitman, 1974; Osborn 
and Wu, 1980; Schäfer et al., 1999), but no A33 Fab´. By contrast, the total A33 Fab´ 
mass accounted for was significantly over-emphasised; most likely arising from 
exaggerated assay of the Fab´ contents of the bottom phase unbound and wash 
fractions and top phase elution fraction by scanning densitometry. The presence of 
residual Fab´ in the bottom phase post adsorption (Table 5.3) confirms that not all of 
the Fab´ had been removed from the extract. This loss in target yield is not due to 
magnetic extraction process per se, but instead to the use of insufficient quantities of 
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particles in the process. In addition to increasing the total magnetic sorbent particle 
concentration in the system, employing a higher capacity sorbent particle would 
guarantee improved binding performance. Visual evidence for the successful 
purification of A33 Fab´ by CME is provided in Fig 5.5. Potential improvements aside, 
comparison of lanes 2 (starting feed) and 4 (the final eluate) clearly demonstrates 
that, even in its unoptimised state, CME can deliver a high level of target purification. 
 
Fig. 5.5 Reducing SDS-PAGE analysis (15% polyacrylamide gel) of fractions from CME based 
purification of A33 Fab´ from a crude E. coli periplasmic extract. Key: lane 1 – Molecular weight 
markers; lane 2 –; crude periplasmic extract lane 3 –rProtein G purified A33 Fab´; lane 4 – bottom 
phase eluate. 
 
In the present example, comparison of the compositions of the feed and exiting 
elution fraction shows magnetic particle and Eumulgin ES removals of >99.9% and 
>98% respectively, combined with depletion of >95% of the total host cell protein and 
>98% of DNA, leading to a final A33 Fab´ purity of >98% and yield of 67%. Further, 
the A33 Fab´ binding capacity of the MagPrep SO3 sorbent in the process was >36 
mg/g.  
 A33 Fab 
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5.4.4. Benchmarking 
The initial feedstocks for CME and chromatography received very different 
pretreatments. During preparation of the AMTPS for CME the heat treated E. coli 
extract was effectively diluted 10 fold with sodium phosphate buffer, pH 5.6, but 
received no further clarification (see sections 5.3.6 & 5.3.7). Thus, the feedstock 
though essentially cell free still contained fine suspended solids (especially fine cell 
envelope debris) and other troublesome species (e.g. nucleic acid polymers) that had 
issued from the cells during heat treatment. Extracts for rProtein G and CEX 
chromatography were not diluted, but instead received extensive pretreatment to 
remove potential column fouling materials, and adjust the pH and/or conductivity for 
binding (see 5.2.8). 
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Table 5.3 Summary of the volumes and concentrations of the bottom phases resulting from conducting the sorption, wash and elution steps in the CME. 
Process step Volume (L) Magnetic support (g/L) 
Eumulgin ES (% 
w/w) 
DNA (mg/L) Total protein (g/L) 
A33 Fab´ 
(g/L) 
Initial Solution 14.723 1.380 10.00 10.43 0.480 0.075 
Post-sorption 11.39 0.006 2.83 7.08 0.178 0.029 
Washing 7.773 0.017 1.67 3.82 0.072 0.021 
Eluate 5.082 0.001 0.34 0.34 0.147 0.145 
Mass 
balance(%)a 
- 
115 67 74 52 140 
a The sum of the mass flow of all bottom phases and the eluate top phase was compared to the initial mass flow in the feed.  
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The initial A33 Fab´ purity increased from 15.6% to nearly 20% (Table 5.4, Fig 5.6) in 
the common high speed centrifugation step (~9,400 gmax for 0.75 h) as >20% of total 
protein was removed (specifically outer membrane species) without loss in Fab´, 
regardless of whether the extract had received prior pH adjustment (for Protein G 
affinity only). The subsequent 0.22 micron filtration step immediately prior to Protein 
G affinity chromatography saw small l losses in both total protein and Fab´, but the 
Fab´ purity (19.8%) was not impaired.  
 
Fig. 5.6 Reducing SDS-PAGE analysis (14% polyacrylamide gel) of E. coli periplasmic extracts during 
conditioning steps prior to chromatography. Key: lane 1 – E. coli cells prior to heat treatment; lane 2 – 
crude periplasmic extract (supernatant recovered after heat treatment and low speed centrifugation – 
3,255 gav, 0.5 h, 4°C); lane 3 – periplasmic extract after high speed centrifugation (9,391 gmax, 0.75 h, 
4°C); lane 4 – periplasmic extract after adjusting pH to 6.4 and high speed centrifugation (9,391 gmax, 
0.75 h, 4°C); lane 5 – after 0.22 m filtered pH adjusted and centrifuged periplasmic extract. 
 
 
 
 
 
 
 
 
 A33 Fab 
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Fig. 5.7 Reducing SDS-PAGE analysis (14% polyacrylamide gel) of flowthrough fractions collected 
during the buffer exchange steps prior to cation exchange chromatography. Key: lane 1 – Molecular 
weight markers; lanes 2 – Flow through fraction of heat extraction sample; land 3 - 7. Flow through 
fraction of 5 sequential buffer exchange steps by adding 20 mL of 20 mM phosphate buffer at pH 7. 
 
Because of the high ionic strength of the periplasmic extract, a diafiltration step was 
necessary prior to CEX chromatography on Fractogel EMD SO3. A centrifugal buffer 
exchange step was employed for this, and substantial and indiscriminate step losses 
of ~45% of the total protein and A33 Fab´ were experienced (Table 5.4, Fig 5.7). 
Collectively, the numerous conditioning steps necessary to prepare the extracts for 
chromatography, while improving initial Fab´ purity (from 15.6 to 20%), resulted in 
overall losses of A33 Fab´ yield of ~10% prior to Protein G affinity and >50% before 
CEX chromatography (Table 5.4).  
The benchmarking was done at much reduced scale cf. CME, using 30 mL volumes 
of conditioned extracts applied to 1 mL beds of rProtein G Sepharose HP and EMD 
Fractogel EMD SO3 (Fig 5.8 & 5.9, Table 5.5 & 5.6).  
The rProtein G Sepharose column was challenged with extract containing 103 mg of 
total protein, of which 20.4 mg was A33 Fab´. More than 80% of total protein and 
 A33 Fab 
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>56% of the Fab´ applied passed through the column in the flowthrough fraction, and 
a further 15% of total protein and >23% of the Fab´ eluted during washing prior to 
elution (Fig 5.6 and Table 5.5). Bound A33 Fab´ was desorbed from the column using 
a pH step gradient (Fig 5.8a). Approximately 4 mg of the Fab´ was recovered in 3.3 
CVs in a highly purified state, i.e. 100% by scanning densitometry (Fig 5.8b); 
corresponding to an overall target recovery of just 20% (Table 5.6), and binding 
capacity of 4.1 mg Fab´ per mL of sorbent. For CEX chromatography, owing to heavy 
losses incurred in preparing the extract for CEX (Table 5.4), the diafiltrated 
periplasmic extract (30 mL) loaded on to the column contained a reduced challenge 
of ~56 mg of total protein and 11.3 mg A33 Fab´ (Table 5.7, Fig 5.9). Seventy 
percent of the total protein was accounted for in the flow-through fraction, but only 
2.3% of the Fab´ was lost. Evidently the capacity of the Fractogel EMD SO3 matrix for 
A33 Fab´ from conditioned periplasmic extract under the binding conditions employed 
(pH 5.6, conductivity= 3 mS/cm) was not challenged in this study 
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Table 5.4 Impact of feedstock conditioning on extract composition and Fab´ yield prior to chromatography. See text for details. 
Sequential conditioning step Volume (L) Fab´ (mg) Protein (mg) Fab´ purity (%) Protein yield (%) Fab´ yield 
(%) 
PFa 
None 0.2 150 960 15.6 100 100 1.0 
pH adjustment (Protein G only) 0.2  - - - - - - 
Centrifugation (+/- prior pH 
adjustment) 
0.2 150 761 19.7 79.3 100 1.26 
0.22 m filtration 0.2 136 686 19.8 71.5 90.7 1.27 
Buffer exchange(CEX only) 0.2 74.5 371 20.1 38.6 49.7 1.29 
aPF = purification factor
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 After washing, the column was developed with a linear salt gradient (Fig 5.9a). 
Ninety-seven percent (11.0 mg) of the Fab´ was detected in the elution peak (Fig. 
5.9b), which was eluted in 5 CVs between 0.2 and 0.5 M added NaCl. The purity of 
the pooled peak (7 CVs) (all fractions containing Fab´, Fig. 5.9 a lane 9-15) was 
purity of 95.4% (Table 5.6).  
The lack of need for expensive, extensive and ‘yield compromising’ feedstock 
conditioning steps prior to sorption represents a key advantage of direct capture 
techniques, such as CME. How CME based purification compares with Protein G 
affinity and CEX chromatography in packed bed columns is shown in Table 5.7. 
Though direct comparisons of CME with chromatography are made difficult by the 
different levels of feedstock conditioning received in each case, it is nevertheless 
clear that the CME process compares very favorably with Protein G affinity and CEX 
chromatography in terms of Fab´ purity and yield. Moreover, the advantages of CME 
over chromatography are further enhanced when the losses in Fab´ yield during 
extract conditioning (Table 5.4) are taken into account. The same sulfonate ligand 
was used for CEX chromatography and CME. It is interesting to note, therefore, that 
despite CME’s lack of multiple stages, the technique delivered comparable or even 
higher purity (98% cf. 95.4%; Table 5.7). Possible differences in surface properties of 
the MagPrepSO3 and Fractogel EMD SO3 sorbents aside, a further potential 
explanation for the higher purity observed in the CME process is the virtually 
complete exclusion of freely dissolved proteins from the micelle-rich phase. The use 
of anionic sulfonate ligands in both processes dictates that measures to reduce the 
ionic strength of the periplasmic feedstock are mandatory. Here, for traditional fixed-
bed CEX chromatography diafiltration, was employed (seriously impairing Fab´ yield; 
Table 5.4), but for the CME process this time-consuming step was rejected in favor of 
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simple dilution, given that the extraction set-up could easily handle large volumes of 
partially clarified feed.  
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Table 5.5 Purification table for the recovery of A33 Fab´ from a conditioned E. coli extract (see Table 5.5) by affinity chromatography on rProtein G Sepharose 
HP. 
Step Fab (mg) Total protein 
(mg) 
Fab yield (%) Total protein yield 
(%) 
Fab purity (%) Purification factor 
Load 20.4 102.9 100 100 19.8 1.0 
FT 11.5 83.0 56.4 80.7 13.9 0.70 
Wash 4.8 15.8 23.5 15.35 30.4 1.53 
Elution 4.1 4.1 20.1 4.0 100 5.05 
 
Table 5.6 Purification table for the recovery of A33 Fab´ from a conditioned periplasmic extract (see Table 5.6) by cation exchange chromatography on Fractogel 
EMD SO3. 
Step Fab (mg) Total protein 
(mg) 
Fab yield (%) Total protein yield 
(%) 
Fab purity (%) Purification factor 
Load 11.3 55.7 100 100 20.1 1.0 
FT 0.26 38.7 2.3 69.5 3.31 0.165 
Wash 0.04 5.4 0.35 9.8 3.57 0.178 
Elution 11.0 11.5 97 20.7 95.4 4.75 
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Fig. 5.8 Chromatogram (a) and (b) corresponding reducing SDS-PAGE analysis (14% polyacrylamide gel) for the recovery of A33 Fab´ from conditioned 
periplasmic extract by affinity chromatography on rProtein G Sepharose HP (Table 5.7). Key: lane 1 – Feed (conditioned extract); lanes 2 - 4 – loading 
flowthrough; lane 5 – wash; lanes 6 & 7 – elution peak.  
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Fig. 5.9 Chromatogram (a) and (b) corresponding reducing SDS-PAGE analysis (14% polyacrylamide gel) for the recovery of A33 Fab´ from conditioned 
periplasmic extract by cation exchange chromatography on Fractogel EMD SO3 (Table 5.6). Key: lanes 1 & 16 – molecular weight markers; lane 2 – rProtein G 
Sepharose HP purified A33 Fab´; lane 3 – feed (conditioned extract); lanes 4 & 5 – loading flowthrough; lane 6 – wash; lanes 7 to 15 – elution peak. 
Lane 7-8 was eluted 2 CV before the peak was detected, lane 9-15 was eluted at the peak and after. 
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Table 5.7 Comparison of CME with conventional adsorption chromatography for the recovery of A33 Fab´ from E. coli extracts. See text for details. 
Method (adsorbent)  Feedstock  Eluate 
Conditioning history (pH, ) Volume (L) Fab´ 
(mg) 
Protein 
(mg) 
Initial Fab´ 
purity (%) 
Final 
Fab´ 
purity (%)
Fab´ 
step 
yield 
(%) 
Step 
PFa 
CME (MagPrepSO3- 100) 10× diluted with buffer 
(pH 5.6, = 4.3 mS/cm) 
14.72 1,104 7,067 15.6 98 67 6.3 
Affinity chromatography 
(rProtein G Sepharose 
HP) 
pH adjusted, centrifuged & 
0.22 m filtered 
(pH 6.6, = 17 mS/cm) 
0.03 20.4 102.9 19.8 100 20 5.1 
CEX chromatography 
(Fractogel EMD SO3-) 
Centrifuged, 0.22 m 
filtered, buffer exchanged 
(pH 5.6; = 2.9 mS/cm) 
0.03 11.2 55.7 20.1 95 97 4.7 
aPF = purification factor 
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The high salt concentration of the original crude periplasmic extract (= 21 mS/cm) 
presented no problems to Protein G affinity chromatography, but the presence of 
suspended solids and fouling materials necessitated subjecting the extract to 
extensive clarification beforehand, which compromised Fab’ yield (Table 5.4); the low 
capacity (4 mg/mL) and expense of the rProtein G derivatised chromatography matrix 
are further detractions.  
5.4.5. Review of the Recyclability of the CME Components 
– Surfactants and Magnetic Sorbent Particles 
Reuse of the phase-forming component of an AMTPS is one striking advantage of 
AMTPS, over conventional ATPS. This is because it is only the micelle-depleted 
phase that is removed or discharged during all steps, i.e. sorption, washing and 
elution. In the case of CME, the micelle-rich top phase contains magnetic particle 
sorbents; which at end of the elution step can be re-cycled back into the next sorption 
stage, and so on. In order to calculate the theoretical amount of the recyclable 
phase-forming component, Eumulgin ES, samples of micelle-depleted bottom phases 
from the binding, washing and elution steps were removed during the continuous 
operation of the CME device for off-line analysis of surfactant, concentration. Table 
5.8 compares the surfactant concentrations measured under continuous mode with 
those immediately after finishing the individual processing steps and discharging the 
separator contents into the collection tank.  
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Table 5.8 Comparison of surfactant concentrations in the bottom phase during CME operation and 
after discharging the separator. 
Process 
step 
[Eumulgin ES] (%w/w) 
During operation After discharging the separator 
Binding 0.9 2.8 
Washing 1.0 1.7 
Elution 0.2 0.34 
 
For all processing steps the Eumulgin ES concentrations are significantly higher (1.7 
– 3.1 fold) after finishing each process step and discharging the separator, and are 
related to the ratio of volumes of the CME separation chamber (2.8 L) to that of the 
fluids processed through it (6.8 – 14.7 L). After complete processing of the feedstock, 
the CME separation chamber must be drained. During this operation, incomplete 
phase separation results in higher losses of surfactant cf. continuous mode. The 
problem of incomplete phase separation during drainage could be reduced by using 
an adjustable weir, which follows the phase boundary during the process. An 
adjustable weir could additionally aid optimisation of the CME set-up for different CR 
values. However, for large feed volumes or truly continuous operation, the impact of 
surfactant that is lost during this drainage would be insignificant; thus values 
indicated in the left hand column (‘During operation’) of Table 5.8 are more pertinent 
to CME.  
The amount of recyclable surfactant, i.e. that which can be recycled from the top 
phase arising from the elution step into a subsequent sorption cycle, was calculated 
(from the loss of surfactant in the bottom phases during the continuous operation of 
the magnetic extraction) to be 87%. Further, the total particle loss after binding, 
washing and elution amounted to only ~1% of the initial amount used, leaving the 
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remaining 99% available for use in a subsequent cycle of CME. In summary, effective 
reuse of both the phase-forming surfactant and magnetic sorbent particles is clearly 
achievable in CME based processes. 
5.5. Conclusions 
Continuous Magnetic Extraction (CME) has been introduced as a promising and 
potentially low cost continuous bioseparation process. It is based on the concerted 
use of functionalised magnetic sorbent particles together with AMTPS. Magnetic 
sorbents which partition exclusively to the micelle-rich phase of an AMTPS are 
separated in a novel pilot-scale extractor comprising a mixer and a magnetic field-
enhanced flow-through phase separator. We have demonstrated that this CME 
device can be operated at flow rates of several liters per hour, at close to ambient 
temperatures (15 – 30°C), with particle separation efficiencies of >99%. Further, the 
phase-forming non-ionic surfactant employed in this work, Eumulgin ES, was 
continuously split into micelle-rich and micelle-depleted phases with a separation 
efficiency of >98%.  
Subsequently, CME was successively applied for the direct capture of the antibody 
fragment A33 Fab´ from a crude E. coli periplasmic extract, employing CEX 
functionalised magnetic nano-particle sorbents. Nearly 70% of the A33 Fab´ initially 
present was recovered in the magnetic particle-free bottom phase eluate in 2 – fold 
concentrated form with a purity of >98%, corresponding to a purification factor of 6.3. 
The corresponding top phase eluate stream contained the magnetic sorbent particles 
and most of the phase-forming surfactant. In CME magnetic nano-particle sorbents 
were recovered with a recycling efficiency of >99% over three consecutively operated 
extractions, during which 13% of the phase-forming surfactant was lost. The 
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remaining 87% of phase-forming surfactant was collected together with the magnetic 
sorbents particles after the final elution step. Clearly therefore, recycling both the 
magnetic sorbents and the phase-surfactant particle into subsequent rounds of CME 
is highly feasible. Taken collectively, the results of this study identify CME as a viable 
means of performing continuous purification of target macromolecules from complex 
biological feedstocks at relatively low cost. 
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6. Fabrication and characterisation of 
thermoresponsive polymer fimbriated 
immobilised metal affinity adsorbents 
6.1. Abstract 
The preparation and characterisation of immobilised metal affinity magnetic 
adsorbents possessing thermoresponsive behaviour is described. Cerium (IV) 
initiated ‘graft from’ polymerisation techniques were employed to the convert 
nonporous magnetite – poly(vinyl alcohol) composite particle, M-PVA, into a 
trio of adsorbents fimbriated with: (i) (poly(N-isopropylacrylamide), pNIPAAm; 
(ii) poly(N-vinylimidazole), pVI; and (iii) both polymers, [pNIPAAm + pVI]. 
Qualitative FTIR was used to corroborate the presence of the different grafted 
polymers in the surfaces of ‘finished’ supports (and intermediate in their 
manufacture in the case of the mixed polymer brush modifed adsorbent) and 
quantitative ATR – FTIR (employed on pre- and post- polymerisation reaction 
supernatants) confirmed that equal amounts of monomers had been grafted 
into all three supports (i.e. 8.75 – 9.35 mmol/g M-PVA), and further that the 
mixed polymer brush modified material [pNIPAAm + pVI] contained roughly 
equal amounts of N-isopropylacrylamide (4.35 mmol/g M-PVA) and N-
vinylimidazole (4.4 mmol/g M-PVA). In binding studies with a recombinant 
heat stable hexahistidine tagged Green Fluorescent Protein (His6-GFP) rapid 
binding was observed for all three Cu2+ charged polymer modified supports, 
and the binding capacities were shown to be strongly influenced by pVI 
content and adsorption temperature, whereas nonspecific binding correlated 
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with pNIPAAm. The weaker binding at higher temperature was successively 
exploited for temperature mediated elution under binding conditions. The 
highest initial capacity for His6-GFP (40 mg/g) and best desorption 
performance (>90% recovery) was observed for M-PVA modified with Cu2+- 
poly(N-vinylimidazole). By contrast, little or no protein elution was observed 
for Cu2+ charged Chelating Sepharose Fast Flow (fixed or immobile Cu2+-IDA 
ligands) during temperature switching. The observed differences in thermally 
mediated elution behaviour of the Cu2+ coordinating polymer brush modified 
M-PVA and Chelating Sepharose Fast Flow media are explained by the 
effects of temperature on the mobility of polymer bound Cu2+ ligands cf. fixed 
immobile Cu2+ ligands, and conclusions on the use of polymers displaying 
normal and inverse temperature solubility behaviour in immobilised metal 
affinity adsorption are reached. 
  
 230 
 
6.2.  Introduction 
High-cost processes consuming excessive amounts of buffers and generating 
disproportionate levels of waste are serious drawbacks of adsorption-
desorption based methods employed by the Biopharmaceutical sector 
(Przybycien et al., 2004; Jagschies, 2008; Maharjan et al., 2008). Effective 
solutions to these problems have not yet been forthcoming, but would clearly 
make for much leaner, greener and more sustainable manufacturing of these 
valuable bio-commodities (Maharjan et al., 2008).  
In the above context, an important objective within the European Framework 7 
‘MagPro2Life’ project is to design, demonstrate and iteratively refine an 
entirely new separation concept that relies on discrete local changes in 
temperature, rather than chemical means, to control adsorption-desorption 
equilibria. This new approach owes much of inspiration to recent advances 
dealing with the use of smart or intelligent polymers to creating novel 
materials with ‘self-adaptive’ surfaces (Luzinov et al., 2004; Kizhakkedathu et 
al., 2004; Kanazawa and Okano, 2011). 
Temperature-sensitive polymers exhibit a critical solution temperature (CST) 
behaviour, where phase separation is induced by surpassing a certain 
temperature. Two categories of thermo-responsive behaviour are known. 
Polymers are either: water-soluble at high temperature, and insoluble at low 
temperature (at the so-called upper critical solution temperature, UCST); or 
water-soluble at low temperature, and insoluble at high temperature. 
Temperature-sensitive polymers falling into the second category (referred to 
as ‘smart thermoresponsive polymers’) are generally more useful, especially 
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for applications involving biological entities that prohibit high temperature 
operation (Taylor and Ceranowski, 1975; Galaev and Mattiasson, 1999), as 
they exhibit inverse temperature solubility behaviour (Fig. 6.1) at a critical 
temperature known as the lower critical solution temperature, LCST (Taylor 
and Ceranowski, 1975; Galaev and Mattiasson, 1999).  
 
Fig. 6.1 Schematics drawings illustrating the phase behaviour of a polymer-solvent system 
with LCST (left) and the inverse temperature solubility behaviour (right) of thermoresponsive 
polymers at the LCST, i.e. hydrated polymer below the LCST and entropic loss of water and 
chain collapse above LCST. Courtesy of K. Zourna. 
 
Below the LCST, the hydrophilic and completely miscible with water polymer 
develops a highly swollen coiled chain conformation (Fig. 6.1, bottom right). 
When the temperature increases above the LCST, the polymer is hydrophobic 
(Fig. 6.1, top right) and becomes incompatible with water, i.e. the polymer–
water homogeneous mixture encounters phase separation (Fig. 6.1, left), 
where the polymer becomes globular and separates from the water-enriched 
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phase (Luzinov et al., 2004; Zourna, 2009)]. Thus, a sudden shift in 
temperature away from the LCST point, can cause reversible and dramatic 
changes in the state of the polymer from hydrophilic to hydrophobic and back. 
Poly(N-isopropylacrylamide), hereafter referred to by the abbreviation 
pNIPAAm, is perhaps the best studied smart thermoresponsive polymer. Its 
phase transition from a hydrophilic to a hydrophobic structure occurs suddenly 
at the LCST, which experimentally lies between ca. 30 and 35 ºC, depending 
on the exact microstructure of the macromolecule (Kubota et al., 1990)). 
pNIPAAm (Fig. 2) is composed of amide groups that are hydrophilic and 
isopropyl groups that are hydrophobic (Kubota et al., 1990; Schild, 1992)). 
 
 
Fig. 6.2 Chemical structure of the poly N-isopropyl acrylamide (pNIPAAm) repeat unit. 
 
Below the LCST, the water molecules cover the hydrophobic groups and the 
hydrogen bonds between the amide groups and water stabilise the solution, 
whereas above the LCST the hydrogen bonds become so weak that the 
attractions between the hydrophobic groups become bigger (de-mixing of 
polymer chains). As the water molecules destabilise around the isopropyl 
group, there is no available energy for mixing as the heat absorbed by the 
system is lower than the change in enthalpy and ultimately the chains de-mix 
(Kubota et al., 1990: Schild, 1992; Zourna, 2009). 
CH2CH ] m
]
O=C
NH
CH
CH3H3C
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A handful of publications have demonstrated that the modification of solid 
substrates with pNIPAAm can impart considerable control over bacterial 
fouling and cell release (Okano et al., 1993, 1995, Kikuchi et al., 1998; Ista et 
al., 1999; Takezawa et al., 1990; Liu, 2009). The accumulation of 
microorganisms at solid-liquid interfaces, results in the formation of biofilms, 
which can pose hygiene and safety concerns and which can be extremely 
difficult to prevent and/or remove. In this context, modification of materials 
with pNIPAAm has been investigated to create switchable substrates for:  
(i) temperature-controlled cell harvesting (Kikuchi et al., 1998)]; 
(ii) recovery of cells from tissue culture substrata without the need for 
enzymes (Okano et al., 1993, 1995; Takezawa et al., 1990); and 
(iii) most recently in our  laboratories for reducing cell sorption and 
enhancing cell release from magnetic adsorbent particles under binding 
conditions, i.e. without changing the buffer composition (Liu, 2009). 
 
Collectively, these studies demonstrate that:  
(i) the solvated for pNIPAAm is not intrinsically fouling resistant;  
(ii) cell release can occur in both directions (i.e. cooling or heating) across 
pNIPAAm’s LCST with the same cell type; and  
(iii) phase transition is perhaps the most important factor in removal of 
microorganisms.  
 
A large body of work on the use of pNIPAAm to modify chromatography 
media has appeared since the first reports appeared in the early 1990s 
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(Gewehr et al., 1992; Hosoya et al., 1994, 1995). Most work thus far has 
concentrated on exploiting the principle of extension and collapse of polymer 
chains for: (i) thermoresponsive size exclusion similar to ‘chemical valves’ 
(Gewehr et al., 1992; Hosoya et al., 1994; Adrados et al., 2001)); (ii) 
modulating hydrophobicity in HPLC (Hosoya et al., 1995; Adrados et al., 2001; 
Yaksuiji et al., 1994; Ayano et al., 2006a; Kanazawa et al., 1996, 1997, 1998); 
(iii) balancing electrostatic and hydrophobic interactions in ion exchange by 
employing thermoresponsive and electrostatic components in the same 
polymer (Kobayashi et al., 2002, 2003; Sakamoto et al., 2004; Ayano et al., 
2006b; Maharjan et al., 2009; Nagase et al., 2010; Müller et al., 2013) or 
surface (Liu, 2009); and (iv) ‘in pseudoaffinity chromatography (Maharjan et 
al., 2008; Yoshizako et al., 2002).  
To date however, most work on pNIPAAm in chromatography concerns the 
modification of small pored inorganic (glass, silica) or hydrophobic 
(polystyrene based) resins chromatography supports intended for use in 
analytical HPLC separations of small molecules (especially mixtures of 
steroids). In stark contrast, the use of pNIPAAm for modifying macroporous 
hydrogel chromatography materials appropriate for bioprocess scale 
separations of macromolecular targets (globular proteins, nucleic acids, 
viruses) has received very little attention thus far. This is surprising given that 
the use of temperature responsive chromatography materials offers cost-
effective environmentally friendly solutions to the isolation of commercially 
valuable biocomponents from biopharma, bioindustry, agricultural, food and 
other complex process streams (Maharjan et al., 2008, 2009; Liu, 2009; 
Nagase et al., 2010; Müller et al., 2013).  
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In the work detailed here, Ce(IV) initiated ‘graft from’ polymerisation 
techniques developed for the fabrication of tentacular chromatography 
matrices (Müller, 1986, 1990; Janzen et al., 1990; Brooks and Müller, 1996; 
Hritcu et al., 1999; Brooks et al., 2000) were employed to convert non-porous 
magnetic supports into thermoresponsive magnetic immobilised metal affinity 
adsorbents by growing ‘mobile’ temperature sensitive Cu2+ coordinating 
polymer brush layers in situ. Three different polymer brush modified supports 
were made, i.e. one featuring the temperature-sensitive smart polymer, 
poly(N-isopropylacrylamide), another of the metal chelating polymer, poly(N-
vinylimidazole), and the third comprising a mixed brush arrangement 
composed of equal numbers of adjacent poly(N-isopropylacrylamide) and 
poly(N-vinylimidazole) chains. Following characterisation by FT-IR, the 
finished supports were charged with Cu2+ ions and then subjected to a battery 
of protein binding and desorption tests aimed at evaluating the feasibility of 
thermally mediated target protein elution under binding conditions. 
Comprehensive control studies were also conducted using a Cu2+ charged 
commercial immobilised metal affinity chromatography matrix featuring ‘fixed’ 
(i.e. immobile) ligands. 
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6.3. Materials and Methods 
6.3.1. Materials 
M-PVA 012 (Lot no. R2-0109027), the spherical beaded ‘magnetite – polyvinyl 
alcohol (Mr 130,000; acetyl content: 10.0-11.6 %; degree of hydrolysis: 86.8-
88.7 %)’ composite base matrix used in this study, was a gift from Chemagen 
Biopolymer-Technologie AG (Baesweiler, Germany). Brown’s (2009) detailed 
magnetic and physical characterisation of this support particle confirmed it as 
superparamagnetic, roughly spherical, relatively monodisperse (D50 = 1.9 m, 
D20-80 of 1.5–2.6 m), possessing high saturation magnetisation (42 Am2 g-1) 
and a highly textured surface (~55 m2/g). Chelating Sepharose Fast Flow was 
purchased from GE Healthcare (Uppsala, Sweden), and the free polymers, 
poly(N-isopropylacrylamide) (Mw 19,000 – 30,000) and poly(N-vinylimidazole) 
(Mn 8,300, Mw/Mn = 3.4) were obtained from Sigma-Aldrich Company Ltd. 
(Gillingham, UK) and Polymer Source Inc. (Montreal, Canada) respectively. 
Haemoglobin from bovine blood (lyophilised powder) was acquired from 
Sigma-Aldrich Company Ltd. (Gillingham, UK) and used without further 
purification. Purified recombinant N-terminal hexa-histidine tagged Aequorea 
victoria Green Fluorescent Protein (His6-GFP) was kindly supplied by J. 
Becker (KIT, Leopoldshafen, Germany). Bovine serum albumin (BSA) 
standards were obtained from Pierce Chemical Company (Rockford, IL, USA). 
The chemicals employed for modification of M-PVA and in subsequent 
binding and desorption studies – acetone (≥99.8%), methanol (≥99.9%), 1-
vinylimidazole (99%, VI), N-isopropylacrylamide (97%, NIPAAm); ammonium 
cerium (IV) nitrate (99.99%), sodium sulphate (ACS reagent, anhydrous 
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powder, ≥99.0%), 4-ethoxyphenol (99%), glacial acetic acid (ACS reagent, 
≥99.7%), sodium acetate (ACS reagent, ≥99.0%), sodium dihydrogen 
phosphate (≥99%), disodium hydrogen phosphate (≥99.0%), imidazole 
(≥99.9%), copper (II) chloride (anhydrous, ≥99.995% trace metals basis), 
sodium chloride (≥99.5%), sodium hydroxide (pellets, anhydrous, >98%) and 
potassium bromide (≥99%, FT-IR grade) – were all from the Sigma-Aldrich 
Company Ltd (Poole, Dorset, UK), and bottled oxygen-free nitrogen gas was 
supplied by British Oxygen Co Ltd (Windlesham, Surrey, UK). All other 
chemicals not stated above were from Sigma-Aldrich or Merck Chemicals Ltd. 
Milli-Q water was used in all experiments.  
6.3.2. Support handling 
Side-pull magnetic racks (Chemagic Stands 50k Type A and 2x12, Chemagen 
Biopolymer-Technologie AG, Baesweiler, Germany) employing neodymium-
iron-boron permanent magnets were employed for recovering magnetic M-
PVA supports from suspension during their modification and subsequent use. 
Depending on experimental requirements Chelating Sepharose Fast Flow 
adsorbents were separated from the small volumes of bulk phases either by 
allowing sufficient time to settle (0.5 h) under gravity or alternatively within 10 
s using a 6,500 g centrifugal pulse administered in a microcentrifuge.  
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6.3.3. Preparation of polymer grafted M-PVA supports 
by Cerium (IV) ‘graft from’ initiated reactions  
The procedures used in this work for the generation of homopolymer and 
mixed polymer grafted M-PVA particles by Ce(IV) initiated ‘graft from’ free-
radical polymerisation are based on methods previously developed in our 
laboratories (Brown, 2009, Brown et al., 2013; Willett, 2009; Zourna, 2009). 
The detailed protocols employed are presented immediately below and are 
schematically represented in Figures 6.3 and 6.4, and the key grafting 
parameters are summarised in Table 6.1. 
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Fig. 6.3 General scheme illustrating the preparation routes and idealised appearance (equal 
polymer chain lengths and graft density; see Table 6.1) of the pVI, pNIPAAm and [pNIPAAm 
+ pVI] modified M-PVA supports made in this work. The calculated intergraft spacing (cited in 
Table 6.1) for the pNIPAAm intermediate (D' = 6.5 Å) in the two step procedure grafting 
procedure and of all three ‘finished’ supports (D" = 4.6 Å) are indicated. 
 
a b 
 
 
Fig. 6.4 Schemes illustrating the basic chemistry involved in single (a) and sequential two-
step (b) cerium (IV) initiated ‘graft from’ polymerisation of vinyl monomers (VI and NIPAAm in 
this work) into the polyvinyl alcohol (PVA) matrix of M-PVA supports. 
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Table 6.1 Summary of key grafting parameters and characterisation data for the polymer fimbriated M-PVA supports made and used in this study. 
Key grafting parameters Support characterisation 
Support 
fimbriated 
with 
Grafting 
in:  
Monomer 
presented 
(mmol monomer 
/g M-PVA) 
Initiator 
(mmol 
Ce4+ /g 
M-PVA) 
DP100% 
(units)a 
Monomer 
consumed 
(%)b 
DPobs 
(units) 
Inter-graft 
spacing 
(Å)c 
Monomer 
installed 
(mmol/g 
M-PVA) 
Grafted polymer content 
(g/g M-PVA) 
Finished support 
Grafted 
polymer 
content 
(% w/w) 
Polymer brush 
description D' D" pNIPAAm pVI Total 
pNIPAAm 1 step NIPAAm (110) 0.44 250 8.5 22 na 4.6 9.35 1.07 na 1.07 51.7 p(NIPAAm)22 – 4.6 Å 
 
pVI 1 step VI (44) 0.44 100 21 21 na 4.6 9.24 na 0.87 0.87 46.5 p(VI)21 – 4.6 Å 
 
pNIPAAm 
followed 
by pVI 
2 steps 1: NIPAAm (55) 
2: VI (4.4) 
0.22 
0.22 
250 
20 
7.9 
100 
20 
20 
6.5 
na 
na 
4.6 
4.35 
4.40 
0.49 na 
0.41 
0.47 
0.90 
na 
47.4 
[p(NIPAAm)20 + 
p(VI)20] – 4.6 Å 
 
Key: aDP100% is the degree of polymerisation expected for 100% monomer consumption; bDetermined by FT-IR; cCalculated inter-graft spacings of assuming 
reaction of every Ce4+ results a grafted polymer chain. D' and D" respectively denote the intermediate and final spacings achieved (depicted in Fig. 6.1); na = 
not applicable. 
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6.3.3.1. M-PVA base matrix conditioning for polymer grafting 
Prior to polymer grafting, 0.5 g quantities of M-PVA particles were transferred 
to fresh 50 mL polypropylene falcon tubes (Fisher Scientific UK Ltd, 
Loughborough, UK) and then washed exhaustively at room temperature by 
sequential cycles of resuspension, mixing and magnetic separation with 30 
mL aliquots of the following solutions: water; 50% (v/v) acetone in water; 
100% acetone; 50% (v/v) acetone in methanol; 100% methanol; 50% (v/v) 
methanol in water; twice with water; 1 M NaCl; and finally twice  with 
degassed nitrogen purged water, before resuspending in a final volume of 15 
mL. During each wash step, the particle mixtures were mixed for 30 s using a 
Fisherbrand WhirliMixer™ (Fisher Scientific UK Ltd., Loughborough, UK), 
before separating magnetically and carefully discarding the wash 
supernatants.  
Immediately prior to polymerisation separate aqueous stock suspensions of 
washed M-PVA particles (33.33 mg/mL), 1-vinylimidazole (VI, 1.47 M), N-
isopropylacrylamide (NIPAAm, 3.67 M) and 147 mM ammonium cerium (IV) 
nitrate in 2 M nitric acid were sparged with steady streams of nitrogen for 0.5 
h, while housed in a zipper-locked inflatable glove box (AtmosBag, Sigma-
Aldrich, UK).  
6.3.3.2. Preparation of linear homopolymer brush modified M-
PVA particles by Cerium (IV) initiated polymerisation 
For the preparation of M-PVA supports grafted with pVI and pNIPAAm 
homopolymer brushes 3 mL aliquots of the nitrogen purged VI (4.4 mmol) or 
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NIPAAm (11.0 mmol) solutions were mixed with 3 mL of nitrogen purged M-
PVA particles (100 mg). The tubes were immediately sealed and then placed 
on a Vibrax shaker (IKA®-Werke GmbH, Staufen, Germany) for 300 s 
operating at 2000 rpm. After this period the tubes were transferred back to the 
nitrogen environment of the glove box, and the ‘graft from’ polymerisation 
reactions were initiated by addition of 300 L portions of ammonium cerium 
nitrate /nitric acid solution (containing 44 mol Ce4+) to each tube, before re-
sealing, and returning to the Vibrax shaker. After 3 h of reaction at room 
temperature the supernatants were removed with the aid of a magnetic rack 
and the polymer grafted supports were subsequently washed on a vortex 
mixer for 60 s each with 10 mL portions of the following solvents: 0.2 M 
Na2SO3 in 10% v/v acetic acid (stop solution); water (2x); 1 M NaCl (2x); 
water (2x) before storing water at 4°C until required.  
The monomers VI and NIPAAm were employed at 44 and 110 mmol per gram 
of M-PVA and the initiator, Ce4+ was used at 0.44 mmol per g M-PVA 
(corresponding to an inter-chain spacing, D" of 4.6 Å; Table 6.1) so that the 
molar ratios of VI: Ce4+ and NIPAAm: Ce4+ entering the reactions were 100:1 
and 275:1 respectively. Based on Zourna’s (2009) findings the 2.5 fold higher 
monomer: initiator ratio employed in reactions with NIPAAm cf. those with VI 
is necessary, given her observation of much lower efficiencies of NIPAAm 
consumption in aqueous Cerium (IV) initiated reactions cf. those towards VI 
and especially acrylic acid monomers.  
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6.3.3.3. Preparation of linear mixed functionality polymer brush 
modified M-PVA particles by sequential Cerium (IV) initiated 
polymerisation 
Creation of mixed [pNIPAAM + pVI] grafted surfaces on M-PVA was 
performed in two overall steps. In the first of these, pNIPAAM was grafted 
onto the unmodified M-PVA surface using half the amounts of NIPAAm 
monomer and ammonium cerium nitrate employed for pNIPAAm 
homopolymer modification of M-PVA, i.e. 55 mmol NIPAAm and 0.22 mmol 
Ce4+ per gram of M-PVA, generating M-PVA supports lightly fimbriated with 
pNIPAAM (D' = 6.5 Å; Table 6.1). This was followed by a second step, in 
which pVI was grafted (in between the tethered pNIPAAm chains on M-PVA’s 
surface leading to supports with mixed polymer brush surfaces comprising 
adjacent pNIPAAm and pVI chains spaced 4.6 Å apart (Table 6.1). The 
amounts of VI and Ce4+ employed in the second step were 4.4 and 0.22 
mmol/g M-PVA respectively. 
In the first step nitrogen purged NIPAAm stock solution (1.5 mL, 5.5 mmol) 
and nitrogen purged water (1.65 mL) were added to 3 mL of nitrogen purged 
M-PVA particle suspension contained in a fresh falcon tube. The tube was 
immediately sealed and placed on a Vibrax shaker (IKA1-Werke GmbH, 
Staufen, Germany) for 300 s operating at 2000 rpm. After this time the tubes 
were transferred back to the nitrogen environment of the glove box where 150 
L of ammonium cerium (IV) nitrate (22 mol) was added, and the tube was 
then re-sealed and returned to the Vibrax shaker for a further 3 h. The 
supernatant was then removed with the aid of a magnetic rack and the 
particles were re-suspended in 10 mL of 14.5 mM 4-ethoxyphenol solution 
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and vortexed for 600 s to quench the reaction. The resulting pNIPAAm-
fimbriated M-PVA supports were then washed sequentially with 10 mL 
portions of 0.2 M Na2SO3 in 10% (v/v) acetic acid; water (2×); 1 M NaCl (2×); 
and water (2×) and resuspended with nitrogen purged water to a volume of 3 
mL. 
For the second step in the synthesis of [pNIPAAm + pVI] modified M-PVA, 
only half of the pNIPAAm-fimbriated support suspension was employed and 
the remainder was retained for FT-IR analysis.  
After sparging the pNIPAAm-fimbriated intermediate slurry (1.5 mL, equivalent 
to 50 mg of original M-PVA particle) with a steady stream of nitrogen for 600 s, 
nitrogen purged VI solution (150 L, 0.22 mmol) and water (1.425 mL) was 
added, the tube was resealed and the contents were mixed on a Vibrax 
shaker at 2000 rpm. After 300 s of incubation the tube was returned nitrogen 
filled and 75 L of 2 M nitric acid containing 11 mol ammonium cerium (IV) 
nitrate was before, resealing the tube and shaking (2000 rpm) at room 
temperature for 3 h. At the end of this period [pNIPAAm+ pVI] fimbriated 
particles were magnetically retrieved from the spent reaction liquor, re-
suspended in 5 mL of 14.5 mM, 4-ethoxyphenol solution and mixed for 600 s 
on a Vibrax shaker. Finally, after washing as previously described(with 0.2 M 
Na2SO3 in 10% (v/v) acetic acid, twice with water, twice with 1 M NaCl, and 
finally twice with water) the finished [pNIPAAm + pVI] fimbriated M-PVA 
supports were stored in 3 mL of water at 4°C until required. 
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6.3.4. Further purification of hexahistine-tagged Green 
Fluorescent Protein (His6-GFP)  
The recombinant His6-GFP received (~3 mg/mL) and used in this work had 
been intracellulary expressed and cultivated in E. coli BW3110 (harbouring 
pJOE 4056.2) and subsequently purified (>95% by SDS-PAGE) from a 
centrifugally clarified cell homogenate by immobilised metal affinity adsorption 
on Cu2+-IDA (iminodiacetic acid) linked supports. Before use portions were 
mixed five-fold with 20 mM sodium phosphate buffer pH 6.8 supplemented 
with 200 mM NaCl and applied to individual centrifugal filter units (Amicon 
Ultra-15, MWCO 10 kDa; Millipore U.K. Ltd, Watford, UK), before centrifuging 
at 4000 rpm and 6°C in a Jouan C 4 22 centrifuge (Jouan, Nantes, France) for 
0.5 h. The pale blue Cu2+ containing permeate was discarded, fresh 20 mM 
sodium phosphate, pH 6.8 + 200 mM NaCl was added to each filter unit, and 
following mixing these were recentrifuged. After a total of five such treatments 
the retained purified His6-GFP (0.6 mg/mL in 20 mM sodium phosphate, pH 
6.8, 200 mM NaCl) was recovered from all of the filter units, pooled and 
stored at 4°C until required. 
6.3.5. Adsorption–desorption experiments with Cu2+ – 
Chelating Sepharose Fast Flow 
Chelating Sepharose Fast Flow was washed exhaustively with water on 
sintered glass filter funnel under vacuum, before transferring to a fresh 50 mL 
plastic falcon tube and resuspending in 0.2 M CuCl2. After mixing for 0.5 h at 
2000 rpm on an orbital shaker the support slurry was poured back into the 
sintered glass filter funnel and washed copiously with the water, then 20 mM 
 246 
sodium acetate buffer pH 4.0 containing 0.5 M NaCl; and finally the binding 
buffer, 20 mM sodium phosphate, pH 6.8 supplemented with 0.2 M NaCl. 
For batch binding tests, pure solutions haemoglobin and His6-GFP solutions 
of defined concentrations (c0 = 25 g/mL to 1.1 mg/mL) were prepared in 
binding buffer. Aliquots (5 mL) of these protein solutions were added to 0.1 
mL volumes of settled Cu2+-charged Chelating Sepharose Fast Flow 
contained in Eppendorf tubes before mixing at various temperatures between 
19 and 42 ºC, for 1 h with shaking (1250 rpm, Thermomixer Comfort shaker, 
Eppendorf, Hamburg, Germany). After an additional 0.5 h at the selected 
incubation temperature without shaking, the supernatants were carefully 
removed and analysed for residual protein content (see 6.3.9 Analysis). 
Protein bound to the supports was determined from the difference in protein 
concentrations of the initial binding solution (c0) and the supernatant after 
binding (c*), and where appropriate the data was fitted to the Langmuir 
equation (Eq. 6.1) using the χ2 minimisation procedure of SigmaPlot software 
version 11.0 (Systat Software Inc, CA, USA): 
ݍ∗ ൌ ሺݍ௠௔௫ ∗ ܿ∗ሻ/ሺܭௗ ൅ ܿ∗ሻ 
Equation 6.1 
 
where q* and c* represent the equilibrium concentrations of the adsorbed and 
liquid-phase protein respectively; qmax is the support’s maximum protein 
binding capacity; and Kd is the dissociation constant.  
Two types of desorption study were performed, i.e. chemically and thermally 
mediated, and for both, between buffer changes, the supports were rapidly 
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recovered from suspension by pulsed (10 s) centrifugation (6,500 g) in a 
microcentrifuge.  
The effect of adsorption temperature on subsequent chemically mediated 
recovery of haemoglobin and His6-GFP was examined in the following way. 
After 1 h of binding at various temperatures under mixing (1250 rpm) the 
supports were allowed to settle (0.5 h) at the same temperature, and the 
supernatants were removed and retained for analysis of residual protein 
content. The supports (0.1 mL) were then washed sequentially, at either room 
temperature or the binding temperature, with changes (each of 600 s duration) 
of the binding buffer (4 × 1 mL) and then 0.2 M imidazole (5 × 1 mL), before 
finally stripping any residually bound protein off the supports in a wash with 1 
mL of 0.5 M NaOH.  
Attempts to dislodge bound protein under binding conditions by cycling the 
temperature between 22 and 42°C were conducted in the following way. 
Following an initial protein binding step conducted at 22°C as described 
above, the settled supports (0.1 mL) were recovered and incubated for 600 s 
contact at 1250 rpm with 1 mL aliquots of: (i) binding buffer at 22° (2×), before 
(ii) initiating the temperature switching regime (i.e.  42°C  22°C  42°C 
 22°C) using fresh binding buffer at each temperature; followed by (iii) three 
changes of binding buffer supplemented with 0.2 M imidazole (22°C); and 
finally (iv) stripped with 1 M NaOH (22°C).  
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6.3.6. Protein binding and elution studies with polymer 
fimbriated M-PVA particles  
After washing once with water polymer brush modified M-PVA supports were 
resuspended with 0.2 M CuCl2 at a particle concentration of 2 mg/mL and 
incubated for 900 s at 2000 rpm on a Vibrax shaker. Following magnetic 
retrieval the supports were subsequently incubated in a similar manner (900 s, 
2000 rpm) with water and then two changes of binding buffer (20 mM sodium 
phosphate buffer, pH 6.8 + 0.2 M NaCl).  
For equilibrium binding studies, 1.33 mL aliquots of pure His6-GFP solutions 
of defined concentrations (c0 = 12 g/mL – 0.60 mg/mL in binding buffer) were 
mixed at 22°C or 42°C with 1 mg portions of the different supports in 
Thermomixer Comfort (Eppendorf, Hamburg, Germany) shakers operated at 
1250 rpm. After 1 h of incubation the supports were magnetically separated 
from the bulk phase, the supernatants were assayed for residual protein 
content (6.2.9 Analysis) and support bound protein (q*) was computed from 
the difference in bulk phase protein concentrations before (c0) and after 
binding (c*), and the resulting ‘q* vs. c* plots were fitted to the Langmuir 
model (Eq. 6.1).  
The kinetics of binding were examined at 22°C using 3 mg quantities of the 
different polymer brush modified supports mixed with 1 mL of 300 mg/L His6-
GFP (i.e. binding challenge of 100 mg His6-GFP/g support) on a Vibrax 
shaker at 2000 rpm. After various times (~15 s to 1 h) the supports were 
rapidly separated from solution, and the amounts of bound protein at each 
were determined from the drop protein concentration. For the 15 s time points 
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supports were rapidly mixed with His6-GFP on a Whirlimixer (<5 s), and then 
immediately separated by in a microcentrifuge (at 6500 g for 10 s).  
Thermally mediated elution studies were performed in the following way. 
Supports (3 mg) were incubated with 1 mL of 0.3 mg/mL His6-GFP for 1 h at 
22°C on a Vibrax shaker (2000 rpm). Each of the support samples was then 
subjected to a total of 9 washes with binding buffer. For each support type 
four different contact times (30, 180, 600 and 1800 s) were investigated and 
these times were kept constant for all 9 washes. The first wash was 
performed at the binding temperature (22°C), but thereafter 8 temperature 
transitions were made with 1 mL aliquots of fresh binding buffer (washes 2 – 
9), i.e. 42°C  22°C  42°C  22°C  42°C  22°C  42°C  22°C, 
maintaining the same elution time for all washes in the series. Two 
thermomixers set at 22 and 42 °C were employed for these experiments, both 
operating at 1250 rpm. 
6.3.7. Temperature measurements 
Prior to carrying out thermally mediated elution studies (6.3.6) time dependent 
temperature measurements were performed on 0.5, 1 and 2 mL samples of 
binding buffer in 2 mL screw-capped Eppendorf vials switched from between 
the two thermomixers. Temperature measurements were conducted in both 
directions, i.e. from 22 to 42°C and from 42 to 22°C samples using an 
electronic handheld two channel thermometer (RS 206-3750, RS 
Components Ltd., Corby, UK.).  
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6.3.8. Temperature induced phase transition 
measurements on additive doped pNIPAAm solutions  
The influence of additives (sodium phosphate, NaCl, and CuCl2) on the phase 
transition behaviour of pNIPAAm in water was studied in a similar manner to 
that we’ve reported recently (Müller et al., 2013). The optical transmittance at 
500 nm of a series of solutions containing 0.5 g/L pNIPAAm (equivalent to a 
NIPAAm monomer concentration of 4.4 mM) variously doped with additives 
(used singly and in combination), i.e. 20 mM sodium phosphate buffer pH 6.8 
containing 0.2 M NaCl, CuCl2 (2.2 or 4.4 mM), pVI (VI concentration = 4.4 mM) 
were measured at various temperatures in a Cecil CE7500 UV/visible dual 
beam spectrophotometer (Cecil Instruments Ltd, Cambridge, UK) equipped 
with a water thermostatted cuvette holder. Control measurements with the 
‘pNIPAAm free’ solutions of the additives, were also conducted.  
6.3.9. Analysis 
Complete consumption of bulk phase ‘orange’ Ce4+ ions by M-PVA supports 
during Ce(IV) initiated ‘graft from’ polymerisation reactions was confirmed by 
measuring the optical densities of pre and post reaction supernatants at 353 
nm using a UVICON 922 spectrophotometer (Kontron Instruments, Bletchley, 
UK).  
Fourier Transform Infrared (FT-IR) spectroscopy analysis was employed for 
both qualitative and quantitative analysis of polymer grafting onto M-PVA. 
Qualitative FT-IR methods were used to detect the chemical changes that 
occur on M-PVA during the grafting of homo and mixed polymer brush 
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surfaces. Quantitative FT-IR methods were used to quantify the presence of 
pNIPAAM and pVI on M-PVA supports, via measurement of NIPAAM and VI 
monomer consumption during polymer grafting. 
Solid samples, used for qualitative FT-IR, were prepared by drying aliquots of 
particle suspension on watchglasses in an oven (60°C, 20 h) and grinding the 
dried particles (~3 mg) with 300 mg potassium bromide in an agate mortar to 
create a very fine homogenous powder. This powder was pressed in a 13 mm 
die at 15 tonnes with an Atlas manual hydraulic press (Model GS15011, 
Specac Ltd, Orpington, Kent, UK) to give tablets suitable for FT-IR analysis. 
FT-IR spectra of these sample tablets were recorded using a Nicolet 380 FT-
IR (Nicolet 380, Thermo Fischer Scientific, Waltham, MA, USA) in direct beam 
mode. The spectra were scanned 64 times at a resolution of 2 cm-1 before 
averaging. 
Quantitative FT-IR was performed from spectra of liquid reaction mixture 
samples (150 L), measured using Attenuated Total Reflectance (ATR) mode 
FT-IR. 10mL of each sample solution was placed on the Smart 53 Orbit 
diamond accessory of the Nicolet 380 FT-IR and scanned 64 times at 2 cm-1 
resolution in ATR mode. Background spectra were taken every 0.5 h during 
the course of sample measurements by taking a measurement with no 
sample on the Smart 53 Orbit. These background spectra provide a reference 
to allow the Nicolet 380 to correctly scale the absorption intensity of sample 
spectra. The concentrations of monomers after reactions were determined 
from the areas of characteristic peaks in their ATR FT-IR spectra. For 
NIPAAm the peak area from 1625 to 1500 cm-1 (corresponding to N-H 
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bending in the amide group at ~1550 cm-1) was used (Müller et al., 2013). The 
amount of VI present in liquid samples was calculated from the peak at 1490 
cm-1 (between 1535 and 1450 cm-1) which is typical of C-C stretching in the 
imidazole ring of VI (Luo et al., 1999; Zhang et al., 2000). The concentrations 
of unreacted NIPAAm and VI were estimated by reference to standard curves 
of peak area vs. concentration with high accuracy for both monomers (R2 
values of >0.992 for NIPAAm and >0.995 for VI; Zourna, 2009).  
Gravimetric analysis was routinely performed on solid supports at all stages 
during their modification and use. Small volumes (typically 0.2 – 1 mL) of 
homogeneously dispersed particle suspensions were pipetted into fresh 
labelled pre-weighed glass HPLC vials which were then dried to constant 
weight in a 60°C oven. After 16 – 20 h at 60°C the vials were cooled to room 
temperature in a dessiccator jar and weighed accurately on Mettler AT261 
analytical balance (Delta range, Leicester, UK). The weight of the sample was 
calculated from the difference in weight of the vial before and after sample 
addition.  
Protein contents in samples arising from batch binding and desorption studies 
were routinely determined by the Bradford (1976) assay employing 
‘Coomassie Plus the Better Bradford™ Reagent' (Pierce, Rockford, IL, USA) 
and were expressed in BSA equivalents. All optical density readings were 
performed at a wavelength of 595 nm in a UVICON 922 dual beam 
spectrophotometer (Kontron Instruments, Bletchley, UK) in disposable high 
optical quality acrylic cuvettes (Sarstedt AG + Co, Nümbrecht, Germany). 
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6.4. Results and Discussion 
6.4.1. Characterisation of the effects of temperature on 
target protein adsorption to and desorption from 
‘immobile’ Cu2+-IDA ligands 
Earlier seminal studies (Hemdan and Porath, 1985; Hutchens and Yip, 1991; 
Finette et al., 1997) have shown the effects of temperature on the binding of 
proteins to immobilised Cu2+ supports to be very complex in nature4. For 
example, Hutchens and Yip (1991) observed that change from 0 to 37°C 
exerted little to no effect on the maximum binding capacities to hen egg white 
lysozyme and ribonuclease A. However, the variance of interaction affinity 
with temperature of the same two protein species was markedly difference; 
binding affinity for lysozyme dropped significantly with increase in temperature, 
but that for ribonuclease remained essentially unchanged. Therefore, it is 
curcial to carefully selecte model proteins, whose binding behaviour should 
not be affected significantly by temperature changes, hence the modules 
proteins could be used for evaluting temperature effect on binding matrices.  
 A prerequisite for the creation of supports featuring surfaces co-grafted with 
immobilised metal affinity ligands and thermoresponsive polymer chains was 
to first study the effects of temperature on the binding and desorption 
behaviour of selected model protein probes on immobilised metal affinity 
supports in the absence of grafted thermoresponsive polymer chains. A 
                                            
4 Best explained by appreciation of differences in solvent-accessibilities, surface distribution 
of histidine residues, pKa values of the individual histidyl side chains and architectural and 
chemical features of the protein surface structure in the immediate environment of the 
surface-exposed histidines (Hutchens and Yip, 1991). 
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commercial macroporous immobilised metal affinity chromatography support, 
(Chelating Sepharose Fast Flow) and two coloured 5  proteins previously 
employed in our laboratories for the characterisation of immobilised metal 
affinity supports (the red haem protein, bovine haemoglobin with its 20 
surface exposed histidine residues and a hexahistidine tagged Green 
Fluorescent Protein (His6-GFP) were selected for this purpose. Haemoglobin 
is a soft tetrameric protein of roughly 60 kDa size, which likely undergoes 
considerable deformation, size change and partial unfolding when it docks on 
Cu2+ functionalised surfaces (Gekko and Hasegawa, 1986; O’Brien et al., 
1997). Further, haemoglobin is acutely thermal sensitive protein, its 
conformation altering significantly with increasing temperature (Clementi et al., 
1994) in particular abrupt conformational changes occur just 2 – 3ºC above 
body temperature (Digel et al., 2006). Compared to haemoglobin, the light 
emitting protein GFP from the jellyfish Aequorea aequorea is a comparatively 
small (27 kDa) and robust -barrelled protein (Li et al., 2001; Scheyhing et al., 
2002) resistant to harsh conditions including extreme temperatures, 
chaotropic salts, proteases, and organic solvents. According to Scheying and 
co-workers (2002) GFP is supremely stable up to 65°C, and undergoes only 
small conformational changes between 15 and 65°C. 
 Target adsorption was studied over the operating temperature range 
employed previously for the successful demonstration of thermally mediated 
elution from thermo-IEX chromatography materials (Li, 2009; Müller et al., 
2013) i.e. 20 – 42°C. Supports laden with adsorbed protein were 
                                            
5 Colour was not exploited for quantitative assay, but was instead employed to rapidly confirm 
target binding (disappearance from solution) and desorption (appearance in solution) in 
advance of quantitative determination by Bradford (1976) assay. 
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subsequently incubated at either room temperature of the adsorption 
temperatures using binding buffer and/or 0.2 M imidazole, before stripping 
with 0.5 M NaOH. Adsorption isotherms conducted at the low and high ends 
of the operating regime, and plots of equilibrium binding capacity vs. 
temperature determined in the linear and non-linear regions of the binding 
isotherms are shown in Figures 6.5 and 6.6 respectively. The fitted Langmuir 
parameters describing the binding data for His6-GFP (Fig. 6.5a) and bovine 
haemoglobin (Fig. 6.5b) on Cu2+ – Chelating Sepharose Fast Flow at 22 and 
42°C are shown in Table 6.2.  
 
Fig. 6.5 Langmuir adsorption isotherms for the binding of (a) His6-GFP and (b) bovine 
haemoglobin to Cu2+ – Chelating Sepharose Fast Flow at 22°C (white symbols) and 42°C 
(black symbols). 
 
Scrutiny of Figs 6.5a and 6.5b reveals that the binding of both target proteins 
to Cu2+-IDA Sepharose Fast Flow deteriorates when the temperature is raised 
from 22°C to 42°C. The effects are more noticeable for the weaker binding, 
softer and less thermally stable haemoglobin molecule (Fig. 6.5b). Here, 
partial unfolding on adsorption exacerbated at the higher temperature, leads 
to multi-layer protein binding, evidenced by capacities 5 times greater than 
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those observed for His6-GFP (Fig. 6.6, i.e. >120 mg/mL cf. <25 mg/mL). By 
contrast, the adsorption of His6-GFP is less affected by the 20°C rise (Figs 
6.5a and 6.6), for example, the qmax falls ~25% (from 25 to 19.5 mg/mL) and 
the Kd rose slightly from 2.6 to ~2.9 mg/mL resulting in reduction in the 
tightness of binding (i.e. the initial slope of the isotherm, qmax/Kd) from 9.7 to 
6.7 mL/mL matrix (Table 6.2). The most significant differences between the 
binding behaviour of the haemoglobin cf. His6-GFP to Cu2+ – Chelating 
Sepharose fast Flow are the weaker binding strength, but much higher 
binding capacity, and more marked deterioration in binding performance with 
temperature increase from 22 to 42°C. The isotherm results suggested that 
both model proteins (i.e. single layer binding region) are suitable candidates 
to evaluate the adsorption and desorption performance on Cu2+ – Chelating 
Sepharose Fast Flow and thermal responsive polymer surface modified 
magnetic pariticles during temperature changes (from 22 to 42°C). 
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Table 6.2 Langmuir parametersa describing the adsorption of bovine haemoglobin and His6-
GFP to Cu2+ – Chelating Sepharose Fast Flow at 22 and 42°C. 
Protein Temperature 
(˚C) 
qmax (mg/mL) Kd (mg/mL) Initial slope, Qmax/Kd 
(mL/mL) 
Bovine 
haemoglobin 
22 56.85  25.45  2.23 
42 31.27  21.47 1.46 
 
His6-GFP 22 25.00  2.58  9.69 
42 19.50  2.92  6.68 
Key: aFigures 6.5a and 6.5b adsorption data were fitted to the Langmuir model (Eqn. 6.1). 
 
 
Fig. 6.6 ‘Q* vs. temperature’ plots for His6-GFP in the non-linear high occupancy binding 
region (----) and haemoglobin in both linear single layer binding (––) and non-linear 
multiple layer (----) binding regions. 
 
Figure 6.7 shows the impact that adsorption temperature/history has on ease 
of target recovery from supports under two sets of conditions, namely 
desorption at the temperature used for adsorption, and desorption at room 
temperature. It is important to recognise that reducing the temperature under 
binding conditions is clearly not an effective means for recovering either target 
protein from a support surface featuring ‘immobile’ i.e. Cu2+-IDA ligands 
(examine the areas shaded light grey of Figs 6.7a and 6.7c). In fact, the best 
recoveries under binding conditions were obtained from supports that had not 
been exposed to a temperature change, and moreover the optimum 
temperatures for haemoglobin (Fig. 6.7b) and His6-GFP (Fig. 6.7d) recovery 
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appeared protein dependent, i.e. 27°C for haemoglobin (24% desorbed) and 
42°C for His6-GFP (17% desorbed).  
Very different patterns of behaviour were noted for imidazole induced elution 
(shown by diagonal lines on white) of haemoglobin and His6-GFP. For Cu2+-
IDA supports heavily saturated with multi-layers of haemoglobin (binding 
challenge = 150 mg/mL adsorbent; Fig. 6.7a) imidazole mediated elution at 
22°C desorbed ~10% of haemoglobin bound at 22 and 42°C, and just half this 
amount at the intermediate temperatures (27 and 32°C) (Fig. 6.7a). 
Interestingly, much better haemoglobin recoveries were observed from 
supports that had been challenged with 5 – fold less haemoglobin per mL of 
adsorbent. Here, a distinct optimum haemoglobin recovery (of ~43%) was 
observed when both binding and elution were performed at 27°C. An 
altogether different response was displayed for His6-GFP regardless of 
whether desorption was performed at room temperature (Fig. 6.7c) or the 
adsorption temperature (Fig. 6.7d), i.e. increasing the adsorption temperature 
made subsequent elution with imidazole progressively more effective (rising 
from ca. 48 at 19°C to 63 – 70% at 42°C recovery).  
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Fig. 6.7 Impact of adsorption temperature on subsequent recovery of (a & c) haemoglobin 
and (c & d) His6-GFP from Cu2+ charged Chelating Sepharose Fast Flow. Protein saturated 
supports (non-linear binding range after being challenged with protein at 30 or 150 mg/mL of adsorbent) 
were treated at room temperature (a & c) or adsorption temperature b & d). Each support was exposed 
sequentially to a total of 10 washes, i.e. 4 washes of binding buffer only (light grey), followed by 5 
washes with 0.2 M imidazole (diagonal lines on white) and finally a single NaOH stripping treatment 
(cross-hatching on white). 
 
Further evidence that changing the bulk phase temperature under binding 
conditions cannot be employed for recovering target proteins from ‘immobile’ 
Cu2+-IDA ligand bearing surfaces is illustrated in Figure 6.8. In these 
experiments repeated temperature switching was employed over 4 of the 10 
desorption cycles by increasing the wash temperature to 42°C during washes 
3 and 5. It is noticeable that the highest release of both His6-GFP (Fig. 6.8a) 
and haemoglobin (Fig. 6.8b) during thermal switching occurred during these 
hot washes. The very tight binding of His6-GFP to Cu2+ at 20°C in binding 
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buffer noted earlier (Fig. 6.5a, Table 6.2) was reflected in calculated partition 
coefficients6, , very close to unity (i.e.  = 0.996 for ‘cold’ washes 4 & 6), and 
raising the temperature to 42°C exerted hardly any relaxation in binding 
affinity ( = 0.985 for ‘hot’ washes 3 and 5). A similar pattern with respect to 
variation in  during temperature switching under binding conditions was 
observed for weaker binding haemoglobin (i.e. mean  values of 0.980 for the 
‘cold’ and 0.972 for the ‘hot’ washes).  
 
 
                                            
6 Numerically, the partition or distribution coefficient, , equals the amount of adsorbed target 
species divided by total target species in the system (i.e. the sum of the adsorbed and free 
target).  
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Fig. 6.8 Recovery of bovine haemoglobin (a) and His6-GFP (b) from Cu2+ charged Chelating 
Sepharose Fast Flow by temperature switching under binding conditions, and corresponding 
partition coefficients () exhibited by the supports for haemoglobin (c) and His6-GFP (d) at 
each step. Supports loaded with haemoglobin to a capacity of 21.5 mg/mL (linear region of 
isotherm in Fig. 6.5b) and His6-GFP to a capacity of 26.2 mg/mL were exposed to 10 
sequential wash treatments. In between each wash the supports were recovered by settling 
under gravity, the supernatants were removed for analysis of desorbed protein content, and 
the supports were then resuspended in the next wash solution in the series. Key: the base 
colour of the bars reflects the temperature employed in each case, i.e. 'white' for 20°C and 
'black' for 42°C; elution with imidazole and stripping with sodium hydroxide are indicated by 
'diagonal lines‘ and 'cross-hatching' respectively. 
 
Full recovery, following thermal switching, of the either residually bound target 
protein from Cu2+- Chelating Sepharose Fast Flow could not be achieved by 
competitive elution with 0.2 M imidazole at 20°C. A single imidazole mediated 
elution (wash 7) dislodged 68% of the originally bound His6-GFP (Fig. 6.8b), 
but only 39% of the bound haemoglobin (Fig. 6.8a), reflecting operational  
values of 0.285 for His6-GFP (Fig. 6.8d) and 0.535 for haemoglobin (Fig. 6.8c). 
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Subsequent imidazole treatments (washes 8 & 9) recovered small additional 
amounts of haemoglobin, but failed to desorb any further His6-GFP. 
Substantial ‘irreversible’ binding to Cu2+ – Chelating Sepharose Fast Flow 
was experienced in these experiments for both target proteins, but was worse 
for softer more labile haemoglobin cf. His6-GFP (reflected during stripping with 
0.5 M NaOH; Fig. 6.8, wash 10). Achieving effective desorption of target 
proteins carrying high numbers of surface accessible histidine residues from 
immobilised metal affinity supports coordinating Cu2+ ions is tricky, and is 
made all the more difficult when the target protein is soft (Gekko and 
Hasegawa, 1990, Kondo et al., 1993) and liable to unfold on binding, as is 
likely the case for bovine haemoglobin (O’Brien et al., 1997). 
6.4.2. Manufacture and characterisation of 
homopolymer and mixed polymer brush fimbriated M-
PVA supports 
In this work, Cerium (IV) initiated graft from polymerisation procedures 
advanced previously in our laboratories (Brown, 2009; Brown et al., 2013; 
Willett, 2009; Zourna, 2009) were employed to convert an underivatised 
beaded magnetic support into three different adsorbent materials (Figs 6.3, 
6.4 and Table 6.1), i.e.: two featuring tethered linear homopolymer brushes, 
one of pNIPAAm and the other of pVI; and a third bearing roughly equal 
numbers of both linear polymers grafted into the same surface in two 
sequential steps.  
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Mino and Kaizerman (1958) were the first to propose the use of cerium (IV) as 
an initiator for the generation of graft copolymers following their demonstration 
that nitrate and sulphate salts of Ce(IV) are highly effective redox systems 
when employed in the presence of organic reductants, e.g. alcohols, thiols, 
glycols, aldehydes and amines. Odian and Kho (1970) subsequently 
described the chemistry involved when Ce(IV) is employed with poly(vinyl 
alcohol), pVA, as substrate7. Chain growth radical polymerisation from pVA is 
initiated by removing hydrogen atoms from its backbone. The abstracted 
hydrogen atoms are subsequently oxidised to hydrogen ions in a reversible 
redox reaction between pVA and Ce4+ ions, during which the latter are 
reduced to Ce3+ and free radicals are generated along the now ‘activated’ 
polymer backbone. These immobilised radicals react rapidly with the vinyl 
functions of the ‘free solution’ monomers so that initiation of polymerisation 
occurs only at the surface of the polymer (Mino and Kaizerman, 1958; Müller, 
1986, 1990), and polymer chains grow out from the substratum. The main 
advantage of Ce(IV) initiated polymer grafting is that the polymer chain length 
and inter-chain spacing can be controlled by tailored the amounts of monomer 
and catalytic Ce4+ initially present in the reaction.  
The left hand side of Table 6.1 summarises the key parameters used in the 
synthesis of the homopolymer and mixed polymer brush modified supports 
manufactured and used in this work. The pNIPAAm and pVI fimbriated M-PVA 
materials were made in single Ce(IV) initiated ‘graft from’ procedures using 
                                            
7  According to Odian and Kho (1970) the efficiency of cerium (IV) graft polymerisation 
appears to be related to the propensity of Ce4+ ions to form ‘complexes’ with appropriate 
polymers, but the exact nature of its interaction with pVA is not understood. Odian and Kho 
(1970) and Pitfield (1992) indicate that the Ce4+ ion’s size enable it to accommodate it within 
‘pockets’ formed between adjacent or proximal secondary hydroxyls along pVA’s backbone, 
whereas larger species (e.g. Ce3+) cannot. 
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conditions Brown (2009) identified as optimal for the preparation of 
poly(acrylic acid) (pAAc) fimbriated M-PVA cation exchange adsorbents  with 
extraordinarily high binding capacities for basic target proteins, i.e. qmax values 
up to 832 mg/g.  
FT-IR methods were employed extensively in this work both qualitatively, i.e. 
for the physico-chemical characterisation of the support starting material, 
intermediates during conversion, and the final polymer brush modified 
materials themselves (Figs 6.9 – 6.11), and quantitatively on the pre- and 
post- polymerisation reaction supernatants for estimation of monomer 
consumption, and from this the amounts of the various polymers grafted on 
the different supports. For sake of clarity FT-IR spectra for the underivatised 
M-PVA starting material are shown in all three figures (i.e. Figs 6.9 – 6.11) to 
ease identification of new peaks corresponding to grafted species, and all 
spectra are normalised for peak height at 1130 cm-1, given that this region is 
characteristic of C-O stretching in polyvinyl alcohol (PVA) (Tretinnikov et al., 
2013).  
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Fig. 6.9 FT-IR spectra of M-
PVA supports before and 
after Ce(IV) initiated ‘graft 
from’ polymerisation with 
NIPAAm. 
 
 
Fig. 6.10 FT-IR spectra of 
M-PVA supports before and 
after Ce(IV) initiated ‘graft 
from’ polymerisation with 
NIPAAm. 
 
 
 
Fig. 6.11 FT-IR spectra of 
M-PVA supports before and 
after Ce(IV) initiated ‘graft’ 
from polymerisation with VI. 
 
The FT-IR spectrum of unmodified M-PVA shows the expected peaks 
associated with the pVA backbone, namely CH2 scissoring and bending at the 
1430 cm-1, and alcohol C-O stretches at 1070-1160 cm-1. The prominent peak 
at 1720 cm-1 likely corresponds to carbonyl C=O stretch and is indicative of 
Wavenumber (cm-1)
400600800100012001400160018002000
A
bs
or
ba
nc
e
M-PVA
After grafting 
with NIPAAm
1640
1380
1130
1430
12601720
1550
Wavenumber (cm-1)
400600800100012001400160018002000
A
bs
or
ba
nc
e
1380 M-PVA
After 1st graft 
with NIPAAm
After 2nd
graft with VI 
1640
1550
1130
1430
12601720
Wavenumber (cm-1)
400600800100012001400160018002000
A
bs
or
ba
nc
e
1380
M-PVA
After grafting 
with VI
1640
1130
1430
12601720
 266 
the presence of residual acetate groups left over following incomplete 
hydrolysis of poly(vinyl acetate) pVAc to pVA. Additional peaks at 1380 cm-1 
(CH3 bend), and 1260 cm-1 (C-C(O)-C stretch) also confirm the presence of 
acetate groups in M-PVA. 
Successful grafting of pNIPAAm into the M-PVA surface was confirmed 
following Ce(IV) initiated graft polymerisation using NIPAAm for both the 
‘finished’ pNIPAAm modified M-PVA (Fig. 6.9) and ‘intermediate’ during 
synthesis of the mixed [pNIPAAm + pVI] modified (Fig. 6.10) by the 
appearance of a new peak at 1550 cm-1, corresponding to N-H bending in the 
amide groups of pNIPAAm. An increase in peak height at 1640 cm-1 was also 
seen in both cases (Figs 6.9 & 6.10), corresponding to amide C=O stretching 
in pNIPAAm.  
Two new peaks appeared following Ce(IV) initiated fimbriation of M-PVA with 
VI (Fig. 6.11) indicating that grafting of pVI into the M-PVA surface had been 
successful. One of these at 1640 cm-1 corresponds to aromatic C-C stretching 
on the imidazole ring, and the other at 1380 cm-1 is consistent with in-plane 
aromatic C-H wagging. Moreover, the same sharp aromatic C-H wagging 
peak at 1380 cm-1 was also noted, though reduced in magnitude, following the 
second stage grafting of pVI into the surface of the pNIPAAm fimbriated 
intermediate (Fig. 6.10), but growth in the signal at 1640 cm-1 could not be 
discerned, most likely owing to masking contributions from the amide C=O of 
pNIPAAm grafted in the previous step. However, the actural physical length of 
pVI and pNIPAAm chains is under further investigation. 
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In the present study the treatment of M-PVA (SA = 55 m2/g) with an overall 
ammonium cerium (IV) nitrate initiator concentration of 0.44 mmol/g M-PVA 
(Table 6.1) resulted in a calculated inter-graft spacing (D") in the all three 
finished supports of 4.6 Å. The inter-graft spacing of the pNIPAAm 
intermediate (D') formed during manufacture of the mixed polymer fimbriated 
support after the first grafting reaction with 0.22 mmol Ce4+/g in the presence 
of NIPAAm was calculated as 6.5 Å (Table 6.1). These values rest on the 
assumption that all of Ce4+ ions supplied will initiate the outgrowth of grafted 
polymer chains from the nonporous surface of M-PVA.8 
The amounts of the NIPAAm and VI monomers supplied in reactions (110 
mmol NIPAAm/g M-PVA and 44 mmol VI/g M-PVA corresponding to DP100% of 
250 and 100 respectively; see Table 6.1) were adjusted (based on calibration 
experiments performed by Zourna, 2009) so that the observed degree of 
polymerisation (DPobs) of the grafted chains of the polymer brush layers and 
total amounts of grafted polymer were roughly the same (i.e. DPobs = 20 – 22; 
8.75 – 9.35 mmol monomer installed/g M-PVA; grafted polymer contents of 
46.5 – 51.7% w/w in the ‘finished’ supports; Table 6.1). 
It should be noted that much higher amounts of NIPAAm monomer were 
supplied in the Ce(IV) reactions cf. VI. The reason for this is that different 
monomers are consumed at different rates in Ce(IV) initiated graft from 
reactions performed in aqueous solution. For example, complete monomer 
consumption was observed in reactions with acrylic acid (AAc) (Brown, 2009) 
                                            
8 Brown and Zourna have confirmed that complete disappearance of Ce4+ from the reaction 
liquor occurs within the first 15 minutes. Note, rapid Ce4+ disappearance from solution likely 
reflects pVA’s affinity for this species (see previous footnote), but it does not necessarily 
follow that all Ce4+ trapped by the pVA are reduced to Ce3+ thereby generating free radicals. 
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and VI (Zourna, 2009) when supplied at monomer to Ce4+ ratios of 20:1, but 
fell sharply as the ratio was increased (i.e. 59% for AAc at a monomer/Ce4+ 
ratio of 100:1 falling to 25% at 400:1; cf. 31-38% for VI at monomer Ce ratio of 
100:1). In contrast, monomer consumption for NIPAAm in Ce(IV) initiated 
grafting reactions was poor (8-12%) at all monomers/Ce4+ ratios (20, 100 and 
250 to 1) investigated by Zourna (2009). For this reason meeting the target 
DPobs for pNIPAAm of ca. 20 in this study for both the pNIPAAm fimbriated 
and mixed polymer brush modified M-PVA supports required the use of a 
monomer/Ce4+ ratio of 250:1 in NIPAAm grafting reactions (Table 6.1). 
6.4.3. Equilibrium protein adsorption behaviour of Cu2+ 
charged ‘homo’ and ‘mixed polymer brush modified M-
PVA supports 
The experiments described here are for three polymer modified M-PVA 
supports with a common final inter-chain spacing of 4.6 Ǻ and polymer chain 
length of 20 – 22. Hereafter, these support materials will be referred to by the 
idealised descriptions of their polymer brush layers given in Table 6.1, i.e.: 
p(VI)21 – 4.6 Å; p(NIPAAm)22 – 4.6 Å; and [p(NIPAAm)20 + p(VI)20] – 4.6 Å. 
The right hand side of Figure 6.11 shows equilibrium adsorption isotherms for 
His6-GFP on the polymer brush M-PVA supports after charging with 
immobilised Cu2+ ions. The isotherms were determined at near neutrality at 
which pH surface accessible histidines are uncoordinated and free to 
coordinate bound metal ions (Todd et al., 1994; O’Brien et al., 1997), and 
were well fitted to the Langmuir model (parameters cited in Table 6.3). 
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Fig. 6.12 Equilibrium binding isotherms (right) and Scatchard (1949) plots (left) for the binding 
of His6-GFP to Cu2+ charged ‘homo’ and ‘mixed’ polymer brush modified M-PVA supports at 
22°C (open symbols) and 42°C (filled symbols). The solid lines through the data sets in both 
types of plots represent the Langmuir curves fitted to the q* vs. c* data points with the 
parameter values presented in Table 6.3. The x- and y- axes intercepts on the Scatchard 
plots thus respectively represent the qmax and initial slope (qmax/Kd) cited in Table 6.3. 
 
However, Scatchard (1949) plots (left hand side of Fig. 6.12) for the 
pVIcontaining brush supports (especially p(VI)21 – 4.6 Å) showed slight 
upward curvature indicative of more complex binding behaviour consistent 
with at least two different types of binding affinity. As noted earlier (Fig. 6.5) 
for protein sorption to Cu2+-IDA Sepharose Fast Flow better target binding 
performance at 22° ۠۠C cf. 42°C was also noted for the Cu2+ charged polymer 
fimbriated M-PVA supports (Fig. 6.12, right). However, the degree of 
separation of the low and high temperature plots was generally greater (Fig. 
6.12, right). For example, in the case of Cu2+ – p(VI)21 – 4.6 Å dropping the 
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adsorption temperature from 42 to 22°C degree resulted in a 38% fall in qmax, 
a 17% rise in the Kd and near halving in the tightness of binding (Table 6.3). 
Table 6.3 Langmuir parametersa describing the adsorption of His6-GFP to Cu2+ charged 
‘homo’ and ‘mixed’ polymer brush modified M-PVA supports. 
M-PVA support Temperature (˚C) qmax (mg/g) Kd (mg/mL) Initial slope, qmax/Kd 
(mL/g) 
p(VI)21 – 4.6 Å  22 31.66 5.18 6.11 
42 19.96 6.10 3.27 
[p(NIPAAm)20 + 
p(VI)20] – 4.6 Å  
22 15.56 3.15 4.94 
42 12.56 2.58 4.87 
p(NIPAAm)22 – 4.6 Å 22 8.97 10.58 0.85 
42 11.74 52.47 0.22 
aFigure 6.11 adsorption data were fitted to the Langmuir model (Eqn 6.1). 
 
Quite different effects on individual Langmuir binding parameters were seen 
for the Cu2+ – p(NIPAAm)22 – 4.6 Å, but the overall impact of raising the 
sorption temperature from 22 to 42°C was the same. Here, though qmax rose 
from 9 to 11.7 mg/g, the Kd rose 5 – fold, leading to a 3.9 – fold reduction in 
qmax/Kd (Table 6.3). The support least affected by temperature was the mixed 
polymer brush M-PVA, Cu2+ – [p(NIPAAm)20 + p(VI)20] – 4.6 Å. The maximum 
His6-GFP binding capacities of this hybrid support material lay midway 
between those exhibited by the two homopolymer fimbriated supports (Table 
6.3). The ~20% drop in qmax (from 15.6 to 12.6 mg/g) with increase in 
temperature was offset by an equivalent drop in Kd (Table 6.3). 
In accordance with previous reports comparing the binding strength of vinyl 
imidazole with iminodiacetic acid (Galaev et al., 1997; Kumar et al., 1998a, 
1998b, 1999) comparison of the dissociation constants in this work for the 
binding of His6-GFP indicate a weaker interaction with Cu2+ ions immobilised 
on the p(VI)21 brush modified M-PVA support (Table 6.3, Kd values of 5.2 and 
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6.1 mg/mL) cf. to the tridentate metal chelating iminodiacetic acid (IDA) of 
Chelating Sepharose Fast Flow (Table 6.2, Kd values of 2.6 and 2.9 mg/mL). 
6.4.4. Characterisation of protein binding kinetics of 
mobile’ Cu2+ bearing polymer brush layers grafted on 
M-PVA 
The binding of His6-GFP to the three Cu2+ charged polymer brush modified M-
PVA supports at 22°C are displayed in Fig. 6.13. It shows that: (i) the kinetics 
of equilibrium protein binding are exceptionally fast approaching their 
maximum capacities within 10 – 15 s in all cases9; (ii) the capacities follow the 
order p(VI)21 > [p(NIPAAm)20 + p(VI)20] > p(NIPAAm)22; (iii) the contribution of 
non-Cu2+ based binding (Fig. 6.13 legend) rises with increasing pNIPAAm 
content in the brush, i.e. from 37% for ‘0% pNIPAAm’ (p(VI)21 – 4.6 Å) through 
43% for ‘50% pNIPAAm’ ([p(NIPAAm)20 + p(VI)20] – 4.6 Å), to 67% for the 
‘100% pure pNIPAAm’ brush modified support (p(NIPAAm)22 – 4.6 Å). 
Contrary to the ideal situation, i.e. where the thermoresponsive polymer 
shouldn’t bind Cu2+ or target protein, it appears that pNIPAAm binds both 
species. Coordination of Cu2+ most likely involves its amide nitrogen (Fig. 6.2). 
                                            
9  This observation is not surprising in light of the M-PVA’s small size (ca. 2 m) and 
nonporous nature. Indeed, Hoffmann (2002) has previously determined half-times of order of 
10 s for the adsorption of different protein species from various feedstocks to the magnetic 
chelator adsorbents of similar size. 
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.  
Fig. 6.13 Kinetics of binding at 22°C to Cu2+ charged ‘homo’ and ‘mixed’ polymer brush 
modified magnetic M-PVA supports. Key: p(VI)21 – 4.6 Å (); [p(NIPAAm)20 + p(VI)20] 4.6 Å 
(); and  p(NIPAAm)22 – 4.6 Å (). In the absence of immobilised Cu2+ the His6-GFP binding 
capacities (after 1 h) were 13.8, 9.8 and 8.2 mg/g for p(VI)21, [p(NIPAAm)20 + p(VI)20] and 
p(NIPAAm)22 respectively 
 
6.4.5. Influence of additives on the temperature 
induced phase transition of ungrafted pNIPAAm in 
solution 
The LCST10 of the pNIPAAm homopolymer in water is widely reported as ca. 
32°C (Heskins and Guillet, 1968; Taylor and Cerankowski, 1975; Schild, 1992; 
Maharjan et al., 2008), but is known to be shifted in response to variation in 
pH (Pei et al., 2004; Maharjan et al., 2008) and the presence of salts (Schild 
and Tirrell, 1991; Park and Hoffman, 1993; Du et al., 2010; Zhang et al., 
2007).  
                                            
10 LCST is defined as the temperature at which 50% optical transmittance occurs (Kanazawa 
et al., 1997). 
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Fig. 6.14 Comparison of temperature-dependent optical transmittance (500 nm) profiles of 4.4 
mM solutions of ungrafted free pNIPAAm and pNIPAAm admixed 50:50 with pVI. Top panel – 
pNIPAAm in water (), water + 4.4 mM Cu2+ (), in buffer (), in buffer + 4.4 mM Cu2+ (), 
in buffer + 2.2 mM Cu2+ ().Bottom panel – pNIPAAm + pVI in water (), in buffer ( ), in 
buffer + 4.4 mM Cu2+ (), in buffer + 2.2 mM Cu2+ (). 
 
Figure. 6.14 shows that in the present study the presence of equal numbers of 
free pVI chains in solution exerted no apparent effect on the temperature 
dependent ‘hydrophilic coil – hydrophobic globule’ transition of ungrafted free 
pNIPAAm. The ‘transmittance – temperature’ profiles for solutions of pVI in 
water or buffer, with or without added CuCl2, were optically transparent across 
the entire temperature range examined (data not shown); consistent with the 
expected behavior of a polymer exhibiting normal temperature solubility 
behavior. Conversely the addition of 4 mM CuCl2 to pNIPAAm in water 
increased the LCST by plus 1°C raising it from 33 to 34°C, while changing the 
bulk suspending phase from water to buffer (20 mM sodium phosphate pH 6.8 
containing 0.2 M NaCl) with or without added CuCl2 shifted by a common 
minus 4°C (i.e. from 33 to 29°C). The above findings are entirely consistent 
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with present scientific understanding. The presence of salt in the bulk phase 
typically lowers the LCST, and this LCST follows the so-called ‘Hofmeister 
series’. According to Du and co-workers (2010) direct interactions between 
the salt cations and pNIPAAm play a critical role in shifting the LCST as they 
exhibit much stronger affinity for the polymer cf. the anions.  
The chain collapse behaviour of pNIPAAm chains tethered to a surface and 
effective LCST is frequently reported as quite different to that of free 
pNIPAAm in solution (Zhulina et al., 1991; Zhu and Napper, 1994; Zhu and 
Napper, 1997; Hu et al., 2002; Balamurugan et al., 2003; Kizhakkedathu et al., 
2004; Wu et al., 2008; Toomey and Tirrell (2008); Müller et al., 2013). The 
phase behaviour is known to be influenced by the method employed, grafting 
density, extent of cross-linking, architecture and molecular weight of the 
tethered pNIPAAm chains (Baulin and Halperin, 2003; Yim et al., 2004; 
Plunkett et al., 2006; Müller et al., 2013). However, in the present case for 
linear pNIPAAm chains grown out of the surface of M-PVA supports by Ce(IV) 
initiated ‘graft from’ polymerisation Zourna (2009) has shown that lower 
transition temperature for pNIPAAm chains tethered to M-PVA surfaces (32 – 
34°C) is the same as that of the free polymer (33°C in water; see Fig. 6.14).  
6.4.6. Characterisation of the effects of temperature on 
target protein desorption from ‘mobile’ Cu2+ bearing 
polymer brush layers grafted on M-PVA 
In stark contrast to the very poor to non-existent thermally mediated elution 
from ‘immobile’ Cu2+-IDA ligands observed for the commercial immobilised 
metal affinity matrix, Cu2+ – Chelating Sepharose Fast Flow, temperature 
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switching proved much more effective with ‘mobile’ Cu2+ bearing polymer 
brush modified M-PVA supports. Following binding at room temperature, the 
supports were washed 9 times in succession and in the process 8 
temperature switches were made using the two thermomixer set up (one set 
at 42°C, the other at 22°C) described in 6.3.7.  
a
 
b
Fig. 6.15 Kinetics of: (a) heating of 22°C samples in a thermomixer set at 42°C; and (b) 
cooling of 42°C samples in a thermomixer set at 22°C. Samples of binding buffer (20 mM 
sodium phoshate, pH 6.8 containing 0.2 M NaCl) of 0.5 mL (), 1 mL () and 2 mL () 
volumes contained in 2 mL screw-capped Eppendorf tubes were incubated with shaking at 
1250 rpm. Tubes were removed after various times and their temperatures were immediately 
recorded using an electronic handheld two channel thermometer. The solid lines through the 
data points represent the fitting of second order exponential decay curves with R2 values 
between 0.996 and 0.9996. 
 
Control experiments with buffer samples of various volumes (0.5 – 2 mL) were 
conducted to ascertain how quickly temperature changes were effected using 
the two thermomixers (Fig. 6.15). It is clear that for both heating (Fig. 6.15a) 
and cooling (Fig. 6.15b) operations the temperature range 29 – 35°C where 
pNIPAAm undergoes the most of its phase transition (Fig. 6.14) is reached 
extremely rapidly, i.e. within the first 30 s. This rapid crossing of the LCST 
explains why the observed kinetics of His6-GFP desorption from Cu2+ – 
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charged polymer fimbriated non-porous M-PVA supports can be as fast as 
they appear in Fig. 6.16. 
a b
c  
Fig. 6.16 Kinetics of thermally mediated eluted elution from Cu2+ charged (a) p(VI)21 – 4.6 Å, 
(b) p(NIPAAm)22 – 4.6 Å and (c) [p(NIPAAm)20 + p(VI)20] – 4.6 Å modified M-PVA. Supports 
contacted with His6-GFP for 1 h at 22°C magnetically separated, washed once  at 22°C (wash 
1) by resuspension in binding buffer before subjecting to 8 sequential temperature transitions 
with fresh binding buffer (washes 2 – 9), i.e. 42  22  42  22  42  22  42  22°C, for 
various times (30 – 1800 s) under binding conditions.The amounts of His6-GFP bound prior to 
washing p(VI)21, p(NIPAAm)22 and [p(NIPAAm)20 + p(VI)20] modified M-PVA supports were 40, 
27 and 15.5 mg/g respectively. The maximum vertical scale of the plots are set to these 
values and reflect 100% desorption in each case. 
 
It is noteworthy that in all cases more effective desorption was observed at 
the higher temperature, and His6-GFP recovery after 9 washes (8 thermal 
changes) was very good, i.e. reaching >77% for Cu2+ – p(NIPAAm)22 – 4.6 Å, 
>84% for Cu2+ – [p(NIPAAm)20 + p(VI)20] – 4.6 Å and >90% for Cu2+ – p(VI)21 
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– 4.6 Å. It is noticeable that for the mixed brush modified (Fig. 6.15c) and 
especially pVI grafted (Fig. 6.15a) M-PVA all of ‘hot’ cycles were more 
effective than ‘cold’ wash cycles. For the Cu2+ charged p(VI)21 – 4.6 Å 
modified support maximum desorption was reached after just 180 s in every 
wash cycle and there was no evidence of detached His6-GFP rebinding to the 
support at longer times (Fig. 6.16c). Quite different behaviour was exhibited 
by Cu2+ charged [p(NIPAAm)20 + p(VI)20] – 4.6 Å (Fig. 6.16c) and especially 
Cu2+ – p(NIPAAm)22 – 4.6 Å (Fig. 6.16b). Here, maximum His6-GFP 
desorption was noted later, at 600 s. Moreover, at longer times the level of 
free His6-GFP fell, providing clear evidence of rebinding (esp. noticeable for 
Cu2+ – p(NIPAAm)22 – 4.6 Å.  
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a b
c  
Fig. 6.17 ‘ vs. time’ plots derived from the thermally mediated His6-GFP elution data 
presented in Fig. 6.13. Panel: (a) Cu2+ charged p(VI)21 – 4.6 Å; (b) Cu2+ charged p(NIPAAm)22 
– 4.6 Å; and (c) Cu2+ charged [p(NIPAAm)20 + p(VI)20] – 4.6 Å modified M-PVA. Symbols: Low 
(22°C) and high (42°C) temperature washes are indicated by open and filled symbols 
respectively; Wash number: 1 (); 2 (); 3 (); 4 (); 5 ();6 (); 7 (); 8 (); and 9 (). 
 
The superior performance of the Cu2+ – p(VI)21 – 4.6 Å M-PVA material in the 
thermally mediated elution study (Fig. 6.16) is clarified by reference to  vs 
time plots (Fig. 6.17) derived from the same data. In stark contrast to the 
simliar  values recorded earlier for the binding of His6-GFP to Cu2+ – 
Chelating Sepharose Fast Flow during ‘cold’ ( = 0.996) and and ‘hot’ ( = 
0.985) transitions (Fig. 6.8b), at all times points beyond 180 s (Fig. 6.17a), 
values during the ‘hot’ washes were significantly lower (0.56 < < 0.69) 
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than those during the ‘cold’ ones (0.87 < < 0.96). Moreover,  remained 
relatively constant throughout the 8 temperature transitions of the experiment. 
For the first ‘hot’ wash,  values for Cu2+ – p(NIPAAm)22 – 4.6 Å (Fig. 6.17b) 
were comparable to those for Cu2+ – p(VI)21 – 4.6 Å (Fig. 6.17a), but as the 
support was cycled through further temperature transitions the difference in  
values for ‘hot’ and ‘cold’ washes was lost. A similar, but less pronounced 
pattern was revealed for the Cu2+ charged mixed brush material, 
[p(NIPAAm)20 + p(VI)20] – 4.6 (Fig. 6.17c). The effectiveness of the ‘hot’ 
washes in desorbing His6-GFP fell progressively with each new transition as  
rose from 0.47 – 0.53 in the first, through 0.68 – 0.71 in the second, and 0.75 
– 0.82 in the third, finally reaching 0.79 – 1.0 in the last. 
Taken collectively, the data for Cu2+ – p(VI)21 – 4.6 Å clearly hint at a support 
material that can be used repeatedly, whereas those featuring pNIPAAm 
containing brushes evidently cannot.  
6.5. Conclusions 
Studies with Cu2+ charged Chelating Sepharose Fast Flow (fixed or immobile 
Cu2+-IDA ligands) confirmed little/no elution by temperature switching under 
binding conditions. In stark contrast, work with polymer brush modified 
supports (mobile Cu2+ coordinating brush layers) demonstrated significant 
thermally mediated elution.  
Opposite to earlier observations with thermoresponsive anion (Liu, 2009) and 
cation (Müller et al., 2013) exchange media fashioned in our laboratories of 
effective protein desorption only occurring when the temperature is lowered, 
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for the Cu2+ charged metal affinity polymers in this work more powerful elution 
was observed during the ‘hot’ transition. The best thermally mediated elution 
of His6-GFP was demonstrated by the Cu2+charged homo pVI brush modified 
M-PVA. The optimal mode of operation for this support would likely be room 
temperature adsorption followed by elution at an elevated temperature 
determined by the thermal stability of the target binding species. For Cu2+ 
charged pVI, the large difference in partition coefficient at 22 and 42°C cf. that 
observed for Cu2+ charged Sepharose Fast Flow can be explained by the 
synergistic effects of heating on: (i) the intrinsic binding strength of the target 
protein for its coordinated Cu2+ ligand; coupled with (ii) chain elongation, 
which increases the ligand spacing, hence reducing the tightness of binding. 
By contrast, in supports featuring pNIPAAm chains, the latter undergo 
collapse on heating. This chain collapse opposes the inherent thermodynamic 
weakening of ‘Cu2+ – target protein’ interactions, by reducing the spacing, 
effectively raising the ligand density. 
Contrary to the thermoresponsive ion-exchange matrices detailed previously 
(Liu, 2009; Müller et al., 2013), the overall conclusion here regarding the utility 
of smart thermoresponsive polymers such as pNIPAAm in combination with 
immobilised metal affinity surfaces is that it is flawed. While changing the 
thermoresponsive polymer to one lacking a nitrogen centre and possessing a 
significantly lower LCST (e.g. newer PEG based alternatives; Lutz et al., 2006; 
Lutz and Hoth, 2006; Magnusson et al., 2008; Müller et al., 2013) should 
reduce non-specific binding, uncouple immobilised metal affinity adsorption 
from gross brush extension and collapse, and minimise thermal denaturation 
and unfolding at the support surface, the overriding problem is that shifting to 
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low temperature to effect brush extension is strongly counteracted by 
significantly increased binding strength. In this particular instance use of pVI 
alone appears to be the best option. This metal chelating polymer is 
temperature sensitive, but displays normal rather than inverse temperature 
solubility behaviour. 
 
 
 
 
 
 
 
 
 
 
 
 
 282 
6.6. References 
Adrados, B.P., Galaev, I.Y. Nilsson, K. and Mattiasson, B. (2001), Size 
exclusion behavior of hydroxypropylcellulose beads with temperature-
dependent porosity, J. Chromatogr. A 930: 73-78. 
E. Ayano, E. Y. Okada, Y., Sakamoto, C., Kanazawa, H., Kikuchi, A., Okano, 
T. (2006a), Study of temperature-responsibility on the surfaces of a thermo-
responsive polymer modified stationary phase, J. Chromatogr. A 1119: 51-57. 
Ayano, E., Nambu, K., Sakamoto, C. Kanazawa, K., Kikuchi, K. Okano, T. 
(2006b), Aqueous chromatography system using pH- and temperature-
responsive stationary phase with ion-exchange groups, J. Chromatogr. A 
1119: 58-65. 
Balamurugan S., Mendez S., Balamurugan S. S., O’Brien, M. J and Lopez 
G.P. (2003), Thermal response of poly(N-isopropylacrylamide) brushes 
probed by surface plasmon resonance, Langmuir, 19: 2545-2549.  
Baulin V. A., Halperin A. (2003), Signatures of a concentration-dependent 
Flory χ parameter: Swelling and collapse of coils and brushes, Macromol. 
Theory Simul, 12: 549-559. 
Bradford, M.M. (1976), A rapid and sensitive method for the quantitation of 
microgram quantities of protein utilizing the principle of protein-dye binding, 
Anal. Biochem. 72, 248-254. 
Brooks, D.E. and Müller, W. (1996), Size-exclusion phases and repulsive 
protein-polymer interaction/recognition, J. Mol. Recognit. 9: 697–700. 
Brooks, D.E., Haynes, C.A., Hritcu, D., Steels, B.M. and Müller, W. (2000), 
Size-exclusion chromatography does not require pores, Proc. Natl. Acad. Sci. 
(USA) 97: 7064-7067. 
Brown, G.N. (2009), Advances magnetic particle based bioprocessing, PhD 
thesis, University of Birmingham, UK. 
Brown, G.N., Müller, C., Theodosiou, E., Franzreb, M. and Thomas, O.R.T. 
(2013), Multi-cycle recovery of lactoferrin and lactoperoxidase from crude 
whey using fimbriated high-capacity magnetic cation exchangers and a novel 
‘rotor-stator’ high-gradient magnetic separator, Biotechnol. Bioeng. 110(6): 
1714-1725. 
Chang, C., Wei, H., Wu, D.-Q., Yang, B., Chen, N., Cheng, S.-X., Zhang, X.-Z. 
and Zhuo, R.-X. (2011), Thermo-responsive shell cross-linked PMMA-b-
P(NIPAAm-co-NAS) micelles for drug delivery, Int. J. Pharmaceut. 420: 333–
40. 
 283 
Clementi, M.E., Condo, S.G., Castagnola, M. and Giardina, B. (1994), 
Hemoglobin function under extreme life conditions, Eur. J. Biochem. 223: 
309–317. 
Digel, I., Maggakis-Kelemen, C., Zerlin, K.F., Linder, P., Kasischke, N., 
Kayser, P., Porst, D., Temiz Artmann, A. and Artmann, G.M. (2006), Body 
temperature-related structural transitions of monotremal and human 
haemoglobin, Biophys. J. 91: 3014-2021. 
Du H, Wickramasinghe R. and Qian X. (2010), Effects of salt on the lower 
critical solution temperature of poly (N-isopropylacrylamide), J. Phys. Chem. B. 
114(49): 16594-16604. 
Finette, G.M.S., Mao, Q.-M. and Hearn, M.T.W. (1997), Comparative studies 
on the isothermal characteristics of proteins adsorbed under batch equilibrium 
conditions to ion-exchange, immobilised metal ion affinity and dye affinity 
matrices with different ionic strength and temperature conditions, J. 
Chromatogr. A 763(1-2): 71-90.  
Galaev I.Y., Kumar A., Agarwal R., Gupta M.N. and Mattiasson, B. (1997), 
Imidazole - a new ligand for metal affinity precipitation. Precipitation of Kunitz 
soybean trypsin inhibitor using Cu(II)-loaded copolymers of 1-Vinylimidazole 
with N-Vinylcaprolactam or N-Isopropylacrylamide, Appl. Biochem. Biotechnol, 
68: 121-133. 
Galaev, I.Y. and. Mattiasson, B. (1999), ‘Smart’ polymers and what they could 
do in biotechnology and medicine, Trends Biotechnol. 17: 335-340. 
Gekko, K. and Hasegawa, Y. (1986), Compressibility-structure relationship of 
globular proteins, Biochemistry 25: 6563-6571. 
Gewehr, M., Nakamura, K., Ise, N. and Kitano, H. (1992), Gel permeation 
chromatography using porous glass beads modified with temperature-
responsive polymers, Die Makromolekulare Chemie 193: 249-256. 
Hemdan, E.S. and Porath, J. (1985), Development of immobilized metal 
affinity chromatography: III. Interaction of oligopeptides with immobilized 
nickel iminodiacetate, J. Chromatogr. A 323(2): 265-272. 
Hochuli, E. (1988), Large-scale chromatography of recombinant proteins, J. 
Chromatogr. 444: 293-302. 
Hoffman, A.S. and Stayton, P. (2004), Bioconjugates of smart polymers and 
proteins: synthesis and applications, Macromol. Symp. 207: 139-151. 
 
 284 
Hosoya, K., Sawada, E., Kimata, K., Araki, T., Tanaka, N. and Fréchet, J.M.J. 
(1994), In situ surface-selective modification of uniform size macroporous 
polymer particles with temperature-responsive poly-N-isopropylacrylamide, 
Macromolecules 27: 3973-3976. 
Hosoya, K., Kimata, K., Araki, T., Tanaka, N. and Fréchet, J.M.J (1995), 
Uniform-size hydrophobic polymer-based separation media selectively 
modified with a hydrophilic external polymeric layer, Anal. Chem. 67: 1907-
1911. 
Hoffman, C. (2002), Einsatz magnetischer Separationverfahren zur 
biotechnologischen Produktaufarbeitung, PhD thesis, University Fridericiana 
Karlsruhe, Karlsruhe, Germany. 
Hritcu D., Muller W. and Brooks D.E. (1999), Poly(styrene) latex carrying 
Cerium(IV)-initiated terminally attached cleavable chains: Analysis of grafted 
chains and model of the surface layer, Macromolecules, 32: 565-573. 
Hu, T., You, Y., Pan, C.Y. and Wu, C. (2002), The coil-to-globule-to-brush 
transition of linear thermally sensitive poly(N-isopropylacrylamide) chains 
grafted on a spherical microgel, J. Phys. Chem. B, 106: 6659-6662. 
Hummel, D.O., Göttgens, S., Neuhoff, U. and Düssel, H.-J. (1995), Linear-
temperature programmed pyrolysis of thermoresistant polymers – mass and 
FT-IR spectrometries. Part 3. Poly(1,4-phenylene terephthalamide) and 
aromatic polyimides, J. Analyt. Appl. Pyrol. 33: 195-212. 
Hutchens, W.T. and Yip, T.-T. (1991), Protein interactions with surface-
immobilized metal ions: Structure-dependent variations in affinity and binding 
capacity with temperature and urea concentration, J. Inorg. Biochem. 42(2): 
105-118. 
Ista, L.K., Perez-Luna, V.H., Lopez, G.P., Pérez-luna, V.H. and López, G.P. 
(1999), Surface-grafted, environmentally sensitive polymers for biofilm release. 
Appl. Enviiron. Microbiol. 65: 1603-1609. 
Jagschies, G. (2008), Where is biopharmaceutical manufacturing heading? 
An analysis of current and upcoming industry challenges, BioPharm Inter. 21 
(October) 72-77. 
Janzen, R., Unger, K.K., Müller, W. and Hearn, M.T.W. (1990), Adsorption of 
proteins on porous and nonporous poly(ethyleneimine) and tentacle-type 
anion-exchangers, J. Chromatogr. 522: 77-93. 
 
 
 285 
Kanazawa, H., Kashiwase, Y., Yamamoto, K., Matsushima, Y., Kikuchi, A., 
Sakurai, Y. and Okano, T. (1997), Temperature-responsive liquid 
chromatography. 2. Effects of hydrophobic groups in N-isopropylacrylamide 
copolymer-modified silica, Anal. Chem. 69: 823-30. 
Kanazawa, H., and Okano, T. (2011), Temperature-responsive 
chromatography for the separation of biomolecules, J. Chromatogr. A 1218: 
8738-8747. 
Kanazawa, H., Yamamoto, K., Matsushima, Y., Takai, N., Kikuchi, A., Sakurai, 
Y. and Okano, T. (1996), Temperature-responsive chromatography using 
poly(N-isopropylacrylamide)-modified silica, Anal. Chem. 68: 100-105. 
Kanazawa, H., Nishikawa, M., Mizutani, A., Sakamoto, C., Morita-Murase, Y., 
Nagata, Y., Kikuchi, A. and Okano, T. (2008), Aqueous chromatographic 
system for separation of biomolecules using thermoresponsive polymer 
modified stationary phase, J. Chromatogr. A 1191: 157-161. 
Kikuchi, A., Okuhara, M., Karikusa, F., Sakurai, Y. and Okano, T. (1998),Two-
dimensional manipulation of confluently cultured vascular endothelial cells 
using temperature-responsive poly(N-isopropylacrylamide)-grafted surfaces, J. 
Biomater. Sci. Polym. Ed. 9: 1331-1348. 
Kizhakkedathu, J.N., Jones N.R. and Brooks E.D. (2004), Synthesis of well-
defined environmentally responsive polymer brushes by aqueous ATRP, 
Macromolecules 37: 734-743. 
Kobayashi, J., Kikuchi, A., Sakai, K. and Okano, T. (2002), Aqueous 
chromatography utilizing hydrophobicity- modified anionic temperature-
responsive hydrogel for stationary phases, J. Chromatogr. A 958: 109-119. 
Kobayashi, J., Kikuchi, A., Sakai, K. and Okano, T. (2003), Cross-linked 
thermoresponsive anionic polymer grafted surfaces to separate bioactive 
basic peptides, Anal. Chem. 75: 3244-3249. 
Kondo, A., Oku, S., Murakami, F. and Higashitani, K. (1993), Conformational 
changes in protein molecules upon adsorption to ultrafine particles, Colloid 
Surface 1: 197-201. 
Kubota, K., Fujishige, S. and Ando, I. (1990), Single-chain transition of poly(N-
isopropylacrylamide) in water, J. Phys. Chem. 94: 5154-5158. 
Kumar A., Galaev, I. Y. and Mattiasson, B. (1998a), Affinity precipitation of 　-
amylase inhibitors from wheat meal by metal chelate affinity binding using 
Cu(II)-loaded copolymers of 1-vinylimidazole with N-isopropylacrylamide, 
Biotechnol. Bioeng. 59(6): 695-704.  
 286 
Kumar A., Galaev, I.Y. and Mattiasson, B. (1998b), Isolation and separation of 
ɑ-amylase inhibitors I-1 and I-2 from seeds of ragi (Indian finger millet, 
Eleusine coracana) by metal chelate affinity precipitation, Bioseparation 7: 
129-136. 
Kumar A., Galaev, I.Y. and Mattiasson, B. (1999), Metal chelate affinity 
precipitation: a new approach to protein purification, Bioseparation 7: 185-194. 
Li, Y., Agrawal, A., Sakon, J. and Beitle, R.R. (2001), Characterization of 
metal affinity of green fluorescent protein and its purification through salt 
promoted, immobilized metal affinity chromatography. J. Chromatogr. A 909: 
183-190. 
Liu, H. (2009), Application of new materials and tools in bioseparations, PhD 
thesis, University of Birmingham, UK. 
Luo, X., Goh, S.H., Lee, S.Y. and Huan, C.H.A. (1999), Spectroscopic studies 
of interactions in complexes of poly(1-vinylimidazole) with poly(styrenesulfonic 
acid) or the zinc salt of poly(styrenesulfonate), Macromol. Chem. Phys. 200: 
874-880. 
Lutz. J-F., Akdemir, Ö. and Hoth, A. (2006), Point by point comparison of two 
thermsensitive polymers exhibiting a similar LCST: Is the age of poly(NIPAM) 
over? J. Am. Chem. Soc. 128: 13046-13047. 
Lutz. J-F. and Hoth, A. (2006) Preparation of ideal PEG analogues with a 
tunable thermosensitivity by controlled radical copolymerization of 2(-2-
methoxyethoxy) methacrylate and oligo(ethylene glycol) methacrylate, 
Macromolecules 39: 893-896. 
Luzinov, I., Minko, S. and Tsukruk, V.V. (2004), Adaptive and responsive 
surfaces through controlled reorganization of interfacial polymer layers, 
Progr.Polym. Sci. 29: 635–698. 
Magnusson, J.P, Khan, A., Pasparakis, G., Saeed, A.O., Wang, W. and 
Alexander, C. (2008), Ion-sensitive “isothermal” responsive polymers 
prepared in water, J. Am. Chem. Soc. 130: 10582-10853. 
Maharjan, P., Hearn, M.T.W., Jackson, W.R., De Silva, K. and Woonton, B.W. 
(2009), Development of a temperature-responsive agarose-based ion-
exchange chromatographic resin, J. Chromatogr. A 1216: 8722-8729. 
Matsuda, N, Shimizu, T., Yamato, M. and Okano, T. (2007), Tissue 
engineering based on cell sheet technology, Adv. Mater. 19: 3089-3099. 
Mino, G. and Kaizerman, S. (1958), A new method for the preparation of graft 
copolymers. Polymerization initiated by ceric ion redox systems, J. Polym. Sci. 
31: 242-243. 
 287 
Müller, T.K.H., Cao, P., Ewert, S., Wohlgemuth, J., Liu, H., Willett, T.C., 
Theodosiou, E., Thomas, O.R.T. and Franzreb, M. (2013), Integrated system 
for temperature-controlled FPLC comprising improved copolymer modified 
beaded agarose adsorbents and a travelling cooling zone reactor (TCZR) 
arrangement’, J. Chromatogr. A, 1285: 97-109.  
Müller, W. (1986), New phase supports for liquid-liquid partition 
chromatography of bio-polymers in aqueous poly(ethyleneglycol)-dextran 
systems – synthesis and application for the fractionation of DNA restriction 
fragments. Eur. J. Biochem. 155(1):213-222. 
Müller, W. (1990), New ion exchangers for the chromatography of 
biopolymers, J. Chromatogr., 510: 133-140. 
Nagase, K., Kobayashi, J., Kikuchi, A., Akiyama, Y., Kanazawa, H., Annaka, 
M. and Okano, T. (2010), Preparation of Thermoresponsive Anionic 
Copolymer Brush Surfaces for Separating Basic Biomolecules, 
Biomacromolecules 11: 215-223. 
Odian, G. and Kho, J. H. T. (1970), Ceric ion initiated graft polymerization 
onto poly(vinyl alcohol), J. Macromol. Sci. Chem. A4(2): 317-330. 
Okano, T., Yamada, N., Okuhara, M., Sakai, H. and Sakurai, Y. (1995), 
Mechanism of cell detachment from temperature-modulated, hydrophilic-
hydrophobic polymer surfaces, Biomaterials 16: 297-303. 
Okano, T., Yamada, N., Sakai, H. and Sakurai, Y. (1993), A novel recovery 
system for cultured cells using plasma-treated polystyrene dishes grafted with 
poly(N-isopropylacrylamide), J.Biomed. Mater. Res. 27: 1243-1251. 
Omer, M., Haider, S., and Park, S.-Y. (2011), A novel route for the preparation 
of thermally sensitive core-shell magnetic nanoparticles, Polymer 52: 91-97. 
O’Brien, S.M., Sloane, R.P., Thomas, O.R.T. and Dunnill, P. (1997), 
Characterisation of non-porous magnetic chelator supports and their use to 
recover polyhistidine-tailed T4 lysozyme from a crude E. coli extract. J. 
Biotechnol. 54: 53-67. 
Pei, Y., Chen, J., Yang, L., Shi, L., Tao, Q., Hui, B. and Li, J. (2004), The 
effect of pH on the LCST of poly(N-isopropylacrylamide) and poly(N-
isopropylacrylamide-co-acrylic acid), J. Biomater. Sci. Polym. Ed. 15(5): 585-
94. 
Pitfield, I.D. (1992), Perflurocarbon chromatographic supports, PhD thesis, 
University of Cambridge, UK. 
 288 
Plunkett, K.N., Xi, Z., Moore, J.S. and Leckband, D.E. (2006), PNIPAM chain 
collapse depends on the molecular weight and grafting density, Langmuir, 22: 
4259-4266. 
Przybycien, T.M., Pujar,N.S., Steele, L.M. (2004), Alternative bioseparation 
operations: Life beyond packed-bed chromatography, Curr. Opin. Biotechnol. 
15: 469-478.  
Sakamoto, C., Okada, Y., Kanazawa, H., Ayano, E., Nishimura, T., Ando, M., 
Kikuchi, A. and Okano, T. (2004), Temperature- and pH-responsive 
aminopropylsilica ion-exchange columns grafted with copolymers of N-
isopropylacrylamide, J. Chromatogr. A 1030: 247-253.  
Scatchard, G. (1949), The attraction of proteins for small molecules and ions, 
Ann. New York Acad. Sci. 51: 660-672. 
Scheyhing, C.H., Meersman, F., Ehrmann, M.A., Heremans, K. and Vogel, 
R.F. (2002), Temperature-pressure stability of green fluorescent protein: a 
Fourier transform infrared spectroscopy study, Biopolymers 65: 244-253. 
Schild, H.G. (1992), Poly(N-isopropylacrylamide): experiment, theory and 
application, Progr. Polym. Sci. 17: 163-249. 
Takezawa, T., Mori, Y. and Yoshizato, K. (1990), Cell culture on a thermo-
responsive polymer surface, Bio/Technology 8: 854-856. 
Taylor, L.D. and Cerankowski, L.D. (1975), Preparation of films exhibiting a 
balanced temperature dependence to permeation by aqueous solutions – a 
study of lower consolute behaviour, J. Polym. Sci. Part A: Polym. Chem. 13: 
2551-2570. 
Teal, H.E., Hu, Z. and Root, D.D. (2000), Native purification of biomolecules 
with temperature-mediated hydrophobic modulation liquid chromatography, 
Anal. Biochem. 283: 159-165. 
Todd, R.J., Haymore, B.L. and Arnold, F.H. (1991) Cu(II)-binding properties of 
a synthetic metal binding cytochrome c: His-X-His in an 　-helix, Protein –
Struct. Funct. Genet. 10: 156-161. 
Toomey, R. and Tirrell. M. (2008), Functional polymer brushes in aqueous 
media from self-assembled and surface-initiated polymers, Annu. Rev. Phys. 
Chem., 59:493-517. 
Tretinnikov, O.N., Sushko, N.I. and Zagorskaya, A. (2013), Detection and 
quantitative determination of the crystalline phase in poly(vinyl alcohol) 
cryogels by ATR FTIR spectroscopy, Polym. Sci. A 55(2): 91-97. 
 289 
Willett, T.C. (2009), Magnetic adsorbents displaying switchable ion-exchange 
behaviour, PhD thesis, University of Birmingham, UK. 
Wu T., Zhang Y., Wang X. and Liu S. (2008), Fabrication of hybrid silica 
nanoparticles densely grafted with thermoresponsive poly(N-
isopropylacrylamide) brushes of controlled thickness via surface-initiated atom 
transfer radical polymerization, Chem. Mater. 20: 101-109. 
Yakushiji, T., Sakai, K., Kikuchi, A., Aoyagi, T., Sakurai, Y. and Okano, T. 
(1999), Effects of cross-linked structure on temperature-responsive 
hydrophobic interaction of PINAAm hydrogel modified surfaces  with steroids, 
Anal. Chem. 71: 1125-1130. 
Yim, H., Kent M.S., Mendez, S., Balamurugan, S., Balamurugan, S.S., Lopez 
G.P. and Satija S. (2004), Temperature-dependent conformational change of 
PNIPAM grafted chains at high surface density in water, Macromolecules 37: 
1994-1997. 
Yoshizako, H., Akiyama, Y., Yamanaka, H., Shinohara, Y., Hasegawa, Y., 
Carredano, E., Kikuchi, A. and Okano, T. (2002), Regulation of protein binding 
toward a ligand on chromatographic matrixes by masking and force-releasing 
effects using thermoresponsive polymer, Anal. Chem. 74: 4160-4166. 
Zhang, X.-Z., Yang, Y.-Y., Chung, T.-S. and Ma, K.-X. (2001), Preparation 
and characterization of fast response macroporous poly(N-
isopropylacrylamide) hydrogels, Langmuir 17: 6094-6099. 
Zhang, Y., Furyk, S., Sagle, L.B., Cho, Y., Bergbreiter, D.E. and Cremer, P.S. 
(2007), Effects of Hofmeister anions on the LCST of pNIPAM as a function of 
molecular weight, J. Phys. Chem. C Nanomater. Interfaces 111(25): 8916-
8924.  
Zourna, K. (2009), Smart magnetic affinity adsorbents, PhD thesis, University 
of Birmingham, UK. 
Zhu P.W. and Napper D.H. (1994), Experimental observation of coil-to-globule 
type transitions at interfaces, J. Colloid Interface Sci., 164: 489-494.  
Zhu P.W. and Napper D.H. (1997), Conformational transitions of poly(N-
isopropylacrylamide) chains loopily absorbed at the surfaces of poly(N-tert-
butylacrylamide) latex particles in water, J. Phys. Chem. B 101: 3155-3160. 
Zhu, X., Yan, C., Winnik, F.M. and Leckband, D. (2007), End-grafted low-
molecular-weight PNIPAM does not collapse above the LCST, Langmuir, 23: 
162-169. 
 290 
Zhulina, E.B., Borisov, O.V., Pryamitsyn, V.A. and Birshtein, T.M. (1991), Coil-
globule type transitions in polymers. 1. Collapse of layers of grafted polymer 
chains, Macromolecules 24: 140-149. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 291 
7. General conclusions and future work 
Escherichia coli has been extensively researched and widely used for 
production recombinant proteins. It offers great advantages in terms of 
economically and procedure complexity to compete with other cell lines (i.e. 
yeasts, plants, insect cells and mammalian cells). For biopharmaceutical 
industry, antibodies own invaluable properties for applications in both 
diagnosis and therapeutic uses. Nearly half century ago, the first mouse 
monoclonal antibody was made but was limited by human immunogenicity for 
its therapeutic use. To date, by the advance of genetic engineering, we are 
not only able to produce humanised monoclonal antibody but also the 
antibody fragment in various forms. However, the problem remains 
unresolved are the optimisation of up-stream fermentation and down-stream 
purifications. Increase products titre is always a goal to pursue during 
fermentation stage, but the quality of products often being forgotten, which 
cause hugely issue when comes to down-stream purifications. Several 
parameters were altered during fermentation to directing desired protein into 
periplasm of E.coli as the periplasm provides the conditions required for 
appropriate disulphide bond formation and protein folding. Subsequently 
dramatically ease the following protein extraction and conditioning, by 
reducing purification steps to increase final production yields. 
In Chapter 2, employing lab scale fermentation (5 L) with CLD048 E.coli to 
produce antibody fragment (Anti-HEWL Fab, so called Fab D1.3) 
demonstrates that in this particular case, E.coli was not able to grow and 
produce recombinant antibody fragment simultaneously, as the result most of 
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products were leaked into culture broth which leads to another problematic 
issue for clarify and purify the proteins. Lower the cultivation temperature was 
the first strategy applied to slow down cell growth therefore prolonged the 
protein synthesis phase after induction. Induce at various biomass conditions 
(i.e. OD~1 or 20) seemed to effect on the final yield as well. Induction with 
lower [IPTG] (0.02 M) resulted in low production yield, but higher [IPTG] 
(0.1~0.2 mM) caused cell lysis in the end of fermentation. In the optimal 
fermentation condition (i.e. batch No.7, induction with 0.2 mM of [IPTG] at 
OD~20, cultivation temperature decreased from 25°C to 20°C upon induction) 
has shown partially controlling the majority of Fab D1.3 into desired 
compartment (periplasm, OS1), also increased overall titre nearly 26 fold 
(1.849 mg/L cf. 48.06 mg/L) and solubility (24% cf. 60%) compared with the 
initial result (batch No.1).  
Chapter 3 was extended the results obtained in chapter 2 fermentations. 
Through systematically conditioning/release experiments followed by 
chromatography purification (HiTrap SP_XL and HiTrap rProtein G) effectively 
release and purify Fab D1.3 from either directly culture broth or OS1 
(periplasmic fraction). Because of the high ionic strength (ca. 35mS/cm) and 
heavily contaminated extract, conditioning (i.e. pH adjustment and dilutions) 
was necessary for the subsequent chromatographic step, which leads 
massive Fab loss during the pH adjustment possibly due to protein 
aggregation, along with gradually precipitation observed when samples were 
left overnight at 4°C fridge. As the result, the feedstock was not able to 
process on chromatography. 
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A33 Fab was successfully produced and extracted by heat treatment in 
chapter 4 (~300 mg/L, 12.5% of total protein in periplasmic space). We then 
extended the studies to optimise the Fab release by heat treatment. In large 
scale, using 1:1 ratio for extracting periplasmic proteins seemed to be the 
optimal condition, which would ensure the solution and cell mixing properly 
during extraction process. 
Newly developed protein separation technique was employed in chapter 5 
benchmarking with commercial available chromatography column (i.e. HiTrap 
rProtein G and Fractogel EDM SO3) The results of this study identify CME as 
a viable means of performing continuous purification of target 
macromolecules from complex biological feedstocks at relatively low cost. 
A preliminary study in chapter 6 confirmed that Cu2+ charged Chelating 
Sepharose Fast Flow (fixed immobile Cu2+-IDA ligands) had very little elution 
by temperature switching under conditions that favour binding. Meanwhile, the 
idea for applying the smart thermoresponsive polymers (such as pNIPAAm) in 
combination with immobilised metal affinity surfaces is not a successful 
combination. This was because of charging thermoresponsive polymer with 
Cu2+ also give the pNIPAAm the ability to bind with rich histidine proteins 
which causing non-specific binding. For the future selection of using 
thermoresponsive polymer would be to one lacking a nitrogen centre and 
possessing a significantly lower LCST, thus would reduce non-specific binding, 
uncouple immobilised metal affinity adsorption from gross brush extension 
and collapse, and minimise thermal denaturation and unfolding at the support 
surface. 
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Clearly, future application of the developed generic fermentation improving 
method in this thesis is of interest. Further studies are to be done to 
demonstrate exploitation of the effectors of E.coli fermentation in producing 
antibody fragments in this thesis for selective accumulation and release to 
ease the subsequently downstream purification processes. The influence of 
upstream changes (i.e. medium composition, timing of induction, phase of 
growth) on the optimal release is to be investigated. Given the marked 
changes that can occur in composition of cell envelopes under different 
growth regimes it will be interesting to see which release method could match 
with newly developed magnetic separation technique to smooth the transition 
between upstream and downstream and optimise the whole recombinant 
protein production process. 
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8. Appendix 
 
 
Fig. 8.1 Calibration curve used for calculation of Fab D1.3 concentration in the samples by 
ELISA. 
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Fig. 8.2 Calibration curve used for calculation of DNA concentration in the samples by DPA 
assay 
 
. 
 
Fig. 8.3 Calibration curve used for calculation of total protein concentration in the samples by 
BCA assay. 
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Fig. 8.4 Chromatogram for the purification of Fab D1.3 from culture broth (conductivity ~ 35 
mS/cm) on a HiTrap rProtein G column.  
 
 
Fig. 8.5 Chromatogram for the purification of Fab D1.3 from benzonase pre-treated culture 
broth (conductivity ~ 35 mS/cm) on a HiTrap rProtein G column.  
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Fig. 8.6 Chromatogram for the purification of Fab D1.3 from 5 times diluted culture broth 
(conductivity ~ 10mS/cm) on a HiTrap rProtein G column. 
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a  b  s  t  r  a  c  t
A  novel  technique  for technical-scale  continuous  puriﬁcation  of proteins  is presented.  It  is  based  on
the  combined  use  of functionalized  magnetic  nano-particles  and  an  Aqueous  Micellar  Two-Phase  System
featuring the  non-ionic  surfactant,  Eumulgin  ES, which  undergoes  temperature  induced  phase  separation
at  ∼25 ◦C. In the ﬁrst  step,  conducted  below  the transition  temperature  (i.e.  15 ◦C), the  magnetic  sorbent
particles  are  added  into  the  single  dispersed  phase  and  bind  the  protein  of  interest.  Next,  on  raising  the
temperature  to 30 ◦C the  protein-laden  magnetic  particles  partition  strongly  into  the micelle-rich  top
phase  of  the  micellar  two-phase  system  that’s formed.  The  magnetically  susceptible  top  phase  is  then
continuously  separated  from  the micelle-poor  phase  in a ﬂowthrough  tailor-made  magnetic  extractor
featuring  a permanent  magnet  providing  an upwardly  acting  magnetic  force.  This  separation  device  was
shown  to  be  effective  for continuous  separation  of  a wide  range  of  differently  sized  magnetic  particle
sorbents  (i.e.  from 2  m diameter  to as small  as 25  nm)  from  a 10%  (w/w) Eumulgin  ES system;  high
separation  efﬁciencies  were  recorded  for the  phase-forming  surfactant  (87  to >98%),  and all  magnetic
sorbent  particles  tested  (95–99.9%).  Finally,  protein  puriﬁcation  by  continuous  magnetic  extraction  was
demonstrated  at  15  L  scale  for  the  recovery  of an  antibody  fragment,  A33  Fab′, from  a crude  extract
of  Escherichia  coli periplasm.  Nearly  70%  of  the  A33  Fab′ initially  present  in the  extract  at 15.6%  of  the
total  protein  content  was  recovered  in a 2-fold  concentrated  and  highly  puriﬁed  (>98%)  state.  Further,
the amounts  of magnetic  sorbent  and phase-forming  surfactant  lost  in the  process  were  very small;
thus  recycling  of both components  into subsequent  rounds  of  continuous  magnetic  extraction  is  highly
feasible.
© 2013 Elsevier B.V. All rights reserved.
1. Introduction
Preparative chromatography, a core technology within the bio-
pharmaceutical sector for several decades, plays critical roles in the
downstream processing of modern biopharmaceuticals. However,
against increasing pressures (rocketing product titers, increasing
size and complexity of emerging bio-products to name but a few),
it is increasingly being viewed as a serious bottleneck in manufac-
turing [1,2]. Against this backdrop, the modiﬁcation/improvement
of existing traditional ﬁxed column chromatography systems [3],
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or their replacement with integrated and/or continuous separation
processes represent increasingly important challenges to solve.
Aqueous two-phase systems (ATPS) have long been regarded as
possible alternatives ever since Albertsson’s classical demonstra-
tion in the mid 1950s [4] of selective partitioning of (bio)molecules
between two  aqueous phases of a mixture of polymers and/or
salts. Aqueous Micellar Two-Phase Systems (AMTPS) introduced
by Bordier [5] some 25 years later differ considerably from clas-
sical ATPS. AMTPS feature non-ionic surfactants which undergo
temperature-induced phase separation resulting in two  phases, i.e.
one ‘micelle-rich’ (or ‘coacervate-rich’) and the other ‘micelle-poor’
[6]. Numerous applications and combinations of phase-forming
polymers have been proposed since the early 1980s for the selec-
tive enrichment of a protein in one of the aqueous phases (also
described as aqueous two-phase extraction, ATPE, or cloud point
extraction, CPE) [6,7]. A striking advantage of ATPE is the ease
with which its operation can be up-scaled and made continu-
ous, and as consequence several process schemes demonstrating
the feasibility of continuous bioprocessing exploiting ATPS [8–10]
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and AMTPS [11,12] have been published within the last decade.
The high cost and loss of phase-forming components in the tar-
get protein-depleted phase represent a signiﬁcant economic hurdle
to overcome, but the main reasons for ATPE’s perceived lack of
viability are that the physical principles underlying the parti-
tioning behavior of a given target protein between the phases
remain unclear; and that very considerable experimental effort
is required to identify an economically attractive system [13].
Afﬁnity-enhanced ATPS were introduced [14] in order to circum-
vent the above issues. In afﬁnity ATPS the phase-forming polymer
is either chemically modiﬁed, or alternatively ligands are ‘intro-
duced’, by one of a variety of ways, into the two-phase system to
enhance the partitioning of a molecule of interest into one of the
two phases [15]. The introduction of ligands into ATPS by adding
functionalized magnetic particles constitutes a particularly attrac-
tive class of afﬁnity-enhanced ATPS [16–18]. The combination of
ATPS with magnetic particles can dramatically enhance the rate
of phase separation following application of an external magnetic
ﬁeld cf. traditional afﬁnity ATPS, provided that the particles parti-
tion strongly into the dispersed phase [19–21].
Previously, in our laboratories we introduced the new concept of
‘Magnetic Extraction Phases (MEPs)’ [22], illustrated by the success-
ful combination of magnetic cation exchange micro-sorbents with
a Triton X-114 based AMTPS, to separate lysozyme from ovalbumin.
Here, sorption of the target molecule, lysozyme, was performed at
a temperature in the single-phase regime (TS). Phase separation
was subsequently induced by raising the temperature (TT, denot-
ing two-phase regime). The protein-loaded particles accumulated
in the micelle-rich phase of the resulting AMTPS and the micelle-
poor phase was removed. In the following step, an AMTPS was
set up using an appropriate elution buffer and the micelle-rich
phase that was obtained post sorption. Previously bound protein
species were desorbed from the particles and partitioned vari-
ously within the AMTPS according to their individual partition
coefﬁcients (K), whilst all of the magnetic sorbent particles moved
into the micelle-rich phase. More recently, we extended the MEP
concept to nano-scaled magnetic sorbents and an AMTPS based
on the non-ionic surfactant, Eumulgin ES [23]. The ‘Eumuglin ES
AMTPS’ represents a signiﬁcant improvement over ‘Triton X-114
AMTPS’. For instance, it simultaneously reduced surfactant costs,
afforded the use of a moderate phase separation temperature,
and importantly, yielded extreme differences in the partition-
ing coefﬁcients of the target protein and the magnetic sorbent
particles. As a direct consequence of extreme K-values, on elu-
tion the target protein partitioned exclusively to the micelle-poor
phase, whereas the magnetic sorbents accumulated entirely in the
micelle-rich phase. The MEP  experiments described above using
the new improved combination (Eumuglin ES AMTPS plus mag-
netic nano-particle sorbents) were performed at laboratory scale.
In this study, we detail the systematic transfer of lab-scale manual
MEP  operation to a technical-scale ‘Continuous Magnetic Extrac-
tion’ (CME) process. We  demonstrate continuous separation of
cation exchange functionalized magnetic nano-particles from the
micelle-poor phase at ﬂow rates of several liters per hour; and sub-
sequently apply CME  for the continuous capture and puriﬁcation
of an antibody fragment from a crude Escherichia coli cell extract.
2. Materials and methods
2.1. Materials
Four different functionalized magnetic particles were employed
in this study. ‘Poly(NIPA-co-AAc)’ particles (200 nm mean diam-
eter by dynamic light scattering), received as a gift from Dr.
Rodica Turcu (National Institute for Research and Development
of Isotopic and Molecular Technologies, NIIMT, Cluj-Napoca,
Romania), featured magnetite cores embedded in a matrix of
poly(N-isopropylacrylamide-co-acrylic acid). ‘MagPrep Silica 25’
and ‘MagPrep SO3 100’ particles were kindly donated by Dr.
Johannes Bauer (Merck KGaA, Darmstadt, Germany). Both parti-
cles comprised magnetite crystals coated with a thin layer of silica,
however, the surface of the latter was  further functionalized with
sulfonate (SO3−) moieties analogous to those commonly employed
for strong cation exchange (CEX) chromatography media. Scanning
electron microscopy revealed single particles of narrow size dis-
tribution, measuring 25 nm and 100 nm across for the base silica
coated and sulfonate derivatized particles respectively. Chemagen
M-PVA-DEAP particles were supplied by PerkinElmer chemagen
Technologie GmbH (Baesweiler, Germany). This material is a spher-
ical beaded ‘polyvinyl alcohol (PVA)-magnetite’ composite of ca.
2 m,  functionalized with diethylaminopropyl (DEAP) groups. The
strong CEX beaded chromatography medium, Fractogel® EMD
SO3 (M)  was  a further donation from Dr. Johannes Bauer (Merck
KGaA, Darmstadt, Germany), and the HiTrap rProtein G column
was from GE Healthcare (Uppsala, Sweden). E. coli strain W3110
expressing the A33 Fab′ [24] and protocols for its cultivation
were acquired from UCB Celltech (Slough, UK) under a Material
Transfer Agreement. The non-ionic surfactant, Eumulgin ES (PPG-
5-Laureth-5, CAS-No.: 68439-51-0), was purchased from Cognis
(Düsseldorf, Germany). The chemicals, sodium tetraphenylborate
(ACS reagent, ≥99.5%), barium chloride (99.9% trace metal basis),
Tris(hydroxymethyl)aminomethane (ACS reagent, ≥99.8%), bicene
(BioXtra, ≥99% by titration), glycine (for electrophoresis, ≥99%),
acetone (≥99.8%), methanol (≥99.9%), glacial acetic acid (ACS
reagent, ≥99.7%), were all obtained from Sigma-Aldrich (St. Louis,
MO,  USA). Phosphate buffered saline (Dulbecco ‘A’ tablets) was
purchased from Oxoid Limited (Basingstoke, UK), disodium hydro-
gen phosphate and sodium chloride were supplied by Carl Roth
(Karlsruhe, Germany) or Sigma–Aldrich, and citric acid mono-
hydrate and Coomassie Brilliant Blue R250 (C.I. 42660) were
from Merck Millipore (Darmstadt, Germany). Pre-cast 15% mini-
PROTEAN® TGXTM gels and Precision Plus ProteinTM All Blue
Standards were supplied by Bio-Rad Laboratories Inc. (Hercules,
CA, USA). Quant-iTTM PicoGreen® dsDNA kit was acquired from
Invitrogen Life Technologies (Carlsbad, CA, USA), and the bicin-
choninic acid (BCA) protein assay kit and bovine serum albumin
(BSA; fraction V powder, ≥96% pure by electrophoresis) were both
obtained from Sigma–Aldrich. All other chemicals not stated above
were from Sigma–Aldrich or Merck Millipore. The water used in all
experiments was  deionized and puriﬁed using a Millipore Milli-Q
Ultrapure system.
2.2. Determination of AMTPS phase diagrams
The location of the curve deﬁning the two-phase and single-
phase regimes within a T−x diagram (where x is the mass fraction
of the surfactant in the mixture) was  determined as follows. Dif-
ferent fractions of surfactant and the corresponding buffers were
weighed into 15 mL  centrifuge tubes. The centrifuge tubes were
tempered in a temperature-controlled water bath (Model RC 20 S,
Lauda Brinkmann, Deran, NJ, USA), and incubated for a minimum of
12 h until complete phase separation had been achieved. After this
period the top and bottom phases of the resulting two-phase sys-
tem were quickly separated and retained for subsequent analysis
of the surfactant concentrations in each phase (see Section 2.9).
2.3. Magnetic extractor for CME
The tailor-made magnetic extractor constructed for the CME
studies described in this work (Fig. 1a) features a separation
chamber, housed within a permanent magnet yoke (627 mm
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Fig. 1. Schematic illustrations of the CME  process and component parts (see text for details) and (b) Finite element simulation of the magnetic ﬁeld generated by the CME
system’s  permanent magnet. The magnet consists of the magnetic ferrite material (M)  and a surrounding pole shoe. A settler can be installed in the space (S), where the
vertical ﬂux density, BY(T) steadily increases towards the upper side, thereby imposing a lifting force on any magnetic particles within ‘S’.
length × 235 mm width × 306 mm height) fabricated by Stein-
ert Elektromagnetbau GmbH (Cologne, Germany). The specially
designed magnet and pole shoe arrangement results in a verti-
cal magnetic ﬁeld component, which steadily increases toward the
upper side of the separator chamber (see Fig. 1b). The above com-
ponents are themselves accommodated in an isolated, temperature
regulated polystyrene case. The inner dimensions of the sepa-
ration chamber are 500 mm (length) × 120 mm (width) × 50 mm
(height), and a 38 mm high ﬁxed weir is installed within it to
give a total liquid volume within the separator chamber of 2.28 L
(500 mm × 120 mm × 38 mm).
2.4. Phase separation experiments
Phase separation velocities within the magnetic extractor were
determined for operation with and without magnetic particles. For
these studies, an AMTPS composed of 10% (w/w)  Eumulgin ES and
90% (w/w) 50 mM sodium citrate, pH 3, poly(NIPA-co-AAc) parti-
cles and a temperature of TT = 30 ◦C were employed. The coacervate
ratio, CR, (deﬁned in the following Section 2.5) was  kept constant
at 0.2, and the feed rate (V˙I) was varied from 0.5 to 25 L/h. The sys-
tem was run at the corresponding ﬂow rate until the volume in the
separation chamber had been exchanged at least twice. Samples
were taken from the top and bottom outlet of the magnetic sep-
arator and analyzed for Eumulgin ES content (see Section 2.9). All
experiments were ﬁrst performed in the absence of the magnetic
particles, and thereafter with poly(NIPA-co-AAc) using the same
set-up and a magnetic particle concentration of 2 g/L.
Long-term continuous operation of the magnetic extractor was
investigated in ‘loop mode’. In this conﬁguration, the exiting top
and bottom phases are re-injected into the tempered stirred tank,
and continuous operation of the magnetic extractor for several
hours without using excessive amounts of material, is possible. The
operational parameters employed for loop mode operation were
as follows: the initial magnetic particle concentration in the stirred
tank was 2 g/L, the total volume of AMTPS was 9 L, the ﬂow rate was
9 L/h, and TS and CR were set to 30 ◦C and 0.33 respectively. Samples
of the initial feed, and the top and bottom phases withdrawn at var-
ious times during operation, were analyzed for magnetic particle
and surfactant contents (see Section 2.9).
2.5. Equations describing CME  performance
The phase separation curve for the above AMTPS was obtained
by plotting the temperature against the surfactant concentrations
determined in the phases after complete phase separation.
The volume fractions of the top (VT) and bottom (VB) phases can
be calculated from the surfactant concentrations according to the
‘lever rule’ [25,26]:
VT
VB
= wS,0 − wS,B
wS,T − wS,0
= R (1)
Here, wS,0, wS,B and wS,T are the surfactant mass fractions of the
phases before and after phase separation, and R is denoted the
‘phase-volume ratio’. During continuous operation of the magnetic
extractor, the phase-volume ratio between the withdrawn top and
bottom phases can be expressed as the pump ratio, P, according to
Eq. (2):
P = V˙T
V˙B
(2)
As shown in Fig. 1a, P is controlled by the feeding rate, V˙I , and
the discharge rate of the bottom phase, V˙B. The amount of liquid
removed by the top efﬂuent is determined by the difference in ﬂow
rates between the inlet and the bottom efﬂuent, and the ratio of the
ﬂow rate leaving the top efﬂuent and the inlet ﬂow rate therefore
is deﬁned as coacervate ratio, CR, (Eq. (3)) with V˙T being the ﬂow
rate of the top phase discharge:
CR =
V˙T
V˙I
= V˙I − V˙B
V˙I
= P
P + 1 (3)
Theoretically, the ideal operation point of the magnetic extrac-
tor should occur when P = R. However, in order to prevent the loss of
target component, particles, and surfactant, the CME  was operated
in a manner that emphasized complete removal of the top phase
rather than preventing contamination of the top phase with traces
of bottom phase. The theoretical minimum CR required (CR,min) to
achieve complete removal of the top phase during CME  operation
was calculated according to Eq. (4):
CR,min≥
R
R + 1 (4)
The CR value employed experimentally was derived from the
theoretical minimum value obtained, but was  adjusted to include
a safety factor of 5–10%.
The rates of removal of magnetic particles and surfactant from
the initial feed during CME  are deﬁned in terms of individual sepa-
ration efﬁciencies for the magnetic particles (SP) and phase-forming
surfactant (SS) according to Eqs. (5) and (6); where the particle and
surfactant concentrations are respectively: cP,I and cS,I in the initial
streams; and cP,B and cS,B in the discharged bottom phases.
SP =
(
1 − V˙B · cP,B
V˙I · cP,I
)
· 100 (5)
SS =
(
1 − V˙B · cS,B
V˙I · cS,I
)
· 100 (6)
2.6. Preparation of crude E. coli extract
Pilot-scale demonstration of CME’s utility for recovery of a
model bioproduct from a realistic biological feedstock (Section
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2.7) and parallel lab-scale chromatographic puriﬁcation experi-
ments (Section 2.8) were conducted using extracts prepared from
fed batch fermented E. coli W3110 cells expressing a recombi-
nant antibody fragment, A33 Fab′ [24] targeted to the periplasm.
Fed batch fermentative production of A33 Fab′ containing cells
was performed in an Electrolab FerMac 300 series reactor (ini-
tial volume = 2 L; ﬁnal volume = 2.28 L) using proprietary methods
originating from UCB Celltech (Slough, UK) and modiﬁed in house.
At the end of cultivation (OD600 nm = 188) the cells (378 g wet
weight) were harvested by centrifugation (11,000 × gav, 0.5 h, 4 ◦C)
in the JA-10 rotor of Beckman Model J2-21 centrifuge (Beckman
Coulter Inc., Brea, CA, USA), before resuspending with 2.28 L of 0.1 M
Tris-HCl buffer, pH 7.4, supplemented with 10 mM EDTA and incu-
bating at 60 ◦C in a water bath. After 16 h the heat permeabilized
cells were removed by low speed centrifugation (3255 gav, 0.5 h,
4 ◦C) in a Jouan C422 bench top centrifuge (SelectScience Ltd., Bath,
UK), to yield a crude extract containing periplasmic species [27,28].
For CME  experiments (Section 2.7) the resulting crude periplas-
mic  extract (conductivity = 21 mS/cm) was simply diluted 10-fold
with 20 mM sodium phosphate buffer, pH 5.6 (yielding a feed with
conductivity of ∼4.3 mS/cm). For chromatographic experiments
(Section 2.8) the crude periplasmic extract was not diluted, but
instead received extensive conditioning to remove troublesome
insoluble and fouling materials (i.e. outer membrane fragments,
lipopolysaccharide and nucleic acids) issued into the extract from
the thermally treated cells, and adjust the pH and/or conductivity
for binding.
2.7. Continuous magnetic extraction of A33 Fab′ from E. coli
extract
An AMPTS consisting of 10-fold diluted crude E. coli periplasmic
extract, 10% (w/w) Emulugin ES, 20 mM sodium phosphate buffer,
pH 5.6, and 1.38 g/L MagPrep SO3 particles was set up in the fol-
lowing way. Emulugin ES (1.47 kg) was ﬁrst mixed with 11.46 L
of 25 mM sodium phosphate buffer in a 50 L double-walled (jack-
eted) glass stirred tank reactor (STR). Three hundred milliliters of a
68 g/L suspension of MagPrep SO3 particles previously equilibrated
in 22 mM sodium phosphate buffer, pH 5.6, was then added to the
vessel. Finally, after 600 s of mixing, the binding step was  initiated
by pouring a 1.47 L portion of crude periplasmic extract into the STR.
In all STR operations the temperature was maintained at TS = 15 ◦C,
and constant stirring at 140 rpm was provided by a PTFE coated 3-
blade impeller (60 mm width × 25 mm height;  ˛ = 45◦) driven by an
overhead mixer (IKA Eurostar digital, IKA-Werke GmbH, Staufen,
Germany) After 900 s of binding in the STR, the resulting mag-
netic particle doped two-phase system was separated by magnetic
extraction (TT = 30 ◦C, CR = 0.2, V˙I = 5 L/h), and the exiting top and
bottom phase streams were collected separately. For the washing
phase, the collected top phase was transferred back into the STR
vessel, were it was mixed with 2 volumes of wash buffer (20 mM
sodium phosphate, pH 5.6) for 900 s, before re-processing through
the magnetic extractor and collecting the separately discharged top
and bottom phase streams. Finally, in the elution step the top phase
leaving the magnetic extractor unit was again transferred into the
stirred tank, and this time mixed with 2 volumes of wash buffer
supplemented with 0.75 M NaCl (so that the ﬁnal NaCl concentra-
tion during elution was 0.5 M).  After 900 s of mixing at 15 ◦C, the
STR contents were subjected to a last round of CME  at 30 ◦C, and
the two discharged phases were collected.
During and after each step in the CME  process, the top and bot-
tom phases were sampled and these were analyzed for magnetic
particle, Eumulgin ES, DNA, total protein and A33 Fab′ contents
(Section 2.9). At the end of each separation when the top phase
discharge ran dry the bottom phase was removed until it started
to cloud, at which point the bottom valve was closed and the
remaining liquor was added into the top phase collection tank.
Prior to conducting the next CME  step, the separation chamber was
ﬂushed with the sodium phosphate buffer solution to displace any
residual particles from the unit back into the STR vessel.
2.8. Chromatography
All chromatography was  done at room temperature using con-
ditioned heat-treated E. coli derived liquors (Section 2.6) and 1 mL
packed beds (diameter ∼7 mm,  bed height ∼25 mm)  in plastic
columns connected to an Äkta Explorer 100 Air chromatography
workstation (GE Healthcare, Uppsala, Sweden). The mobile phase
compositions recommended by Humphreys et al. [29] and Pabst
et al. [30] were employed for Protein G afﬁnity and CEX chromatog-
raphy respectively, and for all chromatographic stages the mobile
phase velocity was  60 mL/h (∼155 cm/h). Prior to application on a
HiTrap rProtein G chromatography column pre-equilibrated with
phosphate buffered saline (PBS), the extract was adjusted to pH
6.6 with 1 M acetic acid, and then clariﬁed by centrifugation at
9391 × gmax and 4 ◦C for 0.75 h in Sigma 3K30 centrifuge (SciQuip
Ltd, Merrington, UK) ﬁtted with type 12150 rotor, followed by ﬁl-
tration through a 0.22 m Millex® GP ﬁlter unit (Merck Millipore,
Nottingham, UK). After loading 30 mL  of extract the column was
sequentially washed with 5 column volumes (CVs) of PBS and then
eluted using 10 CVs of 0.1 M glycine–HCl buffer, pH 2.7. The pH of
eluate fractions was immediately adjusted to neutrality by addition
of 2.5 M Tris base, before storing at 4 ◦C for subsequent analysis by
SDS-PAGE and BCA assay (Section 2.9).
The E. coli extract feedstock employed for CEX chromatography
was prepared by clariﬁcation (9391 × gmax, 0.75 h, 4 ◦C; 0.22 m
ﬁltered) followed by buffer exchange into 20 mM sodium acetate,
pH 5.6. A commercial centrifugal ﬁlter system (Amicon Ultra 15 –
NMWT  10 kDa, Merck Millipore, Nottingham, UK) in a Jouan C422
bench top centrifuge (3255 × gav, 0.5 h, 4 ◦C) was employed for the
buffer exchange step as per the manufacturer’s instructions. Thirty
milliliters of the resulting extract (∼3 mS/cm) was  loaded onto a
packed bed of the Fractogel® EMD  SO3 (M)  matrix previously equil-
ibrated with 20 mM sodium acetate, pH 5.6. After washing with
5 CVs of the same buffer, the column was  developed with linear
gradient of increasing salt (0–1 M NaCl) over 15 CVs. Fractions col-
lected during chromatography were retained for analysis of protein
composition, A33 Fab′ and protein contents (see Section 2.9).
2.9. Analysis
Magnetic ﬁeld simulations were performed using QuickField
5.7 ﬁnite element simulation software (Tera Analysis, Svendborg,
Denmark). The magnetic characteristics of the ferrite material were
supplied by the manufacturer of the magnet (Steinert Elektomag-
netbau GmbH, Cologne, Germany).
Eumulgin ES concentrations were determined using a potentio-
metric end-point method developed for assay of polyoxyethylated
non-ionic surfactants [31], relying on the formation of a pseudo
cationic complex of the polyoxyether moiety with barium ions fol-
lowed by precipitation in the presence of tetraphenyl boronate.
Surfactant concentrations were obtained by comparing recorded
end-point volumes with those obtained from a standard calibration
curve prepared using solutions of known Eumulgin ES concentra-
tion.
The magnetic particle content in samples was determined gravi-
metrically as follows. Magnetic particles in samples were retrieved
from solution with the aid of a powerful permanent bar magnet.
The supernatants were carefully removed and the particles were
washed sequentially once with 15 mL  of methanol and twice with
15 mL  of water. In between each wash, the ‘particle/solution’ mix-
tures were subjected to magnetic separation and the supernatants
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were carefully discarded. The magnetic particles were then resus-
pended with 1 mL  of water, transferred to pre-weighed glass HPLC
vials and dried in an oven at 60 ◦C for at least 16 h. After cooling
to room temperature in a dessicator jar, the vials were re-weighed
and the amount of support particles in each sample was calculated
from the change in weight of the vial.
Protein content in samples was determined using a micro BCA
assay kit (Pierce, Rockford, IL, US) adapted for use with a Cobas Mira
Plus automatic robotic station (Roche Diagnostics, Switzerland).
To eliminate the inﬂuence of Eumulgin ES on the BCA assay and
SDS-PAGE, it was removed from samples in a prior protein pre-
cipitation step. Ice cold 100% (w/v) trichloroacetic acid was added
to samples (and BSA protein standards) to a ﬁnal concentration
of 15% (w/v), and mixed on a vortex mixer before incubating on
ice for 0.5 h. The resulting protein precipitates were recovered by
centrifuging in a microfuge, and then decanting the supernatants,
washing the pellets twice with ice cold acetone and ﬁnally drying
in a centrifugal vacuum concentrator (5301 Vacufuge, Eppendorf,
Hamburg, Germany).
The protein compositions of fractions were analyzed by reduc-
ing SDS-PAGE [32] in 15% (w/v) pre-cast polyacrylamide gels in a
Mini-Protean® Tetracell electrophoresis system (Bio-Rad Labora-
tories, Hercules, CA, USA). After electrophoresis, gels were stained
with 0.1% (w/v) Coomassie Brilliant Blue R250, dissolved in 40%
(v/v) ethanol and 10% (v/v) acetic acid) for 1 h at room tempera-
ture, and were subsequently destained at the same temperature in
a solution composed of 7.5% (v/v) acetic acid and 10% (v/v) ethanol.
The A33 Fab′ content was determined by densitometric analysis
of scanned TIFF images of appropriately loaded Coomassie Blue
stained gels following electrophoresis. The images were captured
with an HP ScanJet C7716A ﬂat bed scanner (Hewlett-Packard Com-
pany, Palo Alto, CA, USA) at a resolution of 2400 dpi, and analyzed
using ImageJ software [33]. Samples and rProteinG afﬁnity chro-
matography puriﬁed A33 Fab′ standards were loaded on the same
gels. A linear correlation between 33 Fab′ applied and band inten-
sity was found in the range 0.1–1 g A33 Fab′; hence, the volumes
of samples applied to gels for ‘densitometry’ were adjusted to fall
within this range.
DNA contents were determined using a commercial ﬂuores-
cence based assay (Quant-iTTM PicoGreen® dsDNA kit) in 96-well
plate format with an Ascent Fluoroskan Fluorometer (Thermo Lab-
systems, Waltham, MA,  USA) employing excitation and emission
wavelengths of 480 nm and 535 nm respectively.
3. Results and discussion
3.1. Apparatus for CME
CME  employs a novel magnetic extractor set-up, the principle of
which is illustrated in Fig. 1a. At the set-up’s core is a temperature-
controlled magnetic ﬁeld enhanced mixer-settler. In the mixer,
sorption of the target molecule to the magnetic sorbent occurs at a
temperature, TS, at which the ﬂuid forms a single phase. In the fol-
lowing continuous settler, the AMTPS is heated up to a temperature,
TT, at which point the ﬂuid forms two phases. For phase separation,
the ﬂuid is pumped into a separation chamber surrounded by a spe-
cially designed permanent magnet, which is itself located within
the interior of a sealed polystyrene case containing a temperature-
controlled heater that functions to maintain the temperature at TT.
Micellar droplets doped with magnetic nano- or micro-particles
form as ﬂuid passes through the reactor. The external magnetic ﬁeld
generated by the permanent magnet simultaneously enhances:
(i) the migration velocity of these micellar droplets; (ii) initial
droplet coalescence; and (iii) coalescence at the inter-phase of the
two-phase system. Finally, a particle-free micelle-depleted bottom
Fig. 2. Phase diagrams (co-existence curves) for 10% (w/w) Eumulgin ES-based
AMTPS in water (), 50 mM sodium phosphate buffer pH 7.0 (©), 50 mM sodium
citrate buffer, pH 3 (), 50 mM bicene buffer, pH 8.8 (), E. coli extract diluted with
20  mM sodium phosphate buffer pH 5.6 ().
phase is discharged from the lower efﬂuent of the separation cham-
ber, while a micelle and particle-enriched phase is withdrawn from
the upper efﬂuent.
3.2. Physico-chemical and hydrodynamic characterization
Fig. 2 illustrates the phase diagram for 10% (w/w) Eumulgin ES-
based AMTPS concocted with various solutions. The similarity of
the plots is striking. The inﬂuence of pH (between 3 and 8.8) on
Eumulgin ES AMTPS phase transition appears negligible over the
studied range of temperature (25–40 ◦C). Further, the impact of pro-
teins and other suspended species within the extract on Eumulgin
ES AMTPS phase transition also appears to be small. In view of the
transition point from the single-phase to the two-phase regime
of ca. 26 ◦C the application of CME  with the present Eumulgin ES
based AMTPS for thermo-labile proteins may  appear challenging. It
should be noted however, that doping the AMPTPS with additional
components (e.g. various salts) can drastically reduce the phase
transition temperature [6]; thereby creating a much ‘friendlier’
environment for more temperature-sensitive proteins.
Important process parameters, R and CR,min can be derived from
the phase diagrams (Fig. 2) and Table 1 shows the calculated val-
ues for an 10% (w/w)  Eumulgin ES based AMTPS in 50 mM sodium
citrate buffer pH 3. For complete top phase removal at 30 ◦C a
minimum CR of 0.19 is required. The phase separation efﬁciency
of the Eumulgin ES-based AMTPS during operation of the CME
process was initially monitored in the absence of magnetic par-
ticles, by analyzing the surfactant’s distribution within the top
and bottom-phase efﬂuents as a function of feed ﬂow rate. In
these runs the Eumulgin ES concentration of the feed was 9.6%
(w/w), and the phase separation temperature and CR were set
to 30 ◦C and 0.2, respectively. Fig. 3 shows the results obtained.
When operated ﬂow rates exceeding 15 L/h no phase separation is
Table 1
Volume ratio (R) and minimum coacervate ratio (CR,min) for a 10% (w/w) Eumulgin
ES-based AMTPS in 50 mM sodium citrate buffer, pH 3. The values were calculated
using Eqs. (1) and (4).
Temperature (◦C) Volume ratio, R Minimum coacervate
ratio, CR,min
29 0.27 0.22
30 0.23 0.19
35 0.16 0.14
40 0.14 0.12
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Fig. 3. Eumulgin ES phase separation in the magnetic extractor during continuous
operation at different ﬂow rates in the absence (©,) and the presence (,) of 2 g/L
poly(NIPA-co-AAc) magnetic particles. The bottom and top phase concentrations are
indicated by open symbols and ﬁlled black symbols respectively.
observed; both streams exit the separator with Eumulgin ES con-
centrations practically equal to that of the feed. But as the ﬂow rate
is reduced from 15 L/h, phase separation starts to occur. For exam-
ple, an approximate halving in ﬂow rate results in top and bottom
phase concentrations of ∼21% (w/w) and ∼4% (w/w)  respectively.
At steady state the maximum top phase and minimum bottom sur-
factant concentrations achievable, of ∼32% and ∼0.7% respectively,
are reached at ﬂow rates of ≤2 L/h.
The beneﬁts of incorporating magnetic particles in the Eumulgin
ES AMTPS are strikingly illustrated (Fig. 3). In this case phase sep-
aration is evident even at a ﬂow rate of 17 L/h, and maximum
phase separation is attained at ca. 9 L/h (surfactant concentrations
in the top and bottom phase of 38% and 0.7% respectively). The
‘seeding’ of magnetic particles partitioning exclusively to the dis-
persed micellar droplets of the nascent two-phase system makes
the droplets strongly susceptible to manipulation from an exter-
nally applied magnetic ﬁeld. In the present system the magnetic
force acts upwards (see Fig. 1b) to enhance the lift or ﬂotation veloc-
ity of the ‘magnetic’ droplets. A further gain from the inclusion
of magnetic particles is the increased rate of droplet coalescence
observed; a direct consequence of which is that the maximum sur-
factant concentration in the micelle-rich top phase rises from 32%
to 38% (see Fig. 3).
However, in both continuous AMTPS extraction processes (i.e.
traditional and magnetic particle doped), the maximum Eumulgin
ES concentration in the top phase, at a phase separation tempera-
ture of 30 ◦C, was much lower than that obtained from the phase
diagram (i.e. ∼50%; Fig. 2). These differences for continuous extrac-
tion most likely reﬂect incomplete phase separation. In batch mode
‘Eumulgin ES AMTPS’ experiments, complete phase separation gen-
erally occurs within 16–20 h. In the magnetic extractor by contrast,
the maximum residence times are just 55 min  when operated with
magnetic particles, and 5 h in their absence.
Complete closing of the mass balance for the surfactant exiting
the extractor against that entering it was not possible, especially
at low ﬂow rates in the absence of magnetic particles where the
lowest mass balance recorded was 67%. The most likely reason
for this is that the micelle-rich top phase accumulates in the
reactor in front of the weir. Much better closure of the surfac-
tant mass balance was achieved when the magnetic particles are
introduced into the AMTPS; presumably because the applied mag-
netic ﬁeld helps to ‘lift’ the magnetic particle-doped surfactant-rich
phase over the weir. Nevertheless, ca. 8% of the surfactant enter-
ing the CME  remained unaccounted for. An investigation into the
long-term stability of CME’s phase separation performance over
several hours (i.e. loop mode operation) was therefore performed,
and the Eumulgin ES and the particle concentrations in the feed and
exiting top and bottom phases were monitored throughout. Fig. 4a
shows how particle concentrations within the injected feed and
the top and bottom phases vary during 2.7 h of continuous oper-
ation. The magnetic particles are continuously separated from the
feed; the particles are concentrated ca. 3.5-fold (relative to the ini-
tial feed) to a value of ∼7 g/L within the micelle-rich top phase
of the system and the clariﬁed bottom phase is discharged with a
very low constant particle concentration of just 0.02 g/L (i.e. equiv-
alent to 1% of the feed value). Also striking is that the injected
particle concentration remained at the initial feed value of 2 g/L
throughout operation. Given that the efﬂuents leaving the magnetic
extracted are recycled back into the stirred feed tank, during long-
term experiments any tendency for particles to build up within
the separation chamber would result in a reduced particle concen-
tration in the efﬂuent, and consequently therefore, dilution of the
recycled feed. Clearly, particles are not held back and accumulated
within the reactor, but are instead continuously discharged from
it. Matching continuous operation data illustrating variance of the
phase-forming surfactant concentrations within the feed, top and
bottom phases is presented in Fig. 4b. Here again, the Eumulgin ES
concentrations of the initial feed and both exiting leaving streams
remain constant over the whole 2.7 h of operation. The initial feed
concentration of 10% (w/w)  Eumulgin ES is steadily separated so
that the concentrations of surfactant in the discharged bottom and
top phases are respectively 0.9% and 29% (w/w). As the CR value
(Eqn. 3) employed in these long-term recycle studies was 0.33, the
surfactant mass balance closed to practically 100%.
In addition to the 200 nm sized poly(NIPA-co-AAc) magnetic
sorbent particles described thus far, we have tested various other
magnetic particle materials in the CME  set-up. An illustration of
this is shown in Table 2 which presents the particle separation
efﬁciencies obtained in experiments conducted with four differ-
ent magnetic particles seeded into Eumulgin ES based AMTPS at a
concentration of 2 g/L. Separation of the two largest functionalized
magnetic particles, i.e. the 200 nm cation exchanger (poly(NIPA-
co-AAc)) and 2 m anion exchange sorbent (M-PVA-DEAP), was
achieved at a ﬂow rate of 9 L/h with >99% efﬁciencies. For the
smaller ‘MagPrep’ materials (25 and 50 nm), maintenance of high
particle separation efﬁciency (>95%) required reduction in the oper-
ating ﬂow rate to 5 L/h. This aside, the data conﬁrm CME  as a
versatile process being able to function with a wide range of differ-
ent magnetic particle sizes (25–2000 nm)  and surface chemistries.
3.3. Continuous magnetic extraction of an antibody fragment
from an E. coli extract
To demonstrate ‘proof-of-concept’, i.e. the feasibility of contin-
uous magnetic extraction of proteins at liter scale, the technique
was applied for the recovery of an industrially relevant antibody
fragment (A33 Fab′) from a crude E. coli periplasmic extract.
The extract was  prepared by incubating freshly grown E. coli
cells containing A33 Fab′ in a buffer held at 60 ◦C for 16 h to
release the periplasmic contents. The fundamental basis for this
periplasmic release method was  ﬁrst reported >30 years ago by
Katsui et al. [27] who  observed ‘blebbing’ and vesiculation of the
outer membrane (exclusively), which increased the latter’s perme-
ability and led to selective release of periplasmic contents. While
inappropriate for thermolabile products, extended thermally medi-
ated release treatments appear well suited to antibody products,
because removal of partially degraded and/or incorrectly folded
antibodies from soluble correctly folded ones is facilitated [28].
A 10% (w/w) Eumulgin ES AMPTS seeded with MagPrepSO3 par-
ticles (1.4 g/L) was  used and the feed ﬂow rate was set to 5 L/h to
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Fig. 4. Continuous separation of (a) magnetic particles and (b) phase-forming surfactant in the magnetic extractor at a ﬂow rate of 9 L/h. The feed contained initial particle
and  surfactant concentrations of 2 g/L and 10% (w/w) respectively. Key: initial feed (ﬁlled gray symbols), bottom phase (open symbols) and top phase (ﬁlled black symbols).
guarantee complete particle separation (Table 2). Additional pro-
cess parameters for CME  were identiﬁed from a phase diagram
constructed using 10% (w/w) Emulgin ES and the A33 Fab′ contain-
ing E. coli extract diluted 10-fold with 20 mM sodium phosphate
buffer, pH 5.6. As noted earlier (Fig. 2) the similarity of the resulting
diagram to those obtained in water and buffered systems conﬁrmed
that the impact of proteins and other suspended species within the
extract on Eumulgin ES AMTPS phase transitions was  negligible.
After 600 s of adsorption in the STR at TS = 15 ◦C the temper-
ature of the feed was raised to 30 ◦C (TT) by means of a heat
exchanger while being pumped into the separation chamber. At this
temperature the single dispersed phase split into two constituent
phases. Protein-laden magnetic CEX particles became enriched in
the micelle-rich top phase leaving the separation chamber, while
unbound host cell proteins and other non-binding species present
in the extract exited in the micelle-poor bottom phase.
In the subsequent washing step, the micelle-rich top phase con-
taining ‘protein-loaded’ magnetic particles was mixed with two
volumes of 20 mM sodium phosphate buffer, pH 5.6, for 900 s and
then separated again by magnetic extraction, to remove entrained
E. coli derived contaminants carried over in the top phase from
the initial adsorption step. Finally, recovery of A33 Fab′ from the
MagPrepSO3 rich top phase was achieved by mixing with two  vol-
umes of binding buffer supplemented with 0.75 M NaCl (bringing
the NaCl concentration to 0.5 M),  and once again subjecting to
magnetic extraction. In this step, the micelle-poor bottom phase
now contained the eluted target species, and the ‘eluted’ magnetic
sorbent particles and the majority of the surfactant were discharged
in the top phase.
The compositions of the initial feed and the bottom discharged
phases arising from each step in the CME  puriﬁcation process are
presented in Table 3. During CME  processing the total volumes
issuing from the each consecutive step fell progressively from an
initial 14.7 L to a ﬁnal <5.1 L. The trace levels of magnetic particles
in all exiting bottom phases (1–17 mg/L) provide striking evidence
for virtually exclusive partitioning of magnetic particles into the
top phase. The concentrations of Eumulgin ES, DNA, protein and
Fab′ carried over into the ﬁnal eluate were 0.34% (w/w), 0.34 mg/L,
147 g/L and 145 g/L respectively, representing mass recover-
ies in this fraction of just 1.1 and 1.2% for DNA and Emulgin ES,
10.6% for protein and 66.7% for the target species, A33 Fab′. Mass
balances of all relevant species (A33 Fab′, total protein, DNA, parti-
cles, surfactant) were calculated by adding together the masses of
each component in all exiting bottom phases and the discharged
eluate top phase and comparing the summated values with the ini-
tial masses supplied in the feed (Table 3). The low mass balances
observed for total protein and DNA likely stem, at least in part, from
incomplete desorption of both biopolymer types from the magnetic
carrier particles. Support for this contention comes from reducing
SDS-PAGE analysis of supernatants obtained after boiling supports
in sample buffer, which conﬁrmed the presence of several charac-
teristic E. coli outer membrane proteins [34–36], but no A33 Fab′.
By contrast, the total A33 Fab′ mass accounted for was  signiﬁcantly
overemphasized; most likely arising from exaggerated assay of the
Table 2
Magnetic particle tested in the CME  set-up and achieved separation efﬁciencies.
Magnetic support (Manufacturer) Description of particle materials Mean size
(nm)
Flow rate
(L/h)
Separation
efﬁciency (%)
MagPrep Silica 25 (Merck KGaA) Magnetite crystals coated with a thin layer of silica 25 5 >95
MagPrep SO3 100 (Merck KGaA) Magnetite crystals coated with a thin layer of silica
and then functionalized with sulfonate moieties
100 5 >99
Poly(NIPA-co-AAc) (NIIMPT, Romania) Magnetite embedded within a
poly(N-isopropylacrylamide-co-acrylic acid)
matrix
200 9 >99
M-PVA-DEAP (PerkinElmer chemagen
Technologie GmbH)
Spherical beaded polyvinyl alcohol – magnetite
composite particle functionalized with
diethylaminopropyl groups
2000 9 >99
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Table 3
Summary of the volumes and concentrations of the bottom phases resulting from conducting the sorption, wash and elution steps in the CME.
Process step Volume (L) Magnetic support (g/L) Eumulgin ES (% w/w)  DNA (mg/L) Total protein (g/L) A33 Fab′ (g/L)
Initial Solution 14.723 1.380 10.00 10.43 0.480 0.075
Post-sorption 11.39 0.006 2.83 7.08 0.178 0.029
Washing 7.773 0.017 1.67 3.82 0.072 0.021
Eluate  5.082 0.001 0.34 0.34 0.147 0.145
Mass  balance (%)a – 115 67 74 52 133
a The sum of the mass ﬂow of all bottom phases and the eluate top phase was compared to the initial mass ﬂow in the feed.
Table 4
Impact of feedstock conditioning on extract composition and Fab′ yield prior to chromatography. See text for details.
Sequential conditioning step Volume (L) Fab′ (mg) Protein (mg) Fab′ purity (%) Protein yield (%) Fab′ yield (%) PFa
None 0.2 150 960 15.6 100 100 1.0
pH  adjustment (Protein G only) 0.2 – – – – – –
Centrifugation (± prior pH adjustment) 0.2 150 761 19.7 79.3 100 1.26
0.22  m ﬁltration 0.2 136 686 19.8 71.5 90.7 1.27
Buffer  exchange (CEX only) 0.2 74.5 371 20.1 38.6 49.7 1.29
a PF = puriﬁcation factor.
Fab′ contents of the bottom phase unbound and wash fractions and
top phase elution fraction by scanning densitometry. The presence
of residual Fab′ in the bottom phase post adsorption (Table 3) con-
ﬁrms that not all of the Fab′ had been removed from the extract.
This loss in target yield is not due to magnetic extraction process
per se, but instead to the use of insufﬁcient quantities of particles
in the process. In addition to increasing the total magnetic sorbent
particle concentration in the system, employing a higher capacity
sorbent particle would guarantee improved binding performance.
Visual evidence for the successful puriﬁcation of A33 Fab′ by CME
is provided in Fig. 5. Potential improvements aside, comparison of
lanes 2 (starting feed) and 4 (the ﬁnal eluate) clearly demonstrates
that, even in its unoptimized state, CME  can deliver a high level
of target puriﬁcation. In the present example, comparison of the
Fig. 5. Reducing SDS-PAGE analysis of fractions from CME  based puriﬁcation of A33
Fab′ from a crude E. coli periplasmic extract. Key: lane 1 – Molecular weight markers;
lane 2 – crude periplasmic extract; lane 3 – rProtein G puriﬁed A33 Fab′; lane 4 –
bottom phase eluate.
compositions of the feed and exiting elution fraction shows mag-
netic particle and Eumulgin ES removals of >99.9% and >98%
respectively, combined with depletion of >95% of the total host
cell protein and >98% of DNA, leading to a ﬁnal A33 Fab′ purity
of >98% and yield of 67%. Further, the A33 Fab′ binding capacity of
the MagPrep SO3 sorbent in the process was >36 mg/g.
3.4. Benchmarking
The initial feedstocks for CME  and chromatography received
very different pretreatments. During preparation of the AMTPS for
CME  the heat treated E. coli extract was effectively diluted 10-
fold with sodium phosphate buffer, pH 5.6, but received no further
clariﬁcation (see Sections 2.6 and 2.7). Thus, the feedstock though
essentially cell free still contained ﬁne suspended solids (espe-
cially ﬁne cell envelope debris) and other troublesome species (e.g.
nucleic acid polymers) that had issued from the cells during heat
treatment. Extracts for rProtein G and CEX chromatography were
not diluted, but instead received extensive pretreatment to remove
potential column fouling materials, and adjust the pH and/or con-
ductivity for binding (see 2.8). The initial A33 Fab′ purity increased
from 15.6% to nearly 20% (Table 4) in the common high speed cen-
trifugation step (∼9400 × gmax for 0.75 h) as >20% of total protein
was removed (speciﬁcally outer membrane species) without loss
in Fab′, regardless of whether the extract had received prior pH
adjustment (for Protein G afﬁnity only). The subsequent 0.22 m
ﬁltration step immediately prior to Protein G afﬁnity chromatog-
raphy saw small l losses in both total protein and Fab′, but the Fab′
purity (19.8%) was not impaired. Because of the high ionic strength
of the periplasmic extract, a diaﬁltration step was necessary prior
to CEX chromatography on Fractogel EMD  SO3. A centrifugal buffer
exchange step was employed for this, and substantial and indis-
criminate step losses of ∼45% of the total protein and A33 Fab′ were
experienced. Collectively, the numerous conditioning steps neces-
sary to prepare the extracts for chromatography, while improving
initial Fab′ purity (from 15.6 to 20%), resulted in overall losses of
A33 Fab′ yield of ∼10% prior to Protein G afﬁnity and >50% before
CEX chromatography. The lack of need for expensive, extensive and
‘yield compromising’ feedstock conditioning steps prior to sorption
represents a key advantage of direct capture techniques, such as
CME. How CME  based puriﬁcation compares with Protein G afﬁn-
ity and CEX chromatography in packed bed columns is shown in
Table 5. The benchmarking was  done at much reduced scale cf. CME,
using 30 mL  volumes of conditioned extracts applied to 1 mL beds
of rProtein G Sepharose HP and EMD  Fractogel EMD  SO3.
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Table 5
Comparison of CME  with conventional adsorption chromatography for the recovery of A33 Fab′ from E. coli extracts. See text for details.
Method (adsorbent) Feedstock Eluate
Conditioning history (pH, ) Volume (L) Fab′
(mg)
Protein
(mg)
Initial Fab′
purity (%)
Final Fab′
purity (%)
Fab′ step
yield (%)
Step
PFa
CME  (MagPrepSO3 100) 10× diluted with buffer (pH 5.6,  = 4.3 mS/cm) 14.72 1104 7067 15.6 98 67 6.3
Afﬁnity chromatography
(rProtein G Sepharose HP)
pH adjusted, centrifuged and 0.22 m ﬁltered
(pH 6.6,  = 17 mS/cm)
0.03 20.4 102.9 19.8 100 20 5.1
CEX  chromatography
(Fractogel EMD  SO3)
Centrifuged, 0.22 m ﬁltered, buffer
exchanged (pH 5.6;  = 2.9 mS/cm)
0.03 11.2 55.7 20.1 95 97 4.7
a PF = puriﬁcation factor.
The rProtein G Sepharose column was challenged with extract
containing 103 mg  of total protein, of which 20.4 mg  was  A33 Fab′.
More than 80% of total protein and >56% of the Fab′ applied passed
through the column in the ﬂowthrough fraction, and a further 15%
of total protein and >23% of the Fab′ eluted during washing prior
to elution. Bound A33 Fab′ was desorbed from the column using a
pH step gradient. Approximately 4 mg  of the Fab′ was  recovered in
3.3 CVs in a highly puriﬁed state, i.e. 100% by scanning densitom-
etry (Fig. 5, lane 2); corresponding to an overall target recovery of
just 20% (Table 5), and binding capacity of 4.1 mg  Fab′ per mL  of
sorbent.
For CEX chromatography, owing to heavy losses incurred in
preparing the extract for CEX (Table 4), the diaﬁltrated periplas-
mic  extract (30 mL)  loaded on to the column contained a reduced
challenge of ∼56 mg  of total protein and 11.3 mg  A33 Fab′. Seventy
percent of the total protein was accounted for in the ﬂow-through
fraction, but only 2.3% of the Fab′ was lost. Evidently the capac-
ity of the Fractogel EMD  SO3 matrix for A33 Fab′ from conditioned
periplasmic extract under the binding conditions employed (pH 5.6,
 = 3 mS/cm) was not challenged in this study. After washing, the
column was developed with a linear salt gradient. Ninety-seven
percent (11.0 mg)  of the Fab′ was detected in the elution peak
(eluted in 5 CVs between 0.2 and 0.5 M added NaCl) with a purity
of 95.4% (Table 5).
Though direct comparisons of CME  with chromatography are
made difﬁcult by the different levels of feedstock conditioning
received in each case, it is nevertheless clear from Table 5 that the
CME  process compares very favorably with Protein G afﬁnity and
CEX chromatography in terms of Fab′ purity and yield. Moreover,
the advantages of CME  over chromatography are further enhanced
when the losses in Fab′ yield during extract conditioning (Table 4)
are taken into account. The same sulfonate ligand was used for
CEX chromatography and CME. It is interesting to note, therefore,
that despite CME’s lack of multiple stages, the technique deliv-
ered comparable or even higher purity (98% cf. 95.4%; Table 5).
Possible differences in surface properties of the MagPrepSO3 and
Fractogel EMD  SO3 sorbents aside, a further potential explana-
tion for the higher purity observed in the CME  process is the
virtually complete exclusion of freely dissolved proteins from the
micelle-rich phase. The use of anionic sulfonate ligands in both pro-
cesses dictates that measures to reduce the ionic strength of the
periplasmic feedstock are mandatory. Here, for traditional ﬁxed-
bed CEX chromatography diaﬁltration, was employed (seriously
impairing Fab′ yield; Table 4), but for the CME  process this time-
consuming step was rejected in favor of simple dilution, given
that the extraction set-up could easily handle large volumes of
partially clariﬁed feed. The high salt concentration of the original
crude periplasmic extract ( = 21 mS/cm) presented no problems
to Protein G afﬁnity chromatography, but the presence of sus-
pended solids and fouling materials necessitated subjecting the
extract to extensive clariﬁcation beforehand, which compromised
Fab′ yield (Table 4); the low capacity (4 mg/mL) and expense of the
rProtein G derivatized chromatography matrix are further detrac-
tions.
Table 6
Comparison of surfactant concentrations in the bottom phase during CME  operation
and  after discharging the separator.
Process step [Eumulgin ES] (% w/w)
During operation After discharging
the separator
Binding 0.9 2.8
Washing 1.0 1.7
Elution 0.2 0.34
3.5. Review of the recyclability of the CME components –
surfactants and magnetic sorbent particles
Reuse of the phase-forming component of an AMTPS is one strik-
ing advantage of AMTPS, over conventional ATPS. This is because it
is only the micelle-depleted phase that is removed or discharged
during all steps, i.e. sorption, washing and elution. In the case of
CME, the micelle-rich top phase contains magnetic particle sor-
bents; which at end of the elution step can be re-cycled back
into the next sorption stage, and so on. In order to calculate the
theoretical amount of the recyclable phase-forming component,
Eumulgin ES, samples of micelle-depleted bottom phases from
the binding, washing and elution steps were removed during the
continuous operation of the CME  device for off-line analysis of
surfactant, concentration. Table 6 compares the surfactant concen-
trations measured under continuous mode with those immediately
after ﬁnishing the individual processing steps and discharging the
separator contents into the collection tank. For all processing steps
the Eumulgin ES concentrations are signiﬁcantly higher (1.7- to
3.1-fold) after ﬁnishing each process step and discharging the
separator, and are related to the ratio of volumes of the CME  sep-
aration chamber (2.8 L) to that of the ﬂuids processed through
it (6.8–14.7 L). After complete processing of the feedstock, the
CME separation chamber must be drained. During this operation,
incomplete phase separation results in higher losses of surfactant
cf. continuous mode. The problem of incomplete phase separa-
tion during drainage could be reduced by using an adjustable
weir, which follows the phase boundary during the process. An
adjustable weir could additionally aid optimization of the CME  set-
up for different CR values. However, for large feed volumes or truly
continuous operation, the impact of surfactant that is lost during
this drainage would be insigniﬁcant; thus values indicated in the
left hand column (‘During operation’) of Table 6 are more pertinent
to CME.
The amount of recyclable surfactant, i.e. that which can be
recycled from the top phase arising from the elution step into a
subsequent sorption cycle, was  calculated (from the loss of sur-
factant in the bottom phases during the continuous operation of
the magnetic extraction) to be 87%. Further, the total particle loss
after binding, washing and elution amounted to only ∼1% of the
initial amount used, leaving the remaining 99% available for use in
a subsequent cycle of CME. In summary, effective reuse of both the
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phase-forming surfactant and magnetic sorbent particles is clearly
achievable in CME  based processes.
4. Conclusions
Continuous Magnetic Extraction (CME) has been introduced as a
promising and potentially low cost continuous bioseparation pro-
cess. It is based on the concerted use of functionalized magnetic
sorbent particles together with AMTPS. Magnetic sorbents which
partition exclusively to the micelle-rich phase of an AMTPS are sep-
arated in a novel pilot-scale extractor comprising a mixer and a
magnetic ﬁeld-enhanced ﬂow-through phase separator. We  have
demonstrated that this CME  device can be operated at ﬂow rates of
several liters per hour, at close to ambient temperatures (15–30 ◦C),
with particle separation efﬁciencies of >99%. Further, the phase-
forming non-ionic surfactant employed in this work, Eumulgin
ES, was continuously split into micelle-rich and micelle-depleted
phases with a separation efﬁciency of >98%.
Subsequently, CME  was successively applied for the direct
capture of the antibody fragment A33 Fab′ from a crude E. coli
periplasmic extract, employing CEX functionalized magnetic nano-
particle sorbents. Nearly 70% of the A33 Fab′ initially present was
recovered in the magnetic particle-free bottom phase eluate in
2-fold concentrated form with a purity of >98%, corresponding
to a puriﬁcation factor of 6.3. The corresponding top phase elu-
ate stream contained the magnetic sorbent particles and most of
the phase-forming surfactant. In CME  magnetic nano-particle sor-
bents were recovered with a recycling efﬁciency of >99% over three
consecutively operated extractions, during which 13% of the phase-
forming surfactant was lost. The remaining 87% of phase-forming
surfactant was collected together with the magnetic sorbents par-
ticles after the ﬁnal elution step. Clearly therefore, recycling both
the magnetic sorbents and the phase-surfactant particle into sub-
sequent rounds of CME  is highly feasible. Taken collectively, the
results of this study identify CME  as a viable means of performing
continuous puriﬁcation of target macromolecules from complex
biological feedstocks at relatively low cost.
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